
<html lang="en"     class="pb-page"  data-request-id="da5c015b-77ce-46b4-94e4-741b9e5b6c25"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.6b00516;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2016.59.issue-16;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain" /></meta><meta name="dc.Creator" content="Herbert H.  Seltzman" /></meta><meta name="dc.Creator" content="Craig  Shiner" /></meta><meta name="dc.Creator" content="Erin E.  Hirt" /></meta><meta name="dc.Creator" content="Anne F.  Gilliam" /></meta><meta name="dc.Creator" content="Brian F.  Thomas" /></meta><meta name="dc.Creator" content="Rangan  Maitra" /></meta><meta name="dc.Creator" content="Rod  Snyder" /></meta><meta name="dc.Creator" content="Sherry L.  Black" /></meta><meta name="dc.Creator" content="Purvi R.  Patel" /></meta><meta name="dc.Creator" content="Yatendra  Mulpuri" /></meta><meta name="dc.Creator" content="Igor  Spigelman" /></meta><meta name="dc.Description" content="Alleviation of neuropathic pain by cannabinoids is limited by their central nervous system (CNS) side effects. Indole and indene compounds were engineered for high hCB1R affinity, peripheral select..." /></meta><meta name="Description" content="Alleviation of neuropathic pain by cannabinoids is limited by their central nervous system (CNS) side effects. Indole and indene compounds were engineered for high hCB1R affinity, peripheral select..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 10, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00516" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00516" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00516" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00516" /></link>
        
    
    

<title>Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00516" /></meta><meta property="og:title" content="Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0009.jpeg" /></meta><meta property="og:description" content="Alleviation of neuropathic pain by cannabinoids is limited by their central nervous system (CNS) side effects. Indole and indene compounds were engineered for high hCB1R affinity, peripheral selectivity, metabolic stability, and in vivo efficacy. An epithelial cell line assay identified candidates with &lt;1% blood–brain barrier penetration for testing in a rat neuropathy induced by unilateral sciatic nerve entrapment (SNE). The SNE-induced mechanical allodynia was reversibly suppressed, partially or completely, after intraperitoneal or oral administration of several indenes. At doses that relieve neuropathy symptoms, the indenes completely lacked, while the brain-permeant CB1R agonist HU-210 (1) exhibited strong CNS side effects, in catalepsy, hypothermia, and motor incoordination assays. Pharmacokinetic findings of ∼0.001 cerebrospinal fluid:plasma ratio further supported limited CNS penetration. Pretreatment with selective CB1R or CB2R blockers suggested mainly CB1R contribution to an indene’s antiallodynic effects. Therefore, this class of CB1R agonists holds promise as a viable treatment for neuropathic pain." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00516"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00516">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00516&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00516&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00516&amp;href=/doi/10.1021/acs.jmedchem.6b00516" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 16</span><span class="cit-fg-pageRange">, 7525-7543</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/16" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00566" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00598" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Herbert+H.++Seltzman">Herbert H. Seltzman</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Craig++Shiner">Craig Shiner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Erin+E.++Hirt">Erin E. Hirt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anne+F.++Gilliam">Anne F. Gilliam</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+F.++Thomas">Brian F. Thomas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rangan++Maitra">Rangan Maitra</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rod++Snyder">Rod Snyder</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sherry+L.++Black">Sherry L. Black</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Purvi+R.++Patel">Purvi R. Patel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yatendra++Mulpuri">Yatendra Mulpuri</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Igor++Spigelman">Igor Spigelman</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Center for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Division of Oral Biology & Medicine, School of Dentistry, University of California, 10833 Le Conte Avenue, 63-078 CHS, Los Angeles, California 090095-1668, United States</span></div><div class="corresp-info"><strong>*</strong>For H.H.S.: phone, 919-541-6690; E-mail, <a href="/cdn-cgi/l/email-protection#dcb4b4af9caea8b5f2b3aebb"><span class="__cf_email__" data-cfemail="c0a8a8b380b2b4a9eeafb2a7">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For I.S.: phone, 310-825-3190; fax, 310-794-7109; E-mail, <a href="/cdn-cgi/l/email-protection#7b121c14093b0e18171a551e1f0e"><span class="__cf_email__" data-cfemail="c7aea0a8b587b2a4aba6e9a2a3b2">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00516&amp;href=/doi/10.1021%2Facs.jmedchem.6b00516" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 16</span><span class="cit-pageRange">, 7525–7543</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 2, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 April 2016</li><li><span class="item_label"><b>Published</b> online</span>10 August 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 August 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00516" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00516</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7525%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHerbert%2BH.%2BSeltzman%252C%2BCraig%2BShiner%252C%2BErin%2BE.%2BHirt%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D16%26contentID%3Dacs.jmedchem.6b00516%26title%3DPeripherally%2BSelective%2BCannabinoid%2B1%2BReceptor%2B%2528CB1R%2529%2BAgonists%2Bfor%2Bthe%2BTreatment%2Bof%2BNeuropathic%2BPain%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7543%26publicationDate%3DAugust%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00516"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1465</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">35</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00516" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Herbert&quot;,&quot;last_name&quot;:&quot;H. Seltzman&quot;},{&quot;first_name&quot;:&quot;Craig&quot;,&quot;last_name&quot;:&quot;Shiner&quot;},{&quot;first_name&quot;:&quot;Erin&quot;,&quot;last_name&quot;:&quot;E. Hirt&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;F. Gilliam&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;F. Thomas&quot;},{&quot;first_name&quot;:&quot;Rangan&quot;,&quot;last_name&quot;:&quot;Maitra&quot;},{&quot;first_name&quot;:&quot;Rod&quot;,&quot;last_name&quot;:&quot;Snyder&quot;},{&quot;first_name&quot;:&quot;Sherry&quot;,&quot;last_name&quot;:&quot;L. Black&quot;},{&quot;first_name&quot;:&quot;Purvi&quot;,&quot;last_name&quot;:&quot;R. Patel&quot;},{&quot;first_name&quot;:&quot;Yatendra&quot;,&quot;last_name&quot;:&quot;Mulpuri&quot;},{&quot;first_name&quot;:&quot;Igor&quot;,&quot;last_name&quot;:&quot;Spigelman&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;16&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;7525-7543&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00516&quot;},&quot;abstract&quot;:&quot;Alleviation of neuropathic pain by cannabinoids is limited by their central nervous system (CNS) side effects. Indole and indene compounds were engineered for high hCB1R affinity, peripheral selectivity, metabolic stability, and in vivo efficacy. An epithelial cell line assay identified candidates with &lt;1% blood–brain barrier penetration for testing in a rat neuropathy induced by unilateral sciatic nerve entrapment (SNE). The SNE-induced mechanical allodynia was reversibly suppressed, partially or completely, after intraperitoneal or oral administration of several indenes. At doses that relieve neuropathy symptoms, the indenes completely lacked, while the brain-permeant CB1R agonist HU-210 (1) exhibited strong CNS side effects, in catalepsy, hypothermia, and motor incoordination assays. Pharmacokinetic findings of ∼0.001 cerebrospinal fluid:plasma ratio further supported limited CNS penetration. Pretreatment with selective CB1R or CB2R blockers suggested mainly CB1R contribution to an indene’s antiallodynic e&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00516&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00516" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00516&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00516" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00516&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00516" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00516&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00516&amp;href=/doi/10.1021/acs.jmedchem.6b00516" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00516" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00516" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00516%26sid%3Dliteratum%253Aachs%26pmid%3D27482723%26genre%3Darticle%26aulast%3DSeltzman%26date%3D2016%26atitle%3DPeripherally%2BSelective%2BCannabinoid%2B1%2BReceptor%2B%2528CB1R%2529%2BAgonists%2Bfor%2Bthe%2BTreatment%2Bof%2BNeuropathic%2BPain%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D16%26spage%3D7525%26epage%3D7543%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292461" title="Neurophysiology">Neurophysiology</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291862" title="Indoles">Indoles</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/16" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/jmcmar.2016.59.issue-16/20160825/jmcmar.2016.59.issue-16.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/medium/jm-2016-00516h_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00516&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Alleviation of neuropathic pain by cannabinoids is limited by their central nervous system (CNS) side effects. Indole and indene compounds were engineered for high hCB1R affinity, peripheral selectivity, metabolic stability, and in vivo efficacy. An epithelial cell line assay identified candidates with <1% blood–brain barrier penetration for testing in a rat neuropathy induced by unilateral sciatic nerve entrapment (SNE). The SNE-induced mechanical allodynia was reversibly suppressed, partially or completely, after intraperitoneal or oral administration of several indenes. At doses that relieve neuropathy symptoms, the indenes completely lacked, while the brain-permeant CB1R agonist HU-210 (<b>1</b>) exhibited strong CNS side effects, in catalepsy, hypothermia, and motor incoordination assays. Pharmacokinetic findings of ∼0.001 cerebrospinal fluid:plasma ratio further supported limited CNS penetration. Pretreatment with selective CB1R or CB2R blockers suggested mainly CB1R contribution to an indene’s antiallodynic effects. Therefore, this class of CB1R agonists holds promise as a viable treatment for neuropathic pain.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53285" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53285" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Various neuropathies and chronic inflammatory conditions pose a major socioeconomic and clinical challenge<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> in part because of poorly understood etiologies and mechanisms and in part because side effects of existing treatments greatly limit their effectiveness.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> This includes synthetic and naturally occurring cannabinoids (CBs), which reduce the hyperalgesia and allodynia associated with persistent pain of neuropathic and inflammatory origin in humans<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and animals<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> yet they exhibit side effects mediated primarily by activation of central nervous system (CNS) CB1 receptors (CB1Rs). These psychotropic CNS effects also account for the abuse potential of plant-based and synthetic CBs.</div><div class="NLM_p">In addition to their CNS expression, CB1Rs, CB2Rs, and their endogenous ligands (endocannabinoids, ECBs) have a diverse distribution in peripheral tissues, including primary afferent neurons.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Local administration of CBs into inflamed tissue attenuates hyperalgesia and allodynia via peripheral CBRs at doses that produce minimal CNS-mediated side effects.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The crucial role of peripheral CBRs in the antihyperalgesic actions of systemically administered CBs was demonstrated using conditional deletion of CB1Rs located on nociceptive primary afferent neurons.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Also, many studies have demonstrated increases in expression of CB1Rs, CB2Rs, and ECBs, both in the peripheral tissues and the CNS, during inflammation and after development of painful neuropathies, reviewed in ref <a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">8</a>. Increases in CBR expression result in increased potency or efficacy of the exogenously applied CBs<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and may also account for the effectiveness of CBs in alleviating neuropathic pain symptoms after chronic repeated treatment,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> unlike opioids, which have only limited long-term effectiveness.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> While selective activation of CB2Rs also inhibits experimentally induced inflammatory pain and itch or the persistent pain of neuropathic origin,<a onclick="showRef(event, 'cit10b ref12'); return false;" href="javascript:void(0);" class="ref cit10b ref12">(10b, 12)</a> activation of both CB1R and CB2Rs appears to have synergistic effects on pain suppression.<a onclick="showRef(event, 'cit12a'); return false;" href="javascript:void(0);" class="ref cit12a">(12a)</a> These studies provided a rationale for the development of peripherally acting endocannabinoid-based therapeutic interventions.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><div class="NLM_p last">With the aim of utilizing the demonstrated benefits of CBs to sustainably ameliorate neuropathic pain, we sought to develop peripherally restricted CB1R agonists, which would not penetrate the blood–brain barrier (BBB) so as to avoid the unwanted psychomimetic effects such as those caused by Δ<sup>9</sup>-tetrahydrocannabinol (Δ<sup>9</sup>-THC) that are also associated with activation of central CB1Rs. Peripheral restriction can be addressed by (1) the inclusion of charge that typically prevents BBB penetration in the absence of active transport, (2) the presence of actively effluxed moieties such as carboxylates, and (3) adjustment of partition coefficient and the topological polar surface area. Other factors potentially impact peripheral restriction such as activation of CB2Rs on the BBB endothelial cells.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> We chose to examine indoles and indenes that have been demonstrated as ligands for CB1R agonist activity as starting points for modifications toward these ends.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03002" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03002" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis of Indoles</h3><div class="NLM_p">The synthesis of the target indoles where the 4-substituent of the naphthyl ring was alkyl or hydrogen followed the established general approaches shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The synthesis of indoles with a 4-acyl substituted naphthylene ring required further modifications as described below. The acylation of indole <b>1</b>-<b>1</b> with the naphthoyl chloride <b>1</b>-<b>2a</b> (X<sub>1</sub> = CO<sub>2</sub>Me) mediated by methyl magnesium bromide and zinc chloride afforded the corresponding <b>1</b>-<b>3b</b> in greater than 80% yield on scales of 20 g. Subsequent alkylation of <b>1</b>-<b>3b</b> with <i>n</i>-pentyl bromide proceeded in yields of about 50% of <b>1</b>-<b>4a</b> (X<sub>1</sub> = CO<sub>2</sub>Me) on a 1 g scale. Upon scale up to 10 and 15 g, the alkylation step did not proceed to completion. Further, work up resulted in hydroxysis or transesterification to the <i>N</i>-alkylated or unalkylated acid or ethyl ester (when ethyl acetate was employed in the work up) that can likely be addressed with modified work up conditions.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/medium/jm-2016-00516h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00516&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Conversion of <b>1</b>-<b>4a</b> to other 4-substituted naphthoyl indoles was achieved by saponification to the acid <b>1</b>-<b>7a</b> (X<sub>2</sub> = CO<sub>2</sub>H, R = Pn), which was converted to the acid chloride (X<sub>2</sub> = COCl, R = Pn) with oxalyl chloride and subsequently to the secondary amide <b>1</b>-<b>7b</b> (X<sub>2</sub> = CONHMe, R = Pn) (87%) with methylamine and to the primary amide <b>1</b>-<b>7c</b> (X<sub>2</sub> = CONH<sub>2</sub>) (98%) with ammonium hydroxide. Conversion of the acid chloride to the methyl or ethyl ketones <b>1</b>-<b>7e</b>,<b>d</b> (X<sub>2</sub> = COMe, COEt) by treatment with either methyl Grignard (no product), dimethyl zinc (trace product), diethyl zinc (trace product), or triethyl aluminum (no product) was disappointing.</div><div class="NLM_p">An alternative sequence to <b>1</b>-<b>7e</b>,<b>d</b> of first preparing the 4-substituted 1-naphthoyl chloride <b>1</b>-<b>2c</b>,<b>d</b> (X<sub>1</sub> = COMe, COEt) followed by coupling to the indole (<i>N</i>-alkylated or not) was examined in an effort to improve yields. Thus, commercially available 4-(methoxycarbonyl)naphthalene-1-carboxylic acid (<b>1</b>-<b>8a</b>) was converted to <b>1</b>-<b>2a</b> (X<sub>1</sub> = CO<sub>2</sub>Me), then treated with dimethyl or diethyl zinc to afford <b>1</b>-<b>8b</b>,<b>c</b> (X<sub>1</sub> = COEt, COMe) in 63% and 37%, respectively, followed by hydrolysis of the esters to the acids <b>1</b>-<b>8d</b>,<b>e</b> in greater than 90% yield and treatment with oxalyl chloride to afford <b>1</b>-<b>2c</b>,<b>d</b> in near quantitative yield. Acylating indole <b>1</b>-<b>1</b> with <b>1</b>-<b>2d</b> (X<sub>1</sub> = COEt) mediated with MeMgBr afforded a 55% yield of <b>1</b>-<b>3d</b> (X<sub>1</sub> = COEt). Alkylation of <b>1</b>-<b>3d</b> with <i>n</i>-pentyl bromide, however, afforded no target compound (the product obtained from the low yield diethyl zinc reaction above was used for testing). Attempting synthesis of the methyl ketone analogue <b>1</b>-<b>7e</b> (X<sub>2</sub> = COMe) by reversing the sequence to acylating the prealkylated <b>1</b>-<b>6a</b> (R = Pn) with <b>1</b>-<b>2c</b> (X<sub>1</sub> = COMe) mediated by ethylaluminum dichloride gave a complex mixture with minimal <b>1</b><b>–7e</b> (X<sub>2</sub> = COMe) that could not be isolated in pure form.</div><div class="NLM_p"><i>N</i>-ω-Carboxyalkyl-indoles (butanoates and pentanoates, <b>1</b>-<b>4f</b> and <b><b>1</b></b>-<b><b>4</b>g</b>, respectively) were prepared by acylation of indole <b>1</b>-<b>1a</b> with <b>1</b>-<b>2e</b> mediated by methylmagnesium bromide affording the naphthoylindole <b>1</b>-<b>3a</b>, which was then alkylated with ethyl ω-bromoalkanoate and sodium hydride to yield the corresponding ethyl butanoate and pentanoate and followed by hydrolysis to provide the corresponding acids <b>1</b>-<b>4f</b>,<b>g</b> (R = −(CH<sub>2</sub>)<sub><i>n</i></sub>-CO<sub>2</sub>H, <i>n</i> = 3,4).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p last">Fluoroindole analogues were prepared from commercially available fluoroindole substituted in the 4, 5, 6, or 7-position (<b>1</b>-<b>1b</b>–<b>e</b>, Z = F) via acylation with <b>1</b>-<b>2e</b> (X<sub>1</sub> = H) in the presence of MeMgBr and ZnCl<sub>2</sub> to afford <b>1</b>-<b>3e</b>–<b>h</b> in 70–85% yields followed by alkylation with <i>n</i>-pentyl bromide/NaH to give <b>1</b>-<b>4h</b>–<b>k</b> (Z = F) in >80% yields. The 4-fluoro indole <b>1</b>-<b>3e</b> was also alkylated with 5-fluoro-1-bromopentane/NaH to give the corresponding <b>1</b>-<b>4l</b> in 27% yield. Similar alkylation with iodoethylmorpholine/NaH afforded <b>1</b>-<b>4m</b> (X<sub>1</sub> = H, Z = 4-F, R = morpholinoethyl) in 68% yield after chloroethylmorpholine did not alkylate <b>1</b>-<b>3e</b> (Z = 4-F). The analogue <b>1</b>-<b>4n</b> (X<sub>1</sub> = <i>n</i>-propyl, Z = 4-F, R = 5-F-pentyl) was prepared from 4-fluoroindole <b>1</b>-<b>1b</b> by acylation with 4-<i>n</i>-propyl-1-naphthoyl chloride (<b>1</b>-<b>2b</b>, X<sub>1</sub> = <i>n</i>-propyl) (MeMgBr, ZnCl<sub>2</sub>) (58%), followed by alkylation with 5-fluoro-1-bromopentane/NaH to give the corresponding <b>1</b>-<b>4n</b> in 24% yield.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Synthesis of Indenes</h3><div class="NLM_p">Synthesis of the target 4-substituted naphthylidene- or substituted benzylidene-3-morpholinoethyl-2-indenes (<b>2</b>-<b>5</b>) with the <i>E</i>-olefin geometry was achieved as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> by alkylation of lithiated indene <b>2</b>-<b>1</b> with 1-chloro-2-(4-morpholino)ethane (<b>2</b>-<b>2</b>) to afford a mixture of the 1- and 3-alkylated 1<i>H</i>-indenes. Treatment of the mixture with sodium hydroxide induced isomerization to the more stable 3-(4-morpholinoethane)-1<i>H</i>-indene<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (<b>2</b>-<b>3</b>) in 45% yield (Z = H). Treatment of <b>2</b>-<b>3</b> with the appropriate 1-naphthaldehyde, benzaldehyde, or aryl aldehyde in the presence of sodium methoxide gave the target <i>E</i>-olefin <b>2</b>-<b>5a</b>–<b>s</b> after either 18 h of heating at reflux (in 66% yield <b>2</b>-<b>5a</b>) or microwave heating. Microwave heating provided the same product more expeditiously in 15 min at 105 °C but in lesser yield (53% <b>2</b>-<b>5a</b>), a process that we employed for the majority of the analogues which were obtained in >90% purity (HPLC). Phenyl acetaldehyde, 4-hydroxy-1-naphthaldehyde, 2-nitro-, and 2-cyano-benzaldehyde were not ammenable to this method of synthesis, but particular interest in preparing and testing the phenyl acetaldehyde derived product, (1<i>E</i>)-3-hexyl-1-(2-phenylethylidene)-1<i>H</i>-indene (<b>2</b>-<b>7</b>) with only a distal aromatic ring (see above), was achieved by Horner–Wittig chemistry.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The <i>E</i>-geometry was established for the <b>2</b>-<b>5a</b>–<b>s</b> analogues by comparison of the <sup>1</sup>H NMR on the architype <i>E</i>-(1-naphthylidene)-3-morpholinoethyl-2-indenes prepared via the condensation chemistry from <b>2</b>-<b>3</b> with that prepared by Horner–Wittig chemistry that was characterized by NOE NMR spectroscopy.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/medium/jm-2016-00516h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00516&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Neuropathy Testing</h3><div class="NLM_p">We examined the effectiveness of select indenes in alleviating the painful symptoms of neuropathy induced by unilateral sciatic nerve entrapment (SNE).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> SNE was demonstrated to produce consistent pain behaviors,<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> a transient loss of varicosities in nociceptive fibers,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and increased excitability of sciatic nerve.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The hyperexcitability and ectopic burst discharge of primary sensory neurons are widely considered as major contributors to pain symptomatology of peripheral neuropathy models. The SNE-induced mechanical allodynia models the most common complaint of human neuropathy patients of dynamic mechanical allodynia. <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> illustrates that systemic injection of 0.3 mg/kg of PrNMI (<b>2</b>-<b>5u</b>) or MoNMI (<b>2</b>-<b>5j</b>) results in large, reversible decreases in mechanical allodynia. By contrast, ENMI (<b>2</b>-<b>5a</b>) has a much smaller effect, consistent with its lower CBR affinity and faster metabolism (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).</div><figure id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/medium/jm-2016-00516h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reversible suppression of SNE-induced mechanical allodynia by representative indenes. (A) Schematic of sciatic nerve entrapment and relevant peripheral nerve and spinal ganglia. (B) Graph of withdrawal thresholds to mechanical stimulation of hindpaws ipsilateral and contralateral to SNE at 1 h before and 3, 6, 24, and 48 h after <b>2</b>-<b>5u</b> (0.3 mg/kg, ip) injection. At 3 h postinjection, ipsilateral thresholds are increased to levels of predrug contralateral thresholds and are indistinguishable from thresholds measured prior to neuropathy development (pre-SNE). Also note the drug-induced small, but significant increases in contralateral thresholds (mean ± SEM, <i>n</i> = 8 rats). (C) In the same rats, administration of <b>2</b>-<b>5j</b> (0.3 mg/kg), but not vehicle alone, results in similar increases in ipsilateral thresholds to pre-SNE values. (D) <b>2</b>-<b>5a</b> (0.3 mg/kg) produces considerably smaller increases in thresholds than <b>2</b>-<b>5u</b> or <b>2</b>-<b>5j</b>. (E) Changes in plasma [<b>2</b>-<b>5u</b>] and calculated pharmacokinetic parameters after injection (0.3 mg/kg, ip) in naı̈ve rats (<i>n</i> = 3) are consistent with the time course of its effects on SNE neuropathy symptoms. Brain and CSF/plasma ratios of PrNMI obtained from samples collected from 3 other rats at ∼75 min after <b>2</b>-<b>5u</b> (0.3 mg/kg, ip) suggest minimal CNS penetration. (F) Oral administration of <b>2</b>-<b>5u</b> (3 mg/kg) reversibly suppresses SNE neuropathy symptoms (<i>n</i> = 8 rats). *, <i>p</i> < 0.05 vs predrug (−1 h) values (one-way RM ANOVA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00516&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Pharmacokinetics</h3><div class="NLM_p">Analysis of plasma samples after <b>2</b>-<b>5u</b> injections yielded its initial pharmacokinetic profile (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>E), which was in good agreement with its antiallodynic effects (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B). Measurements of drug brain penetration include drug partitioned into brain lipids + unbound drug in equilibrium with extracellular fluid. The cerebrospinal fluid (CSF)/plasma ratios are considered to be more precise estimates of a drug’s brain penetration because of the continuity of CSF with extracellular space.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> However, both measures are needed to confirm minimal CNS access and to compare with other reported peripherally restricted CB1R ligands.<a onclick="showRef(event, 'cit13c ref23'); return false;" href="javascript:void(0);" class="ref cit13c ref23">(13c, 23)</a> Analysis of plasma, brain, and CSF samples confirmed the minimal penetration of <b>2</b>-<b>5u</b> into the CNS after systemic administration (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>E).</div><div class="NLM_p last">In subsequent experiments, we demonstrated that <b>2</b>-<b>5u</b> was also effective in suppressing neuropathy symptoms after oral administration, which is more representative of future therapeutic uses. The high oral dose of <b>2</b>-<b>5u</b> (3 mg/kg) likely accounts for its continued antiallodynic effectiveness at the 24 h time point (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>F).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Tetrad Testing</h3><div class="NLM_p">The CNS-mediated psychotropic actions of CB1R ligands represent their most troubling side effects. The catalepsy, motor performance, hypothermia, and analgesia tests are classically predictive of CNS CB1R activation.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Effects in all four tests have been thought to be mediated by the activation of central CB1Rs, but it is now well established that peripheral CBRs make a major contribution to the analgesic effects of CBs.<a onclick="showRef(event, 'cit6d cit12a cit12c'); return false;" href="javascript:void(0);" class="ref cit6d cit12a cit12c">(6d, 12a, 12c)</a> We used the “tetrad” to determine whether the novel ligands have antinociceptive effects and side effect profile consistent with central CB1R activation. We also studied the potent CB1R agonist, <b>1</b> (HU-210, <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (Tocris Bioscience, Ellisville, MO), to allow comparisons of this positive control with the putatively brain-impermeant analogues. The systemic doses of <b>1</b><a onclick="showRef(event, 'cit4b'); return false;" href="javascript:void(0);" class="ref cit4b">(4b)</a> and of novel indenes (e.g., <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) were consistent with their demonstrated effectiveness in alleviating painful neuropathy symptoms. The “tetrad” tests were modified for rats, with rotarod substituting for the spontaneous activity test. Unlike <b>1</b>, <b>2</b>-<b>5u</b> and other indenes lack effects in the catalepsy, rotarod, or hypothermia assays, although a small effect in the tail-flick assay is observed, as expected for analgesic peripherally acting CB1R ligands (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/medium/jm-2016-00516h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00516&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/medium/jm-2016-00516h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Activity of <b>1</b>, <b>2</b>-<b>5u</b>, <b>2</b>-<b>5t</b>, and <b>2</b>-<b>5j</b> in the “tetrad” assays. (A–D) Rats were tested in each assay 1 h prior and up to 48 h following intraperitoneal injection of vehicle, <b>1</b> (0.01 mg/kg) or <b>2</b>-<b>5u</b> (0.3 mg/kg). Note the profound CNS side effects of <b>1</b> vs <b>2</b>-<b>5u</b> in the ring, core temperature, and rotarod tests. The small analgesic effect of <b>2</b>-<b>5u</b> in the tail-flick assay is consistent with peripheral activation of CBRs. *, <i>p</i> < 0.05 vs predrug (−1 h) values (one-way RM ANOVA). (E–H) Dose-dependence of brain-permeant <b>1</b> and compounds <b>2</b>-<b>5t</b>, <b>2</b>-<b>5u</b>, or <b>2</b>-<b>5j</b> in the tetrad assays after intraperitoneal administration. Each point represents mean peak effect ± SEM of <b>1</b> (<i>n</i> = 6 rats), <b>2</b>-<b>5t</b> (<i>n</i> = 8 rats), <b>2</b>-<b>5u</b> (<i>n</i> = 8 rats), and <b>2</b>-<b>5j</b> (<i>n</i> = 8 rats), each subtracted from its vehicle control. (I–L) Dose-dependence of <b>2</b>-<b>5t</b>, <b>2</b>-<b>5u</b>, and <b>2</b>-<b>5j</b> in the tetrad assays after oral administration. Each point represents mean peak effect ± SEM of <b>2</b>-<b>5t</b> (<i>n</i> = 8 rats), <b>2</b>-<b>5u</b> (<i>n</i> = 8 rats), and <b>2</b>-<b>5j</b> (<i>n</i> = 8 rats), each subtracted from its vehicle control. Note the relative lack of side effects in the catalepsy, motor incoordination, and hypothermia assays. The small effects in the tail-flick assay are consistent with antinociceptive effects due to activation of peripheral CBRs in naı̈ve rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00516&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> CB1Rs Mediate Antiallodynic Effects of <b>2</b>-<b>5u</b></h3><div class="NLM_p">Despite similar affinities for the CB1R and CB2R subtypes, indene PRCBs are full agonists at hCB1R but only partial agonists at hCB2R (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). To determine which receptor subtype is responsible for the antiallodynic effects of the novel CBR ligands in the SNE neuropathy, we measured the ability of a representative ligand, <b>2</b>-<b>5u</b>, to suppress mechanical allodynia in SNE rats in the presence of either CB1R or CB2R selective antagonists. <b>2</b>-<b>5u</b> was administered alone or 30 min after pretreatment with CBR blockers in SNE rats at 3-day intervals (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). Pretreatment with the CB1R inverse agonist, SR141716 (<b>2</b>, <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>),<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> completely blocked the antiallodynic effect of <b>2</b>-<b>5u</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B,E), whereas pretreatment with a CB2R selective inverse agonist, SR144528 (<b>3</b>, <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>), had little effect on suppression of allodynia by <b>2</b>-<b>5u</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>D). In the same rats, pretreatment with a peripherally restricted analogue of <b>2</b>, <b>18A</b>, recently developed by our group,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> also prevented the antiallodynic effect of <b>2</b>-<b>5u</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C,E). These studies demonstrated the CB1R dependence of <b>2</b>-<b>5u</b>’s antiallodynic effects in the SNE neuropathy.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/medium/jm-2016-00516h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. CB1Rs mediate antiallodynic effects of <b>2</b>-<b>5u</b> in the SNE neuropathy. (A) Suppression of SNE-induced mechanical allodynia by <b>2</b>-<b>5u</b> (0.6 mg/kg). (B) In the same rats (<i>n</i> = 8), pretreatment with the CB1R inhibitor <b>2</b> (rimonabant, 3 mg/kg, ip) completely blocks the response to <b>2</b>-<b>5u</b>. (C) A peripherally restricted rimonabant analogue, <b>18A</b>, also blocked the response to <b>2</b>-<b>5u</b>. (D) By contrast, the selective CB2R inhibitor <b>3</b> (3 mg/kg, ip) produced only a small decrease in the response to <b>2</b>-<b>5u</b>. (E) Summary of effects of selective CB1R and CB2R inhibition on antiallodynic effects of <b>2</b>-<b>5u</b>. *, <i>p</i> < 0.05 vs treatment with <b>2</b>-<b>5u</b> alone (one-way ANOVA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00516&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43827" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43827" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Structure–Activity Relationships (SAR)</h3><div class="NLM_p">The introduction of charge to CB1R ligands to impart peripheral selectivity was explored via quaternization of morpholinoethyl-indoles and -indenes of demonstrated CB1R agonists. Thus, morpholinoethylindoles 1-[2-(4-morpholino)ethyl]-3-(1-naphthoyl)indole (<b>1</b>-<b>9a</b>, JWH-200),<a onclick="showRef(event, 'cit15a'); return false;" href="javascript:void(0);" class="ref cit15a">(15a)</a> 1-[2-(4-morpholino)ethyl]-3-(4-methoxy-1-naphthoyl)indole (<b>1</b>-<b>9c</b>, JWH-198),<a onclick="showRef(event, 'cit15a'); return false;" href="javascript:void(0);" class="ref cit15a">(15a)</a> and 1-[2-(4-morpholino)ethyl]-3-(4-methyl-1-naphthoyl)indole (<b>1</b>-<b>9e</b>, JWH-193),<a onclick="showRef(event, 'cit15a'); return false;" href="javascript:void(0);" class="ref cit15a">(15a)</a> respectively, and pravadoline<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a><b>1</b>-<b>9g</b> were quaternized to <b>1</b>-<b>9b</b>,<b>d</b>,<b>f</b>,<b>h</b>. Also, conformationally constrained morpholinoethyl indenes, (<b>2</b>-<b>5a</b>, <i>E</i>-4-[2-[1-(1-naphthalenylmethylene)-1<i>H</i>-inden-3-yl]ethyl]morpholine)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and its 2-methyl analogue <b>2</b>-<b>5v</b>, were quaternized to afford the corresponding charged quaternary ammonium analogues (<b>2</b>-<b>6a</b> and <b>2</b>-<b>6b</b>). Both of these changes resulted in a reduction of hCB1R binding affinity of between one and 2 orders of magnitude (see <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Similarly, alkyl carboxy chains linked to the indole nitrogen as ω-butanoic (<b>1</b>-<b>4f</b>) and -pentanoic (<b>1</b>-<b>4g</b>) acids, as putative effluxed moieties, also exhibited no hCB1R affinity (<i>K</i><sub>i</sub> = > 10 μM) in contrast to the unmodified pentyl chain of 3-(naphthalene-1-carbonyl)-1-pentyl-1<i>H</i>-indole, JWH-018 (<b>1</b>-<b>4p</b>) (<i>K</i><sub>i</sub> = 4.3 nM).<a onclick="showRef(event, 'cit15a'); return false;" href="javascript:void(0);" class="ref cit15a">(15a)</a> The 4-carboxy substituted naphthoyl analogue <b>1</b>-<b>7a</b> also showed no receptor affinity (<i>K</i><sub>i</sub> = >10 μM). These results steered our efforts away from charged analogues.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Compounds Key: Indoles (<b>1</b>) and Indenes (<b>2</b>)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">Z</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">X<sub>1/2</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> (nM) hCB1R vs CP55,940</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>4a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Pn</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="center">20.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>4b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>Et</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>4c</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Pn</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>Et</td><td class="colsep0 rowsep0" align="center">115</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>4d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub>-CO<sub>2</sub>Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">747</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>4e</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub>-CO<sub>2</sub>Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">1469</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>4f</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub>-CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>4g</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub>-CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>4h</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">Pn</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">6.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>4i</b></td><td class="colsep0 rowsep0" align="left">5-F</td><td class="colsep0 rowsep0" align="left">Pn</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">9.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>4j</b></td><td class="colsep0 rowsep0" align="left">6-F</td><td class="colsep0 rowsep0" align="left">Pn</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">2.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>4k</b></td><td class="colsep0 rowsep0" align="left">7-F</td><td class="colsep0 rowsep0" align="left">Pn</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">3.62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>4l</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">5-F-Pn</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">4.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>4m</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">237</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>4n</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">5-F-Pn</td><td class="colsep0 rowsep0" align="left">4-Pr</td><td class="colsep0 rowsep0" align="center">2.55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>4o</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="center">52.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>4p</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Pn</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">4.3 (15a)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>7a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Pn</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="center">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>7b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Pn</td><td class="colsep0 rowsep0" align="left">CONHMe</td><td class="colsep0 rowsep0" align="center">127</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>7c</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Pn</td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="center">96.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>7d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Pn</td><td class="colsep0 rowsep0" align="left">COEt</td><td class="colsep0 rowsep0" align="center">5.71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>7e</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Pn, not prep</td><td class="colsep0 rowsep0" align="left">COMe</td><td class="colsep0 rowsep0" align="center">not tested</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>9a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>9b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me, Et-Morp</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>9c</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="center">88</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>9d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me, Et-Morp</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="center">4083</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>9e</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="center">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>9f</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me, Et-Morp</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="center">4174</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>9g</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">pravadoline</td><td class="colsep0 rowsep0" align="center">2511 (rat)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>-<b>9h</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me, Et-Morp</td><td class="colsep0 rowsep0" align="left">Me-pravadoline</td><td class="colsep0 rowsep0" align="center">>10000</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center"><i>E</i>-arylidene (morpholinoethyl indene)</th><th class="colsep0 rowsep0" align="center">W/X<sub>1</sub></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> (nM) hCB1R vs CP55,940</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>5a</b> ENMI</td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">1-naphthylidene</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">4.69 (2.72)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>5b</b></td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">benzylidene</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">1297</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>5c</b></td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">2-iodobenzylidene</td><td class="colsep0 rowsep0" align="left">2-I</td><td class="colsep0 rowsep0" align="center">607</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>5d</b></td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">2-fluorobenzylidene</td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="center">1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>5e</b></td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">3-phenylbenzylidene</td><td class="colsep0 rowsep0" align="left">3-Ph</td><td class="colsep0 rowsep0" align="center">2603</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>5f</b></td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">2-chlorobenzylidene</td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="center">862</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>5g</b></td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">2-bromobenzylidene</td><td class="colsep0 rowsep0" align="left">2-Br</td><td class="colsep0 rowsep0" align="center">647</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>5h</b></td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">2-methoxybenzylidene</td><td class="colsep0 rowsep0" align="left">2-OMe</td><td class="colsep0 rowsep0" align="center">149</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>5i</b></td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">2-methylbenzylidene</td><td class="colsep0 rowsep0" align="left">2-Me</td><td class="colsep0 rowsep0" align="center">623</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>5j</b> MoNMI</td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">4-methoxynaphthylidene</td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="center">2.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>5k</b></td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">2-phenylbenzylidene</td><td class="colsep0 rowsep0" align="left">2-Ph</td><td class="colsep0 rowsep0" align="center">82.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>5l</b></td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">7-indolidene</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">107</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>5m</b></td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">2-thienylmethylene</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">8528</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>5n</b></td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">2-furanylmethylene</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>5o</b></td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">5-isoquinolidene</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">454</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>5p</b></td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">4-quinolidene</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">23.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>5q</b> AceNMI</td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">1,2-dihydroacenaphthylidene-5-yl-methylene</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">15.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>5r</b></td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">2-naphthylidene</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">134</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>5s</b></td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">4-phenanthrylidene</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">22.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>5t</b> EtNMI</td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">4-ethylnaphthylidene</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="center">0.859</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>5u</b> PrNMI</td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">4-propylnaphthylidene</td><td class="colsep0 rowsep0" align="left">Pr</td><td class="colsep0 rowsep0" align="center">1.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>5v</b></td><td class="colsep0 rowsep0" align="left">Et-Morp</td><td class="colsep0 rowsep0" align="left">1-naphthylidene (2-Me-indene)</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">2.84 (2.89)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>6a</b></td><td class="colsep0 rowsep0" align="left">Me, Et-Morp</td><td class="colsep0 rowsep0" align="left">1-naphthylidene (indene)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">982</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>6b</b></td><td class="colsep0 rowsep0" align="left">Me, Et-Morp</td><td class="colsep0 rowsep0" align="left">1-naphthylidene (2-Me-indene)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">1614</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>7a</b></td><td class="colsep0 rowsep0" align="left">Pn</td><td class="colsep0 rowsep0" align="left">1-naphthylidene (indene)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">17.2 (26)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>7b</b></td><td class="colsep0 rowsep0" align="left">Hx</td><td class="colsep0 rowsep0" align="left">1-naphthylidene (indene)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">436</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>-<b>7c</b></td><td class="colsep0 rowsep0" align="left">Hx</td><td class="colsep0 rowsep0" align="left"><i>E</i>-2-phenylethylidene</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">4414</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a> for X<sub>1</sub> and X<sub>2</sub></p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. E-Arylidene Morpholinoethyl Indene Structures, hCB1R/hCB2R Binding, Permeability in the MDCK Cell Line Assay, Ca<sup>2+</sup> Flux (hCB1R and hCB2R Agonist) Activity, and Metabolic Stability<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/medium/jm-2016-00516h_0007.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">--, not tested.</p></div></div><div></div></div><div class="NLM_p">Screening results of peripheral selectivity and hCB1R affinity on our early analogues redirected ligand design. The peripheral selectivity of the high affinity compounds was tested in the Madin–Darby canine kidney (MDCK) epithelial cell line assay as a model of the BBB<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and showed an association with the <i>n</i>-pentyl indoles and morpholinoethyl indenes, respectively. Thus, the <i>N</i>-pentyl 4-carboxy methyl ester indole <b>1</b>-<b>4a</b> was compared to the <i>N</i>-morpholinoethyl 4-carboxy methyl ester indole analogue <b>1</b>-<b>4o</b>. The basolateral:apical ratio (B:A) of the <i>n</i>-pentyl analogue <b>1</b>-<b>4a</b> was 0.00, while that of the <i>N</i>-morpholinoethyl analogue <b>1</b>-<b>4o</b> was 1.02, indicating nonpermeability of <b>1</b>-<b>4a</b> and equal central:peripheral distribution of <b>1</b>-<b>4o</b> in the MDCK model. This would suggest similar permeability for these indole analogues across the BBB.</div><div class="NLM_p">The morpholinoethyl indene <b>2</b>-<b>5a</b><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and the <i>n</i>-pentyl indene 1-{[(1<i>E</i>)-3-pentyl-1<i>H</i>-inden-1-ylidene]methyl}naphthalene, JWH-176,<a onclick="showRef(event, 'cit15a'); return false;" href="javascript:void(0);" class="ref cit15a">(15a)</a><b>2</b>-<b>7a</b>, were also chosen as candidates for modification as they had high affinity for the CB1R (<i>K</i><sub>i</sub> = 4.69 and 17.2 nM, respectively). Surprisingly, both tested in the MDCK assay<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> as peripherally restricted (B:A = 0.00 and 0.04, respectively) with the morpholinoethyl moiety <b>2</b>-<b>5a</b>, showing slightly greater preferral restriction over the pentyl moiety (<b>2</b>-<b>7a</b>). This is the opposite order of the indole morpholinoethyl and the indole pentyl side chain pair tested (above) and of significant difference of B:A of the morpholinoethyl substituted indole <b>1</b>-<b>4o</b>. Thus, subsequent indene modifications were evolved from the morpholinoethyl indene analogue <b>2</b>-<b>5a</b> and subsequent indole modifications were evolved from <i>n</i>-pentyl indoles to examine SAR trends in affinity, MDCK permeability, and metabolic stability in order to select candidates for in vivo testing.</div><div class="NLM_p">The effect upon hCB1R affinity of substituting the naphthoyl 4-position on the indoles, which has been associated with high receptor affinity in reported analogues,<a onclick="showRef(event, 'cit15b'); return false;" href="javascript:void(0);" class="ref cit15b">(15b)</a> was examined in the <i>N</i>-pentyl family. Thus, in contrast to the 4-carboxy substituted naphthoyl analogue <b>1</b>-<b>7a</b> (<i>K</i><sub>i</sub> = >10 μM), the corresponding ethyl ester (<b>1</b>-<b>4c</b>) exhibited a <i>K</i><sub>i</sub> = 115 nM and the shorter methyl ester (<b>1</b>-<b>4a</b>) exhibited a <i>K</i><sub>i</sub> = 20 nM. The three atom-long chain 4-propanoyl-naphthyl analogue (<b>1</b>-<b>7d</b>) exhibited a <i>K</i><sub>i</sub> = 5.7 nM. The 4-<i>N</i>-methylamido analogue <b>1</b>-<b>7b</b> (<i>K</i><sub>i</sub> = 127 nM) was less active than its isosteric oxygen or carbon analogues (<b>1</b>-<b>4a</b> and <b>1</b>-<b>7d</b>). The 4-amido analogue (<b>1</b>-<b>7c</b>), however, had higher affinity for hCB1R (<i>K</i><sub>i</sub> = 96 nM) than the corresponding acid <b>1</b>-<b>7a</b>.</div><div class="NLM_p">A similar effect of the 4-position substituent was observed for the indenes in the morpholinoethyl family. The hCB1R affinity progressed from 4-H (4.69 nM) (<b>2</b>-<b>5a</b>) to 4-OMe (2.43 nM) (<b>2</b>-<b>5j</b>) to 4-<i>n</i>-Pr (1.18 nM) (<b>2</b>-<b>5u</b>) to 4-Et (0.86 nM) (<b>2-5t</b>), all of which were subsequently tested in vivo.</div><div class="NLM_p">Modeling and SAR studies of indole CB1R agonists and, similarly for the indene mimics of the indoles, support that the favored conformation of the naphthoyl ring for binding/activation in the analogues of <b>1</b>-<b>4p</b> and <b>5</b> (WIN 55,212-2)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> in the CB1R site is one in which the naphthoyl ring is nearly parallel to the XZ plane when the indole ring (pentyl chain pointing down) is in the XY plane.<a onclick="showRef(event, 'cit15a ref17 ref30'); return false;" href="javascript:void(0);" class="ref cit15a ref17 ref30">(15a, 17, 30)</a> Further, for the indoles, it is the distal ring of the naphthoyl bicyclic system that has the role of binding stabilization by aromatic stacking interactions with the receptor pocket.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Hence, we prepared and tested the 2-phenylethylidene indene analogue (<b>2</b>-<b>7c</b>) wherein the naphthylidene ring was replaced with 2-phenylethylidene that retains only the distal aromatic ring in analogy with similar active indole analogues.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> This change lost 10-fold affinity versus the corresponding naphthylidene analogue <b>2</b>-<b>7b</b> (both with an <i>n</i>-hexyl pendant group on inden-3-yl) and 256-fold versus <b>2</b>-<b>7a</b>, which carries a pentyl pendant group on inden-3-yl).</div><div class="NLM_p">Reported studies on indenes that are conformationally restrained by an arylidene double bond indicate that it is the orientation defined by the E-geometry that is active in the indenes and, by extension, in the more conformationally mobile naphthoyl indoles.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Designing forward from these factors, other arrangements of arylidene rings on the indenes were synthesized and tested to evolve an SAR that mapped the regions proximal to the 1-naphthyl ring. Thus, fusing an additional phenyl ring to naphthylene gave the 5-phenanthrylidene ring (<b>2</b>-<b>5s</b>) (<i>K</i><sub>i</sub> = 22.9 nM) versus the naphylidene <b>2</b>-<b>5a</b> (4.69 nM), indicating a tolerence for the extra ligand volume. In contrast, an alternate fusing of a phenyl ring to a naphthyl ring in indoles to give the symmetrical 9-anthranoyl ring is reported to result in a significant loss of binding affinity.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> This suggests that the volume available to the naphthoyl is not equivalent on both sides of the 9-anthranoyl bond to the indole and by extension to the indene.</div><div class="NLM_p">Displacing the distal phenyl ring of the naphthylidene group of <b>2</b>-<b>5a</b> from the fused to a pendant arrangement as in a 2- or 3-phenylbenzylidene group (<b>2</b>-<b>5k</b> and <b>2</b>-<b>5e</b>, respectively) results in a reasonably tolerated receptor binding for hCB1R for <b>2</b>-<b>5k</b> (<i>K</i><sub>i</sub> = 82.9 nM) but not for <b>2</b>-<b>5e</b> (<i>K</i><sub>i</sub> = 2603 nM). Reorienting the 1-naphylidene ring to the 2-naphylidene ring (<b>2</b>-<b>5r</b>) (<i>K</i><sub>i</sub> = 134 nM) reduces binding affinity by a moderate extent.</div><div class="NLM_p">Ortho-substituted benzylidene morpholinoethyl indenes were also synthesized and screened for hCB1R affinity based on the reported activity of 2-substituted benzoyl indoles.<a onclick="showRef(event, 'cit15b'); return false;" href="javascript:void(0);" class="ref cit15b">(15b)</a> Versus the unsubstituted 2-protio analogue <b>2</b>-<b>5b</b> (<i>K</i><sub>i</sub> = 1297 nM), the 2-halogeno analogues (<b>2</b>-<b>5d</b>,<b>f</b>,<b>g</b>,<b>c</b>) (2-F, Cl, Br, I, respectively) showed increasing affinity (<i>K</i><sub>i</sub> = 1000, 862, 647, 607 nM, respectively) with larger halogen atoms but never rising to the effect of the much larger 2-phenylbenzylidene analogue (<b>2</b>-<b>5k</b>, <i>K</i><sub>i</sub> = 82.9 nM). The 2-methoxy substituent (<b>2</b>-<b>5h</b>, <i>K</i><sub>i</sub> = 149 nM) gave a large increase in binding affinity (vs <b>2</b>-<b>5b</b>) that was likely due to electronic issues given the similar enhancement in affinity seen for the 4-methoxynaphthylidene <b>2</b>-<b>5j</b> vs <b>2</b>-<b>5a</b>.</div><div class="NLM_p">The affinity and possibly the functional bias of the receptor with its binding ligand can be influenced by the interaction of the arylidene or aroyl moieties of the indenes or the indoles, respectively. Modeling suggests that this interaction is one of aromatic stacking, which is effected by the electronic character of the interacting aromatic rings. Varying the arylidene ring systems to introduce electron-rich and electron-poor proximal or distal rings, we examined the effect on binding affinity. Thus, comparing the monocyclic electron-rich furanylidene <b>2</b>-<b>5n</b> (<i>K</i><sub>i</sub> = > 10 μM) to the electron-poor thiophenylidene <b>2</b>-<b>5m</b> (<i>K</i><sub>i</sub> = 8.5 μM), binding is favored by the electron-poor proximal ring. Similarly, comparing the bicyclic electron-poor 4-quinolidene <b>2</b>-<b>5p</b> (<i>K</i><sub>i</sub> = 23.3 nM) to the electron-neutral naphthylidene <b>2</b>-<b>5a</b> (<i>K</i><sub>i</sub> = 4.69 nM), binding is favored by the electron-neutral (or relatively electron-rich) proximal ring. Even though the binding by the electron-poor proximal ring was quite good, other factors such as interaction with the basic nitrogen atoms could contribute to the overall binding preference change toward electron density. Comparing the bicyclic electron-rich 7-indolydene <b>2</b>-<b>5l</b> (<i>K</i><sub>i</sub> = 107 nM) to the electron-poor 5-isoquinolidene <b>2</b>-<b>5o</b> (<i>K</i><sub>i</sub> = 454 nM), binding is favored by the electron-rich distal ring.</div><div class="NLM_p">Given the ready metabolism of indoles, which not only leads to the consumption of the drug candidate but also to multiple metabolites that exhibit mixed pharmacologies,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> the issue of stabilizing lead compounds was also addressed by introducing fluorine substitution on the indole ring to develop improved resistance to metabolism. The 4-, 5-, 6-, and 7-F indole analogues of <b>1</b>-<b>4p</b> (<b>1</b><b>-4h</b>–<b>k</b>) all had <i>K</i><sub>i</sub>s in the single-digit nM range. Tested for stability in rat plasma, where they exhibited stability of 69–99% after 1 h (see <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>), and S9 plasma fraction, where stability increased from 3% to 50% in 1 h with F substitution going from positions 4 to 7. In our analogues, the indenes were more metabolically stable than the indoles.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Indole Core Structures, hCB1R/hCB2R Binding, Permeability in the MDCK Cell Line Assay, Ca<sup>2+</sup> Flux (hCB1R agonist) Activity, and Metabolic Stability<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/medium/jm-2016-00516h_0008.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">-- not tested.</p></div></div><div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vivo Efficacy of Indenes</h3><div class="NLM_p">We show that systemic (0.3 mg/kg, ip) administration of <b>2</b>-<b>5u</b> (<b>2</b>-<b>5u</b>) or <b>2</b>-<b>5j</b> (<b>2</b>-<b>5j</b>) produced complete suppression of mechanical allodynia symptoms (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B,C), while the same and 3-fold higher doses of these compounds had no effect in the assays of CNS CB1R activation compared to the brain-permeant positive control, <b>1</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Similarly, an oral dose of 3 mg/kg <b>2</b>-<b>5u</b> produced complete suppression of allodynia symptoms at peak effect, while a 10 mg/kg oral dose had no significant effect on central CB1Rs (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). These data support the high antiallodynic efficacy of indene-based peripherally restricted cannabinoids (PRCBs) at doses that do not produce any CNS side effects.</div><div class="NLM_p">The pharmacokinetic data, which showed a CSF:plasma ratio of 0.001 at ∼75 min after <b>2</b>-<b>5u</b> (0.3 mg/kg, ip) administration (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>E) supports its relative lack of brain permeability. Generally, increasing aqueous solubility decreases the likelihood of a drug gaining access to brain tissue. However, numerous lipid-soluble molecules, among them many useful therapeutic drugs, have lower brain permeability than would be predicted from a determination of their lipid solubility.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Given the very low aqueous solubility of PRCBs, their relative lack of BBB permeability suggests that they may be substrates for active drug efflux transporters such as P-glycoprotein or multidrug resistance proteins. Future studies using selective inhibitors of such transporters (e.g., ref <a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">35</a>) or transporter knockout rodents (e.g., ref <a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">36</a>) should help identify precisely the efflux transporters for which PRCBs serve as substrates.</div><div class="NLM_p">We also demonstrated that PRCBs such as <b>2</b>-<b>5u</b> have small effects on acute nociception compared to the brain-permeable <b>1</b> in the tail-flick assay in naı̈ve rats (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>D,H,L), yet at the same doses exhibit potent antiallodynic effects in SNE neuropathy. Previous studies have demonstrated increases in expression of both CB1R and CB2R in sensory ganglia after inflammation and peripheral nerve injuries.<a onclick="showRef(event, 'cit6a ref37'); return false;" href="javascript:void(0);" class="ref cit6a ref37">(6a, 37)</a> Increases in CBR expression result in increased potency or efficacy of the exogenously applied CBs;<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> such increases may also account for the effectiveness of CBs in alleviating neuropathic pain symptoms after chronic repeated treatment.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Thus, increases in CB1R and CB2R expression may potentially account for the increased potency/efficacy of PRCBs after SNE injury. An alternative explanation for the increased efficacy of <b>2</b>-<b>5u</b> in SNE involves alterations in blood–nerve barrier (BNB) function. Many of the BBB efflux transporters are also involved in maintaining BNB function.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> In normal conditions, these transporters may limit PRCB access to CBRs on nociceptors, which would account for the weak antinociceptive efficacy of PRCBs. However, there is growing evidence that chronic pain syndromes exhibit tissue abnormalities caused by microvasculature dysfunction in the blood vessels of skin, muscle, or nerve.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Such dysfunction, e.g., loosening of the tight junctions between the endoneurial endothelial cells,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> may increase PRCB access to CBRs on sensory neurons, thereby increasing their effectiveness in suppressing painful neuropathy symptoms.</div><div class="NLM_p last">Our binding studies revealed similar affinities of <b>2</b>-<b>5u</b> and related indenes for the CB1R and CB2R subtypes. However, subsequent Ca<sup>2+</sup> flux assays revealed that indene PRCBs are full agonists at hCB1R but only partial agonists at hCB2R (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). In vivo, pretreatment with the CB2R-selective inverse agonist, <b>3</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>), had only a small effect on suppression of allodynia by <b>2</b>-<b>5u</b>, while pretreatment with the brain-permeable CB1R-selective inverse agonist, rimonabant, or it is peripherally restricted analogue, <b>18A</b>,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> prevented the antiallodynic effect of <b>2</b>-<b>5u</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). These studies suggested that CB1Rs are mainly responsible for the antiallodynic effects of PRCBs. Previous studies with the brain-permeant synthetic CB, <b>4</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>), which has full agonist activity at both CB1R and CB2R, demonstrated that its antiallodynic effects in some neuropathy models were mediated primarily by CB1R activation,<a onclick="showRef(event, 'cit6c cit10a ref40'); return false;" href="javascript:void(0);" class="ref cit6c cit10a ref40">(6c, 10a, 40)</a> whereas in other models both CB1R and CB2R were involved.<a onclick="showRef(event, 'cit12d ref41'); return false;" href="javascript:void(0);" class="ref cit12d ref41">(12d, 41)</a> Further, our conclusions must be tempered by the fact that in vivo effects of inverse agonists such as rimonabant may be affected by changes in levels of endocannabinoids and their activation of CBRs in SNE neuropathy. Future studies using transgenic mice with deletions of CB1Rs and CB2Rs should be able to determine more precisely the relative contribution of CBR subtypes to the antiallodynic effects of PRCBs in different neuropathy models.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27865" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27865" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The hydrophobic PRCB compounds, which we developed, are the first in their class of high peripheral selectivity CB1R agonists to exhibit, after systemic or oral administration, potent, and repeated suppression of neuropathy symptoms with a lack of side effects mediated by activation of central CB1 receptors. The potency, peripheral selectivity, in vivo efficacy, and absence of CNS side effects of the PRCBs hold promise as a viable treatment for neuropathic pain states.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35181" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35181" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General</h3><div class="NLM_p"><sup>1</sup>H and <sup>13</sup>C NMR spectra were run on a Bruker Avance 300 MHz or a Varian Unity Inova 500 MHz NMR spectrometer. Mass spectra (MS) were run on a PerkinElmer Sciex API 150 EX mass spectrometer. High resolution mass spectra (HRMS) were run on a Waters Synapt G2 Q-TOF mass spectrometer in high-resolution mode. Column chromatography was carried out using a Teledyne Isco Combiflash Rf system with RediSep Rf silica cartridges. Preparative thin layer chromatography was carried out using Analtech TLC Uniplates (silica gel, 1000 mm, 20 cm × 20 cm). High pressure liquid chromatography was performed using a system consisting of a Waters 1525 pump unit, driven by Empower software, and a Waters 2487 detector. Microwave chemistry was carried out using a CEM Discover SP microwave with 10 mL irradiation tubes.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 4-Propylnaphthalene-1-carbonyl Chloride (<b>1</b>-<b>2b</b>)</h4><div class="NLM_p last">4-Propylnaphthalene-1-carboxylic acid (500 mg, 2.33 mmol) was dissolved in dichloromethane (15 mL) and cooled to 0 °C in an ice bath. Oxalyl chloride (1.49 g) was then added dropwise over 5 min. Once the addition was complete, the mixture was allowed to stir at room temperature for 45 min and then under reflux for 45 min. The solution was then cooled to room temperature. Removal of the solvent afforded 4-propylnaphthalene-1-carbonyl chloride (<b>1</b>-<b>2b</b>), which was used in the preparation of <b>1</b>-<b>3f</b> without further purification (assuming 542 mg, 100%).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Methyl 4-[(1<i>H</i>-Indol-3-yl)carbonyl]naphthalene-1-carboxylate (<b>1</b>-<b>3b</b>)</h4><div class="NLM_p last">Indole (<b>1</b>-<b>1</b>) (8.12 g, 98%, 0.068 mol) was dissolved in dichloromethane (150 mL), purged with nitrogen, and cooled to 0 °C in an ice bath. Methylmagnesium bromide (0.023 L, 3 M in ether, 0.069 mol) was added to the solution over 10 min and mixture stirred for an additional 10 min at 0 °C. Powdered ZnCl<sub>2</sub> (31.3 g, solid addition funnel) and anhydrous ether (80 mL, addition funnel) were then added over 10 min and the mixture stirred for an additional 10 min at 0 °C. The solution was allowed to warm to room temperature and stirred for 30 min. Methyl 4-(carbonochloridoyl)naphthalene-1-carboxylate (<b>1</b>-<b>2a</b>) (17.24 g, 0.069 mol) in CH<sub>2</sub>CL<sub>2</sub> (80 mL) was then added over several minutes and the solution stirred at room temperature overnight. Subsequently, saturated aqueous ammonium chloride solution (80 mL) was added and the mixture stirred for 15 min. The solid was removed by filtration and washed with water and ether. This solid was vacuumed dried to give the title product (11.97 g). The organic and aqueous layers of the filtrate were then separated. The organic layer was then washed with water, dried over sodium sulfate, and the solvent removed under reduced pressure. The residue was then triturated with a small amount of ether. The solid was removed by filtration and vacuumed dried to give additional product (8.36 g, 20.33 g total, 91%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 4.05 (s, 3H), 7.31–7.52 (m, 5H), 7.58–7.67 (m, 2H), 8.12 (d, <i>J</i> = 8.4 Hz, 1H), 8.18 (d, <i>J</i> = 7.4 Hz, 1H), 8.45–8.52 (m, 1H), 8.78 (br s, 1H), 8.91 (d, <i>J</i> = 8.6 Hz, 1H).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> X-Fluoro-3-[(naphthalen-1-yl)carbonyl]-1<i>H</i>-indole (X = 4–7) (<b>1</b>-<b>3e</b>–<b>h</b>)</h4><div class="NLM_p">These analogues were prepared by a similar method described for <b>1–3b</b> with variations of additional further extractions of the aqueous layer with ether or dichloromethane, drying, and trituration in dichloromethane or ether.</div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> 4-Fluoro-3-[(naphthalen-1-yl)carbonyl]-1<i>H</i>-indole (<b>1</b>-<b>3e</b>)</h5><div class="NLM_p last">4-Fluoroindole (<b>1</b>-<b>1b</b>) (2.03 g, 0.0147 mol) was dissolved in dichloromethane (60 mL) and cooled to 0 °C in an ice bath. Methylmagnesium bromide (0.005 L, 3 M in ether, 0.015 mol) was added to the solution, under nitrogen, over 5 min. The mixture was then stirred for 10 min at 0 °C, ZnCl<sub>2</sub> solution (0.0049 L, 1 M in ether, 0.0496 mol) added dropwise over 10 min, and the mixture stirred for an additional 10 min at 0 °C. The solution was allowed to warm to room temperature and stir for 30 min. 1-Naphthoyl chloride (<b>1</b>-<b>2e</b>) (0.002 L, 97%, 0.015 mol) was then added over several minutes and the solution stirred at room temperature overnight. Subsequently, saturated aqueous ammonium chloride solution (120 mL) was added and the mixture stirred for 30 min. The precipitate was removed by filtration, washed well with water, and dried under vacuum to give the title compound as an off-white solid (3.40 g, 80%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.95–7.05 (m, 1H), 7.23–7.33 (m, 1H), 7.38 (d, <i>J</i> = 8.0 Hz, 1C), 7.48–7.62 (m, 3H), 7.65–7.73 (m, 2H), 8.00–8.13 (m, 3H), 8.08–8.17 (m, 2H), 12.30 (s, 1H). <sup>13</sup>C NMR (75.5 MHz, DMSO-<i>d</i><sub>6</sub>) δ 107.51 (d, <i>J</i> = 20.8 Hz, 1C), 108.82 (d, <i>J</i> =<i>J</i> = 3.8 Hz, 1C), 113.37 (d, <i>J</i> = 21.2 Hz, 1C), 117.20 (d, <i>J</i> = 5.9 Hz, 1C), 124.15 (d, <i>J</i> = 7.5 Hz, 1C), 124.80, 125.28, 126.20 (2C), 126.75, 128.28, 129.91, 130.25, 133.25, 137.22, 138.81 (d, <i>J</i> = 2.3 Hz, 1C), 140.03 (d, <i>J</i> = 11.4 Hz, 1C), 155.88 (d, <i>J</i> = 251.0 Hz, 1C), 189.48.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> 5-Fluoro-3-[(naphthalen-1-yl)carbonyl]-1<i>H</i>-indole (<b>1</b>-<b>3f</b>)</h5><div class="NLM_p last">Off-white solid (3.37 g, 85%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.11–7.22 (m, 1H), 7.48–7.67 (m, 4H), 7.68–7.75 (m, 1H), 7.78 (s, 1H), 7.94–8.14 (m, 4H), 12.20 (s, 1H). <sup>13</sup>C NMR (75.5 MHz, DMSO-<i>d</i><sub>6</sub>) δ 106.28 (d, <i>J</i> = 24.6 Hz, 1C), 111.39 (d, <i>J</i> = 26.0 Hz, 1C), 113.71 (d, <i>J</i> = 9.8 Hz, 1C), 117.17 (d, <i>J</i> = 4.4 Hz, 1C), 124.88, 125.22, 125.73, 126.25, 126.44 (d, <i>J</i> = 11.0 Hz, 1C), 126.74, 128.27, 129.78, 129.99,133.29, 133.56, 138.01, 138.23, 158.83 (d, <i>J</i> = 234.9 Hz, 1C), 191.17.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> 6-Fluoro-3-[(naphthalen-1-yl)carbonyl]-1<i>H</i>-indole (<b>1</b>-<b>3g</b>)</h5><div class="NLM_p last">Light-pink solid (3.42 g total, 80%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.11–7.22 (m, 1H), 7.30–7.38 (m, 1H), 7.48–7.66 (m, 3H), 7.67–7.76 (m, 2H), 7.97–8.06 (m, 2H), 8.10 (d, <i>J</i> = 8.1 Hz, 1H), 8.25–8.36 (m, 1H), 12.12 (s, 1H). <sup>13</sup>C NMR (75.5 MHz, DMSO-<i>d</i><sub>6</sub>) δ 98.67 (d, <i>J</i> = 25.8 Hz, 1C), 110.44 (d, <i>J</i> = 23.9 Hz, 1C), 117.10, 122.52 (d, <i>J</i> = 1.7 Hz, 1C), 122.66, 124.86, 125.23, 125.75, 126.24, 126.74, 128.27, 129.76, 130.01, 133.28, 137.08 (d, <i>J</i> = 12.5 Hz, 1C), 137.35 (d, <i>J</i> = 1.9 Hz, 1C), 138.25, 159.46 (d, <i>J</i> = 237.4 Hz, 1C), 191.23.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> 7-Fluoro-3-[(naphthalen-1-yl)carbonyl]-1<i>H</i>-indole (<b>1</b>-<b>3h</b>)</h5><div class="NLM_p last">White solid (1.51 g total, 72%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.11–7.21 (m, 1H), 7.22–7.32 (m, 1H), 7.49–7.68 (m, 3H), 7.70–7.78 (m, 2H), 8.00–8.07 (m, 2H), 8.08–8.17 (m, 2H), 12.68 (s, 1H). <sup>13</sup>C NMR (75.5 MHz, DMSO-<i>d</i><sub>6</sub>) δ 108.30 (d, <i>J</i> = 15.8 Hz, 1C), 117.56 (d, <i>J</i> = 3.5 Hz, 1C), 117.91 (d, <i>J</i> = 1.3 Hz, 1C), 122.80 (d, <i>J</i> = 6.0 Hz, 1C), 124.76 (d, <i>J</i> = 13.3 Hz, 1C), 124.89, 125.19, 125.92, 126.26, 126.78, 128.30, 129.47 (d, <i>J</i> = 4.6 Hz, 1C), 129.92, 129.99, 133.31, 137.06, 138.18, 149.12 (d, <i>J</i> = 245.1 Hz, 1C), 191.34.</div></div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 4-Fluoro-3-[(4-propylnaphthalen-1-yl)carbonyl]-1<i>H</i>-indole (<b>1</b>-<b>3i</b>)</h4><div class="NLM_p last">4-Fluoroindole (<b>1</b>-<b>1b</b>) (1.47 mmol), methylmagnesium bromide (2.4 mmol), ZnCl<sub>2</sub> solution (1 M in ether, 8.0 mmol), and 4-propylnaphthalene-1-carbonyl chloride<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> (<b>1</b>-<b>2b</b>) (2.33 mmol) were similarly processed as for <b>1</b>-<b>3b</b>. White solid (440 mg total, 58%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.02 (t, <i>J</i> = 7.3 Hz, 3C), 1.67–1.82 (m, 2H), 3.09 (t, <i>J</i> = 7.4 Hz, 2C), 6.92–7.02 (m, 1H), 7.20–7.31 (m, 1H), 7.36 (d, <i>J</i> = 8.0 Hz, 1H), 7.42 (d, <i>J</i> = 7.2 Hz, 1H), 7.47–7.63 (m, 3H), 7.66 (s, 1H), 8.09 (d, <i>J</i> = 8.1 Hz, 1H), 8.17 (d, <i>J</i> = 8.3 Hz, 1H), 12.30 (s, 1H). <sup>13</sup>C NMR (75.5 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.99, 23.45, 34.47, 107.41 (d, <i>J</i> = 20.8 Hz, 1C), 108.80 (d, <i>J</i> = 3.7 Hz, 1C), 113.44 (d, <i>J</i> = 21.1 Hz, 1C), 117.31 (d, <i>J</i> = 5.9 Hz, 1C), 124.03 (d, <i>J</i> = 7.7 Hz, 1C), 124.12, 124.73, 126.07 (3C), 126.22, 130.75, 131.58, 137.00, 137.28 (d, <i>J</i> = 2.4 Hz, 1C), 140.02 (d, <i>J</i> = 11.4 Hz, 1C), 140.60, 155.90 (d, <i>J</i> = 251.1 Hz, 1C), 189.63.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Methyl 4-[(1-Pentyl-1<i>H</i>-indol-3-yl)carbonyl]naphthalene-1-carboxylate (<b>1</b>-<b>4a</b>)</h4><div class="NLM_p last">DMF (15 mL) was cooled to 0 °C, and sodium hydride (245 mg, 60% in mineral oil, 6.1 mmol) added over a few minutes. After the addition was complete, the mixture was stirred for an additional 10 min before adding a solution of methyl 4-[(1<i>H</i>-Indol-3-yl)carbonyl]naphthalene-1-carboxylate (<b>1</b>-<b>3b</b>) (1 g, 0.003 mol) in DMF (15 mL) dropwise. The solution was then stirred for 30 min at 0 °C. A solution of pentyl bromide (0.415 mL) in DMF (8 mL) was added and the mixture allowed to warm to room temperature and stirred overnight. The solvent was removed under reduced pressure and EtOAc (25 mL) and water (25 mL) added to the residue. The mixture was shaken and the organic layer removed and washed with water. The solvent was removed under reduced pressure and residue was columned over silica gel (Isco, gradient from 100% hexane to 30% EtOAc/70% hexane) to give the title product as an off-white solid (630 mg, 52%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 0.84 (t, <i>J</i> = 6.6 Hz, 3H), 1.17–1.37 (m, 4H), 1.72–1.88 (m, 2H), 3.98–4.10 (m, 5H), 7.23–7.29 (m, 1H), 7.32–7.43 (m, 3H), 7.44–7.54 (m, 1H), 7.68–7.78 (m, 2H), 8.09–8.17 (m, 1H), 8.20 (d, <i>J</i> = 7.4 Hz, 1H), 8.42–8.50 (m, 1H), 8.92 (d, <i>J</i> = 8.5 Hz, 1H).</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Ethyl 4-[(1<i>H</i>-Indol-3-yl)carbonyl]naphthalene-1-carboxylate (<b>1</b>-<b>4b</b>) and Ethyl 4-[(1-Pentyl-1<i>H</i>-indol-3-yl)carbonyl]naphthalene-1-carboxylate (<b>1</b>-<b>4c</b>)</h4><div class="NLM_p">DMF (150 mL) was cooled to 0 °C and sodium hydride (3.68 g, 60% in mineral oil, 0.092 mol) was added over several minutes. The mixture was then stirred for an additional 10 min, and a solution of methyl 4-[(1<i>H</i>-Indol-3-yl)carbonyl]naphthalene-1-carboxylate (<b>1</b>-<b>3b</b>) (15 g, 0.046 mol) in DMF (150 mL) was added dropwise. The solution was then stirred for 30 min at 0 °C. A solution of pentyl bromide (7.56 g, 0.05 mol) in DMF (75 mL) was added and the mixture allowed to warm to room temperature and stir overnight. The solvent was removed, EtOAc (100 mL) added to the residue, and the inorganic solid removed by filtration. Water (100 mL) was then added to the filtrate and the mixture stirred for 10 min. The organic layer was removed, dried over sodium sulfate, and the solvent removed under reduced pressure. The residue was purified over silica gel (Isco, gradient from 100% hexane to 30% EtOAc/70% hexane) to give the title compounds via transesterification as light-yellow solids.</div><div id="sec5_1_10_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> Ethyl 4-[(1<i>H</i>-Indol-3-yl)carbonyl]naphthalene-1-carboxylate (<b>1</b>-<b>4b</b>)</h5><div class="NLM_p last">Yield (3.0 g, 19%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.49 (t, <i>J</i> = 7.1 Hz, 3H), 4.52 (q, <i>J</i> = 7.1 Hz, 2H), 7.26 (s, 1H), 7.28–7.49 (m, 4H), 7.54–7.65 (m, 2H), 8.09 (d, <i>J</i> = 8.5 Hz, 1H), 8.15 (d, <i>J</i> = 7.4 Hz, 1H), 8.89 (d, <i>J</i> = 8.7 Hz, 1H), 8.89 (d, <i>J</i> = 8.7 Hz, 1H), 9.08 (broad s, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 14.40, 61.41, 11.60, 118.93, 122.56, 123.23, 123.77, 124.28, 125.73, 125.93, 126.29, 126.95, 127.93, 128.50, 129.23, 131.06, 131.52, 135.25, 136.60, 142.23, 167.40, 192.11.</div></div><div id="sec5_1_10_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> Ethyl 4-[(1-Pentyl-1<i>H</i>-indol-3-yl)carbonyl]naphthalene-1-carboxylate (<b>1</b>-<b>4c</b>)</h5><div class="NLM_p last">Yield (6.7 g, 36%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 0.84 (t, <i>J</i> = 6.8 Hz, 3H), 1.16–1.36 (m, 4H), 1.49 (t, <i>J</i> = 7.1 Hz, 3H), 1.71–1.85 (m, 2H), 4.04 (t, <i>J</i> = 7.2 Hz, 2H), 4.52 (q, <i>J</i> = 7.1 Hz, 2H), 7.27 (s, 1H), 7.32–7.45 (m, 3H), 7.46–7.53 (m, 1H), 7.58–7.69 (m, 2H), 8.14 (d, <i>J</i> = 8.2 Hz, 1H), 8.19 (d, <i>J</i> = 7.1 Hz, 1H), 8.43–8.53 (m, 1H) 8.92 (d, <i>J</i> = 8.6 Hz, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 13.84, 14.43, 22.15, 28.91, 29.45, 47.26, 61.36, 110.08, 117.41, 122.91, 123.10, 123.72, 123.81, 125.92, 126.48, 126.79, 126.87, 127.91, 128.59, 129.01, 131.18, 131.57, 137.12, 138.09, 143.65, 167.47, 191.31. HPLC 97% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 10 mM aqueous NH<sub>4</sub>OAc-CH<sub>3</sub>CN, 40:60, UV detection at 254 nm). HRMS: calculated for C<sub>27</sub>H<sub>28</sub>NO<sub>3</sub> (M + H) 414.2069, found 414.2063 (M + H).</div></div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>-(3-Ethoxycarbonylpropyl)-3-(1-naphthoyl)-1<i>H</i>-indole (<b>1</b>-<b>4d</b>)</h4><div class="NLM_p last">To a vacuum-dried flask under N<sub>2</sub> was added NaH (60% dispersion in oil, 9.1 mmol, 0.37 mg) and the flask was cooled to 0 °C and dry DMF (29 mL) was added. The mixture was stirred for 10 min and a solution of 3-(1-naphthoyl)indole<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (2.0 g, 0.00729 mol) in DMF (28 mL) was added dropwise over 30 min. After complete addition, the mixture was stirred an additional 30 min and then a solution of ethyl bromobutyrate (3.55 g, 0.0182 mol) in 14 mL of DMF was added over 15 min and the reaction mixture was allowed to warm to room temperature overnight. TLC (SiO<sub>2</sub>; hexane/EtOAc (10:1)) showed the consumption of starting material. The DMF was removed under reduced pressure, and the resulting residue was partitioned between water (100 mL) and EtOAc (3 × 100 mL) followed by CH<sub>2</sub>Cl<sub>2</sub> (2 × 100 mL). The organics were combined, the solvent removed in vacuo, and the residual material was chromatographed on an Isco 80 g silica column eluting with a gradient from hexanes (100%) to hexane/EtOAc (7:3) that afforded the desired compound in 92% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.08 (t, <i>J</i> = 7.13 Hz, 3H), 1.93–2.08 (m, 2H), 2.10–2.22 (m, 2H), 3.91–4.11 (m, 4H), 7.19–7.48 (m, 7H), 7.55 (d, <i>J</i> = 6.9 Hz, 1H), 7.80 (d, <i>J</i> = 7.5 Hz, 1H), 7.86 (d, <i>J</i> = 8.2 Hz, 1H), 8.09 (d, <i>J</i> = 8.0 Hz, 1H), 8.37–8.47 (m, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 14.11, 24.97, 30.77, 46.05, 60.68, 109.92, 117.89, 122.98, 123.01, 123.80, 124.54, 125.82, 125.95, 126.28, 126.76, 127.01, 128.17, 130.01, 130.79, 133.77, 137.00, 137.80, 139.00, 172.31, 192.00.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>-(3-Ethoxycarbonylbutyl)-3-(1-naphthoyl)-1<i>H</i>-indole (<b>1</b>-<b>4e</b>)</h4><div class="NLM_p last">Prepared as for the ethoxycarbonylpropyl analogue <b>1</b>-<b>4d</b> from ethyl bromovalerate (0.160 mL, 1.014 mmol) afforded 85% of the title compound. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.09 (t, <i>J</i> = 7.1 Hz, 3H), 1.41–1.55 (m, 2H), 1.65–1.81 (m, 2H), 2.16 (t, <i>J</i> = 7.2 Hz, 3H), 3.90–4.06 (m, 4H), 7.21–7.48 (m, 7H), 7.55 (d, <i>J</i> = 7.0 Hz, 1H), 7.79 (d, <i>J</i> = 7.7 Hz, 1H), 7.85 (d, <i>J</i> = 8.2 Hz, 1H), 8.09 (d, <i>J</i> = 8.1 Hz, 1H), 8.36–8.44 (m, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 14.17, 22.14, 29.21, 33.52, 46.82, 60.43, 109.87, 117.77, 122.91, 123.02, 123.70, 124.56, 125.84, 125.98, 126.28, 126.75, 127.05, 128.17, 129.98, 130.81, 133.78, 136.99, 137.69, 139.07, 172.81, 191.97</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>N</i>-(3-Carboxypropyl)-3-(1-naphthoyl)-1<i>H</i>-indole (<b>1</b>-<b>4f</b>)</h4><div class="NLM_p last">Ester <b>1</b>-<b>4d</b> (50 mg) was then treated with sodium hydroxide and water:methanol (1:1) mixture and heated to 50 °C for 2 h. Cooling and treatment with 2 N HCl, extraction with ethyl acetate, and drying with magnesium sulfate followed by filtration and concentration provided the desired acid for testing purposes in yields of 96%. <sup>1</sup>H NMR (300 MHz, <sub>3</sub>acetonitrile-<i>d</i><sub>3</sub>) δ 1.96–2.10 (m, 2H), 2.17–2.29 (m, 2H), 4.19 (d, <i>J</i> = 7.1 Hz, 2H), 7.30–7.43 (m, 2H), 7.46–7.63 (m, 5H), 7.67–7.75 (m, 1H), 7.95–8.14 (m, 3H), 8.36–8.46 (m, 1H). <sup>13</sup>C NMR (75.5 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ 24.44, 29.66, 45.47, 110.35, 116.70, 121.84, 122.35, 123.23, 124.55, 125.26, 125.64, 126.01, 126.41, 126.64, 127.97, 129.46, 130.27, 133.46, 136.91, 138.69, 138.75, 172.89, 191.34. EIMS: calculated for C<sub>23</sub>H<sub>19</sub>NO<sub>3</sub> 357.40, found 358.4 (M + H).</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>-(3-Carboxybutyl)-3-(1-naphthoyl)-1<i>H</i>-indole (<b>1</b>-<b>4g</b>)</h4><div class="NLM_p last">Prepared as for the above carboxypropyl analogue from the corresponding ester in 78% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.45–1.58 (m, 2H), 1.71–1.84 (m, 2H), 2.24 (t, <i>J</i> = 7.2 Hz, 2H), 3.97–4.05 (m, 2H), 7.24–7.48 (m, 7H), 7.57 (d, <i>J</i> = 6.7 Hz, 1H), 7.78–7.92 (m, 2H), 8.10 (d, <i>J</i> = 8.1 Hz, 1H), 8.37–8.44 (m, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 21.84, 29.11, 33.14, 46.75, 109.85, 117.77, 122.97, 123.01, 123.74, 124.56, 125.87, 125.94, 126.26, 126.76, 127.00, 128.17, 130.03, 130.77, 133.74, 136.97, 137.77, 138.96, 178.13, 192.14. EIMS: calculated for C<sub>24</sub>H<sub>21</sub>NO<sub>3</sub> 371.43, found 372.1 (M + H).</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> X-Fluoro-3-[(naphthalen-1-yl)carbonyl]-1-alkyl-1<i>H</i>-indole (X = 4–7) (<b>1</b>-<b>4h</b>–<b>m</b>)</h4><div class="NLM_p">These analogues were prepared by the same method described for <b>1</b>-<b>4h</b> on the same or 55, 55, 59, and 25% scale (<b>1</b>-<b>4k</b>–<b>n</b>).</div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> 4-Fluoro-3-[(naphthalen-1-yl)carbonyl]-1-pentyl-1<i>H</i>-indole (<b>1</b>-<b>4h</b>)</h5><div class="NLM_p last">Sodium hydride (207 mg, 60% in oil, 5.18 mmol) was added to DMF (20 mL) at 0 °C and the mixture stirred for 10 min. A solution of 4-fluoro-3-[(naphthalen-1-yl)carbonyl]-1<i>H</i>-indole (<b>1</b>-<b>3e</b>) (750 mg, 2.59 mmol) in DMF (10 mL) was added dropwise over 5 min and the resulting solution stirred at 0 °C for 30 min. A solution of 1-bromopentane (431 mg, 2.85 mmol) in DMF (1 mL) was then added dropwise to the stirred mixture. Cooling was continued for an additional 10 min before allowing the solution to warm to room temperature and stir overnight. The reaction was quenched with water (75 mL), and EtOAc (50 mL) was added. The mixture was shaken and the organic layer removed. The aqueous layer was then extracted with additional EtOAc (50 mL). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent removed under reduced pressure. The residue was purified over silica gel (Isco, 120 g column, gradient from 100% hexane to 30% EtOAc/70% hexane) to give the title compound as a colorless resin (760 mg, 82%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 0.85 (t, <i>J</i> = 6.8 Hz, 3H), 1.15–1.38 (m, 4H), 1.72–1.87 (m, 2H), 4.04 (t, <i>J</i> = 7.2 Hz, 2H), 6.93–7.03 (m, H), 7.16 (d, <i>J</i> = 8.0 Hz, 1H), 7.22–7.30 (m, 1H), 7.33 (s, 1H), 7.43–7.55 (m, 3H), 7.63–7.70 (m, 1H), 7.85–7.93 (m, 1H), 7.97 (d, <i>J</i> = 8.3 Hz, 1H), 8.23–8.31 (m, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 13.83, 22.14, 28.86, 29.32, 47.43, 106.11 (d, <i>J</i> = 4.1 Hz, 1C), 108.48 (d, <i>J</i> = 21.5 Hz, 1C), 114.91 (d, <i>J</i> = 21.2 Hz, 1C), 117.64 (d, <i>J</i> = 5.8 Hz, 1C), 124.33 (d, <i>J</i> = 8.0 Hz, 1C), 124.41, 126.08, 126.26, 126.75, 126.86, 128.18, 130.40, 131.07, 133.74, 138.12, 139.09 (d, <i>J</i> = 2.7 Hz, 1C), 139.91 (d, <i>J</i> = 11.0 Hz, 1C), 157.03 (d, <i>J</i> = 254.0 Hz, 1C), 190.34. HPLC 99% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, H<sub>2</sub>O–CH<sub>3</sub>CN, 35:65, UV detection at 254 nm). HRMS: calculated for C<sub>24</sub>H<sub>23</sub>NOF (M + H) 360.1764, found 360.1760 (M + H).</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 5-Fluoro-3-[(naphthalen-1-yl)carbonyl]-1-pentyl-1<i>H</i>-indole (<b>1</b>-<b>4i</b>)</h5><div class="NLM_p last">Colorless resin (760 mg, 81%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 0.85 (t, <i>J</i> = 6.8 Hz, 3H), 1.17–1.38 (m, 4H), 1.71–1.88 (m, 2H), 4.05 (t, <i>J</i> = 7.2 Hz, 2H), 7.04–7.14 (m, 2H), 7.37 (s, 1H), 7.43–7.57 (m, 3H), 7.61–7.68 (m, 1H), 7.87–7.94 (m, 1H), 7.98 (d, <i>J</i> = 8.2 Hz, 1H), 8.13–8.21 (m, 1H), 8.39–8.48 (m, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 13.83, 22.14, 28.89, 29.48, 47.46, 108.33 (d, <i>J</i> = 24.8 Hz, 1C), 110.76 (d, <i>J</i> = 9.8 Hz, 1C), 112.00 (d, <i>J</i> = 26.7 Hz, 1C), 117.50 (d, <i>J</i> = 4.5 Hz, 1C), 124.54, 125.82, 125.91, 126.36, 126.84, 127.75 (d, <i>J</i> = 11.7 Hz, 1C), 128.21, 130.12, 130.76, 133.57, 133.80, 138.68, 138.84, 159.92 (d, <i>J</i> = 238.7 Hz, 1C), 191.73. HPLC 99% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, H<sub>2</sub>O–CH<sub>3</sub>CN, 35:65, UV detection at 254 nm). HRMS: calculated for C<sub>24</sub>H<sub>23</sub>NOF (M + H) 360.1764, found 360.1763 (M + H).</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 6-Fluoro-3-[(naphthalen-1-yl)carbonyl]-1-pentyl-1<i>H</i>-indole (<b>1</b>-<b>4j</b>)</h5><div class="NLM_p last">Colorless resin (840 mg, 90%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 0.85 (t, <i>J</i> = 6.8 Hz, 3H), 1.18–1.40 (m, 4H), 1.72–1.87 (m, 2H), 4.00 (t, <i>J</i> = 7.2 Hz, 2H), 7.02–7.16 (m, 2H), 7.32 (s, 1H), 7.43–7.58 (m, 3H), 7.61–7.69 (m, 1H), 7.87–7.95 (m, 1H), 7.98 (d, <i>J</i> = 8.2 Hz, 1H), 8.14–8.22 (m, 1H), 8.39–8.48 (m, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 13.82, 22.15, 28.88, 29.35, 47.32, 96.64 (d, <i>J</i> = 26.9 Hz, 1C), 111.34 (d, <i>J</i> = 23.9 Hz, 1C), 117.70, 123.38, 124.09 (d, <i>J</i> = 10.1 Hz, 1C), 124.51, 125.89, 125.93, 126.35, 126.83, 128.21, 130.13, 130.80, 133.79, 137.31 (d, <i>J</i> = 11.6 Hz, 1C), 138.13 (d, <i>J</i> = 2.9 Hz, 1C), 138.83, 160.57 (d, <i>J</i> = 241.0 Hz, 1C), 191.88. HPLC 99% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, H<sub>2</sub>O–CH<sub>3</sub>CN, 35:65, UV detection at 254 nm). HRMS: calculated for C<sub>24</sub>H<sub>23</sub>NOF (M + H) 360.1764, found 360.1758 (M + H).</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> 7-Fluoro-3-[(naphthalen-1-yl)carbonyl]-1-pentyl-1<i>H</i>-indole (<b>1</b>-<b>4k</b>)</h5><div class="NLM_p last">Colorless resin (430 mg, 83%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 0.85 (t, <i>J</i> = 6.7 Hz, 3H), 1.17–1.38 (m, 4H), 1.72–1.88 (m, 2H), 4.20 (t, <i>J</i> = 7.2 Hz, 2H), 6.97–7.08 (m, 1H), 7.20–7.31 (m, 2H), 7.43–7.58 (m, 3H), 7.61–7.68 (m, 1H), 7.87–7.94 (m, 2H), 8.13–8.21 (m, 1H), 8.27 (d, <i>J</i> = 8.0 Hz, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 13.84, 22.14, 28.65, 30.83 (d, <i>J</i> = 2.0 Hz, 1C), 50.0 (d, <i>J</i> = 5.1 Hz, 1C), 109.47 (d, <i>J</i> = 18.2 Hz, 1C), 118.02, 118.67 (d, <i>J</i> = 3.6 Hz, 1C), 123.31 (d, <i>J</i> = 6.5 Hz, 1C), 124.54, 124.88 (d, <i>J</i> = 7.5 Hz, 1C), 125.91 (2C), 126.37, 126.86, 128.22, 130.18, 130.72, 130.76, 133.79, 138.89, 139.08, 149.89 (d, <i>J</i> = 245.3 Hz, 1C), 191.89. HPLC 99% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, H<sub>2</sub>O–CH<sub>3</sub>CN, 35:65, UV detection at 254 nm). HRMS: calculated for C<sub>24</sub>H<sub>23</sub>NOF (M + H) 360.1764, found 360.1763 (M + H).</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> 4-Fluoro-1-(5-fluoropentyl)-3-[(naphthalen-1-yl)carbonyl]-1<i>H</i>-indole (<b>1</b>-<b>4l</b>)</h5><div class="NLM_p last">Colorless resin (150 mg, 28%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.32–1.46 (m, 2H), 1.55–1.76 (m, 2H), 1.77–1.92 (m, 2H), 4.07 (t, <i>J</i> = 7.2 Hz, 2H), 4.29 (t, <i>J</i> = 7.2 Hz, 1H), 4.45 (t, <i>J</i> = 5.8 Hz, 1H), 6.93–7.03 (m, 1H), 7.16 (d, <i>J</i> = 8.1 Hz, 1H), 7.22–7.31 (m, 1H), 7.33 (s, 1H), 7.43–7.55 (m, 3H), 7.63–7.69 (m, 1H), 7.85–7.92 (m, 1H), 7.96 (d, <i>J</i> = 8.2 Hz, 1H), 8.22–8.29 (m, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 22.76 (d, <i>J</i> = 4.9 Hz, 1C), 29.31, 29.82 (d, <i>J</i> = 19.8 Hz, 1C), 47.27, 83.51(d, <i>J</i> = 165.1 Hz, 1C), 106.04 (d, <i>J</i> = 4.0 Hz, 1C), 108.54 (d, <i>J</i> = 21.3 Hz, 1C), 114.92 (d, <i>J</i> = 21.2 Hz, 1C), 117.79 (d, <i>J</i> = 5.8 Hz, 1C), 124.43, 124.45 (d, <i>J</i> = 7.8 Hz, 1C), 126.04, 126.28, 126.79, 126.87, 128.21, 130.46, 131.05, 133.75, 137.99, 139.00 (d, <i>J</i> = 2.8 Hz, 1C), 139.85 (d, <i>J</i> = 11.0 Hz, 1C), 157.05 (d, <i>J</i> = 254.3 Hz, 1C), 190.31. HPLC 98% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, H<sub>2</sub>O–CH<sub>3</sub>CN, 35:65, UV detection at 254 nm). HRMS: calculated for C<sub>24</sub>H<sub>22</sub>NOF<sub>2</sub> (M + H) 378.1669, found 378.1671 (M + H).</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> 4-Fluoro-1-[2-(morpholin-4-yl)ethyl]-3-[(naphthalen-1-yl)carbonyl]-1<i>H</i>-indole (<b>1</b>-<b>4m</b>)</h5><div class="NLM_p last">Light-yellow liquid (420 mg, 69%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.34 (t, <i>J</i> = 4.6 Hz, 4H), 2.65 (t, <i>J</i> = 6.2 Hz, 2H), 3.49 (t, <i>J</i> = 4.5 Hz, 4H), 4.11 (t, <i>J</i> = 6.2 Hz, 2H), 6.95–7.04 (m, 1H), 7.15 (d, <i>J</i> = 8.1 Hz, 1H), 7.21–7.32 (m, 1H), 7.42 (s, 1H), 7.39–7.55 (m,3H), 7.62–7.69 (m, 1H), 7.86–7.93 (m, 1H), 7.96 (d, <i>J</i> = 8.0 Hz, 1H), 8.19–8.27 (m, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 42.10, 51.32 (2C), 55.01, 64.54 (2C), 103.57 (d, <i>J</i> = 3.8 Hz, 1C), 106.39 (d, <i>J</i> = 21.3 Hz, 1C), 112.48 (d, <i>J</i> = 21.3 Hz, 1C), 115.46 (d, <i>J</i> = 5.9 Hz, 1C), 122.13, 122.25, 123.79, 124.06, 124.27, 124.62, 125.97, 128.07, 128.77, 131.48, 136.91 (d, <i>J</i> = 2.7 Hz, 1C), 137.12, 137.70 (d, <i>J</i> = 11.1 Hz, 1C), 154.85 (d, <i>J</i> = 254.3 Hz, 1C), 188.03. HPLC 99% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 10 mM aqueous NH<sub>4</sub>OAc-CH<sub>3</sub>CN, 45:55, UV detection at 254 nm). HRMS: calculated for C<sub>25</sub>H<sub>24</sub>N<sub>2</sub>O<sub>2</sub>F (M + H) 403.1822, found 403.1830 (M + H).</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 4-Fluoro-1-(5-fluoropentyl)-3-[(4-propylnaphthalen-1-yl)carbonyl]-1<i>H</i>-indole (<b>1</b>-<b>4n</b>)</h5><div class="NLM_p last">Light-yellow liquid (68 mg, 24%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.06 (t, <i>J</i> = 7.3 Hz, 3H), 1.33–1.46 (m, 2H), 1.56–1.75 (m, 2H), 1.76–1.91 (m, 4H), 3.11 (t, <i>J</i> = 7.5 Hz, 2H), 4.07 (t, <i>J</i> = 7.1 Hz, 2H), 4.30 (t, <i>J</i> = 5.8 Hz, 1H), 4.46 ((t, <i>J</i> = 5.9 Hz, 1H), 6.94–7.03 (m, 1H), 7.16 (d, <i>J</i> = 8.1 Hz, 1H), 7.23–7.29 (m, 1H), 7.30–7.37 (m, 2H), 7.43–7.57 (m, 2H), 7.58–7.62 (m, 2H), 8.11 (d, <i>J</i> = 8.0 Hz, 1H), 8.28–8.36 (m, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 14.29, 22.77 (d, <i>J</i> = 5.0 Hz, 1C), 29.33, 29.83 (d, <i>J</i> = 19.7 Hz, 1C), 35.50, 47.24, 83.51 (d, <i>J</i> = 165.1 Hz, 1C), 105.97 (d, <i>J</i> = 3.9 Hz, 1C), 108.33, 108.61, 115.01 (d, <i>J</i> = 21.2 Hz, 1C), 117.97 (d, <i>J</i> = 5.8 Hz, 1C), 118.01, 124.03, 124.36 (d, <i>J</i> = 7.9 Hz, 1C), 124.50, 126.01, 126.33, 126.80, 126.82, 131.49, 132.21, 137.35 (d, <i>J</i> = 2.6 Hz, 1C), 139.76, 139.90, 141.66, 157.08 (d, <i>J</i> = 254.4 Hz, 1C), 190.54. HPLC 99% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, H<sub>2</sub>O–CH<sub>3</sub>CN, 35:65, UV detection at 254 nm). HRMS: Calculated for C<sub>27</sub>H<sub>28</sub>NOF<sub>2</sub> (M + H) 420.2139, found, 420.2151 (M + H).</div></div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 4-(2-Iodoethyl)morpholine (<b>1</b>-<b>5</b>, X = I)</h4><div class="NLM_p last">4-(2-Chloroethyl)morpholine hydrochloride (5 g, 0.0269 mol) and sodium iodide (20 g, 0.1334 mol) were placed in acetone (50 mL) and refluxed for 16 h. Chloroform (50 mL) and brine solution (50 mL) were then added and the mixture stirred for 10 min. The solid was removed by filtration and added to a mixture of chloroform (50 mL) and saturated sodium bicarbonate solution (50 mL). The mixture was stirred for 5 min and the organic layer removed. The aqueous layer was then extracted with additional chloroform (2 × 25 mL). The organic layers were combined, washed with brine, and dried over sodium sulfate. The solvent was removed under reduced pressure to give the title product as a yellow oil (3.05 g, 47%), which contained approximately 5% 4-(2-chloroethyl)morpholine. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.49 (t, <i>J</i> = 4.7 Hz, 4H), 2.72 (t, <i>J</i> = 7.6 Hz, 2H), 3.21 (t, <i>J</i> = 7.6 Hz, 2H), 3.71 (t, <i>J</i> = 4.7 Hz, 4H).</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 4-[(1-Pentyl-1<i>H</i>-indol-3-yl)carbonyl]naphthalene-1-carboxylic Acid (<b>1</b>-<b>7a</b>)</h4><div class="NLM_p last">Ethyl 4-[(1-pentyl-1<i>H</i>-indol-3-yl)carbonyl]naphthalene-1-carboxylate (<b>1</b>-<b>4c</b>) (3.0 g, 0.0073 mol) was dissolved in dioxane (50 mL). Sodium hydroxide solution (5N, 50 mL) was added and the mixture refluxed for 3 h. The solution was then allowed to cool to room temperature and stir overnight. The layers were separated and the solvent removed from the organic layer. The resulting residue was dissolved in water (50 mL) and extracted with EtOAc (2 × 50 mL) to remove unreacted starting material. The pH of the aqueous layer was then adjusted to 3 by the addition of HCl solution (1N) and extracted with EtOAc (2 × 50 mL). The organic layers were combined and dried over sodium sulfate. The solvent was removed under reduced pressure to give the title compound as a golden foam (2.05 g, 73%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 0.85 (t, <i>J</i> = 6.7 Hz, 3H), 1.18–1.38 (m, 4H), 1.74–1.87 (m, 2H), 4.06 (t, <i>J</i> = 6.7 Hz, 2H), 7.31 (s, 1H), 7.34–7.45 (m, 3H), 7.48–7.57 (m, 1H), 7.63–7.72 (m, 2H), 8.17 (d, <i>J</i> = 8.4 Hz, 1H), 8.43 (d, <i>J</i> = 7.4 Hz, 1H), 8.45–8.53 (m, 1H), 9.11 (d, <i>J</i> = 8.7 Hz, 1H), OH proton not observed.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-Methyl-4-[(1-pentyl-1<i>H</i>-indol-3-yl)carbonyl]naphthalene-1-carboxamide (<b>1</b>-<b>7b</b>)</h4><div class="NLM_p last">4-[(1-Pentyl-1<i>H</i>-indol-3-yl)carbonyl]naphthalene-1-carboxylic acid (<b>1</b>-<b>7a</b>) (830 mg, 2.15 mmol) was dissolved in THF (50 mL) and cooled in an ice bath. Oxalyl chloride (0.6 mL) was then added dropwise to the stirred solution under nitrogen. After the addition was complete (2 min), the mixture was stirred an additional 10 min at 0 °C and then at room temperature overnight. Subsequently, the solvent was removed under reduced pressure and the residue redissolved in THF (50 mL). The resulting solution was cooled to 0 °C in an ice bath, aqueous methylamine (1.5 mL, 40%) added, and the mixture stirred at 0 °C for 15 min. The ice bath was removed and the solution stirred at room temperature for 5 min. The solvent was removed under reduced pressure and the residue partitioned between EtOAc (75 mL) and water (75 mL). The organic layer was removed and the aqueous layer extracted with additional EtOAc (50 mL). The organic layers were combined, washed with brine, and dried over anhydrous sodium sulfate. The solvent was removed under reduced pressure and the residue purified over silica gel (Isco, gradient from 100% hexane to 60% EtOAc/40% hexane) to give the title compound as a golden foam (750 mg, 87%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 0.83 (t, <i>J</i> = 6.8 Hz, 3H), 1.15–1.35 (m, 4H), 1.71–1.83 (m, 2H), 3.12 (d, <i>J</i> = 4.9 Hz, 3H), 4.03 (t, <i>J</i> = 7.1 Hz, 2H), 6.44–6.55 (m, 1H), 7.23 (s, 1H), 7.32–7.52 (m, 7H), 8.08 (d, <i>J</i> = 8.3 Hz, 1H), 8.26 (d, <i>J</i> = 8.6 Hz, 1H), 8.43–8.52 (m, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 13.84, 22.14, 26.90, 28.90, 29.40, 47.24, 110.10, 117.36, 122.82, 123.08, 123.61, 123.78, 124.08, 125.65, 126.23, 126.79, 127.06, 127.35, 130.36, 130.97, 136.20, 137.12, 138.44, 141.23, 170.08, 191.58. HPLC 98% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 10 mM aqueous NH<sub>4</sub>OAc–CH<sub>3</sub>CN, 40:60, UV detection at 254 nm). HRMS: calculated for C<sub>26</sub>H<sub>27</sub>N<sub>2</sub>O<sub>2</sub> (M + H) 399.2073, found 399.2069 (M + H).</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 4-[(1-Pentyl-1<i>H</i>-indol-3-yl)carbonyl]naphthalene-1-carboxamide (<b>1</b>-<b>7c</b>)</h4><div class="NLM_p last">Prepared as for <b>1</b>-<b>7b</b> with aqueous ammonium hydroxide (1.5 mL, 30%) and similarly chromatographed on silica gel (Isco, gradient from 100% hexane to 70% EtOAc/30% hexane) to give the title compound as a white solid (810 mg, 81%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 0.83 (t, <i>J</i> = 6.6 Hz, 3H), 1.14–1.36 (m, 4H), 1.70–1.84 (m, 3H), 4.03 (t, <i>J</i> = 7.2 Hz, 2H), 6.27 (broad s, 1H), 6.47 (broad s, 1H), 7.25 (s, 1H), 7.31–7.61 (m, 6H), 7.68 (d, <i>J</i> = 7.2 Hz, 1H), 8.10 (d, <i>J</i> = 8.4 Hz, 1H), 8.38 (d, <i>J</i> = 8.3 Hz, 1H), 8.43–8.52 (m, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 13.84, 22.14, 28.89, 29.41, 47.26, 110.11, 117.34, 122.83, 123.12, 123.82, 123.99, 124.06, 125.63, 126.32, 126.78, 127.16, 127.56, 130.27, 131.04, 134.80, 137.13, 138.37, 141.75, 171.40, 191.43. HPLC 98% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 10 mM aqueous NH<sub>4</sub>OAc–CH<sub>3</sub>CN, 40:60, UV detection at 254 nm). HRMS: calculated for C<sub>25</sub>H<sub>25</sub>N<sub>2</sub>O<sub>2</sub> (M + H) 385.1916, found 385.1920 (M + H).</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 1-{4-[(1-Pentyl-1<i>H</i>-indol-3-yl)carbonyl]naphthalen-1-yl}<sup>34</sup>propan-1-one (<b>1</b>-<b>7d</b>)</h4><div class="NLM_p last">4-[(1-Pentyl-1<i>H</i>-indol-3-yl)carbonyl]naphthalene-1-carboxylic acid (<b>1</b>-<b>7a</b>) (830 mg, 2.15 mmol) was dissolved in THF (40 mL). DMF (0.2 mL) was added and the mixture purged with nitrogen. Oxalyl chloride (0.8 mL) was then added dropwise to the stirred solution over several minutes. After the addition was complete, the mixture was stirred at room temperature overnight. At the end of this time, the mixture was filtered to remove a small amount of solid material and the solvent removed from the filtrate under reduced pressure. The residue was dissolved in toluene (40 mL), and the resulting solution was cooled to 0 °C in a ice bath. Diethyl zinc (5.18 mL, 1 M in hexanes, 5.18 mmol) was then added over 2 min and the mixture stirred at 0 °C for an additional 10 min. The ice bath was removed and the solution stirred at room temperature for 4.5 h. The reaction was quenched with saturated ammonium chloride solution (40 mL total) and EtOAc (40 mL) was added. The mixture was stirred for 20 min, the organic layer removed, and the aqueous layer extracted with additional EtOAc (40 mL). The organic layers were combined, and the solvent was removed under reduced pressure. The reaction was repeated using 410 mg of <b>1</b>-<b>7a</b> (1.24 g total between the two reactions) and the material from both reactions combined. The residue was initially purified over silica gel (Isco, 120 g column, gradient from 100% hexane to 30% EtOAc/70% hexane) and subsequently twice by preparative thin layer chromatography (silica, 20 cm × 20 cm plate, 1000 μm, dichloromethane). A final purification by preparative thin layer chromatography (15% EtOAc/85% hexane) afforded the title compound as an off-white solid (two fractions: 11.6 mg, 98% pure by HPLC, 0.91%; 6.2 mg, 98% pure by HPLC, 0.48%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 0.83 (t, <i>J</i> = 6.7 Hz, 3H), 1.19–1.37 (m, 4H), 1.32 (t, <i>J</i> = 7.2 Hz, 3H),1.73–1.86 (m, 2H), 3.12 (q, <i>J</i> = 7.3 Hz, 2H), 4.05 (t, <i>J</i> = 7.2 Hz, 2H), 7.28 (s, 1H), 7.32–7.43 (m, 3H), 7.44–7.53 (m, 1H), 7.54–7.66 (m, 2H), 7.82 (d, <i>J</i> = 7.3 Hz, 1H), 8.13 (d, <i>J</i> = 8.4 Hz, 1H), 8.42–8.52 (m, 2H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 8.58, 13.83, 22.14, 28.91, 29.45, 35.91, 47.26, 110.06, 117.39, 122.91, 123.10, 123.70, 123.81, 125.15, 125.76, 126.43, 126.79. 127.08, 127.93, 130.30. 131.30, 137.12, 138.11, 138.21, 142.73. 191.29, 205.75. HPLC (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, H<sub>2</sub>O–CH<sub>3</sub>CN, 35:65, UV detection at 254 nm). HRMS: calculated for C<sub>27</sub>H<sub>28</sub>NO<sub>2</sub> (M + H) 398.2120; found 398.2131 (M + H).</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 4-[2-(1<i>H</i>-Inden-3-yl)ethyl]morpholine (<b>2</b>-<b>3</b>)</h4><div class="NLM_p last">Indene (<b>2</b>–<b>1</b>) (10 g, 0.086 mol) was dissolved in anhydrous THF (130 mL) and the solution cooled in a dry ice/acetonitrile bath. nBuLi (0.0538 L, 1.6 M in hexane, 0.0861 mol) was then added dropwise over 10 min. The cooling was continued for 10 min, the bath removed, and the solution stirred at room temperature for 20 min. The mixture was again cooled in a dry ice/acetonitrile bath and 4-(2-chloroethyl)morpholine (<b>2</b>-<b>2</b>) (12.89 g, 0.0861 mmol) added dropwise over 10 min. The cooling was continued for 10 min, the bath removed, and the solution stirred overnight at room temperature. The mixture was quenched with methanol (20 mL) and the solvent removed under reduced pressure. The residue was partitioned between CH<sub>2</sub>CL<sub>2</sub> (50 mL) and water (50 mL). The organic layer was removed and the aqueous layer extracted with additional CH<sub>2</sub>Cl<sub>2</sub> (50 mL). The organic layers were combined, filtered through Celite, and the solvent removed under reduced pressure to give a crude mixture of (<b>1-yl</b>) and (<b>3-yl</b><b>2</b>-<b>3</b>). The residue was dissolved in dioxane (75 mL) and NaOH solution (4N, 75 mL) added to the mixture. The resulting solution was then heated under reflux for 5 h. Subsequently, the organic layer was removed and EtOAc (50 mL) and water (50 mL) added to the aqueous layer. The resulting mixture was shaken, the organic layer removed, and the aqueous layer extracted with additional EtOAc (2 × 25 mL). The organic layers were combined, washed with water, and dried over sodium sulfate. The solvent was removed under reduced pressure and residue was columned over silica gel (Isco, gradient from 100% hexane to 80% EtOAc/20% hexane) to give recovered indene (890 mg) and the title product (<b>2</b>-<b>3</b>) as a yellow oil (8.92 g, 45%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.56 (t, <i>J</i> = 4.6 Hz, 4H), 2.66–2.83 (m, 4H), 3.33 (d, <i>J</i> = 4.7 Hz, 2H), 3.77 (t, <i>J</i> = 4.7 Hz, 4H), 6.26 (s, 1H), 7.17–7.24 (m, 1H), 7.26–7.34 (m, 1H), 7.35–7.41 (m, 1H), 7.46 (d, <i>J</i> = 7.3 Hz, 1H).</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 4-Ethylnaphthalene-1-carbaldehyde (<b>2</b>-<b>4t</b>)</h4><div class="NLM_p last">Prepared as for <b>2</b>-<b>4u</b> in 51% yield. Light-brown oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.41 (t, <i>J</i> = 7.5 Hz, 3H), 3.18 (q, <i>J</i> = 7.5 Hz, 2H), 7.50 (d, <i>J</i> = 7.3 Hz, 1H), 7.55–7.70 (m, 2H), 7.90 (d, <i>J</i> = 7.3 Hz, 1H), 8.13 (d, <i>J</i> = 8.5 Hz, 1H), 9.33 (d, <i>J</i> = 8.4 Hz, 1H), 10.33 (s, 1H).</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 4-Propylnaphthalene-1-carbaldehyde (<b>2</b>-<b>4u</b>)</h4><div class="NLM_p last">Dichloromethyl methyl ether (0.39 mL, 97%, 4.2 mmol) was dissolved in dichloroethane (5 mL) and cooled to 0 °C. TiCl<sub>4</sub> (0.46 mL, 4.2 mmol) was added dropwise over 2 min. Once the addition was complete, the solution was stirred at 0 °C for 45 min. 1-Propyl naphthalene (550 mg, 3.23 mmol) in dichloroethane (5 mL) was then added dropwise over 5 min. The solution was allowed to warm to room temperature and stirred overnight. The reaction mixture was then poured into ice–water (100 mL), the organic layer removed, and the aqueous layer extracted with dichloroethane (2 × 25 mL). The organic layers were combined, washed with saturated sodium bicarbonate solution and water, and dried over sodium sulfate. The solvent was removed under reduced pressure, and the residue was columned over silica gel (Isco, gradient from 100% hexane to 10% EtOAc/90% hexane) to give the title product as a light-brown oil (480 mg, 75%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.05 (t, <i>J</i> = 7.4 Hz, 3H), 1.74–1.88 (m, 2H), 3.11 (t, <i>J</i> = 7.5 Hz, 2H), 7.47 (d, <i>J</i> = 7.3 Hz, 1H), 7.57–7.71 (m, 2H), 7.89 (d, <i>J</i> = 7.3 Hz, 1H), 8.09–8.16 (m, 1H), 9.30–9.37 (m, 1H), 10.33 (s, 1H).</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 4-{2-[(1<i>E</i>)-1-(Arylidene)-1<i>H</i>-inden-3-yl]ethyl}morpholine (<b>2</b>-<b>5a</b>–<b>2</b>-<b>5u</b>)</h4><div class="NLM_p">Method 1 (<b>2</b>-<b>5a</b>–<b>e</b>): Reflux 18 h or Method 2 (<b>2</b>-<b>5f</b>–<b>u</b>): Microwave for 15–17 min; with variations in purification of the reaction residue after cooling and evaporation that were either recrystallization or silica gel chromatography typified by preparation of <b>2</b>-<b>5d</b> (method 1) or <b>2</b>-<b>5h</b> (method 2).</div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> 4-{2-[(1<i>E</i>)-1-[(2-Fluorophenyl)methylidene]-1<i>H</i>-inden-3-yl]ethyl}morpholine (<b>2</b>-<b>5d</b>): Method 1</h5><div class="NLM_p last">Method 1: 4-[2-(1<i>H</i>-Inden-3-yl)ethyl]morpholine (<b>2</b>-<b>3</b>) (260 mg, 1.13 mmol) was dissolved in methanol (1.0 mL) and the reaction mixture purged with nitrogen. Sodium methoxide (2.50 mL, 0.5 M in MeOH; 1.25 mmol) was added dropwise over 5 min, and the solution stirred for 10 min. 2-Fluorobenzaldehyde (0.14 mL, 97%, 1.29 mmol) was added dropwise and the mixture stirred for 5 min. The solution was then heated under reflux for 18 h then allowed to cool to room temperature, and the solvent was removed under reduced pressure. The residue was purified over silica gel (Isco, 120 g column, 100% EtOAc) to give the title compound as a yellow film (76 mg, 93% pure by HPLC, 20%). A second fraction of less pure material was also collected (42 mg, 91% pure by HPLC, 11%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.56 (t, <i>J</i> = 4.6 Hz, 4H), 2.68–2.77 (m, 2H), 2.79–2.90 (m, 2H), 3.76 (t, <i>J</i> = 4.7 Hz, 4H), 6.72 (s, 1H), 7.04–7.43 (m, 6H), 7.48 (s, 1H), 7.58–7.74 38 (m, 2H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 25.46, 53.75 (2C), 57.49, 67.07 (2C), 115.72 (d, <i>J</i> = 21.9 Hz, 1C), 118.50 (d, <i>J</i> = 4.6 Hz, 1C), 118.74, 119.38, 121.91, 124.16 (d, <i>J</i> = 3.6 Hz, 1C) 125.21 (d, <i>J</i> = 13.4 Hz, 1C), 125.62, 127.70, 129.77 (d, <i>J</i> = 8.4 Hz, 1C), 131.66 (d, <i>J</i> = 2.8 Hz, 1C), 137.90, 140.84, 142.43, 147.25, 161.09 (d, <i>J</i> = 250.1 Hz, 1C). HPLC (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 10 mM aqueous NH<sub>4</sub>OAc–CH<sub>3</sub>CN, 40:60, UV detection at 254 nm). HRMS: calculated for C<sub>22</sub>H<sub>23</sub>NOF (M + H) 336.1764, found 336.1763 (M + H).</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> 4-{2-[(1<i>E</i>)-1-(Naphthalen-1-ylmethylidene)-1<i>H</i>-inden-3-yl]ethyl}morpholine (<b>2</b>-<b>5a</b>)</h5><div class="NLM_p last">Golden solid (2.98 g, 66%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.41 (t, <i>J</i> = 4.2 Hz, 4H), 2.54–2.64 (m, 2H), 2.71–2.82 (m, 2H), 3.56 (t, <i>J</i> = 4.5 Hz, 4H), 3H), 6.67 (s, 1H), 7.26–7.41 (m, 3H), 7.55–7.71 (m, 4H), 7.93–8.08 (m, 3H), 8.22–8.31 (m, 2H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 24.65, 53.15 (2C), 56.74, 66.20 (2C), 118.76, 119.86, 122.11, 124.44, 124.52, 125.32, 125.65, 126.22, 126.55, 127.54, 128.47, 128.51, 128.87, 131.58, 133.21, 133.54, 137.31, 140.67, 142.28, 146.74. HPLC 99% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 10 mM aqueous NH<sub>4</sub>OAc–CH<sub>3</sub>CN, 40:60, UV detection at 254 nm). HRMS: calculated for C<sub>26</sub>H<sub>26</sub>NO (M + H) 368.2014, found 368.2013 (M + H).</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> 4-{2-[(1<i>E</i>)-1-(Phenylmethylidene)-1<i>H</i>-inden-3-yl]ethyl}morpholine (<b>2</b>-<b>5b</b>)</h5><div class="NLM_p last">Dark-yellow resin (258 mg, 46%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.57 (t, <i>J</i> = 4.5 Hz, 4H), 2.70–2.79 (m, 2H), 2.81–2.91(m, 2H), 3.77 (t, <i>J</i> = 4.7 Hz, 4H, 6.83 (s, 1H), 7.21–7.48 (m, 7H), 7.56–7.63 (m, 2H), 7.66–7.72 (m, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 25.42, 53.75 (2C), 57.57, 67.05 (2C), 118.71, 119.04, 122.06, 125.41, 126.62, 127.39, 128.09, 128.68 (2C), 130.10 (2C), 137.23, 138.24, 139.41, 142.23, 146.58. HPLC 99% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 10 mM aqueous ammonium formate–acetonitrile, 40:60, UV detection at 254 nm). HRMS: calculated for C<sub>22</sub>H<sub>24</sub>NO (M + H) 318.1858, found 318.1857 (M + H).</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> 4-{2-[(1<i>E</i>)-1-[(2-Iodophenyl)methylidene]-1<i>H</i>-inden-3-yl]ethyl}morpholine (<b>2</b>-<b>5c</b>)</h5><div class="NLM_p last">Yellow solid (1.00 g, 57%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.55 (t, <i>J</i> = 4.6 Hz, 4H), 2.66–2.75 (m, 2H), 2.77–2.87 (m, 2H), 3.75 (t, <i>J</i> = 4.6 Hz, 4H), 3H), 6.57 (s, 1H), 6.98–7.07 (m, 1H), 7.22–7.34 (m, 3H), 7.35–7.47 (m, 2H), 7.52–7.59 (m, 1H), 7.71–7.79 (m, 1H), 7.89–7.97 (m, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 25.45, 53.74 (2C), 57.43, 67.06 (2C), 100.92, 118.80, 119.49, 121.87, 125.63, 127.83, 128.12, 129.26, 129.92, 131.65, 137.57, 139.35, 140.52, 140.54, 142.64, 147.05. HPLC 98% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 10 mM aqueous NH<sub>4</sub>OAc–CH<sub>3</sub>CN, 40:60, UV detection at 254 nm). HRMS: calculated for C<sub>22</sub>H<sub>23</sub>NOI (M + H) 444.0824, found 444.0828 (M + H).</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> 4-{2-[(1<i>E</i>)-1-[(3-Phenylphenyl)methylidene]-1<i>H</i>-inden-3-yl]ethyl}morpholine (<b>2</b>-<b>5e</b>)</h5><div class="NLM_p last">Yellow film (21%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.56 (t, <i>J</i> = 4.4 Hz, 4H), 2.69–2.79 (m, 2H), 2.80–2.91 (m, 2H), 3.74 (t, <i>J</i> = 4.6 Hz, 4H), 6.87 (s, 1H), 7.21–7.34 (m, 3H), 7.35–7.73 (m, 10H), 7.79 (s, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 25.42, 53.72 (2C), 57.56, 67.03 (2C), 118.78, 119.11, 122.14, 125.48, 126.50, 126.97, 127.23 (2C), 127.48, 127.59, 128.90 (4C), 129.12, 137.73, 138.24, 139.75, 140.90, 141.78, 142.29, 146.80. HPLC 94% (Waters X-Bridge C-18 5 mm, 4.6 mm × 100 mm column, 10 mM aqueous NH<sub>4</sub>OAc–CH<sub>3</sub>CN, 35:65, UV detection at 254 nm). HRMS: calculated for C<sub>28</sub>H<sub>28</sub>NO (M + H) 394.2171; found 394.2176 (M + H).</div></div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> 4-{2-[(1<i>E</i>)-1-[(2-Methoxyphenyl)methylidene]-1<i>H</i>-inden-3-yl]ethyl}morpholine (<b>2</b>-<b>5h</b>): Methods 2</h5><div class="NLM_p last">Method 2: 4-[2-(1<i>H</i>-Inden-3-yl)ethyl]morpholine (<b>2</b>-<b>3</b>) (260 mg, 1.13 mmol) and methanol (1.5 mL) were placed in a 10 mL microwave tube equipped with a rubber septa. The system was purged with nitrogen, sodium methoxide (2.30 mL, 0.5 M in MeOH; 1.15 mmol) added dropwise over 5 min and the solution stirred for 10 min. 2-Methoxybenzaldehyde (0.15 mL, 98%, 1.22 mmol) was added and the mixture stirred for an additional 5 min. The septa was replaced with a microwave cap and the tube irradiated for 15.0 min at 105 °C. Subsequently, the mixture was allowed to cool to room temperature and the solvent removed under reduced pressure. The residue was purified over silica gel (Isco, 120 g column, 100% EtOAc) to give two fractions of title compound (13 mg, 96% pure by HPLC, 3.3%; 110 mg, 95% pure by HPLC, 28%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.56 (t, <i>J</i> = 4.5 Hz, 4H), 2.68–2.78 (m, 2H), 2.80–2.90 (m, 2H), 3.76 (t, <i>J</i> = 4.6 Hz, 4H), 3.90 (s, 3H), 6.75 (s, 1H), 6.94 (d, <i>J</i> = 8.2 Hz, 7.04 (t, <i>J</i> = 5.0 Hz, 1H), 7.18–7.38 (m, 4H), 7.55–7.62 (m, 1H), 7.67 (s,1H), 7.71–7.78 (d, <i>J</i> = 6.7 Hz, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 25.42, 53.76 (2C), 55.59, 57.53, 67.08 (2C), 110.69, 118.53, 119.33, 120.61, 122.38 (2C), 126.36, 127.14, 129.60, 130.19, 131.75, 138.19, 139.18, 142.37, 145.82, 158.20. HPLC (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 10 mM aqueous NH<sub>4</sub>OAc-CH<sub>3</sub>CN, 40:60, UV detection at 254 nm). HRMS: calculated for C<sub>23</sub>H<sub>25</sub>NO<sub>2</sub> (M + H) 348.1964, found 348.1967 (M + H).</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> 4-{2-[(1<i>E</i>)-1-[(2-Chlorophenyl)methylidene]-1<i>H</i>-inden-3-yl]ethyl}morpholine (<b>2</b>-<b>5f</b>)</h5><div class="NLM_p last">Yield 85 mg, 97% pure by HPLC, 20%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.55 (t, <i>J</i> = 4.5 Hz, 4H), 2.66–2.76 (m, 2H), 2.78–2.88 (m, 2H), 3.75 (t, <i>J</i> = 4.7 Hz, 4H), 3H), 6.63 (s, 1H), 7.22–7.37 (m, 5H), 7.42–7.48 (m, 1H), 7.55–7.64 (m,2H), 7.71–7.77 (m, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 25.44, 53.74 (2C), 57.46, 67.06 (2C), 118.77, 119.51, 121.85, 123.09, 125.63, 126.70, 127.82, 129.12, 129.74, 132.21, 134.77, 135.48, 137.72, 140.96, 142.60, 147.29. HPLC (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 10 mM aqueous NH<sub>4</sub>OAc–CH<sub>3</sub>CN, 40:60, UV detection at 254 nm). HRMS: calculated for C<sub>22</sub>H<sub>23</sub>NOCl (M + H) 352.1468, found 352.1455 (M + H).</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> 4-{2-[(1<i>E</i>)-1-[(2-Bromophenyl)methylidene]-1<i>H</i>-inden-3-yl]ethyl}morpholine (<b>2</b>-<b>5g</b>)</h5><div class="NLM_p last">Yield 157 mg, 95% pure by HPLC, 34%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.54 (t, <i>J</i> = 4.4 Hz, 4H), 2.65–2.75 (m, 2H), 2.76–2.87 (m, 2H), 3.75 (t, <i>J</i> = 4.7 Hz, 4H), 3H), 6.60 (s, 1H), 7.14–7.42 (m, 5H), 7.50 (s, 1H), 7.55–7.67 (m, 2H), 7.70–7.76 (m, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 25.44, 53.74 (2C), 57.44, 67.06 (2C), 118.77, 119.51, 121.85, 125.08, 125.48, 125.63, 127.29, 127.82, 129.26, 132.33, 132.93, 137.21, 137.66, 140.81, 142.620, 147.21. HPLC (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 10 mM aqueous NH<sub>4</sub>OAc–CH<sub>3</sub>CN, 40:60, UV detection at 254 nm). HRMS: calculated for C<sub>22</sub>H<sub>23</sub>NOBr (M + H) 396.0963, found 396.0959 (M + H).</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> 4-{2-[(1<i>E</i>)-1-[(2-Methylphenyl)methylidene]-1<i>H</i>-inden-3-yl]ethyl}morpholine (<b>2</b>-<b>5i</b>)</h5><div class="NLM_p last">Yield 251 mg, 94% pure by HPLC, 63%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.42 (s, 3H), 2.55 (t, <i>J</i> = 4.2 Hz, 4H), 2.67–2.76 (m, 2H), 2.79–2.89 (m, 2H), 3.76 (t, <i>J</i> = 4.6 Hz, 4H), 6.64 (s, 1H), 7.20–7.36 (m, 6H), 7.45–7.54 (m, 2H), 7.73 (d, <i>J</i> = 6.7 Hz, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 20.13, 25.38, 53.75 (2C), 57.53, 67.06 (2C), 118.68, 119.13, 122.56, 125.30, 125.41, 125.88, 127.45, 128.14, 130.19, 130.94, 136.19, 137.44, 137.78, 139.93, 142.65, 146.01. HPLC (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 10 mM aqueous NH<sub>4</sub>OAc–CH<sub>3</sub>CN, 40:60, UV detection at 254 nm). HRMS: calculated for C<sub>23</sub>H<sub>26</sub>NO (M + H) 332.2014, found 332.2022 (M + H).</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> 4-{2-[(1<i>E</i>)-1-[(4-Methoxynaphthalen-1-yl)methylidene]-1<i>H</i>-inden-3-yl]ethyl}morpholine (<b>2</b>-<b>5j</b>)</h5><div class="NLM_p last">Yellow solid (134 mg, 31%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.51 (t, <i>J</i> = 4.5 Hz, 4H), 2.64–2.75 (m, 2H), 2.77–2.87 (m, 2H), 3.73 (t, <i>J</i> = 4.6 Hz, 4H), 4.02 (s, 3H), 6.67 (s, 1H), 6.87 (d, <i>J</i> = 8.0 Hz, 1H), 7.25–7.38 (m, 3H), 7.46–7.61 (m, 3H), 7.75–7.84 (m, 1H), 7.96 (s, 1H), 8.04–8.12 (m, 1H), 8.29–8.38 (m, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 25.41, 53.76 (2C), 56.66, 57.61, 67.07 (2C), 103.76, 118.71, 119.17, 122.62, 122.95, 124.42, 124.61, 125.27, 125.53, 125.67, 126.61, 127.06, 127.29, 129.79, 133.15, 137.84, 139.99, 142.77, 145.42, 156.05. HPLC 95% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 10 mM aqueous ammonium formate–acetonitrile, 40:60, UV detection at 254 nm). HRMS: calculated for C<sub>27</sub>H<sub>28</sub>NO<sub>2</sub> (M + H) 398.2120, found 398.2124 (M + H).</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> 4-{2-[(1<i>E</i>)-1-[(2-Phenylphenyl)methylidene]-1<i>H</i>-inden-3-yl]ethyl}morpholine (<b>2</b>-<b>5k</b>)</h5><div class="NLM_p last">Yellow film (133 mg, 30%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.56 (t, <i>J</i> = 4.4 Hz, 4H), 2.69–2.80 (m, 2H), 2.81–2.92 (m, 2H), 3.76 (t, <i>J</i> = 4.6 Hz, 4H), 6.84 (s, 1H), 7.09–7.18 (m, 1H), 7.22–7.48 (m, 12H), 7.64–7.73 (m, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 25.51, 53.84 (2C), 57.66, 67.12 (2C), 118.66, 119.33, 122.56, 125.34, 127.03, 127.36, 127.38, 127.47, 128.23 (2C), 128.33, 130.02 (2C), 130.12, 131.94, 135.20, 137.94, 139.45, 140.62, 142.42, 146.46, 146.09. HPLC 92% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 10 mM aqueous NH<sub>4</sub>OAc–CH<sub>3</sub>CN, 35:65, UV detection at 254 nm). HRMS: calculated for C<sub>28</sub>H<sub>28</sub>NO (M + H) 394.2171, round 394.2176 (M + H).</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> 7-{[(1<i>E</i>)-3-[2-(Morpholin-4-yl)ethyl]-1<i>H</i>-inden-1-ylidene]methyl}-1<i>H</i>-indole (<b>2</b>-<b>5l</b>)</h5><div class="NLM_p last">Yellow film (115 mg, 31%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.49 (t, <i>J</i> = 4.4 Hz, 4H), 2.60–2.72 (m, 2H), 2.73–2.86 (m, 2H), 3.72 (t, <i>J</i> = 4.5 Hz, 4H), 6.55–6.65 (m, 1H), 6.67 (s, 1H), 7.12–7.40 (m, 6H), 7.57 (s, 1H), 7.60–7.78 (m, 2H), 8.63 (s, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 25.34, 53.71 (2C), 57.46, 67.04 (2C), 103.17, 118.95, 119.20, 120.18, 120.94, 121.32, 122.30, 122.73, 124.14, 124.42, 125.55, 127.56, 128.47, 134.55, 137.81, 140.22, 142.61, 146.31. HPLC 94% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 10 mM aqueous NH<sub>4</sub>OAc–CH<sub>3</sub>CN, 35:65, UV detection at 254 nm). HRMS: calculated for C<sub>24</sub>H<sub>25</sub>N<sub>2</sub>O (M + H) 357.1967, found 357.1966 (M + H).</div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> 4-{2-[(1<i>E</i>)-1-(Thiophen-2-ylmethylidene)-1<i>H</i>-inden-3-yl]ethyl}morpholine (<b>2</b>-<b>5m</b>)</h5><div class="NLM_p last">Yellow solid (235 mg, 67%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.56 (t, <i>J</i> = 4.5 Hz, 4H), 2.68–2.78 (m, 2H), 2.80–2.90 (m, 2H), 3.76 (t, <i>J</i> = 4.6 Hz, 4H), 7.01 (s, 1H), 7.03–7.09 (m, 1H), 7.16–7.31 (m, 4H), 7.37–7.44 (m, 2H), 7.55–7.64 (m, 2H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 25.47, 53.77 (2C), 57.56, 67.10 (2C), 118.90, 118.97 (2C), 121.85, 125.40, 127.11, 127.64, 128.53, 131.03, 136.79, 138.39, 140.96, 142.14, 146.37. HPLC 94% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 10 mM aqueous NH<sub>4</sub>OAc–CH<sub>3</sub>CN, 35:65, UV detection at 254 nm). HRMS: calculated for C<sub>20</sub>H<sub>22</sub>NOS (M + H) 324.1422, found 324.1431 (M + H).</div></div><div id="sec5_2_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> 4-{2-[(1<i>E</i>)-1-(Furan-2-ylmethylidene)-1<i>H</i>-inden-3-yl]ethyl}morpholine (<b>2</b>-<b>5n</b>)</h5><div class="NLM_p last">Yellow solid (231 mg, 64%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.47–2.53 (m, 4H), 2.70–2.96 (m, 4H), 3.65–3.90 (m, 4H), 6.45–6.55 (m, 1H), 6.57–6.65 (m, 1H), 6.98 (s, 1H), 7.10–7.34 (m, 4H), 7.50–7.64 (m, 2H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 25.48, 53.79 (2C), 57.67, 67.08 (2C), 112.26, 112.38, 114.22, 118.81, 118.88, 123.24, 125.18, 127.13, 136.02, 138.19, 142.17, 144.38, 145.68, 153.52. HPLC 94% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 10 mM aqueous NH<sub>4</sub>OAc–CH<sub>3</sub>CN, 40:60, UV detection at 254 nm). HRMS: calculated for C<sub>20</sub>H<sub>22</sub>NO<sub>2</sub> (M + H) 308.1651, found 308.1632 (M + H).</div></div><div id="sec5_2_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> 5-{[(1<i>E</i>)-3-[2-(Morpholin-4-yl)ethyl]-1<i>H</i>-inden-1-ylidene]methyl}isoquinoline (<b>2</b>-<b>5o</b>)</h5><div class="NLM_p last">Yellow solid (70 mg, 17%, 93% pure by HPLC). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.53 (t, <i>J</i> = 4.5 Hz, 4H), 2.65–2.75 (m, 2H), 2.77–2.88 (m, 2H), 3.74 (t, <i>J</i> = 4.5 Hz, 4H), 6.56 (s, 1H), 7.27–7.40 (m, 3H), 7.62–7.72 (m, 1H), 7.76–7.94 (m, 4H), 7.98 (d, <i>J</i> = 8.1 Hz, 1H), 8.58 (d, <i>J</i> = 5.9 Hz, 1H), 9.30 (s, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 25.43, 53.72 (2C), 57.40, 67.03 (2C), 117.53, 118.93, 119.39, 121.97, 122.23, 125.69, 126.88, 127.84, 128.01, 128.78, 132.68, 133.45, 134.84, 137.41, 142.37, 142.89, 143.65, 147.35, 153.09. HPLC (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 10 mM aqueous ammonium formate–acetonitrile, 40:60, UV detection at 254 nm). HRMS: calculated for C<sub>25</sub>H<sub>25</sub>N<sub>2</sub>O (M + H) 369.1967; found 369.1961 (M + H).</div></div><div id="sec5_2_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> 4-{[(1<i>E</i>)-3-[2-(Morpholin-4-yl)ethyl]-1<i>H</i>-inden-1-ylidene]methyl}quinoline (<b>2</b>-<b>5p</b>)</h5><div class="NLM_p last">Yellow solid (25 mg, 5.8%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.55 (t, <i>J</i> = 4.4 Hz, 4H), 2.65–2.76 (m, 2H), 2.78–2.89 (m, 2H), 3.75 (t, <i>J</i> = 4.5 Hz, 4H), 6.54 (s, 1H), 7.27–7.40 (m, 3H), 7.47 (d, <i>J</i> = 4.4 Hz, 1H), 7.55–7.64 (m, 1H), 7.70–7.82 (m, 2H), 7.85 (s, 1H), 8.02–8.22 (m, 2H) 8.97 (d, <i>J</i> = 4.4 Hz, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 25.34, 53.66 (2C), 57.24, 66.92 (2C), 119.06, 119.61, 120.86, 122.04, 122.51, 124.60, 125.93, 126.86, 127.20, 128.40, 129.59, 130.14, 137.12, 142.63, 143.06, 143.91, 148.17, 148.51, 149.93. HPLC 95% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 10 mM aqueous NH<sub>4</sub>OAc–CH<sub>3</sub>CN, 40:60, UV detection at 254 nm). HRMS: calculated for C<sub>25</sub>H<sub>25</sub>N<sub>2</sub>O (M + H) 369.1967, found 369.1957 (M + H).</div></div><div id="sec5_2_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> 4-{2-[(1<i>E</i>)-1-(1,2-Dihydroacenaphthylen-5-ylmethylidene)-1<i>H</i>-inden-3-yl]ethyl}morpholine (<b>2</b>-<b>5q</b>)</h5><div class="NLM_p last">Yellow solid (120 mg, 26%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.52 (t, <i>J</i> = 4.5 Hz, 4H), 2.65–2.75 (m, 2H), 2.77–2.87 (m, 2H), 3.41 (s, 4H), 3.74 (t, <i>J</i> = 4.5 Hz, 4H), 6.73 (s, 1H), 7.23–7.38 (m, 5H), 7.46–7.54 (m, 1H), 7.66 (d, <i>J</i> = 7.2 Hz, 1H), 7.76–7.86 (m, 2H), 7.96 (s, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 23.15, 28.04, 28.33, 51.49 (2C), 55.33, 64.81 (2C), 116.45, 116.53, 117.00, 117.52, 120.71, 121.61, 123.03, 125.06, 126.13, 127.82, 128.40, 128.53, 135.72, 137.16, 137.89, 139.83, 140.40, 143.46, 144.22, 144.64. HPLC 95% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 10 mM aqueous NH<sub>4</sub>OAc–CH<sub>3</sub>CN, 40:60, UV detection at 254 nm). HRMS: calculated for C<sub>28</sub>H<sub>28</sub>NO (M + H) 394.2171, found 394.2172 (M + H).</div></div><div id="sec5_2_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> 4-{2-[(1<i>E</i>)-1-(Naphthalen-2-ylmethylidene)-1<i>H</i>-inden-3-yl]ethyl}morpholine (<b>2</b>-<b>5r</b>)</h5><div class="NLM_p last">Yellow film (172 mg, 38%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.57 (t, <i>J</i> = 4.4 Hz, 4H), 2.70–2.80 (m, 2H), 2.81–2.93 (m, 2H), 3.77 (t, <i>J</i> = 4.6 Hz, 4H), 6.94 (s, 1H), 7.22–7.36 (m, 3H), 7.47–7.56 (m, 3H), 7.69–7.79 (m, 3H), 7.80–7.92 (m, 3H), 8.02 (s, 1H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 23.35, 51.62 (2C), 55.46, 64.95 (2C), 116.63, 116.96, 120.02, 123.32, 124.39, 124.49, 124.55, 125.26, 125.29, 125.60, 126.14, 126.18, 127.76, 130.82, 131.38, 132.67, 136.19, 137.51, 140.05, 144.68. HPLC 99% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 0.05% aqueous TFA–CH<sub>3</sub>CN, 40:60, UV detection at 254 nm). HRMS: calculated for C<sub>26</sub>H<sub>26</sub>NO (M + H) 368.2014, found 368.2011 (M + H).</div></div><div id="sec5_2_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> 4-{2-[(1<i>E</i>)-1-(Phenanthren-4-ylmethylidene)-1<i>H</i>-inden-3-yl]ethyl}morpholine (<b>2</b>-<b>5s</b>)</h5><div class="NLM_p last">Yellow solid (190 mg, 37%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.51 (t, <i>J</i> = 4.4 Hz, 4H), 2.64–2.73 (m, 2H), 2.78–2.88 (m, 2H), 3.73 (t, <i>J</i> = 4.6 Hz, 4H), 6.66 (s, 1H), 7.27–7.38 (m, 3H), 7.59–7.74 (m, 4H), 7.81–7.87 (m, 2H), 7.91–7.96 (m, 1H), 7.98 (m, 3H), 8.12–8.19 (m, 1H), 8.66–8.78 (m, 2H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 25.41, 53.73 (2C), 57.45, 67.06 (2C), 118.83, 119.37, 122.67, 122.83, 123.13, 124.66, 125.47, 125.63, 126.85, 126.89, 126.98, 127.12, 127.71, 129.01, 130.05, 130.39, 130.44, 131.28, 131.57, 132.94, 137.51, 141.78, 143.13, 146.14. HPLC 99% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 0.05% aqueous TFA–CH<sub>3</sub>CN, 40:60, UV detection at 254 nm). HRMS: calculated for C<sub>30</sub>H<sub>28</sub>NO (M + H) 418.2171, found 418.2174 (M + H).</div></div><div id="sec5_2_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> 4-{2-[(1<i>E</i>)-1-[(4-Ethylnaphthalen-1-yl)methylidene]-1<i>H</i>-indenyl]ethyl}morpholine (<b>2</b>-<b>5t</b>)</h5><div class="NLM_p last">Yellow film (290 mg, 62%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.40 (t, <i>J</i> = 7.6 Hz, 3H), 2.48 (t, <i>J</i> = 4.4 Hz, 4H), 2.60–2.70 (m, 2H), 2.73–2.85 (m, 2H), 3.12 (q, <i>J</i> = 7.5 Hz, 2H), 3.71 (t, <i>J</i> = 4.5 Hz, 4H), 6.63 (s, 1H), 7.22–7.34 (m, 3H), 7.38 (d, <i>J</i> = 7.4 Hz, 1H), 7.46–7.58 (m, 3H), 7.74–7.81 (m, 1H), 7.98 (s, 1H), 8.04–8.18 (m, 2H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 15.08, 25.44, 26.14, 53.78 (2C), 57.58, 67.09 (2C), 118.79, 119.33, 123.02, 124.38, 124.68, 124.86, 125.41, 125.54, 126.03 (2C), 127.55, 129.19, 131.97, 132.55, 132.60, 137.77, 140.95, 141.18, 142.94, 145.89. HPLC 97% (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 10 mM aqueous NH<sub>4</sub>OAc–CH<sub>3</sub>CN, 40:60, UV detection at 254 nm). HRMS: calculated for C<sub>28</sub>H<sub>30</sub>NO (M + H) 396.2327, found 396.2332 (M + H).</div></div><div id="sec5_2_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> 4-{2-[(1<i>E</i>)-1-[(4-Propylnaphthalen-1-yl)methylidene]-1<i>H</i>-inden-3-yl]ethyl}morpholine (<b>2</b>-<b>5u</b>)</h5><div class="NLM_p last">Yellow solid (135 mg, 96% pure by HPLC, 29%; scale up 913 mg, 62%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.07 (t, <i>J</i> = 7.3 Hz, 3H), 1.74–1.90 (m, 2H), 2.53 (t, <i>J</i> = 4.5 Hz, 4H), 2.63–2.76 (m, 2H), 2.77–2.89 (m, 2H), 3.09 (q, <i>J</i> = 7.5 Hz, 2H), 3.74 (t, <i>J</i> = 4.6 Hz, 4H), 6.65 (s, 1H), 7.25–7.36 (m, 3H), 7.39 (d, <i>J</i> = 7.3 Hz, 1H), 7.48–7.60 (m, 3H), 7.77–7.84 (m, 1H), 8.00 (s, 1H), 8.07–8.19 (m, 2H). <sup>13</sup>C NMR (75.5 MHz, CDCl<sub>3</sub>) δ 14.36, 23.97, 25.40, 35.38, 53.75 (2C), 57.55, 67.07 (2C), 118.73, 119.24, 123.00, 124.53, 124.83, 125.33, 125.46, 125.70, 125.90, 125.93, 127.48, 128.96, 132.08, 132.52, 132.60, 137.71, 139.67, 140.86, 142.89, 145.82. HPLC (Waters X-Bridge C-18 5 μm, 4.6 mm × 100 mm column, 10 mM aqueous ammonium formate–acetonitrile, 40:60, UV detection at 254 nm). HRMS: calculated for C<sub>29</sub>H<sub>32</sub>NO (M + H) 410.2484, found 410.2474 (M + H).</div></div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> CB1/CB2R Binding Assays</h3><div class="NLM_p last">Detailed radioligand displacement assays (using the well-characterized CBR agonist (−)-<i>cis</i>-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-<i>trans</i>-4-(3-hydroxypropyl)cyclohexanol [2,3,4-<sup>3</sup>H] [<sup>3</sup>H]-CP55940 as the radioligand)<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> were conducted to determine the affinity (<i>K</i><sub>i</sub>) of the test compounds for CB1R and CB2R as has been previously described by our group.<a onclick="showRef(event, 'ref27 ref43'); return false;" href="javascript:void(0);" class="ref ref27 ref43">(27, 43)</a> Heterologous competition binding assays were performed to calculate receptor affinities. Unlabeled <b>2</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> or <b>3</b> were used as appropriate controls for nonspecific binding in the assay. Calculation of the equilibrium dissociation constant (<i>K</i><sub>i</sub>) was performed using the Cheng–Prusoff equation.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Calcium Flux Assay</h3><div class="NLM_p last">Chinese hamster ovary cells stably expressing either human CB1 or CB2 cDNA and the promiscuous G-protein Gαq<sub>16</sub> were removed from their flasks using the nonenzymatic cell-stripper (Mediatech Inc.) and quenched with DMEM/F12, 10% FBS, centrifuged, and resuspended in the serum-containing media. Cells were counted with a hemocytometer and 40000 cells were transferred to each well of a black Costar 96-well optical bottom plate (Corning Corporation). Each plate was incubated at 37 °C for 24 h to confluence. The culture media were removed from the plates, and cells were subsequently loaded with a fluorescent calcium probe (Fluo-4 AM dye, Invitrogen/Molecular Probes) at a final loading concentration of 2 μM in a HBSS-based buffer containing 20 mM HEPES, 1% BSA, and 10 μM Probenecid (Sigma) in a total volume of 225 μL. Cells were incubated at 37 °C for 1 h and then stimulated with various concentrations of a test agent using a FlexStation plate-reader, which automatically added the agonist at 10× concentration to each well after reading baseline values for ∼17 s. Agonist-mediated change in fluorescence (488 nm excitation, 525 nm emission) was monitored in each well at 1 s intervals for 60 s and reported for each well. Data were collected using Softmax version 4.8 (MDS Analytical Technologies) and analyzed using Prism software (GraphPad). Nonlinear regression analysis was performed to fit data and obtain maximum response (<i>E</i><sub>max</sub>), effective concentration for 50% response (EC<sub>50</sub>), correlation coefficient (<i>r</i><sup>2</sup>), and other parameters. All experiments were performed 3–6 times to ensure reproducibility and data reported as mean ± standard error of the mean unless noted otherwise.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> MDCK-mdr1 Permeability Assays</h3><div class="NLM_p last">MDCK-mdr1 cells obtained from The Netherlands Cancer Institute were grown on Transwell type filters (Corning) for 4 days to confluence in DMEM/F12 media containing 10% fetal bovine serum and antibiotics as has been described previously.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Compounds were added to the apical side at a concentration of 10 μM in a transport buffer comprising of Hank’s balanced salt solution, 25 mM <span class="smallcaps smallerCapital">d</span>-glucose and buffered with HEPES to pH 7.4. Samples were incubated for 1 h at 37 °C and carefully collected from both the apical and basal side of the filters. Compounds selected for MDCK-mdr1 cell assays were infused on an Applied Biosystems API-4000 mass spectrometer to optimize for analysis using multiple reaction monitoring (MRM). Flow injection analysis was also conducted to optimize for mass spectrometer parameters. Samples from the apical and basolateral side of the MDCK cell assay were dried under nitrogen on a Turbovap LV. The chromatography was conducted with an Agilent 1100 binary pump with a flow rate of 0.5 mL/min. Mobile phase solvents were A, 0.1% formic acid in water, and B, 0.1% formic acid in methanol. The initial solvent conditions were 10% B for 1 min, then a gradient was used by increasing to 95% B over 5 min, then returning to initial conditions. Data reported are average values from 2 to 3 measurements.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Plasma Stability Assay</h3><div class="NLM_p last">Compounds were incubated at 10 μM in rat plasma at 37 °C. A solution of each compound was prepared in ethanol at a concentration of 1 mM. A 2.5 μL volume of the 1 mM solution was added to 247.5 μL of rat plasma (adult male Sprague–Dawley) in a glass test tube in a 37 °C water bath. Samples (50 μL) were removed at 0, 30, and 60 min and immediately extracted with 3 volumes (150 μL) of methanol. Samples were centrifuged (2500 rpm for 10 min at 4 °C) to pellet protein and supernatants transferred to LC/MS vials for analysis. Samples were stored at −80 °C prior to analysis.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> S9 Fraction Stability Assay</h3><div class="NLM_p last">Compounds were incubated at 10 μM in rat (male Sprague–Dawley) liver S9 fraction at 37 °C. Each compound was prepared in ethanol at a concentration of 1 mM. An assay mixture containing S9 (1 mg protein/mL final concentration) and an NADPH regenerating system (NADP [1 mM final], glucose 6-phosphate [5 mM final], and glucose 6-phosphate dehydrogenase [1 U/mL final]) in a buffer consisting of 50 mM KPO<sub>4</sub> phosphate buffer, pH 7.4, with 3 mM MgCl<sub>2</sub> was prepared and preincubated at 37 °C for 5 min. A 10 μL volume of the 1 mM solution was added to 990 μL of assay mixture in a glass test tube at 37 °C to initiate the assay. Samples (50 μL) were removed at 0, 15, 30, 60, and 120 min and immediately extracted with 3 volumes (150 μL) of methanol, centrifuged to pellet protein, and supernatants transferred to LC/MS vials for analysis.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Animals</h3><div class="NLM_p">The Institutional Animal Care and Use Committee approved all animal experiments. Sprague–Dawley male rats (Harlan Laboratories) weighing 200–220 g at arrival were maintained on a 12 h light/dark cycle with free access to food and water at the UCLA Division of Laboratory of Animal Medicine facilities.</div><div id="sec5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Behavioral Testing</h4><div class="NLM_p last">Naı̈ve rats were tested for CNS side effects before and after drug administration in the “tetrad” of tests that are classically predictive of cannabinoid receptor activation.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Rats were also tested for behavioral responses to tactile stimuli before and after sciatic nerve entrapment neuropathy induction. The methods for generation of this model were exactly as previously described.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Analgesic effectiveness of PRCBs was tested at 3-day intervals beginning 8 days after SNE surgery. Each behavioral test is described briefly below.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Rotarod</h4><div class="NLM_p last">Rats were tested for motor function and the ataxic effects of drugs as described previously.<a onclick="showRef(event, 'cit4b ref45'); return false;" href="javascript:void(0);" class="ref cit4b ref45">(4b, 45)</a> Rats were trained 72 h before the test (3 sessions 24 h apart) to remain for at least 180 s on a rotarod revolving at an acceleration of 4–40 revs over 5 min). Rats were tested 1 h before vehicle or drug injections and tested again at 2, 6, 24, and 48 h after drug or vehicle administration. The time for which the rats are able to remain on the rotarod was recorded up to a cutoff of 3 min.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Hypothermia</h4><div class="NLM_p last">Rats were acclimated to a plastic restrainer apparatus (Model RTV-180 Braintree Scientific Inc.) on the day of testing by placing them in the restrainer twice for 5 min separated by 20 min. Baseline core temperature was taken before treatment, and again at 2, 6, and 24 and 48 h after drug/vehicle injection.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> Catalepsy (Ring) Test</h4><div class="NLM_p last">Catalepsy was determined with a ring immobility test,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> modified for rats.<a onclick="showRef(event, 'cit4b cit24a'); return false;" href="javascript:void(0);" class="ref cit4b cit24a">(4b, 24a)</a> Rats were placed with their forepaws on a horizontal metal ring (12 cm diameter) at a height that allowed their hindpaws to just touch the bench surface. Immobility was recorded as the time for the rat to move off the ring with a 100 s cutoff. Rats were tested before vehicle/drug injections and again at 2, 6, 24, and 48 h after injection.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> Tail-Flick Test</h4><div class="NLM_p last">A modified Hargreaves apparatus (model 390, IITC Instr.) was also used to measure tail-flick latency (TFL). Radiant heat was directed to a point 3 cm from the tail tip and the TFL observed and timed with a photo cell counter. The intensity of the radiant heat was adjusted for a baseline TFL of approximately 5–7 s for naı̈ve rats, with a 25 s cutoff set to avoid tissue damage.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> Mechanical Sensitivity</h4><div class="NLM_p last">Rats were placed in a plastic-walled cage (10 × 20 × 13 cm<sup>3</sup>) with a metal mesh floor (0.6 × 0.6 cm<sup>2</sup> holes) and allowed to acclimate for 10 min. The amount of pressure (g) needed to evoke a hindpaw withdrawal response was measured 4 times on each paw separated by 30-s intervals using a von Frey-type digital meter (model 1601C, IITC Instr.). Results of 4 tests/session were averaged for each paw.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> Drug Administration</h4><div class="NLM_p last">For intraperitoneal (ip) injection, drugs were first dissolved in a 50/50% mixture of pure DMSO and Cremophor EL (Sigma-Aldrich), then appropriately diluted in sterile saline (1.5 mL/kg for ip) and administered using 271/2 gauge sterile needles and 1 cm<sup>3</sup> syringes equipped with a 0.22 μm filter. For oral administration, drugs were dissolved in pure DMSO, appropriately diluted in 20% sweet condensed milk (16 mL/kg), and delivered directly in the stomach by oral intubation with the aid of a ball-tipped gavage needle and a 5 cc syringe.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> Body Fluid and Tissue Collection for Pharmacokinetics Assays</h4><div class="NLM_p last">(A) Plasma collection: rats were administered CB1R ligands and blood samples (∼110 μL) collected from the tail vein at various intervals after brief (<5 min) placement in a plastic restraining apparatus (RTV-180, Braintree Scientific Inc., Braintree, MA). Samples were centrifuged at 12000 rpm for 3 min and the plasma supernatant (∼50 μL) placed in heparinized capillary tubes and stored at −20 °C until analysis. (B) CSF collection: rats were anesthetized (isoflurane) placed in a stereotactic frame, the dura exposed at the level of the cisterna magna, 100–150 μL of CSF collected as per,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> and stored at −20 °C until analysis. (C) Brain collection: rats were terminally anesthetized (pentobarbital, 75 mg/kg), perfused intracardially with 60 mL of cold saline, and the brain rapidly removed and stored at −20 °C until analysis.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> Mass Spectroscopy Analysis of Fluid and Tissue Samples</h4><div class="NLM_p last">Plasma, CSF, and brain samples were analyzed by LC-MS/MS and quantified using standard curves prepared from appropriate drug dilutions in samples obtained from untreated animals.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div></div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> Statistical Analysis</h3><div class="NLM_p last">The investigator performing all of the behavioral tests was blind to the dose and nature of drugs administered to the rats. One-way or two-way repeated measurements analysis of variance (RM ANOVA) were used to assess significance of drug effects.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="NOTES-d7e6794-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i88"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00516">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52554" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52554" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00516" class="ext-link">10.1021/acs.jmedchem.6b00516</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00516/suppl_file/jm6b00516_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00516/suppl_file/jm6b00516_si_001.csv">jm6b00516_si_001.csv (4.46 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00516" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71728" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71728" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Herbert H. Seltzman</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#670f0f142715130e49081500"><span class="__cf_email__" data-cfemail="d3bbbba093a1a7bafdbca1b4">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Igor Spigelman</span> - <span class="hlFld-Affiliation affiliation">Division
of Oral Biology & Medicine, School of Dentistry, University of California, 10833 Le Conte Avenue, 63-078 CHS, Los Angeles, California 090095-1668, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#650c020a1725100609044b000110"><span class="__cf_email__" data-cfemail="86efe1e9f4c6f3e5eae7a8e3e2f3">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Craig Shiner</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erin E. Hirt</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne F. Gilliam</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian F. Thomas</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rangan Maitra</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rod Snyder</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sherry L. Black</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Purvi R. Patel</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yatendra Mulpuri</span> - <span class="hlFld-Affiliation affiliation">Division
of Oral Biology & Medicine, School of Dentistry, University of California, 10833 Le Conte Avenue, 63-078 CHS, Los Angeles, California 090095-1668, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e6813-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i89">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70085" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70085" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Bradley Snyder, Andrei Marechek, Dmitry Ivanov, and Daniel Malkin for help with behavioral studies at UCLA. This work was made possible with support by NIH grant DA023163 (I.S., H.H.S.), UCLA Academic Senate Faculty Grant (I.S.), and UCLA Graduate Studies stipend (Y.M.).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i90" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i90"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i91" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i91"> Abbreviations Used</h2><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">BNB</td><td class="NLM_def"><p class="first last">blood–nerve barrier</p></td></tr><tr><td class="NLM_term">CB</td><td class="NLM_def"><p class="first last">cannabinoid</p></td></tr><tr><td class="NLM_term">CB1R</td><td class="NLM_def"><p class="first last">cannabinoid 1 receptor</p></td></tr><tr><td class="NLM_term">CB2R</td><td class="NLM_def"><p class="first last">cannabinoid 2 receptor</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">ECBs</td><td class="NLM_def"><p class="first last">endocannabinoids</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney</p></td></tr><tr><td class="NLM_term">PRCBs</td><td class="NLM_def"><p class="first last">peripherally restricted cannabinoids</p></td></tr><tr><td class="NLM_term">SNE</td><td class="NLM_def"><p class="first last">sciatic nerve entrapment</p></td></tr><tr><td class="NLM_term">TFL</td><td class="NLM_def"><p class="first last">tail-flick latency</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i92">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76083" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76083" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 48 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Johannes, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dworkin, R. H.</span><span> </span><span class="NLM_article-title">The prevalence of chronic pain in United States adults: results of an Internet-based survey</span> <span class="citation_source-journal">J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1230</span><span class="NLM_x">–</span> <span class="NLM_lpage">1239</span><span class="refDoi"> DOI: 10.1016/j.jpain.2010.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.jpain.2010.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=20797916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADC%252BC3cblt1Siuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=1230-1239&author=C.+B.+Johannesauthor=T.+K.+Leauthor=X.+Zhouauthor=J.+A.+Johnstonauthor=R.+H.+Dworkin&title=The+prevalence+of+chronic+pain+in+United+States+adults%3A+results+of+an+Internet-based+survey&doi=10.1016%2Fj.jpain.2010.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The prevalence of chronic pain in United States adults: results of an Internet-based survey</span></div><div class="casAuthors">Johannes Catherine B; Le T Kim; Zhou Xiaolei; Johnston Joseph A; Dworkin Robert H</div><div class="citationInfo"><span class="NLM_cas:title">The journal of pain : official journal of the American Pain Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1230-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">UNLABELLED:  A cross-sectional, Internet-based survey was conducted in a nationally representative sample of United States (US) adults to estimate the point prevalence of chronic pain and to describe sociodemographic correlates and characteristics of chronic pain.  The survey was distributed to 35,718 members (aged 18 years and older) of a Web-enabled panel that is representative of the US population, and 27,035 individuals responded.  Crude and weighted prevalence estimates were calculated and stratified by age, sex, and type of chronic pain.  The weighted point-prevalence of chronic pain (defined as chronic, recurrent, or long-lasting pain lasting for at least 6 months) was 30.7% (95% CI, 29.8-31.7).  Prevalence was higher for females (34.3%) than males (26.7%) and increased with age.  The weighted prevalence of primary chronic lower back pain was 8.1% and primary osteoarthritis pain was 3.9%.  Half of respondents with chronic pain experienced daily pain, and average (past 3 months) pain intensity was severe (≥ 7 on a scale ranging from 0 to 10) for 32%.  Multiple logistic regression analysis identified low household income and unemployment as significant socioeconomic correlates of chronic pain.  Chronic pain is prevalent among US adults and is related to indicators of poorer socioeconomic status.  PERSPECTIVE:  The results of this cross-sectional Internet-based survey suggest a considerable burden of chronic pain in US adults.  Chronic pain, experienced by about a third of the population, was correlated with indicators of poorer socioeconomic status.  Primary chronic pain was most commonly attributed to lower back pain, followed by osteoarthritis pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSDQ-bsE_l1rTDnmmyUf5qOfW6udTcc2ebuECJdl7QRJbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cblt1Siuw%253D%253D&md5=d328413cc4c38bf33309705a7b39cbef</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2010.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2010.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DJohannes%26aufirst%3DC.%2BB.%26aulast%3DLe%26aufirst%3DT.%2BK.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DJohnston%26aufirst%3DJ.%2BA.%26aulast%3DDworkin%26aufirst%3DR.%2BH.%26atitle%3DThe%2520prevalence%2520of%2520chronic%2520pain%2520in%2520United%2520States%2520adults%253A%2520results%2520of%2520an%2520Internet-based%2520survey%26jtitle%3DJ.%2520Pain%26date%3D2010%26volume%3D11%26spage%3D1230%26epage%3D1239%26doi%3D10.1016%2Fj.jpain.2010.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sessle, B.</span><span> </span><span class="NLM_article-title">Unrelieved pain: a crisis</span> <span class="citation_source-journal">Pain Res. Manag.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">416</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span><span class="refDoi"> DOI: 10.1155/2011/513423</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1155%2F2011%2F513423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=22184550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADC%252BC38%252Fos1ynuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=416-420&author=B.+Sessle&title=Unrelieved+pain%3A+a+crisis&doi=10.1155%2F2011%2F513423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Unrelieved pain: a crisis</span></div><div class="casAuthors">Sessle Barry</div><div class="citationInfo"><span class="NLM_cas:title">Pain research & management</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">416-20</span>
        ISSN:<span class="NLM_cas:issn">1203-6765</span>.
    </div><div class="casAbstract">Despite many recent advances in the past 40 years in the understanding of pain mechanisms, and in pain diagnosis and management, considerable gaps in knowledge remain, with chronic pain present in epidemic proportions in most countries.  It is often unrelieved and is associated with significant socioeconomic burdens.  Several opportunities and approaches to address this crisis are identified in the present article.  Most crucial is the need to increase pain awareness, enhance pain education, improve access to pain care and increase pain research resources.  Given the variability among countries in health care policies and programs, resources and educational programs, many of the approaches and strategies outlined will need to be tailored to each country's socioeconomic and educational situation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTR4JB_Qz01vbmQt-ICR3qNfW6udTcc2ea8mfXyqeeyBLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252Fos1ynuw%253D%253D&md5=e26edc0c8d5421ffc0e65727b9a6eb40</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1155%2F2011%2F513423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2011%252F513423%26sid%3Dliteratum%253Aachs%26aulast%3DSessle%26aufirst%3DB.%26atitle%3DUnrelieved%2520pain%253A%2520a%2520crisis%26jtitle%3DPain%2520Res.%2520Manag.%26date%3D2011%26volume%3D16%26spage%3D416%26epage%3D420%26doi%3D10.1155%2F2011%2F513423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ossipov, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span> </span><span class="NLM_article-title">Challenges in the development of novel treatment strategies for neuropathic pain</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">650</span><span class="NLM_x">–</span> <span class="NLM_lpage">661</span><span class="refDoi"> DOI: 10.1602/neurorx.2.4.650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1602%2Fneurorx.2.4.650" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=650-661&author=M.+H.+Ossipovauthor=F.+Porreca&title=Challenges+in+the+development+of+novel+treatment+strategies+for+neuropathic+pain&doi=10.1602%2Fneurorx.2.4.650"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.650%26sid%3Dliteratum%253Aachs%26aulast%3DOssipov%26aufirst%3DM.%2BH.%26aulast%3DPorreca%26aufirst%3DF.%26atitle%3DChallenges%2520in%2520the%2520development%2520of%2520novel%2520treatment%2520strategies%2520for%2520neuropathic%2520pain%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D650%26epage%3D661%26doi%3D10.1602%2Fneurorx.2.4.650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kinloch, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, P. J.</span><span> </span><span class="NLM_article-title">New targets for neuropathic pain therapeutics</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span><span class="refDoi"> DOI: 10.1517/14728222.9.4.685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1517%2F14728222.9.4.685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=16083337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFelsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2005&pages=685-698&author=R.+A.+Kinlochauthor=P.+J.+Cox&title=New+targets+for+neuropathic+pain+therapeutics&doi=10.1517%2F14728222.9.4.685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">New targets for neuropathic pain therapeutics</span></div><div class="casAuthors">Kinloch, Ross A.; Cox, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">685-698</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Neuropathic pain (NeP) is initiated by a lesion or dysfunction in the nervous system.  Unlike physiol. pain it serves no useful purpose and is usually sustained and chronic.  NeP encompasses a wide range of pain syndromes of diverse etiologies which together account for > 12 million sufferers in the US.  Currently, there are a no. of therapies available for NeP, including gabapentin, pregabalin, anticonvulsants (tiagabine HCl), tricyclic antidepressants (amitriptyline, nortriptyline) and acetaminophen/opioid combination products (Vicodin, Tylenol #3).  However, these products do not provide sufficient pain relief and a significant proportion of sufferers are refractory (60%).  Therefore, there is a need for new therapies that provide more predictable efficacy in all patients with improved tolerability.  Over the last decade, understanding of the basic mechanisms contributing to the generation of NeP in preclin. animal models has greatly improved.  Together with the completion of the various genome sequencing projects and significant advances in microarray and target validation strategies, new therapeutic approaches are being rigorously pursued.  This article reviews the rationale behind a no. of these mechanism-based approaches, briefly discusses specific challenges that they face, and finally, speculates on the potential of emerging technologies as alternative therapeutic strategies to the traditional "small-mol." approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqREHZgouV37LVg90H21EOLACvtfcHk0lhZR06amE6TAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFelsrY%253D&md5=38f5aaae4eddffda1f9721e9f2c1581a</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1517%2F14728222.9.4.685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.9.4.685%26sid%3Dliteratum%253Aachs%26aulast%3DKinloch%26aufirst%3DR.%2BA.%26aulast%3DCox%26aufirst%3DP.%2BJ.%26atitle%3DNew%2520targets%2520for%2520neuropathic%2520pain%2520therapeutics%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2005%26volume%3D9%26spage%3D685%26epage%3D698%26doi%3D10.1517%2F14728222.9.4.685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sullivan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, C. Q.</span><span> </span><span class="NLM_article-title">Opioid therapy for chronic pain in the United States: promises and perils</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S94</span><span class="NLM_x">–</span> <span class="NLM_lpage">S100</span><span class="refDoi"> DOI: 10.1016/j.pain.2013.09.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.pain.2013.09.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=S94-S100&issue=Suppl+1&author=M.+D.+Sullivanauthor=C.+Q.+Howe&title=Opioid+therapy+for+chronic+pain+in+the+United+States%3A+promises+and+perils&doi=10.1016%2Fj.pain.2013.09.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2013.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2013.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DM.%2BD.%26aulast%3DHowe%26aufirst%3DC.%2BQ.%26atitle%3DOpioid%2520therapy%2520for%2520chronic%2520pain%2520in%2520the%2520United%2520States%253A%2520promises%2520and%2520perils%26jtitle%3DPain%26date%3D2013%26volume%3D154%26issue%3DSuppl%25201%26spage%3DS94%26epage%3DS100%26doi%3D10.1016%2Fj.pain.2013.09.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Karst, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conrad, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, U.</span><span> </span><span class="NLM_article-title">Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial</span> <span class="citation_source-journal">JAMA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">1757</span><span class="NLM_x">–</span> <span class="NLM_lpage">1762</span><span class="refDoi"> DOI: 10.1001/jama.290.13.1757</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1001%2Fjama.290.13.1757" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2003&pages=1757-1762&author=M.+Karstauthor=K.+Salimauthor=S.+Bursteinauthor=I.+Conradauthor=L.+Hoyauthor=U.+Schneider&title=Analgesic+effect+of+the+synthetic+cannabinoid+CT-3+on+chronic+neuropathic+pain%3A+a+randomized+controlled+trial&doi=10.1001%2Fjama.290.13.1757"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1001%2Fjama.290.13.1757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.290.13.1757%26sid%3Dliteratum%253Aachs%26aulast%3DKarst%26aufirst%3DM.%26aulast%3DSalim%26aufirst%3DK.%26aulast%3DBurstein%26aufirst%3DS.%26aulast%3DConrad%26aufirst%3DI.%26aulast%3DHoy%26aufirst%3DL.%26aulast%3DSchneider%26aufirst%3DU.%26atitle%3DAnalgesic%2520effect%2520of%2520the%2520synthetic%2520cannabinoid%2520CT-3%2520on%2520chronic%2520neuropathic%2520pain%253A%2520a%2520randomized%2520controlled%2520trial%26jtitle%3DJAMA%26date%3D2003%26volume%3D290%26spage%3D1757%26epage%3D1762%26doi%3D10.1001%2Fjama.290.13.1757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Berman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symonds, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birch, R.</span><span> </span><span class="NLM_article-title">Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">306</span><span class="refDoi"> DOI: 10.1016/j.pain.2004.09.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.pain.2004.09.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2004&pages=299-306&author=J.+S.+Bermanauthor=C.+Symondsauthor=R.+Birch&title=Efficacy+of+two+cannabis+based+medicinal+extracts+for+relief+of+central+neuropathic+pain+from+brachial+plexus+avulsion%3A+results+of+a+randomised+controlled+trial&doi=10.1016%2Fj.pain.2004.09.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2004.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2004.09.013%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DJ.%2BS.%26aulast%3DSymonds%26aufirst%3DC.%26aulast%3DBirch%26aufirst%3DR.%26atitle%3DEfficacy%2520of%2520two%2520cannabis%2520based%2520medicinal%2520extracts%2520for%2520relief%2520of%2520central%2520neuropathic%2520pain%2520from%2520brachial%2520plexus%2520avulsion%253A%2520results%2520of%2520a%2520randomised%2520controlled%2520trial%26jtitle%3DPain%26date%3D2004%26volume%3D112%26spage%3D299%26epage%3D306%26doi%3D10.1016%2Fj.pain.2004.09.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Notcutt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newport, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sansom, C.</span><span> </span><span class="NLM_article-title">Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 ’N of 1’ studies</span> <span class="citation_source-journal">Anaesthesia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span><span class="refDoi"> DOI: 10.1111/j.1365-2044.2004.03674.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1111%2Fj.1365-2044.2004.03674.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2004&pages=440-452&author=W.+Notcuttauthor=M.+Priceauthor=R.+Millerauthor=S.+Newportauthor=C.+Phillipsauthor=S.+Simmonsauthor=C.+Sansom&title=Initial+experiences+with+medicinal+extracts+of+cannabis+for+chronic+pain%3A+results+from+34+%E2%80%99N+of+1%E2%80%99+studies&doi=10.1111%2Fj.1365-2044.2004.03674.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2044.2004.03674.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2044.2004.03674.x%26sid%3Dliteratum%253Aachs%26aulast%3DNotcutt%26aufirst%3DW.%26aulast%3DPrice%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DNewport%26aufirst%3DS.%26aulast%3DPhillips%26aufirst%3DC.%26aulast%3DSimmons%26aufirst%3DS.%26aulast%3DSansom%26aufirst%3DC.%26atitle%3DInitial%2520experiences%2520with%2520medicinal%2520extracts%2520of%2520cannabis%2520for%2520chronic%2520pain%253A%2520results%2520from%252034%2520%25E2%2580%2599N%2520of%25201%25E2%2580%2599%2520studies%26jtitle%3DAnaesthesia%26date%3D2004%26volume%3D59%26spage%3D440%26epage%3D452%26doi%3D10.1111%2Fj.1365-2044.2004.03674.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Herzberg, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eliav, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopin, I. J.</span><span> </span><span class="NLM_article-title">The analgesic effects of R(+)-WIN 55,212–2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">221</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span><span class="refDoi"> DOI: 10.1016/S0304-3940(96)13308-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2FS0304-3940%2896%2913308-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=1997&pages=157-160&author=U.+Herzbergauthor=E.+Eliavauthor=G.+J.+Bennettauthor=I.+J.+Kopin&title=The+analgesic+effects+of+R%28%2B%29-WIN+55%2C212%E2%80%932+mesylate%2C+a+high+affinity+cannabinoid+agonist%2C+in+a+rat+model+of+neuropathic+pain&doi=10.1016%2FS0304-3940%2896%2913308-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2896%2913308-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252896%252913308-5%26sid%3Dliteratum%253Aachs%26aulast%3DHerzberg%26aufirst%3DU.%26aulast%3DEliav%26aufirst%3DE.%26aulast%3DBennett%26aufirst%3DG.%2BJ.%26aulast%3DKopin%26aufirst%3DI.%2BJ.%26atitle%3DThe%2520analgesic%2520effects%2520of%2520R%2528%252B%2529-WIN%252055%252C212%25E2%2580%25932%2520mesylate%252C%2520a%2520high%2520affinity%2520cannabinoid%2520agonist%252C%2520in%2520a%2520rat%2520model%2520of%2520neuropathic%2520pain%26jtitle%3DNeurosci.%2520Lett.%26date%3D1997%26volume%3D221%26spage%3D157%26epage%3D160%26doi%3D10.1016%2FS0304-3940%2896%2913308-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fox, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesingland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNair, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I.</span><span> </span><span class="NLM_article-title">The role of central and peripheral Cannabinoid<sub>1</sub> receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span><span class="refDoi"> DOI: 10.1016/S0304-3959(00)00474-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2FS0304-3959%2800%2900474-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2001&pages=91-100&author=A.+Foxauthor=A.+Kesinglandauthor=C.+Gentryauthor=K.+McNairauthor=S.+Patelauthor=L.+Urbanauthor=I.+James&title=The+role+of+central+and+peripheral+Cannabinoid1+receptors+in+the+antihyperalgesic+activity+of+cannabinoids+in+a+model+of+neuropathic+pain&doi=10.1016%2FS0304-3959%2800%2900474-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1016%2FS0304-3959%2800%2900474-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3959%252800%252900474-7%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DA.%26aulast%3DKesingland%26aufirst%3DA.%26aulast%3DGentry%26aufirst%3DC.%26aulast%3DMcNair%26aufirst%3DK.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DUrban%26aufirst%3DL.%26aulast%3DJames%26aufirst%3DI.%26atitle%3DThe%2520role%2520of%2520central%2520and%2520peripheral%2520Cannabinoid1%2520receptors%2520in%2520the%2520antihyperalgesic%2520activity%2520of%2520cannabinoids%2520in%2520a%2520model%2520of%2520neuropathic%2520pain%26jtitle%3DPain%26date%3D2001%26volume%3D92%26spage%3D91%26epage%3D100%26doi%3D10.1016%2FS0304-3959%2800%2900474-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Mackie, K.</span><span> </span><span class="NLM_article-title">Distribution of cannabinoid receptors in the central and peripheral nervous system</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span><span class="refDoi"> DOI: 10.1007/3-540-26573-2_10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1007%2F3-540-26573-2_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=16596779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFeqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2005&pages=299-325&author=K.+Mackie&title=Distribution+of+cannabinoid+receptors+in+the+central+and+peripheral+nervous+system&doi=10.1007%2F3-540-26573-2_10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of cannabinoid receptors in the central and peripheral nervous system</span></div><div class="casAuthors">Mackie, K.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">Cannabinoids</span>),
    <span class="NLM_cas:pages">299-325</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  CB1 cannabinoid receptors appear to mediate most, if not all of the psychoactive effects of delta-9-tetrahydrocannabinol and related compds.  This G protein-coupled receptor has a characteristic distribution in the nervous system: it is particularly enriched in cortex, hippocampus, amygdala, basal ganglia outflow tracts, and cerebellum-a distribution that corresponds to the most prominent behavioral effects of cannabis.  In addn., this distribution helps to predict neurol. and psychol. maladies for which manipulation of the endocannabinoid system might be beneficial.  CB1 receptors are primarily expressed on neurons, where most of the receptors are found on axons and synaptic terminals, emphasizing the important role of this receptor in modulating neurotransmission at specific synapses.  While our knowledge of CB1 localization in the nervous system has advanced tremendously over the past 15 yr, there is still more to learn.  Particularly pressing is the need for (1) detailed anatomical studies of brain regions important in the therapeutic actions of drugs that modify the endocannabinoid system and (2) the detn. of the localization of the enzymes that synthesize, degrade, and transport the endocannabinoids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyn5OlPTVo9LVg90H21EOLACvtfcHk0lj1de2qDIRhlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFeqsL0%253D&md5=9c050ab9a3d1ff72b874235e2d683594</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2F3-540-26573-2_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F3-540-26573-2_10%26sid%3Dliteratum%253Aachs%26aulast%3DMackie%26aufirst%3DK.%26atitle%3DDistribution%2520of%2520cannabinoid%2520receptors%2520in%2520the%2520central%2520and%2520peripheral%2520nervous%2520system%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2005%26volume%3D168%26spage%3D299%26epage%3D325%26doi%3D10.1007%2F3-540-26573-2_10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Amaya, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimosato, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span> </span><span class="NLM_article-title">Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span><span class="refDoi"> DOI: 10.1016/j.pain.2006.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.pain.2006.04.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2006&pages=175-183&author=F.+Amayaauthor=G.+Shimosatoauthor=Y.+Kawasakiauthor=S.+Hashimotoauthor=Y.+Tanakaauthor=R.+R.+Jiauthor=M.+Tanaka&title=Induction+of+CB1+cannabinoid+receptor+by+inflammation+in+primary+afferent+neurons+facilitates+antihyperalgesic+effect+of+peripheral+CB1+agonist&doi=10.1016%2Fj.pain.2006.04.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2006.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2006.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DAmaya%26aufirst%3DF.%26aulast%3DShimosato%26aufirst%3DG.%26aulast%3DKawasaki%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DR.%2BR.%26aulast%3DTanaka%26aufirst%3DM.%26atitle%3DInduction%2520of%2520CB1%2520cannabinoid%2520receptor%2520by%2520inflammation%2520in%2520primary%2520afferent%2520neurons%2520facilitates%2520antihyperalgesic%2520effect%2520of%2520peripheral%2520CB1%2520agonist%26jtitle%3DPain%26date%3D2006%26volume%3D124%26spage%3D175%26epage%3D183%26doi%3D10.1016%2Fj.pain.2006.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gutierrez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farthing, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvonok, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohmann, A. G.</span><span> </span><span class="NLM_article-title">Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0706984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1038%2Fsj.bjp.0706984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=17160008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFeqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2007&pages=153-163&author=T.+Gutierrezauthor=J.+N.+Farthingauthor=A.+M.+Zvonokauthor=A.+Makriyannisauthor=A.+G.+Hohmann&title=Activation+of+peripheral+cannabinoid+CB1+and+CB2+receptors+suppresses+the+maintenance+of+inflammatory+nociception%3A+a+comparative+analysis&doi=10.1038%2Fsj.bjp.0706984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis</span></div><div class="casAuthors">Gutierrez, T.; Farthing, J. N.; Zvonok, A. M.; Makriyannis, A.; Hohmann, A. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-163</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Effects of locally administered agonists and antagonists for cannabinoid CB1 and CB2 receptors on mech. and thermal hypersensitivity were compared after the establishment of chronic inflammation.  Carrageenan was administered unilaterally to the rat hindpaw on day 1.  Prophylactic efficacy of locally administered CB1- and CB2-selective agonists, ACEA and AM1241, resp.- on mech. and thermal hypersensitivity were compared on day 2.  Pharmacol. specificity was evaluated using locally administered CB1 and CB2-selective antagonists, SR141716A and SR144528, resp.  Administration of either ACEA or AM1241 to the inflamed but not noninflamed paw suppressed the maintenance of carrageenan-evoked mech. hyperalgesia and tactile allodynia and attenuated thermal hyperalgesia.  The ACEA-induced suppression of mech. and thermal hypersensitivity was blocked by local injection of SR141716A but not SR144528.  AM1241 suppressed mech. hypersensitivity with the reverse pharmacol. specificity.  The AM1241-induced suppression of thermal hyperalgesia was blocked by SR144528 and to a lesser extent by SR14176A.  Coadministration of ACEA with AM1241 in the inflamed paw increased the magnitude but not the duration of thermal antihyperalgesia compared to intraplantar administration of either agonist alone.  Cannabinoids act locally through distinct CB1 and CB2 mechanisms to suppress mech. hypersensitivity after the establishment of chronic inflammation, at doses that produced modest changes in thermal hyperalgesia.  Additive antihyperalgesic effects were obsd. following prophylactic coadministration of the CB1- and CB2-selective agonists.  Our results suggest that peripheral cannabinoid antihyperalgesic actions may be exploited for treatment of inflammatory pain states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkP6JkKBYGErVg90H21EOLACvtfcHk0liN4C2Xl0XwAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFeqtQ%253D%253D&md5=61eda426c6f792b1483b3184cbf328b0</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706984%26sid%3Dliteratum%253Aachs%26aulast%3DGutierrez%26aufirst%3DT.%26aulast%3DFarthing%26aufirst%3DJ.%2BN.%26aulast%3DZvonok%26aufirst%3DA.%2BM.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DHohmann%26aufirst%3DA.%2BG.%26atitle%3DActivation%2520of%2520peripheral%2520cannabinoid%2520CB1%2520and%2520CB2%2520receptors%2520suppresses%2520the%2520maintenance%2520of%2520inflammatory%2520nociception%253A%2520a%2520comparative%2520analysis%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D150%26spage%3D153%26epage%3D163%26doi%3D10.1038%2Fsj.bjp.0706984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Johanek, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simone, D. A.</span><span> </span><span class="NLM_article-title">Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">432</span><span class="NLM_x">–</span> <span class="NLM_lpage">442</span><span class="refDoi"> DOI: 10.1016/j.pain.2004.02.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.pain.2004.02.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2004&pages=432-442&author=L.+M.+Johanekauthor=D.+A.+Simone&title=Activation+of+peripheral+cannabinoid+receptors+attenuates+cutaneous+hyperalgesia+produced+by+a+heat+injury&doi=10.1016%2Fj.pain.2004.02.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2004.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2004.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DJohanek%26aufirst%3DL.%2BM.%26aulast%3DSimone%26aufirst%3DD.%2BA.%26atitle%3DActivation%2520of%2520peripheral%2520cannabinoid%2520receptors%2520attenuates%2520cutaneous%2520hyperalgesia%2520produced%2520by%2520a%2520heat%2520injury%26jtitle%3DPain%26date%3D2004%26volume%3D109%26spage%3D432%26epage%3D442%26doi%3D10.1016%2Fj.pain.2004.02.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Richardson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, K. M.</span><span> </span><span class="NLM_article-title">Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">119</span><span class="refDoi"> DOI: 10.1016/S0304-3959(97)00213-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2FS0304-3959%2897%2900213-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1998&pages=111-119&author=J.+D.+Richardsonauthor=S.+Kiloauthor=K.+M.+Hargreaves&title=Cannabinoids+reduce+hyperalgesia+and+inflammation+via+interaction+with+peripheral+CB1+receptors&doi=10.1016%2FS0304-3959%2897%2900213-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1016%2FS0304-3959%2897%2900213-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3959%252897%252900213-3%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DJ.%2BD.%26aulast%3DKilo%26aufirst%3DS.%26aulast%3DHargreaves%26aufirst%3DK.%2BM.%26atitle%3DCannabinoids%2520reduce%2520hyperalgesia%2520and%2520inflammation%2520via%2520interaction%2520with%2520peripheral%2520CB1%2520receptors%26jtitle%3DPain%26date%3D1998%26volume%3D75%26spage%3D111%26epage%3D119%26doi%3D10.1016%2FS0304-3959%2897%2900213-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Agarwal, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacher, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tegeder, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaya, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constantin, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalski, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsicano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monory, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marian, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batkai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parolaro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kress, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolf, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuner, R.</span><span> </span><span class="NLM_article-title">Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">870</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span><span class="refDoi"> DOI: 10.1038/nn1916</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1038%2Fnn1916" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=17558404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmvFKmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=870-879&author=N.+Agarwalauthor=P.+Pacherauthor=I.+Tegederauthor=F.+Amayaauthor=C.+E.+Constantinauthor=G.+J.+Brennerauthor=T.+Rubinoauthor=C.+W.+Michalskiauthor=G.+Marsicanoauthor=K.+Monoryauthor=K.+Mackieauthor=C.+Marianauthor=S.+Batkaiauthor=D.+Parolaroauthor=M.+J.+Fischerauthor=P.+Reehauthor=G.+Kunosauthor=M.+Kressauthor=B.+Lutzauthor=C.+J.+Woolfauthor=R.+Kuner&title=Cannabinoids+mediate+analgesia+largely+via+peripheral+type+1+cannabinoid+receptors+in+nociceptors&doi=10.1038%2Fnn1916"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors</span></div><div class="casAuthors">Agarwal, Nitin; Pacher, Pal; Tegeder, Irmgard; Amaya, Fumimasa; Constantin, Cristina E.; Brenner, Gary J.; Rubino, Tiziana; Michalski, Christoph W.; Marsicano, Giovanni; Monory, Krisztina; Mackie, Ken; Marian, Claudiu; Batkai, Sandor; Parolaro, Daniela; Fischer, Michael J.; Reeh, Peter; Kunos, George; Kress, Michaela; Lutz, Beat; Woolf, Clifford J.; Kuner, Rohini</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">870-879</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although endocannabinoids constitute one of the first lines of defense against pain, the anatomical locus and the precise receptor mechanisms underlying cannabinergic modulation of pain are uncertain.  Clin. exploitation of the system is severely hindered by the cognitive deficits, memory impairment, motor disturbances and psychotropic effects resulting from the central actions of cannabinoids.  We deleted the type 1 cannabinoid receptor (CB1) specifically in nociceptive neurons localized in the peripheral nervous system of mice, preserving its expression in the CNS, and analyzed these genetically modified mice in preclin. models of inflammatory and neuropathic pain.  The nociceptor-specific loss of CB1 substantially reduced the analgesia produced by local and systemic, but not intrathecal, delivery of cannabinoids.  We conclude that the contribution of CB1-type receptors expressed on the peripheral terminals of nociceptors to cannabinoid-induced analgesia is paramount, which should enable the development of peripherally acting CB1 analgesic agonists without any central side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAZzekYhyFgbVg90H21EOLACvtfcHk0liN4C2Xl0XwAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmvFKmsL8%253D&md5=d10b61aba8255952cbbd5fc1ab7f796e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnn1916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn1916%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DN.%26aulast%3DPacher%26aufirst%3DP.%26aulast%3DTegeder%26aufirst%3DI.%26aulast%3DAmaya%26aufirst%3DF.%26aulast%3DConstantin%26aufirst%3DC.%2BE.%26aulast%3DBrenner%26aufirst%3DG.%2BJ.%26aulast%3DRubino%26aufirst%3DT.%26aulast%3DMichalski%26aufirst%3DC.%2BW.%26aulast%3DMarsicano%26aufirst%3DG.%26aulast%3DMonory%26aufirst%3DK.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DMarian%26aufirst%3DC.%26aulast%3DBatkai%26aufirst%3DS.%26aulast%3DParolaro%26aufirst%3DD.%26aulast%3DFischer%26aufirst%3DM.%2BJ.%26aulast%3DReeh%26aufirst%3DP.%26aulast%3DKunos%26aufirst%3DG.%26aulast%3DKress%26aufirst%3DM.%26aulast%3DLutz%26aufirst%3DB.%26aulast%3DWoolf%26aufirst%3DC.%2BJ.%26aulast%3DKuner%26aufirst%3DR.%26atitle%3DCannabinoids%2520mediate%2520analgesia%2520largely%2520via%2520peripheral%2520type%25201%2520cannabinoid%2520receptors%2520in%2520nociceptors%26jtitle%3DNat.%2520Neurosci.%26date%3D2007%26volume%3D10%26spage%3D870%26epage%3D879%26doi%3D10.1038%2Fnn1916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Spigelman, I.</span><span> </span><span class="NLM_article-title">Frontiers in neuroscience: therapeutic targeting of peripheral cannabinoid receptors in inflammatory and neuropathic pain states</span>. In  <span class="citation_source-book">Translational Pain Research: from Mouse to Man</span>; <span class="NLM_contrib-group">Kruger, L.; Light, A. R.</span>, Eds.; <span class="NLM_publisher-name">Taylor & Francis Group, LLC</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=99-137&author=I.+Spigelmanauthor=L.+Kruger&author=A.+R.+Light&title=Translational+Pain+Research%3A+from+Mouse+to+Man"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSpigelman%26aufirst%3DI.%26atitle%3DFrontiers%2520in%2520neuroscience%253A%2520therapeutic%2520targeting%2520of%2520peripheral%2520cannabinoid%2520receptors%2520in%2520inflammatory%2520and%2520neuropathic%2520pain%2520states%26btitle%3DTranslational%2520Pain%2520Research%253A%2520from%2520Mouse%2520to%2520Man%26aulast%3DKruger%26aufirst%3DL.%26pub%3DTaylor%2520%2526%2520Francis%2520Group%252C%2520LLC%26date%3D2010%26spage%3D99%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Pertwee, R. G.</span><span> </span><span class="NLM_article-title">The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0707442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1038%2Fsj.bjp.0707442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=17828291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFCkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=199-215&author=R.+G.+Pertwee&title=The+diverse+CB1+and+CB2+receptor+pharmacology+of+three+plant+cannabinoids%3A+%CE%949-tetrahydrocannabinol%2C+cannabidiol+and+%CE%949-tetrahydrocannabivarin&doi=10.1038%2Fsj.bjp.0707442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin</span></div><div class="casAuthors">Pertwee, R. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-215</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cannabis sativa is the source of a unique set of compds. known collectively as plant cannabinoids or phytocannabinoids.  This review focuses on the manner with which three of these compds., (-)-trans-Δ9-tetrahydrocannabinol (Δ9-THC), (-)-cannabidiol (CBD) and (-)-trans-Δ9-tetrahydrocannabivarin (Δ9-THCV), interact with cannabinoid CB1 and CB2 receptors. Δ9-THC, the main psychotropic constituent of cannabis, is a CB1 and CB2 receptor partial agonist and in line with classical pharmacol., the responses it elicits appear to be strongly influenced both by the expression level and signalling efficiency of cannabinoid receptors and by ongoing endogenous cannabinoid release.  CBD displays unexpectedly high potency as an antagonist of CB1/CB2 receptor agonists in CB1- and CB2-expressing cells or tissues, the manner with which it interacts with CB2 receptors providing a possible explanation for its ability to inhibit evoked immune cell migration. Δ9-THCV behaves as a potent CB2 receptor partial agonist in vitro.  In contrast, it antagonizes cannabinoid receptor agonists in CB1-expressing tissues.  This it does with relatively high potency and in a manner that is both tissue and ligand dependent. Δ9-THCV also interacts with CB1 receptors when administered in vivo, behaving either as a CB1 antagonist or, at higher doses, as a CB1 receptor agonist.  Brief mention is also made in this review, first of the prodn. by Δ9-THC of pharmacodynamic tolerance, second of current knowledge about the extent to which Δ9-THC, CBD and Δ9-THCV interact with pharmacol. targets other than CB1 or CB2 receptors, and third of actual and potential therapeutic applications for each of these cannabinoids.  British Journal of Pharmacol. (2008) 153, 199-215; doi:10.1038/sj.bjp.0707442; published online 10 Sept. 2007.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdNia0Z97Wz7Vg90H21EOLACvtfcHk0lhxd0znBxnrgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFCkuw%253D%253D&md5=53187d5a54c048cbbd0d0b0143feb206</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707442%26sid%3Dliteratum%253Aachs%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26atitle%3DThe%2520diverse%2520CB1%2520and%2520CB2%2520receptor%2520pharmacology%2520of%2520three%2520plant%2520cannabinoids%253A%2520%25CE%25949-tetrahydrocannabinol%252C%2520cannabidiol%2520and%2520%25CE%25949-tetrahydrocannabivarin%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D199%26epage%3D215%26doi%3D10.1038%2Fsj.bjp.0707442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bridges, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, A. S.</span><span> </span><span class="NLM_article-title">The synthetic cannabinoid WIN55,212–2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">586</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0704110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1038%2Fsj.bjp.0704110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=11399676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkvFSlur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2001&pages=586-594&author=D.+Bridgesauthor=K.+Ahmadauthor=A.+S.+Rice&title=The+synthetic+cannabinoid+WIN55%2C212%E2%80%932+attenuates+hyperalgesia+and+allodynia+in+a+rat+model+of+neuropathic+pain&doi=10.1038%2Fsj.bjp.0704110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain</span></div><div class="casAuthors">Bridges, Daniel; Ahmad, Kamran; Rice, Andrew S. C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">586-594</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The analgesic properties of the synthetic cannabinoid WIN55,212-2 were investigated in a model of neuropathic pain.  In male Wistar rats, bilateral hind limb withdrawal thresholds to cold, mech. and noxious thermal stimuli were measured.  Following this, unilateral L5 spinal nerve ligation was performed.  Seven days later, sensory thresholds were reassessed and the development of allodynia to cold and mech. stimuli and hyperalgesia to a noxious thermal stimulus confirmed.  The effect of WIN55,212-2 (0.1-5.0 mg kg-1, i.p.) on the signs of neuropathy was then detd.; there was a dose related reversal of all three signs of painful neuropathy at doses which did not generally alter sensory thresholds in the contralateral unligated limb.  This effect was prevented by co-administration of the CB1 receptor antagonist SR141716a, but not by co-administration of the CB2 receptor antagonist SR144528, suggesting this action of WIN55,212-2 is mediated via the CB1 receptor.  Administration of SR141716a alone had no affect on the obsd. allodynia and hyperalgesia, which does not support the concept of an endogenous analgesic tone.  These data indicate that cannabinoids may have therapeutic potential in neuropathic pain, and that this effect is mediated through the CB1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofAvZq7kfVY7Vg90H21EOLACvtfcHk0lhxd0znBxnrgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkvFSlur0%253D&md5=65055bbe7877dd7e55fec92950a3cb54</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704110%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DD.%26aulast%3DAhmad%26aufirst%3DK.%26aulast%3DRice%26aufirst%3DA.%2BS.%26atitle%3DThe%2520synthetic%2520cannabinoid%2520WIN55%252C212%25E2%2580%25932%2520attenuates%2520hyperalgesia%2520and%2520allodynia%2520in%2520a%2520rat%2520model%2520of%2520neuropathic%2520pain%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D133%26spage%3D586%26epage%3D594%26doi%3D10.1038%2Fsj.bjp.0704110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Costa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colleoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trovato, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotgiu, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giagnoni, G.</span><span> </span><span class="NLM_article-title">Repeated treatment with the synthetic cannabinoid WIN 55,212–2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0705587</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1038%2Fsj.bjp.0705587" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=14662732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFaltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2004&pages=4-8&author=B.+Costaauthor=M.+Colleoniauthor=S.+Contiauthor=A.+E.+Trovatoauthor=M.+Bianchiauthor=M.+L.+Sotgiuauthor=G.+Giagnoni&title=Repeated+treatment+with+the+synthetic+cannabinoid+WIN+55%2C212%E2%80%932+reduces+both+hyperalgesia+and+production+of+pronociceptive+mediators+in+a+rat+model+of+neuropathic+pain&doi=10.1038%2Fsj.bjp.0705587"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain</span></div><div class="casAuthors">Costa, B.; Colleoni, M.; Conti, S.; Trovato, A. E.; Bianchi, M.; Sotgiu, M. L.; Giagnoni, G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-8</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The antinociceptive properties of cannabinoids in persistent pain are not fully elucidated.  We investigated the effect of repeated treatment with the synthetic cannabinoid receptor agonist WIN 55,212-2 on the neuropathic pain induced in rats by chronic constriction of the sciatic nerve.  WIN 55,212-2 administered daily throughout the development of neuropathy reversed the hyperalgesia, at a dose (0.1 mg kg-1, s.c.) that had no effect on the nociceptive responses of either paw contralateral to the sciatic ligation or of animals subjected to sham surgery.  At 14 days after injury, the levels of mediators known to be involved in neuropathic pain, such as prostaglandin E2, NO and the neuronal NOS, were increased.  Repeated treatment with WIN 55,212-2 abolished these increases.  In the light of the current clin. need for neuropathic pain treatments, these findings indicate that cannabinoid agonists, at doses devoid of psychoactive effects, could constitute important compds. for the development of new analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfUpCdA8eperVg90H21EOLACvtfcHk0liRtijmDmn8gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFaltbY%253D&md5=8cd5073c34b0f25453b269e390d99767</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705587%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DB.%26aulast%3DColleoni%26aufirst%3DM.%26aulast%3DConti%26aufirst%3DS.%26aulast%3DTrovato%26aufirst%3DA.%2BE.%26aulast%3DBianchi%26aufirst%3DM.%26aulast%3DSotgiu%26aufirst%3DM.%2BL.%26aulast%3DGiagnoni%26aufirst%3DG.%26atitle%3DRepeated%2520treatment%2520with%2520the%2520synthetic%2520cannabinoid%2520WIN%252055%252C212%25E2%2580%25932%2520reduces%2520both%2520hyperalgesia%2520and%2520production%2520of%2520pronociceptive%2520mediators%2520in%2520a%2520rat%2520model%2520of%2520neuropathic%2520pain%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D141%26spage%3D4%26epage%3D8%26doi%3D10.1038%2Fsj.bjp.0705587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, D. J.</span><span> </span><span class="NLM_article-title">Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1016/0304-3959(95)00022-K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2F0304-3959%2895%2900022-K" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1995&pages=353-364&author=J.+Maoauthor=D.+D.+Priceauthor=D.+J.+Mayer&title=Experimental+mononeuropathy+reduces+the+antinociceptive+effects+of+morphine%3A+implications+for+common+intracellular+mechanisms+involved+in+morphine+tolerance+and+neuropathic+pain&doi=10.1016%2F0304-3959%2895%2900022-K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2895%2900022-K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252895%252900022-K%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BD.%26aulast%3DMayer%26aufirst%3DD.%2BJ.%26atitle%3DExperimental%2520mononeuropathy%2520reduces%2520the%2520antinociceptive%2520effects%2520of%2520morphine%253A%2520implications%2520for%2520common%2520intracellular%2520mechanisms%2520involved%2520in%2520morphine%2520tolerance%2520and%2520neuropathic%2520pain%26jtitle%3DPain%26date%3D1995%26volume%3D61%26spage%3D353%26epage%3D364%26doi%3D10.1016%2F0304-3959%2895%2900022-K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ossipov, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span> </span><span class="NLM_article-title">The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">199</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span><span class="refDoi"> DOI: 10.1016/0304-3940(95)12022-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2F0304-3940%2895%2912022-V" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=199&publication_year=1995&pages=87-90&author=M.+H.+Ossipovauthor=Y.+Lopezauthor=M.+L.+Nicholsauthor=D.+Bianauthor=F.+Porreca&title=The+loss+of+antinociceptive+efficacy+of+spinal+morphine+in+rats+with+nerve+ligation+injury+is+prevented+by+reducing+spinal+afferent+drive&doi=10.1016%2F0304-3940%2895%2912022-V"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2F0304-3940%2895%2912022-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3940%252895%252912022-V%26sid%3Dliteratum%253Aachs%26aulast%3DOssipov%26aufirst%3DM.%2BH.%26aulast%3DLopez%26aufirst%3DY.%26aulast%3DNichols%26aufirst%3DM.%2BL.%26aulast%3DBian%26aufirst%3DD.%26aulast%3DPorreca%26aufirst%3DF.%26atitle%3DThe%2520loss%2520of%2520antinociceptive%2520efficacy%2520of%2520spinal%2520morphine%2520in%2520rats%2520with%2520nerve%2520ligation%2520injury%2520is%2520prevented%2520by%2520reducing%2520spinal%2520afferent%2520drive%26jtitle%3DNeurosci.%2520Lett.%26date%3D1995%26volume%3D199%26spage%3D87%26epage%3D90%26doi%3D10.1016%2F0304-3940%2895%2912022-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rashid, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, H.</span><span> </span><span class="NLM_article-title">Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span><span class="refDoi"> DOI: 10.1124/jpet.103.060582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1124%2Fjpet.103.060582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=14718584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivFamur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=380-387&author=M.+H.+Rashidauthor=M.+Inoueauthor=K.+Todaauthor=H.+Ueda&title=Loss+of+peripheral+morphine+analgesia+contributes+to+the+reduced+effectiveness+of+systemic+morphine+in+neuropathic+pain&doi=10.1124%2Fjpet.103.060582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain</span></div><div class="casAuthors">Rashid, Md Harunor; Inoue, Makoto; Toda, Kazuo; Ueda, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">380-387</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">It is well known that the analgesic potency of morphine is reduced in neuropathic pain.  In this study, we demonstrate that the decreased effectiveness of systemic morphine in neuropathic pain might be caused by the loss of morphine analgesia at the periphery.  When given s.c. or i.t., the dose-response curves for morphine analgesia in Hargreaves thermal test were shifted rightward in partial sciatic nerve-injured mice compared with control sham-operated mice.  The dose-response curves for i.c.v. morphine analgesia, however, were unchanged in nerve-injured mice, indicating no decrease in morphine potency at the supraspinal level.  On the other hand, the dose-dependent analgesia produced by intraplantar (i.pl.) morphine in sham-operated mice almost completely disappeared in nerve-injured mice.  With the more sensitive algogenic-induced nociceptive flexion test, significant redn. in the analgesic potency of systemic morphine was obsd. for bradykinin (BK) nociception in nerve-injured mice, and the analgesic effect of i.pl. morphine against BK nociception in sham-operated mice disappeared in nerve-injured mice.  In immunohistochem. expts., we found that, under normal state, μ-opioid receptors (MOPs) were mainly expressed in small-diam. unmyelinated dorsal root ganglion (DRG) neurons and colocalized with bradykinin B2 receptors.  When we examd. MOP expression in the DRG of nerve-injured mice, we obsd. a drastic decrease in MOP expression.  Altogether, these data suggest that the lower potency of systemic morphine in neuropathic pain could be at least partly caused by the decreased MOP expression in DRG and subsequent loss of peripheral morphine analgesia in such a condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy5q3DvHJjcLVg90H21EOLACvtfcHk0liRtijmDmn8gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivFamur0%253D&md5=ec8382a4d5ade2f5f956f9cc339d519e</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.060582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.060582%26sid%3Dliteratum%253Aachs%26aulast%3DRashid%26aufirst%3DM.%2BH.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DToda%26aufirst%3DK.%26aulast%3DUeda%26aufirst%3DH.%26atitle%3DLoss%2520of%2520peripheral%2520morphine%2520analgesia%2520contributes%2520to%2520the%2520reduced%2520effectiveness%2520of%2520systemic%2520morphine%2520in%2520neuropathic%2520pain%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D380%26epage%3D387%26doi%3D10.1124%2Fjpet.103.060582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ballantyne, J. C.</span><span> </span><span class="NLM_article-title">Opioid analgesia: perspectives on right use and utility</span> <span class="citation_source-journal">Pain Physician</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">491</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=479-491&author=J.+C.+Ballantyne&title=Opioid+analgesia%3A+perspectives+on+right+use+and+utility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBallantyne%26aufirst%3DJ.%2BC.%26atitle%3DOpioid%2520analgesia%253A%2520perspectives%2520on%2520right%2520use%2520and%2520utility%26jtitle%3DPain%2520Physician%26date%3D2007%26volume%3D10%26spage%3D479%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Ballantyne, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaForge, K. S.</span><span> </span><span class="NLM_article-title">Opioid dependence and addiction during opioid treatment of chronic pain</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1016/j.pain.2007.03.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.pain.2007.03.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=235-255&author=J.+C.+Ballantyneauthor=K.+S.+LaForge&title=Opioid+dependence+and+addiction+during+opioid+treatment+of+chronic+pain&doi=10.1016%2Fj.pain.2007.03.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11e&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2007.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2007.03.028%26sid%3Dliteratum%253Aachs%26aulast%3DBallantyne%26aufirst%3DJ.%2BC.%26aulast%3DLaForge%26aufirst%3DK.%2BS.%26atitle%3DOpioid%2520dependence%2520and%2520addiction%2520during%2520opioid%2520treatment%2520of%2520chronic%2520pain%26jtitle%3DPain%26date%3D2007%26volume%3D129%26spage%3D235%26epage%3D255%26doi%3D10.1016%2Fj.pain.2007.03.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Holtman, J. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jellish, W. S.</span><span> </span><span class="NLM_article-title">Opioid-induced hyperalgesia and burn pain</span> <span class="citation_source-journal">J. Burn Care Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">692</span><span class="NLM_x">–</span> <span class="NLM_lpage">701</span><span class="refDoi"> DOI: 10.1097/BCR.0b013e31825adcb0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1097%2FBCR.0b013e31825adcb0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=23143613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADC%252BC3s7isFelsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=692-701&author=J.+R.+Holtmanauthor=W.+S.+Jellish&title=Opioid-induced+hyperalgesia+and+burn+pain&doi=10.1097%2FBCR.0b013e31825adcb0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11fR"><div class="casContent"><span class="casTitleNuber">11f</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid-induced hyperalgesia and burn pain</span></div><div class="casAuthors">Holtman Joseph R Jr; Jellish W Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of burn care & research : official publication of the American Burn Association</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">692-701</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The treatment of pain produced during the management of burn injury has been an ongoing problem for physicians caring for these patients.  The main therapeutic option for analgesia has been the repeated and prolonged use of opioids.  The adverse effects of opioids are well known but the long term use of opioids which produces tolerance with accompanying dose escalation and dependence is most problematic.  Another potentially important consequence of opioid exposure that sometimes masks as tolerance is that of opioid induced hyperalgesia.  This syndrome is manifest as enhanced pain, sensitivity and loss of analgesic efficacy in patients treated with opioids who actually become sensitized to painful stimuli.  This article focuses on the treatment of burn pain and how current analgesic therapies with opioids may cause hyperalgesia and affect the adequacy of treatment for burn pain.  This article also provides possible modalities to help therapeutically manage these patients and considers future analgesic strategies which may help to improve pain management in this complicated patient population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVktREYYSs3bxanA7vODO6fW6udTcc2ebl4OhL_gUuELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7isFelsg%253D%253D&md5=a5c6121786efc6314cf14d5e800b697c</span></div><a href="/servlet/linkout?suffix=cit11f&amp;dbid=16384&amp;doi=10.1097%2FBCR.0b013e31825adcb0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FBCR.0b013e31825adcb0%26sid%3Dliteratum%253Aachs%26aulast%3DHoltman%26aufirst%3DJ.%2BR.%26aulast%3DJellish%26aufirst%3DW.%2BS.%26atitle%3DOpioid-induced%2520hyperalgesia%2520and%2520burn%2520pain%26jtitle%3DJ.%2520Burn%2520Care%2520Res.%26date%3D2012%26volume%3D33%26spage%3D692%26epage%3D701%26doi%3D10.1097%2FBCR.0b013e31825adcb0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Pohl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L.</span><span> </span><span class="NLM_article-title">Chronic pain and addiction: challenging co-occurring disorders</span> <span class="citation_source-journal">J. Psychoact. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1080/02791072.2012.684621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1080%2F02791072.2012.684621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=22880539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADC%252BC38fmvFyisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2012&pages=119-124&author=M.+Pohlauthor=L.+Smith&title=Chronic+pain+and+addiction%3A+challenging+co-occurring+disorders&doi=10.1080%2F02791072.2012.684621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11gR"><div class="casContent"><span class="casTitleNuber">11g</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic pain and addiction: challenging co-occurring disorders</span></div><div class="casAuthors">Pohl Mel; Smith Logan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychoactive drugs</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-24</span>
        ISSN:<span class="NLM_cas:issn">0279-1072</span>.
    </div><div class="casAbstract">Chronic pain is commonly treated by prescribing an opioid medication.  For those suffering from both chronic pain and substance dependence, barriers to adequate pain management increase.  This often causes both disorders to exacerbate one another.  Effective treatment may also be hampered by opioid-induced hyperalgesia, tolerance, physical dependence, "chemical coping," and diminished physical and emotional functioning.  This article reviews current research trends, potential problems stemming from prescription opioid use, and suggestions for clinical practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSeg6RX_ioKkzAEfvC7EH1LfW6udTcc2ebl4OhL_gUuELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38fmvFyisg%253D%253D&md5=54113e585c97d355487d3df4fc00ff9e</span></div><a href="/servlet/linkout?suffix=cit11g&amp;dbid=16384&amp;doi=10.1080%2F02791072.2012.684621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F02791072.2012.684621%26sid%3Dliteratum%253Aachs%26aulast%3DPohl%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DL.%26atitle%3DChronic%2520pain%2520and%2520addiction%253A%2520challenging%2520co-occurring%2520disorders%26jtitle%3DJ.%2520Psychoact.%2520Drugs%26date%3D2012%26volume%3D44%26spage%3D119%26epage%3D124%26doi%3D10.1080%2F02791072.2012.684621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Calignano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Rana, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuffrida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Control of pain initiation by endogenous cannabinoids</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">394</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span><span class="refDoi"> DOI: 10.1038/28393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1038%2F28393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=9685157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADyaK1cXkvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=1998&pages=277-281&author=A.+Calignanoauthor=G.+La+Ranaauthor=A.+Giuffridaauthor=D.+Piomelli&title=Control+of+pain+initiation+by+endogenous+cannabinoids&doi=10.1038%2F28393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Control of pain initiation by endogenous cannabinoids</span></div><div class="casAuthors">Calignano, Antonio; La Rana, Giovanna; Giuffrida, Andrea; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">394</span>
        (<span class="NLM_cas:issue">6690</span>),
    <span class="NLM_cas:pages">277-281</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The potent analgesic effects of cannabis-like drugs and the presence of CB1-type cannabinoid receptors in pain-processing areas of the brain and spinal cord indicate that endogenous cannabinoids such as anandamide may contribute to the control of pain transmission within the central nervous system (CNS).  Here the authors show that anandamide attenuates the pain behavior produced by chem. damage to cutaneous tissue by interacting with CB1-like cannabinoid receptors located outside the CNS.  Palmitylethanolamide (PEA), which is released together with anandamide from a common phospholipid precursor, exerts a similar effect by activating peripheral CB2-like receptors.  When administered together, the two compds. at synergistically reducing pain responses 100-fold more potently than does each compd. alone.  Gas-chromatog./mass-spectrometry measurements indicate that the levels of anandamide and PEA in the skin are enough to cause a tonic activation of local cannabinoid receptors.  In agreement with this possibility, the CB1 antagonist SR141716A and the CB2 antagonist SR144528 prolong and enhance the pain behavior produced by tissue damage.  These results indicate that peripheral CB1-like and CB2-like receptors participate in the intrinsic control of pain initiation and that locally generated anandamide and PEA may mediate this effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpKwHMI3BI9LVg90H21EOLACvtfcHk0liulJGsWx63_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvVKjt7w%253D&md5=811026d275d0cba5c01567bdebe16ec8</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1038%2F28393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F28393%26sid%3Dliteratum%253Aachs%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DGiuffrida%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DControl%2520of%2520pain%2520initiation%2520by%2520endogenous%2520cannabinoids%26jtitle%3DNature%26date%3D1998%26volume%3D394%26spage%3D277%26epage%3D281%26doi%3D10.1038%2F28393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Elmes, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winyard, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhurst, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendall, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, V.</span><span> </span><span class="NLM_article-title">Activation of CB<sub>1</sub> and CB<sub>2</sub> receptors attenuates the induction and maintenance of inflammatory pain in the rat</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span><span class="refDoi"> DOI: 10.1016/j.pain.2005.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.pain.2005.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=16289798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSjsb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2005&pages=327-335&author=S.+J.+Elmesauthor=L.+A.+Winyardauthor=S.+J.+Medhurstauthor=N.+M.+Claytonauthor=A.+W.+Wilsonauthor=D.+A.+Kendallauthor=V.+Chapman&title=Activation+of+CB1+and+CB2+receptors+attenuates+the+induction+and+maintenance+of+inflammatory+pain+in+the+rat&doi=10.1016%2Fj.pain.2005.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat</span></div><div class="casAuthors">Elmes, Steven J. R.; Winyard, Lisa A.; Medhurst, Stephen J.; Clayton, Nick M.; Wilson, Alex W.; Kendall, David A.; Chapman, Victoria</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">327-335</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The aim of the present study was to investigate the effects of cannabinoid agonists on established inflammatory hyperalgesia.  We have compared the effects of pre-administration vs. post-administration of a potent non-selective cannabinoid agonist HU210 and a selective CB2 receptor agonist JWH-133 on hindpaw wt. bearing and paw edema in the carrageenan model of inflammatory hyperalgesia.  For comparative purposes we also detd. the effects of the μ-opioid receptor agonist morphine and the COX2 inhibitor rofecoxib in this model.  At 3 h following intraplantar injection of carrageenan (2%, 100 μl) there was a significant (P<0.001) redn. in wt. bearing on the ipsilateral hindpaw, compared to vehicle treated rats and a concomitant increase in ipsilateral hindpaw vol. (P<0.001), compared to vehicle treated rats.  Systemic administration of HU210 (10 μg/kg) and JWH-133 (10 mg/kg) at 3 h following injection of carrageenan, significantly attenuated decreases in ipsilateral hindpaw wt. bearing (P<0.05 for both) and paw vol. (P<0.001 for both).  Pre-administration of HU210 and JWH-133 had similar effects on wt. bearing in this model.  Pre-administered HU210 also significantly decreased carrageenan-induced changes in paw vol. (P<0.001), this was not the case for JWH-133.  Effects of post-administered HU210 and JWH-133 on ipsilateral hindpaw wt. bearing and paw vol. were comparable to the effect of systemic post-administration of morphine and rofecoxib (3 mg/kg for both).  In summary, both HU210 and JWH-133 attenuated established inflammatory hypersensitivity and swelling, suggesting that cannabinoid-based drugs have clin. potential for the treatment of established inflammatory pain responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZo9E44b0qx7Vg90H21EOLACvtfcHk0lgKsPPjrs1Sug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSjsb3E&md5=03b0af0fd44cb8b40660e093dd44892d</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2005.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2005.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DElmes%26aufirst%3DS.%2BJ.%26aulast%3DWinyard%26aufirst%3DL.%2BA.%26aulast%3DMedhurst%26aufirst%3DS.%2BJ.%26aulast%3DClayton%26aufirst%3DN.%2BM.%26aulast%3DWilson%26aufirst%3DA.%2BW.%26aulast%3DKendall%26aufirst%3DD.%2BA.%26aulast%3DChapman%26aufirst%3DV.%26atitle%3DActivation%2520of%2520CB1%2520and%2520CB2%2520receptors%2520attenuates%2520the%2520induction%2520and%2520maintenance%2520of%2520inflammatory%2520pain%2520in%2520the%2520rat%26jtitle%3DPain%26date%3D2005%26volume%3D118%26spage%3D327%26epage%3D335%26doi%3D10.1016%2Fj.pain.2005.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Malan, T. P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mata, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderah, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span> </span><span class="NLM_article-title">CB<sub>2</sub> cannabinoid receptor-mediated peripheral antinociception</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.1016/S0304-3959(01)00321-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2FS0304-3959%2801%2900321-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=11514083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtFWis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2001&pages=239-245&author=T.+P.+Malanauthor=M.+M.+Ibrahimauthor=H.+Dengauthor=Q.+Liuauthor=H.+P.+Mataauthor=T.+Vanderahauthor=F.+Porrecaauthor=A.+Makriyannis&title=CB2+cannabinoid+receptor-mediated+peripheral+antinociception&doi=10.1016%2FS0304-3959%2801%2900321-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12c</span><div class="casTitle"><span class="NLM_cas:atitle">CB2 cannabinoid receptor-mediated peripheral antinociception</span></div><div class="casAuthors">Malan, T. P., Jr.; Ibrahim, M. M.; Deng, H.; Liu, Q.; Mata, H. P.; Vanderah, T.; Porreca, F.; Makriyannis, A.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">239-245</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Cannabinoid receptor agonists diminish responses to painful stimuli.  Extensive evidence implicates the CB1 receptor in the prodn. of antinociception.  However, the capacity of CB2 receptors, which are located outside the central nervous system (CNS), to produce antinociception is not known.  Using AM1241, a CB2 receptor-selective agonist, the authors demonstrate that CB2 receptors produce antinociception to thermal stimuli.  Injection of AM1241 in the hindpaw produced antinociception to a stimulus applied to the same paw.  Injection of an equiv. dose of AM1241 into the paw contralateral to the side of testing did not.  The antinociceptive actions of AM1241 were blocked by the CB2 receptor-selective antagonist AM630, but not by the CB1 receptor-selective antagonist AM251.  AM1241 also produced antinociception when injected systemically (i.p.).  The antinociceptive actions of systemic AM1241 were blocked by injection of AM630 into the paw where the thermal stimulus was applied, but not the contralateral paw.  These findings demonstrate the local, peripheral nature of CB2 cannabinoid antinociception.  AM1241 did not produce the CNS cannabinoid effects of hypothermia, catalepsy, inhibition of activity or impaired ambulation, while this tetrad of effects was produced by the mixed CB1/CB2 receptor agonist WIN55,212-2.  Peripheral antinociception without CNS effects is consistent with the peripheral distribution of CB2 receptors.  CB2 receptor agonists may have promise clin. for the treatment of pain without CNS cannabinoid side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbSM0BBV85Z7Vg90H21EOLACvtfcHk0lgKsPPjrs1Sug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtFWis7Y%253D&md5=640486f3ba52db896bdc7fe2f040381c</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1016%2FS0304-3959%2801%2900321-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3959%252801%252900321-9%26sid%3Dliteratum%253Aachs%26aulast%3DMalan%26aufirst%3DT.%2BP.%26aulast%3DIbrahim%26aufirst%3DM.%2BM.%26aulast%3DDeng%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DMata%26aufirst%3DH.%2BP.%26aulast%3DVanderah%26aufirst%3DT.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DCB2%2520cannabinoid%2520receptor-mediated%2520peripheral%2520antinociception%26jtitle%3DPain%26date%3D2001%26volume%3D93%26spage%3D239%26epage%3D245%26doi%3D10.1016%2FS0304-3959%2801%2900321-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Nackley, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suplita, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohmann, A. G.</span><span> </span><span class="NLM_article-title">A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">659</span><span class="NLM_x">–</span> <span class="NLM_lpage">670</span><span class="refDoi"> DOI: 10.1016/S0306-4522(02)00870-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2FS0306-4522%2802%2900870-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2003&pages=659-670&author=A.+G.+Nackleyauthor=R.+L.+Suplitaauthor=A.+G.+Hohmann&title=A+peripheral+cannabinoid+mechanism+suppresses+spinal+fos+protein+expression+and+pain+behavior+in+a+rat+model+of+inflammation&doi=10.1016%2FS0306-4522%2802%2900870-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=10.1016%2FS0306-4522%2802%2900870-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0306-4522%252802%252900870-9%26sid%3Dliteratum%253Aachs%26aulast%3DNackley%26aufirst%3DA.%2BG.%26aulast%3DSuplita%26aufirst%3DR.%2BL.%26aulast%3DHohmann%26aufirst%3DA.%2BG.%26atitle%3DA%2520peripheral%2520cannabinoid%2520mechanism%2520suppresses%2520spinal%2520fos%2520protein%2520expression%2520and%2520pain%2520behavior%2520in%2520a%2520rat%2520model%2520of%2520inflammation%26jtitle%3DNeuroscience%26date%3D2003%26volume%3D117%26spage%3D659%26epage%3D670%26doi%3D10.1016%2FS0306-4522%2802%2900870-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Quartilho, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mata, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderah, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malan, T. P.,  Jr.</span><span> </span><span class="NLM_article-title">Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors</span> <span class="citation_source-journal">Anesthesiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">955</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span><span class="refDoi"> DOI: 10.1097/00000542-200310000-00031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1097%2F00000542-200310000-00031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2003&pages=955-960&author=A.+Quartilhoauthor=H.+P.+Mataauthor=M.+M.+Ibrahimauthor=T.+W.+Vanderahauthor=F.+Porrecaauthor=A.+Makriyannisauthor=T.+P.+Malan&title=Inhibition+of+inflammatory+hyperalgesia+by+activation+of+peripheral+CB2+cannabinoid+receptors&doi=10.1097%2F00000542-200310000-00031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12e&amp;dbid=16384&amp;doi=10.1097%2F00000542-200310000-00031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00000542-200310000-00031%26sid%3Dliteratum%253Aachs%26aulast%3DQuartilho%26aufirst%3DA.%26aulast%3DMata%26aufirst%3DH.%2BP.%26aulast%3DIbrahim%26aufirst%3DM.%2BM.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DMalan%26aufirst%3DT.%2BP.%26atitle%3DInhibition%2520of%2520inflammatory%2520hyperalgesia%2520by%2520activation%2520of%2520peripheral%2520CB2%2520cannabinoid%2520receptors%26jtitle%3DAnesthesiology%26date%3D2003%26volume%3D99%26spage%3D955%26epage%3D960%26doi%3D10.1097%2F00000542-200310000-00031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Guindon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P.</span><span> </span><span class="NLM_article-title">Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">814</span><span class="NLM_x">–</span> <span class="NLM_lpage">823</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2005.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.neuropharm.2005.12.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=814-823&author=J.+Guindonauthor=P.+Beaulieu&title=Antihyperalgesic+effects+of+local+injections+of+anandamide%2C+ibuprofen%2C+rofecoxib+and+their+combinations+in+a+model+of+neuropathic+pain&doi=10.1016%2Fj.neuropharm.2005.12.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12f&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2005.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2005.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DGuindon%26aufirst%3DJ.%26aulast%3DBeaulieu%26aufirst%3DP.%26atitle%3DAntihyperalgesic%2520effects%2520of%2520local%2520injections%2520of%2520anandamide%252C%2520ibuprofen%252C%2520rofecoxib%2520and%2520their%2520combinations%2520in%2520a%2520model%2520of%2520neuropathic%2520pain%26jtitle%3DNeuropharmacology%26date%3D2006%26volume%3D50%26spage%3D814%26epage%3D823%26doi%3D10.1016%2Fj.neuropharm.2005.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cheng, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pourashraf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walpole, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salois, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St-Onge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payza, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lessard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszewski, M. J.</span><span> </span><span class="NLM_article-title">γ-Carbolines: a novel class of cannabinoid agonists with high aqueous solubility and restricted CNS penetration</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1619</span><span class="NLM_x">–</span> <span class="NLM_lpage">1624</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.12.124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.bmcl.2011.12.124" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1619-1624&author=Y.+X.+Chengauthor=M.+Pourashrafauthor=X.+Luoauthor=S.+Srivastavaauthor=C.+Walpoleauthor=D.+Saloisauthor=S.+St-Ongeauthor=K.+Payzaauthor=E.+Lessardauthor=X.+H.+Yuauthor=M.+J.+Tomaszewski&title=%CE%B3-Carbolines%3A+a+novel+class+of+cannabinoid+agonists+with+high+aqueous+solubility+and+restricted+CNS+penetration&doi=10.1016%2Fj.bmcl.2011.12.124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.12.124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.12.124%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%2BX.%26aulast%3DPourashraf%26aufirst%3DM.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DSrivastava%26aufirst%3DS.%26aulast%3DWalpole%26aufirst%3DC.%26aulast%3DSalois%26aufirst%3DD.%26aulast%3DSt-Onge%26aufirst%3DS.%26aulast%3DPayza%26aufirst%3DK.%26aulast%3DLessard%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DX.%2BH.%26aulast%3DTomaszewski%26aufirst%3DM.%2BJ.%26atitle%3D%25CE%25B3-Carbolines%253A%2520a%2520novel%2520class%2520of%2520cannabinoid%2520agonists%2520with%2520high%2520aqueous%2520solubility%2520and%2520restricted%2520CNS%2520penetration%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1619%26epage%3D1624%26doi%3D10.1016%2Fj.bmcl.2011.12.124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dziadulewicz, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevan, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brain, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coote, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culshaw, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groarke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesingland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Vecchia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyothier, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNair, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Farrell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peacock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schopfer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaqoob, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zadrobilek, J.</span><span> </span><span class="NLM_article-title">Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: a potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3851</span><span class="NLM_x">–</span> <span class="NLM_lpage">3856</span><span class="refDoi"> DOI: 10.1021/jm070317a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070317a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3851-3856&author=E.+K.+Dziadulewiczauthor=S.+J.+Bevanauthor=C.+T.+Brainauthor=P.+R.+Cooteauthor=A.+J.+Culshawauthor=A.+J.+Davisauthor=L.+J.+Edwardsauthor=A.+J.+Fisherauthor=A.+J.+Foxauthor=C.+Gentryauthor=A.+Groarkeauthor=T.+W.+Hartauthor=W.+Huberauthor=I.+F.+Jamesauthor=A.+Kesinglandauthor=L.+La+Vecchiaauthor=Y.+Loongauthor=I.+Lyothierauthor=K.+McNairauthor=C.+O%E2%80%99Farrellauthor=M.+Peacockauthor=R.+Portmannauthor=U.+Schopferauthor=M.+Yaqoobauthor=J.+Zadrobilek&title=Naphthalen-1-yl-%284-pentyloxynaphthalen-1-yl%29methanone%3A+a+potent%2C+orally+bioavailable+human+CB1%2FCB2+dual+agonist+with+antihyperalgesic+properties+and+restricted+central+nervous+system+penetration&doi=10.1021%2Fjm070317a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Fjm070317a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070317a%26sid%3Dliteratum%253Aachs%26aulast%3DDziadulewicz%26aufirst%3DE.%2BK.%26aulast%3DBevan%26aufirst%3DS.%2BJ.%26aulast%3DBrain%26aufirst%3DC.%2BT.%26aulast%3DCoote%26aufirst%3DP.%2BR.%26aulast%3DCulshaw%26aufirst%3DA.%2BJ.%26aulast%3DDavis%26aufirst%3DA.%2BJ.%26aulast%3DEdwards%26aufirst%3DL.%2BJ.%26aulast%3DFisher%26aufirst%3DA.%2BJ.%26aulast%3DFox%26aufirst%3DA.%2BJ.%26aulast%3DGentry%26aufirst%3DC.%26aulast%3DGroarke%26aufirst%3DA.%26aulast%3DHart%26aufirst%3DT.%2BW.%26aulast%3DHuber%26aufirst%3DW.%26aulast%3DJames%26aufirst%3DI.%2BF.%26aulast%3DKesingland%26aufirst%3DA.%26aulast%3DLa%2BVecchia%26aufirst%3DL.%26aulast%3DLoong%26aufirst%3DY.%26aulast%3DLyothier%26aufirst%3DI.%26aulast%3DMcNair%26aufirst%3DK.%26aulast%3DO%25E2%2580%2599Farrell%26aufirst%3DC.%26aulast%3DPeacock%26aufirst%3DM.%26aulast%3DPortmann%26aufirst%3DR.%26aulast%3DSchopfer%26aufirst%3DU.%26aulast%3DYaqoob%26aufirst%3DM.%26aulast%3DZadrobilek%26aufirst%3DJ.%26atitle%3DNaphthalen-1-yl-%25284-pentyloxynaphthalen-1-yl%2529methanone%253A%2520a%2520potent%252C%2520orally%2520bioavailable%2520human%2520CB1%252FCB2%2520dual%2520agonist%2520with%2520antihyperalgesic%2520properties%2520and%2520restricted%2520central%2520nervous%2520system%2520penetration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3851%26epage%3D3856%26doi%3D10.1021%2Fjm070317a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yu, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morinville, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St-Onge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lessard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laird, J. M.</span><span> </span><span class="NLM_article-title">A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span><span class="refDoi"> DOI: 10.1016/j.pain.2010.07.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.pain.2010.07.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2010&pages=337-344&author=X.+H.+Yuauthor=C.+Q.+Caoauthor=G.+Martinoauthor=C.+Pumaauthor=A.+Morinvilleauthor=S.+St-Ongeauthor=E.+Lessardauthor=M.+N.+Perkinsauthor=J.+M.+Laird&title=A+peripherally+restricted+cannabinoid+receptor+agonist+produces+robust+anti-nociceptive+effects+in+rodent+models+of+inflammatory+and+neuropathic+pain&doi=10.1016%2Fj.pain.2010.07.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2010.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2010.07.019%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%2BH.%26aulast%3DCao%26aufirst%3DC.%2BQ.%26aulast%3DMartino%26aufirst%3DG.%26aulast%3DPuma%26aufirst%3DC.%26aulast%3DMorinville%26aufirst%3DA.%26aulast%3DSt-Onge%26aufirst%3DS.%26aulast%3DLessard%26aufirst%3DE.%26aulast%3DPerkins%26aufirst%3DM.%2BN.%26aulast%3DLaird%26aufirst%3DJ.%2BM.%26atitle%3DA%2520peripherally%2520restricted%2520cannabinoid%2520receptor%2520agonist%2520produces%2520robust%2520anti-nociceptive%2520effects%2520in%2520rodent%2520models%2520of%2520inflammatory%2520and%2520neuropathic%2520pain%26jtitle%3DPain%26date%3D2010%26volume%3D151%26spage%3D337%26epage%3D344%26doi%3D10.1016%2Fj.pain.2010.07.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Clapper, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno-Sanz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guijarro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacondio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciolino, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spradley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohmann, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calignano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1265</span><span class="NLM_x">–</span> <span class="NLM_lpage">1270</span><span class="refDoi"> DOI: 10.1038/nn.2632</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1038%2Fnn.2632" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=20852626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOht73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=1265-1270&author=J.+R.+Clapperauthor=G.+Moreno-Sanzauthor=R.+Russoauthor=A.+Guijarroauthor=F.+Vacondioauthor=A.+Durantiauthor=A.+Tontiniauthor=S.+Sanchiniauthor=N.+R.+Sciolinoauthor=J.+M.+Spradleyauthor=A.+G.+Hohmannauthor=A.+Calignanoauthor=M.+Morauthor=G.+Tarziaauthor=D.+Piomelli&title=Anandamide+suppresses+pain+initiation+through+a+peripheral+endocannabinoid+mechanism&doi=10.1038%2Fnn.2632"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13dR"><div class="casContent"><span class="casTitleNuber">13d</span><div class="casTitle"><span class="NLM_cas:atitle">Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism</span></div><div class="casAuthors">Clapper, Jason R.; Moreno-Sanz, Guillermo; Russo, Roberto; Guijarro, Ana; Vacondio, Federica; Duranti, Andrea; Tontini, Andrea; Sanchini, Silvano; Sciolino, Natale R.; Spradley, Jessica M.; Hohmann, Andrea G.; Calignano, Antonio; Mor, Marco; Tarzia, Giorgio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1265-1270</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Peripheral cannabinoid receptors exert a powerful inhibitory control over pain initiation, but the endocannabinoid signal that normally engages this intrinsic analgesic mechanism is unknown.  To address this question, we developed a peripherally restricted inhibitor (URB937) of fatty acid amide hydrolase (FAAH), the enzyme responsible for the degrdn. of the endocannabinoid anandamide.  URB937 suppressed FAAH activity and increased anandamide levels outside the rodent CNS.  Despite its inability to access brain and spinal cord, URB937 attenuated behavioral responses indicative of persistent pain in rodent models of peripheral nerve injury and inflammation and prevented noxious stimulus-evoked neuronal activation in spinal cord regions implicated in nociceptive processing.  CB1 cannabinoid receptor blockade prevented these effects.  These results suggest that anandamide-mediated signaling at peripheral CB1 receptors controls the access of pain-related inputs to the CNS.  Brain-impenetrant FAAH inhibitors, which strengthen this gating mechanism, might offer a new approach to pain therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2AxNb5bVlE7Vg90H21EOLACvtfcHk0lhgAllkrW0FvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOht73O&md5=f75c13a37e3524ab4130b2ebd67d6348</span></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=10.1038%2Fnn.2632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2632%26sid%3Dliteratum%253Aachs%26aulast%3DClapper%26aufirst%3DJ.%2BR.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DGuijarro%26aufirst%3DA.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DSanchini%26aufirst%3DS.%26aulast%3DSciolino%26aufirst%3DN.%2BR.%26aulast%3DSpradley%26aufirst%3DJ.%2BM.%26aulast%3DHohmann%26aufirst%3DA.%2BG.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAnandamide%2520suppresses%2520pain%2520initiation%2520through%2520a%2520peripheral%2520endocannabinoid%2520mechanism%26jtitle%3DNat.%2520Neurosci.%26date%3D2010%26volume%3D13%26spage%3D1265%26epage%3D1270%26doi%3D10.1038%2Fnn.2632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Hind, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tufarelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neophytou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Sullivan, S. E.</span><span> </span><span class="NLM_article-title">Endocannabinoids modulate human blood-brain barrier permeability in vitro</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">3015</span><span class="NLM_x">–</span> <span class="NLM_lpage">3027</span><span class="refDoi"> DOI: 10.1111/bph.13106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1111%2Fbph.13106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=25651941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVent73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=3015-3027&author=W.+H.+Hindauthor=C.+Tufarelliauthor=M.+Neophytouauthor=S.+I.+Andersonauthor=T.+J.+Englandauthor=S.+E.+O%E2%80%99Sullivan&title=Endocannabinoids+modulate+human+blood-brain+barrier+permeability+in+vitro&doi=10.1111%2Fbph.13106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoids modulate human blood-brain barrier permeability in vitro</span></div><div class="casAuthors">Hind, William H.; Tufarelli, Cristina; Neophytou, Maria; Anderson, Susan I.; England, Timothy J.; O'Sullivan, Saoirse E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3015-3027</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Endocannabinoids alter permeability at various epithelial barriers, and cannabinoid receptors and endocannabinoid levels are elevated by stroke, with potential neuroprotective effects.  We therefore explored the role of endocannabinoids in modulating blood-brain barrier (BBB) permeability in normal conditions and in an ischemia/reperfusion model.  Exptl. Approach : Human brain microvascular endothelial cell and astrocyte co-cultures modelled the BBB.  Ischemia was modelled by oxygen-glucose deprivation (OGD) and permeability was measured by transepithelial elec. resistance.  Endocannabinoids or endocannabinoid-like compds. were assessed for their ability to modulate baseline permeability or OGD-induced hyperpermeability.  Target sites of action were investigated using receptor antagonists and subsequently identified with real-time PCR.  Key Results : Anandamide (10 μM) and oleoylethanolamide (OEA, 10 μM) decreased BBB permeability (i.e. increased resistance).  This was mediated by cannabinoid CB2 receptors, transient receptor potential vanilloid 1 (TRPV1) channels, calcitonin gene-regulated peptide (CGRP) receptor (anandamide only) and PPARα (OEA only).  Application of OEA, palmitoylethanolamide (both PPARα mediated) or virodhamine (all 10 μM) decreased the OGD-induced increase in permeability during reperfusion. 2-Arachidonoyl glycerol, noladin ether and oleamide did not affect BBB permeability in normal or OGD conditions.  N-arachidonoyl-dopamine increased permeability through a cytotoxic mechanism.  PPARα and γ, CB1 receptors, TRPV1 channels and CGRP receptors were expressed in both cell types, but mRNA for CB2 receptors was only present in astrocytes.  Conclusion and Implication : The endocannabinoids may play an important modulatory role in normal BBB physiol., and also afford protection to the BBB during ischemic stroke, through a no. of target sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4GmdriBZaObVg90H21EOLACvtfcHk0lhgAllkrW0FvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVent73O&md5=a8632c455cd771221a9c879c7bd1fc7f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fbph.13106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13106%26sid%3Dliteratum%253Aachs%26aulast%3DHind%26aufirst%3DW.%2BH.%26aulast%3DTufarelli%26aufirst%3DC.%26aulast%3DNeophytou%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DS.%2BI.%26aulast%3DEngland%26aufirst%3DT.%2BJ.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DS.%2BE.%26atitle%3DEndocannabinoids%2520modulate%2520human%2520blood-brain%2520barrier%2520permeability%2520in%2520vitro%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D3015%26epage%3D3027%26doi%3D10.1111%2Fbph.13106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Huffman, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mabon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggio, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB<sub>1</sub> cannabinoid receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">539</span><span class="NLM_x">–</span> <span class="NLM_lpage">549</span><span class="refDoi"> DOI: 10.1016/S0968-0896(02)00451-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2FS0968-0896%2802%2900451-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=539-549&author=J.+W.+Huffmanauthor=R.+Mabonauthor=M.+J.+Wuauthor=J.+Luauthor=R.+Hartauthor=D.+P.+Hurstauthor=P.+H.+Reggioauthor=J.+L.+Wileyauthor=B.+R.+Martin&title=3-Indolyl-1-naphthylmethanes%3A+new+cannabimimetic+indoles+provide+evidence+for+aromatic+stacking+interactions+with+the+CB1+cannabinoid+receptor&doi=10.1016%2FS0968-0896%2802%2900451-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2802%2900451-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252802%252900451-0%26sid%3Dliteratum%253Aachs%26aulast%3DHuffman%26aufirst%3DJ.%2BW.%26aulast%3DMabon%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DM.%2BJ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DHart%26aufirst%3DR.%26aulast%3DHurst%26aufirst%3DD.%2BP.%26aulast%3DReggio%26aufirst%3DP.%2BH.%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3D3-Indolyl-1-naphthylmethanes%253A%2520new%2520cannabimimetic%2520indoles%2520provide%2520evidence%2520for%2520aromatic%2520stacking%2520interactions%2520with%2520the%2520CB1%2520cannabinoid%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D539%26epage%3D549%26doi%3D10.1016%2FS0968-0896%2802%2900451-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewin, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascarella, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seltzman, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P. A.</span><span> </span><span class="NLM_article-title">Designer drugs: a medicinal chemistry perspective</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1248</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span><span class="refDoi"> DOI: 10.1111/j.1749-6632.2011.06199.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1111%2Fj.1749-6632.2011.06199.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=22092008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks1yit7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1248&publication_year=2012&pages=18-38&author=F.+I.+Carrollauthor=A.+H.+Lewinauthor=S.+W.+Mascarellaauthor=H.+H.+Seltzmanauthor=P.+A.+Reddy&title=Designer+drugs%3A+a+medicinal+chemistry+perspective&doi=10.1111%2Fj.1749-6632.2011.06199.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Designer drugs: a medicinal chemistry perspective</span></div><div class="casAuthors">Carroll, F. Ivy; Lewin, Anita H.; Mascarella, S. Wayne; Seltzman, Herbert H.; Reddy, P. Anantha</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1248</span>
        (<span class="NLM_cas:issue">Addiction Reviews</span>),
    <span class="NLM_cas:pages">18-38</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  There are numerous medicinal chem. reports in the literature describing the pharmacol. properties of thousands of narcotics, stimulants, hallucinogens, sedative-hypnotic drugs, cannabinoids, and other psychoactive substances as well as synthetic methods for their prepns.  This information, while essential for the advancement of science, has been used by clandestine chemists to manuf. and market an endless variety of analogs of so-called designer drugs.  In this review, we describe how clandestine chemists used the principles of medicinal chem. to design mols., referred to as designer drugs, that elicit the effects of opioids, amphetamine and analogs, cannabinoids, and phencyclidine analogs while circumventing the law.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOD7q1w811wLVg90H21EOLACvtfcHk0lhgAllkrW0FvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xks1yit7w%253D&md5=9156e46929ce795b7fde9d2ad3f8532f</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.2011.06199.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.2011.06199.x%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DLewin%26aufirst%3DA.%2BH.%26aulast%3DMascarella%26aufirst%3DS.%2BW.%26aulast%3DSeltzman%26aufirst%3DH.%2BH.%26aulast%3DReddy%26aufirst%3DP.%2BA.%26atitle%3DDesigner%2520drugs%253A%2520a%2520medicinal%2520chemistry%2520perspective%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2012%26volume%3D1248%26spage%3D18%26epage%3D38%26doi%3D10.1111%2Fj.1749-6632.2011.06199.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Huffman, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zengin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hynd, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bushell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bushell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggio, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassidy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.1016/j.bmc.2004.09.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.bmc.2004.09.050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=89-112&author=J.+W.+Huffmanauthor=G.+Zenginauthor=M.+J.+Wuauthor=J.+Luauthor=G.+Hyndauthor=K.+Bushellauthor=A.+L.+Thompsonauthor=S.+Bushellauthor=C.+Tartalauthor=D.+P.+Hurstauthor=P.+H.+Reggioauthor=D.+E.+Selleyauthor=M.+P.+Cassidyauthor=J.+L.+Wileyauthor=B.+R.+Martin&title=Structure-activity+relationships+for+1-alkyl-3-%281-naphthoyl%29indoles+at+the+cannabinoid+CB%281%29+and+CB%282%29+receptors%3A+steric+and+electronic+effects+of+naphthoyl+substituents.+New+highly+selective+CB%282%29+receptor+agonists&doi=10.1016%2Fj.bmc.2004.09.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.09.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.09.050%26sid%3Dliteratum%253Aachs%26aulast%3DHuffman%26aufirst%3DJ.%2BW.%26aulast%3DZengin%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DM.%2BJ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DHynd%26aufirst%3DG.%26aulast%3DBushell%26aufirst%3DK.%26aulast%3DThompson%26aufirst%3DA.%2BL.%26aulast%3DBushell%26aufirst%3DS.%26aulast%3DTartal%26aufirst%3DC.%26aulast%3DHurst%26aufirst%3DD.%2BP.%26aulast%3DReggio%26aufirst%3DP.%2BH.%26aulast%3DSelley%26aufirst%3DD.%2BE.%26aulast%3DCassidy%26aufirst%3DM.%2BP.%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DStructure-activity%2520relationships%2520for%25201-alkyl-3-%25281-naphthoyl%2529indoles%2520at%2520the%2520cannabinoid%2520CB%25281%2529%2520and%2520CB%25282%2529%2520receptors%253A%2520steric%2520and%2520electronic%2520effects%2520of%2520naphthoyl%2520substituents.%2520New%2520highly%2520selective%2520CB%25282%2529%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D89%26epage%3D112%26doi%3D10.1016%2Fj.bmc.2004.09.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Innocenzi, P.; Benchikh, E.; Fitzgerald, P.; Lowry, P.; McConnell, I.</span><span> </span><span class="NLM_article-title">Detection of synthetic cannabinoids</span>. EP2487155A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=P.+Innocenzi&author=E.+Benchikh&author=P.+Fitzgerald&author=P.+Lowry&author=I.+McConnell&title=Detection+of+synthetic+cannabinoids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DInnocenzi%26aufirst%3DP.%26atitle%3DDetection%2520of%2520synthetic%2520cannabinoids%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Reggio, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu-Dutt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett-Norris, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seltzman, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliam, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertwee, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abood, M. E.</span><span> </span><span class="NLM_article-title">The bioactive conformation of aminoalkylindoles at the cannabinoid CB1 and CB2 receptors: insights gained from (E)- and (Z)-naphthylidene indenes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">5177</span><span class="NLM_x">–</span> <span class="NLM_lpage">5187</span><span class="refDoi"> DOI: 10.1021/jm9801197</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9801197" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=5177-5187&author=P.+H.+Reggioauthor=S.+Basu-Duttauthor=J.+Barnett-Norrisauthor=M.+T.+Castroauthor=D.+P.+Hurstauthor=H.+H.+Seltzmanauthor=M.+J.+Rocheauthor=A.+F.+Gilliamauthor=B.+F.+Thomasauthor=L.+A.+Stevensonauthor=R.+G.+Pertweeauthor=M.+E.+Abood&title=The+bioactive+conformation+of+aminoalkylindoles+at+the+cannabinoid+CB1+and+CB2+receptors%3A+insights+gained+from+%28E%29-+and+%28Z%29-naphthylidene+indenes&doi=10.1021%2Fjm9801197"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm9801197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9801197%26sid%3Dliteratum%253Aachs%26aulast%3DReggio%26aufirst%3DP.%2BH.%26aulast%3DBasu-Dutt%26aufirst%3DS.%26aulast%3DBarnett-Norris%26aufirst%3DJ.%26aulast%3DCastro%26aufirst%3DM.%2BT.%26aulast%3DHurst%26aufirst%3DD.%2BP.%26aulast%3DSeltzman%26aufirst%3DH.%2BH.%26aulast%3DRoche%26aufirst%3DM.%2BJ.%26aulast%3DGilliam%26aufirst%3DA.%2BF.%26aulast%3DThomas%26aufirst%3DB.%2BF.%26aulast%3DStevenson%26aufirst%3DL.%2BA.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DAbood%26aufirst%3DM.%2BE.%26atitle%3DThe%2520bioactive%2520conformation%2520of%2520aminoalkylindoles%2520at%2520the%2520cannabinoid%2520CB1%2520and%2520CB2%2520receptors%253A%2520insights%2520gained%2520from%2520%2528E%2529-%2520and%2520%2528Z%2529-naphthylidene%2520indenes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D5177%26epage%3D5187%26doi%3D10.1021%2Fjm9801197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Mosconi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, L.</span><span> </span><span class="NLM_article-title">Fixed-diameter polyethylene cuffs applied to the rat sciatic nerve induce a painful neuropathy: Ultrastructural morphometric analysis of axonal alterations</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span><span class="refDoi"> DOI: 10.1016/0304-3959(95)00077-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2F0304-3959%2895%2900077-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1996&pages=37-57&author=T.+Mosconiauthor=L.+Kruger&title=Fixed-diameter+polyethylene+cuffs+applied+to+the+rat+sciatic+nerve+induce+a+painful+neuropathy%3A+Ultrastructural+morphometric+analysis+of+axonal+alterations&doi=10.1016%2F0304-3959%2895%2900077-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2895%2900077-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252895%252900077-1%26sid%3Dliteratum%253Aachs%26aulast%3DMosconi%26aufirst%3DT.%26aulast%3DKruger%26aufirst%3DL.%26atitle%3DFixed-diameter%2520polyethylene%2520cuffs%2520applied%2520to%2520the%2520rat%2520sciatic%2520nerve%2520induce%2520a%2520painful%2520neuropathy%253A%2520Ultrastructural%2520morphometric%2520analysis%2520of%2520axonal%2520alterations%26jtitle%3DPain%26date%3D1996%26volume%3D64%26spage%3D37%26epage%3D57%26doi%3D10.1016%2F0304-3959%2895%2900077-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Pitcher, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritchie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, J. L.</span><span> </span><span class="NLM_article-title">Nerve constriction in the rat: model of neuropathic, surgical and central pain</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span><span class="refDoi"> DOI: 10.1016/S0304-3959(99)00085-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2FS0304-3959%2899%2900085-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10506670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADyaK1MvjvVaitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1999&pages=37-46&author=G.+M.+Pitcherauthor=J.+Ritchieauthor=J.+L.+Henry&title=Nerve+constriction+in+the+rat%3A+model+of+neuropathic%2C+surgical+and+central+pain&doi=10.1016%2FS0304-3959%2899%2900085-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Nerve constriction in the rat: model of neuropathic, surgical and central pain</span></div><div class="casAuthors">Pitcher G M; Ritchie J; Henry J L</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-46</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">In preparation for a series of electrophysiological experiments in a model of neuropathic pain, the present spinal reflex study was done to determine the optimal time after sciatic nerve constriction in the rat for tactile allodynia and to determine also the appropriate 'control' for the nerve constriction model.  Therefore, this study focused on the magnitude and time course of change in paw withdrawal threshold following unilateral sciatic nerve constriction in the rat.  Male Sprague-Dawley rats (375-425g) were used.  Nerve constriction was done by placing a 2 mm polyethylene cuff (PE-90) around the left sciatic nerve (n=8).  A second group of rats (n=8) received unilateral sham surgery and a third group (n=8) was unoperated.  The ipsi- and contralateral hind paw withdrawal thresholds in each of the 3 groups were measured using von Frey hairs.  In unoperated rats, the withdrawal threshold of each of the hind paws remained unchanged at approximately 50 g throughout the entire time course of the study, which lasted 145 days.  However, in cuff-implanted rats, the withdrawal threshold of the nerve-injured hind paw decreased as soon as 1 day after surgery, reached as low as 1 to 2 g by 5 days and remained low throughout the test period.  Threshold in sham-operated rats showed a bilateral decrease starting on days 1-3, which stabilised at about 30 g until about day 40, after which values returned gradually toward the unoperated withdrawal thresholds.  In nerve-constricted rats the withdrawal threshold of the hind paw contralateral to the cuff followed the same change seen in sham-operated rats until about day 37, after which the withdrawal threshold matched that of the cuff-implanted hind paw.  The data show that the cuff-induced sciatic nerve constriction produces a sustained hypersensitivity to normally innocuous tactile sensory input and that a relatively constant ipsilateral mechanical hyperalgesia can be found from days 5-27.  It is also demonstrated that the contralateral hind paw and either hind paw in sham-operated rats are inappropriate as 'controls'.  The data in this study suggest that three distinct types of allodynia are expressed.  Ipsilateral allodynia may be representative of a model of neuropathic pain.  The contralateral allodynia may be a model of central pain, as it likely arises from changes in central sensory processing.  Allodynia in sham-operated rats was also expressed bilaterally and may be a model of long-term postoperative pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQQNm5x0OdY95agfuraLLzSfW6udTcc2eahpEy2pUN6Zrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1MvjvVaitQ%253D%253D&md5=1d7eeb9b5fec35a0f5c466ba1a6bb8fe</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0304-3959%2899%2900085-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3959%252899%252900085-8%26sid%3Dliteratum%253Aachs%26aulast%3DPitcher%26aufirst%3DG.%2BM.%26aulast%3DRitchie%26aufirst%3DJ.%26aulast%3DHenry%26aufirst%3DJ.%2BL.%26atitle%3DNerve%2520constriction%2520in%2520the%2520rat%253A%2520model%2520of%2520neuropathic%252C%2520surgical%2520and%2520central%2520pain%26jtitle%3DPain%26date%3D1999%26volume%3D83%26spage%3D37%26epage%3D46%26doi%3D10.1016%2FS0304-3959%2899%2900085-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Bailey, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro-da-Silva, A.</span><span> </span><span class="NLM_article-title">Transient loss of terminals from non-peptidergic nociceptive fibers in the substantia gelatinosa of spinal cord following chronic constriction injury of the sciatic nerve</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">690</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2005.11.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.neuroscience.2005.11.051" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2006&pages=675-690&author=A.+L.+Baileyauthor=A.+Ribeiro-da-Silva&title=Transient+loss+of+terminals+from+non-peptidergic+nociceptive+fibers+in+the+substantia+gelatinosa+of+spinal+cord+following+chronic+constriction+injury+of+the+sciatic+nerve&doi=10.1016%2Fj.neuroscience.2005.11.051"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2005.11.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2005.11.051%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DA.%2BL.%26aulast%3DRibeiro-da-Silva%26aufirst%3DA.%26atitle%3DTransient%2520loss%2520of%2520terminals%2520from%2520non-peptidergic%2520nociceptive%2520fibers%2520in%2520the%2520substantia%2520gelatinosa%2520of%2520spinal%2520cord%2520following%2520chronic%2520constriction%2520injury%2520of%2520the%2520sciatic%2520nerve%26jtitle%3DNeuroscience%26date%3D2006%26volume%3D138%26spage%3D675%26epage%3D690%26doi%3D10.1016%2Fj.neuroscience.2005.11.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Thakor, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruangsri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spigelman, I.</span><span> </span><span class="NLM_article-title">Increased peripheral nerve excitability and local NaV1.8 mRNA up-regulation in painful neuropathy</span> <span class="citation_source-journal">Mol. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="refDoi"> DOI: 10.1186/1744-8069-5-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1186%2F1744-8069-5-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=19320998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADC%252BD1M3mvFKhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=14&author=D.+K.+Thakorauthor=A.+Linauthor=Y.+Matsukaauthor=E.+M.+Meyerauthor=S.+Ruangsriauthor=I.+Nishimuraauthor=I.+Spigelman&title=Increased+peripheral+nerve+excitability+and+local+NaV1.8+mRNA+up-regulation+in+painful+neuropathy&doi=10.1186%2F1744-8069-5-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Increased peripheral nerve excitability and local NaV1.8 mRNA up-regulation in painful neuropathy</span></div><div class="casAuthors">Thakor Devang Kashyap; Lin Audrey; Matsuka Yoshizo; Meyer Edward M; Ruangsri Supanigar; Nishimura Ichiro; Spigelman Igor</div><div class="citationInfo"><span class="NLM_cas:title">Molecular pain</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Neuropathic pain caused by peripheral nerve injury is a chronic disorder that represents a significant clinical challenge because the pathological mechanisms have not been fully elucidated.  Several studies have suggested the involvement of various sodium channels, including tetrodotoxin-resistant NaV1.8, in affected dorsal root ganglion (DRG) neurons.  We have hypothesized that altered local expression of NaV1.8 in the peripheral axons of DRG neurons could facilitate nociceptive signal generation and propagation after neuropathic injury.  RESULTS:  After unilateral sciatic nerve entrapment injury in rats, compound action potential amplitudes were increased in both myelinated and unmyelinated fibers of the ipsilateral sciatic nerve.  Tetrodotoxin resistance of both fiber populations and sciatic nerve NaV1.8 immunoreactivity were also increased.  Further analysis of NaV1.8 distribution revealed that immunoreactivity and mRNA levels were decreased and unaffected, respectively, in the ipsilateral L4 and L5 DRG; however sciatic nerve NaV1.8 mRNA showed nearly an 11-fold ipsilateral increase.  Nav1.8 mRNA observed in the sciatic nerve was likely of axonal origin since it was not detected in non-neuronal cells cultured from nerve tissue.  Absence of changes in NaV1.8 mRNA polyadenylation suggests that increased mRNA stability was not responsible for the selective peripheral mRNA increase.  Furthermore, mRNA levels of NaV1.3, NaV1.5, NaV1.6, NaV1.7, and NaV1.9 were not significantly different between ipsilateral and contralateral nerves.  We therefore propose that selective NaV1.8 mRNA axonal transport and local up-regulation could contribute to the hyperexcitability of peripheral nerves in some neuropathic pain states.  CONCLUSION:  Cuff entrapment injury resulted in significantly elevated axonal excitability and increased NaV1.8 immunoreactivity in rat sciatic nerves.  The concomitant axonal accumulation of NaV1.8 mRNA may play a role in the pathogenesis of this model of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRpaCUg5wG0du2qxNLjzXe8fW6udTcc2eYkgwyY-YNlKLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3mvFKhsw%253D%253D&md5=52d7b734a503554f91da581db489276e</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1186%2F1744-8069-5-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-8069-5-14%26sid%3Dliteratum%253Aachs%26aulast%3DThakor%26aufirst%3DD.%2BK.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DMatsuka%26aufirst%3DY.%26aulast%3DMeyer%26aufirst%3DE.%2BM.%26aulast%3DRuangsri%26aufirst%3DS.%26aulast%3DNishimura%26aufirst%3DI.%26aulast%3DSpigelman%26aufirst%3DI.%26atitle%3DIncreased%2520peripheral%2520nerve%2520excitability%2520and%2520local%2520NaV1.8%2520mRNA%2520up-regulation%2520in%2520painful%2520neuropathy%26jtitle%3DMol.%2520Pain%26date%3D2009%26volume%3D5%26spage%3D14%26doi%3D10.1186%2F1744-8069-5-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ruangsri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulpuri, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spigelman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, I.</span><span> </span><span class="NLM_article-title">Relationship of axonal voltage-gated sodium channel 1.8 (NaV1.8) mRNA accumulation to sciatic nerve injury-induced painful neuropathy in rats</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">39836</span><span class="NLM_x">–</span> <span class="NLM_lpage">39847</span><span class="refDoi"> DOI: 10.1074/jbc.M111.261701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1074%2Fjbc.M111.261701" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=39836-39847&author=S.+Ruangsriauthor=A.+Linauthor=Y.+Mulpuriauthor=K.+Leeauthor=I.+Spigelmanauthor=I.+Nishimura&title=Relationship+of+axonal+voltage-gated+sodium+channel+1.8+%28NaV1.8%29+mRNA+accumulation+to+sciatic+nerve+injury-induced+painful+neuropathy+in+rats&doi=10.1074%2Fjbc.M111.261701"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.261701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.261701%26sid%3Dliteratum%253Aachs%26aulast%3DRuangsri%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DMulpuri%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DSpigelman%26aufirst%3DI.%26aulast%3DNishimura%26aufirst%3DI.%26atitle%3DRelationship%2520of%2520axonal%2520voltage-gated%2520sodium%2520channel%25201.8%2520%2528NaV1.8%2529%2520mRNA%2520accumulation%2520to%2520sciatic%2520nerve%2520injury-induced%2520painful%2520neuropathy%2520in%2520rats%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D39836%26epage%3D39847%26doi%3D10.1074%2Fjbc.M111.261701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Martin, I.</span><span> </span><span class="NLM_article-title">Prediction of blood-brain barrier penetration: are we missing the point?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span><span class="refDoi"> DOI: 10.1016/S1359-6446(03)02961-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2FS1359-6446%2803%2902961-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=161-162&author=I.+Martin&title=Prediction+of+blood-brain+barrier+penetration%3A+are+we+missing+the+point%3F&doi=10.1016%2FS1359-6446%2803%2902961-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2803%2902961-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252803%252902961-1%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DI.%26atitle%3DPrediction%2520of%2520blood-brain%2520barrier%2520penetration%253A%2520are%2520we%2520missing%2520the%2520point%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D161%26epage%3D162%26doi%3D10.1016%2FS1359-6446%2803%2902961-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Adam, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fields, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeremiah, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyoi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maidment, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratcliffe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottney, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deehan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, I.</span><span> </span><span class="NLM_article-title">Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2932</span><span class="NLM_x">–</span> <span class="NLM_lpage">2937</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.bmcl.2012.02.048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2932-2937&author=J.+M.+Adamauthor=J.+K.+Clarkauthor=K.+Daviesauthor=K.+Everettauthor=R.+Fieldsauthor=S.+Francisauthor=F.+Jeremiahauthor=T.+Kiyoiauthor=M.+Maidmentauthor=A.+Morrisonauthor=P.+Ratcliffeauthor=A.+Prosserauthor=J.+Schulzauthor=G.+Wishartauthor=J.+Bakerauthor=S.+Boyceauthor=R.+Campbellauthor=J.+E.+Cottneyauthor=M.+Deehanauthor=I.+Martin&title=Low+brain+penetrant+CB1+receptor+agonists+for+the+treatment+of+neuropathic+pain&doi=10.1016%2Fj.bmcl.2012.02.048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.048%26sid%3Dliteratum%253Aachs%26aulast%3DAdam%26aufirst%3DJ.%2BM.%26aulast%3DClark%26aufirst%3DJ.%2BK.%26aulast%3DDavies%26aufirst%3DK.%26aulast%3DEverett%26aufirst%3DK.%26aulast%3DFields%26aufirst%3DR.%26aulast%3DFrancis%26aufirst%3DS.%26aulast%3DJeremiah%26aufirst%3DF.%26aulast%3DKiyoi%26aufirst%3DT.%26aulast%3DMaidment%26aufirst%3DM.%26aulast%3DMorrison%26aufirst%3DA.%26aulast%3DRatcliffe%26aufirst%3DP.%26aulast%3DProsser%26aufirst%3DA.%26aulast%3DSchulz%26aufirst%3DJ.%26aulast%3DWishart%26aufirst%3DG.%26aulast%3DBaker%26aufirst%3DJ.%26aulast%3DBoyce%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DCottney%26aufirst%3DJ.%2BE.%26aulast%3DDeehan%26aufirst%3DM.%26aulast%3DMartin%26aufirst%3DI.%26atitle%3DLow%2520brain%2520penetrant%2520CB1%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520neuropathic%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2932%26epage%3D2937%26doi%3D10.1016%2Fj.bmcl.2012.02.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Martin, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Little, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razdan, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melvin, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechoulam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. J.</span><span> </span><span class="NLM_article-title">Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span><span class="refDoi"> DOI: 10.1016/0091-3057(91)90349-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2F0091-3057%2891%2990349-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1666911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADyaK38XnsFOjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1991&pages=471-478&author=B.+R.+Martinauthor=D.+R.+Comptonauthor=B.+F.+Thomasauthor=W.+R.+Prescottauthor=P.+J.+Littleauthor=R.+K.+Razdanauthor=M.+R.+Johnsonauthor=L.+S.+Melvinauthor=R.+Mechoulamauthor=S.+J.+Ward&title=Behavioral%2C+biochemical%2C+and+molecular+modeling+evaluations+of+cannabinoid+analogs&doi=10.1016%2F0091-3057%2891%2990349-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs</span></div><div class="casAuthors">Martin, Billy R.; Compton, David R.; Thomas, Brian F.; Prescott, William R.; Little, Patrick J.; Razdan, Raj K.; Johnson, M. Ross; Melvin, Lawrence S.; Mechoulam, Raphael; Ward, Susan J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">471-8</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    </div><div class="casAbstract">Numerous cannabinoids have been synthesized by the authors that are extremely potent in behavioral assays.  An important feature in increasing potency has been the substitution of a dimethylheptyl (DMH) side chain for the pentyl side chain.  The authors previous studies have shown that (-)-11-OH-Δ8-THC-dimethylheptyl was 80-1150 times more potent than Δ9-THC.  Stereospecificity was demonstrated by its (+)-enantiomer which was more than 1400-7500 times less potent.  A related series of DMH cannabinoid analogs has recently been synthesized and preliminary evaluations reported here.  (-)-11-OH-Δ9-THC-DMH was found to be equipotent with (-)-11-OH-Δ8-THC-DMH.  The aldehyde (-)-11-oxo-Δ9-THC-DMH was 15-50 times more potent than Δ9-THC.  Surprisingly, (-)-11-carboxy-Δ9-THC-DMH was also active, being slightly more potent than Δ9-THC.  In the bicyclic cannabinoid series, the length and bulk of the side chain were found to be equally important.  Aminoalkylindoles, which are structurally dissimilar from classical cannabinoids, have been found to exhibit a pharmacol. profile similar to Δ9-THC.  Though not extremely potent in vivo, they appear to represent an entirely new approach to studying the actions of the cannabinoids.  The structural diversity and wide-ranging potencies of the analogs described herein provide the opportunity to develop a pharmacophore for the cannabinoids using mol. modeling techniques.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgUpOWKwFy3LVg90H21EOLACvtfcHk0liSJ52hfewG1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XnsFOjsA%253D%253D&md5=f285af18dbc132632d65d84d168079f3</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2891%2990349-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252891%252990349-7%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DB.%2BR.%26aulast%3DCompton%26aufirst%3DD.%2BR.%26aulast%3DThomas%26aufirst%3DB.%2BF.%26aulast%3DPrescott%26aufirst%3DW.%2BR.%26aulast%3DLittle%26aufirst%3DP.%2BJ.%26aulast%3DRazdan%26aufirst%3DR.%2BK.%26aulast%3DJohnson%26aufirst%3DM.%2BR.%26aulast%3DMelvin%26aufirst%3DL.%2BS.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DWard%26aufirst%3DS.%2BJ.%26atitle%3DBehavioral%252C%2520biochemical%252C%2520and%2520molecular%2520modeling%2520evaluations%2520of%2520cannabinoid%2520analogs%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1991%26volume%3D40%26spage%3D471%26epage%3D478%26doi%3D10.1016%2F0091-3057%2891%2990349-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Smith, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razdan, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechoulam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=8035318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADyaK2cXkvF2lurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1994&pages=219-227&author=P.+B.+Smithauthor=D.+R.+Comptonauthor=S.+P.+Welchauthor=R.+K.+Razdanauthor=R.+Mechoulamauthor=B.+R.+Martin&title=The+pharmacological+activity+of+anandamide%2C+a+putative+endogenous+cannabinoid%2C+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice</span></div><div class="casAuthors">Smith, Peter B.; Compton, David R.; Welch, Sandra P.; Razdan, Raj K.; Mechoulam, Raphael; Martin, Billy R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">219-27</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The arachidonic acid deriv. anandamide (arachidonylethanolamide) has been isolated from porcine brain and has been shown to bind competitively to the cannabinoid receptor.  Although the pharmacol. activity of this compd. has not yet been fully detd., preliminary data suggest that it produces several effects similar to the cannabinoids.  In the present expts. anandamide produced effects similar to those of Δ9-tetrahydrocannabinol, including antinociception (as detd. in a latency to tail-flick evaluation), hypothermia, hypomotility and catalepsy in mice after i.v., i.t. and i.p. administration.  In general, the effects of anandamide occurred with a rapid onset, but with a rather short duration of action.  Prominent antinociceptive effects (>80% maximal possible effect) were measured immediately after i.v. and i.t. administration.  Anandamide produced significant decreases in rectal temp. (2-4°C) after either i.v. or i.t. injection.  Maximal effects on motor activity (approx. 85% inhibition) were obsd. immediately after i.v. and i.p. administration and 10 min after i.t. administration.  Max. immobility obsd. after i.v. administration was over 80%, yet that produced after i.p. and i.t. administration was too small (≤20%) to be considered pharmacol. relevant.  Anandamide was less potent (1.3 to 18 times) than Δ9-tetrahydrocannibinol in all behavioral assays.  Pretreatment with nor-binaltorphimine, a kappa opioid antagonist which blocks i.t. Δ9-tetrahydrocannibinol-induced antinociception, failed to alter antinociception after i.t. anandamide administration.  Binding studies demonstrated that anandamide displaces [3H]CP-55,940 from rat whole brain P2 membrane prepns. with a KD of 101 ± 15 nM.  These findings demonstrate that anandamide produces effects in a tetrad of tests used to predict cannabimimetic activity and supports the contention of its role as an endogenous cannabinoid ligand.  However, there appear to be distinct differences between anandamide and the cannabinoids with regard to their antinociceptive properties, and other properties vary as a function of route of administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUxz_HmpJfMbVg90H21EOLACvtfcHk0liSJ52hfewG1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkvF2lurw%253D&md5=ad31867900269b1cd3909b878f3b059e</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DP.%2BB.%26aulast%3DCompton%26aufirst%3DD.%2BR.%26aulast%3DWelch%26aufirst%3DS.%2BP.%26aulast%3DRazdan%26aufirst%3DR.%2BK.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DThe%2520pharmacological%2520activity%2520of%2520anandamide%252C%2520a%2520putative%2520endogenous%2520cannabinoid%252C%2520in%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1994%26volume%3D270%26spage%3D219%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Compton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Costa, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razdan, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melvin, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Cannabinoid structure–activity relationships: correlation of receptor binding and in vivo activities</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">265</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=8474008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADyaK3sXks1ansLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1993&pages=218-226&author=D.+R.+Comptonauthor=K.+C.+Riceauthor=B.+R.+de+Costaauthor=R.+K.+Razdanauthor=L.+S.+Melvinauthor=M.+R.+Johnsonauthor=B.+R.+Martin&title=Cannabinoid+structure%E2%80%93activity+relationships%3A+correlation+of+receptor+binding+and+in+vivo+activities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24cR"><div class="casContent"><span class="casTitleNuber">24c</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities</span></div><div class="casAuthors">Compton, David R.; Rice, Kenner C.; De Costa, Brian R.; Razdan, Raj K.; Melvin, Lawrence S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">265</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">218-26</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Although a receptor exists for cannabinoid drugs, it is uncertain which pharmacol. actions this receptor mediates.  The structure-activity relationship investigation was initiated to det. which effects might correspond to binding affinity for the cannabinoid receptor, as well as to explore the binding requirements of this site.  The ability of nearly 60 cannabinoids to displace [3H]CP-55,940 {(-)-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-4-[3-hydroxy propyl] cyclohexan-1-ol} was determinated before establishing correlations between receptor affinity and in vivo pharmacol. potency.  Anal. of [3H]CP-55,940 binding indicated a Hill coeff. of 0.97, a Bmax of 499 pM (3.3 pmol/mg of protein) and an apparent Kd of 924 pM.  Closer inspection indicated the binding assay exhibited "zone B" characteristics, and use of correction equations indicated a true Kd for CP-55,940 of 675 pM.  The structure-activity relationship indicated the importance of side chain structure to high-affinity binding, with the most potent analogs (Ki < 10 nM) possessing either a dimethylheptyl side-chain, a similarly complex branched side chain or a halogen substituent at the 5' position.  Comparative anal. of KI values to in vivo potency in a mouse model indicated a high degree of correlation between parameters for the depression of spontaneous locomotor activity (r = 0.91) and for the prodn. of antinociception (r = 0.90), hypothermia (r = 0.89) and catalepsy (r = 0.85).  Similarly high correlations were demonstrated between binding affinity and in vivo potency in both the rat drug discrimination model (r = 0.81) and for psychotomimetic activity in humans (r = 0.88).  Thus, these studies appear to indicate that the requirements for activation of the cannabinoid receptor are similar across different species, and that receptor binding is sufficient to mediate many of the known pharmacol. effects of cannabinoids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDemJQ_tCfxLVg90H21EOLACvtfcHk0liSJ52hfewG1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXks1ansLs%253D&md5=29e4889026f638bf4699d5eda5333a93</span></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCompton%26aufirst%3DD.%2BR.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3Dde%2BCosta%26aufirst%3DB.%2BR.%26aulast%3DRazdan%26aufirst%3DR.%2BK.%26aulast%3DMelvin%26aufirst%3DL.%2BS.%26aulast%3DJohnson%26aufirst%3DM.%2BR.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DCannabinoid%2520structure%25E2%2580%2593activity%2520relationships%253A%2520correlation%2520of%2520receptor%2520binding%2520and%2520in%2520vivo%2520activities%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1993%26volume%3D265%26spage%3D218%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Devane, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breuer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheskin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarbe, T. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisen, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechoulam, R.</span><span> </span><span class="NLM_article-title">A novel probe for the cannabinoid receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2065</span><span class="NLM_x">–</span> <span class="NLM_lpage">2069</span><span class="refDoi"> DOI: 10.1021/jm00089a018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00089a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADyaK38XltVensLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=2065-2069&author=W.+A.+Devaneauthor=A.+Breuerauthor=T.+Sheskinauthor=T.+U.+Jarbeauthor=M.+S.+Eisenauthor=R.+Mechoulam&title=A+novel+probe+for+the+cannabinoid+receptor&doi=10.1021%2Fjm00089a018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A novel probe for the cannabinoid receptor</span></div><div class="casAuthors">Devane, William A.; Breuer, Aviva; Sheskin, Tzviel; Jaerbe, Torbjoern U. C.; Eisen, Moris S.; Mechoulam, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2065-9</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The 1,1-dimethylheptyl (DMH) homolog of 7-hydroxy-Δ6-tetrahydrocannabinol (I) is the most potent cannabimimetic substance reported so far.  Hydrogenation of I leads to a mixt. of the epimers of 10-(1,1-dimethylheptyl)-7-hydroxyhexahydrocannabinol or to either the equatorial (II) or to the axial epimer (III), depending on the catalysts and conditions used.  II discriminates for Δ1-THC in pigeons (ED50 = 0.002 mg/kg, after 4.5 h), at the potency level of I, and binds to the cannabinoid receptor with a KD of 45 pM, considerably lower than the Ki of 180 pM measured for compd. I and the Ki of 2.00 nM measured for CP-55940, a widely employed ligand.  Tritiated II was used as a novel probe for the cannabinoid receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUfsrZby2tgLVg90H21EOLACvtfcHk0lhfe2FqeMNJNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XltVensLY%253D&md5=4828d5b76236f906546b716fb9d2ff3e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm00089a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00089a018%26sid%3Dliteratum%253Aachs%26aulast%3DDevane%26aufirst%3DW.%2BA.%26aulast%3DBreuer%26aufirst%3DA.%26aulast%3DSheskin%26aufirst%3DT.%26aulast%3DJarbe%26aufirst%3DT.%2BU.%26aulast%3DEisen%26aufirst%3DM.%2BS.%26aulast%3DMechoulam%26aufirst%3DR.%26atitle%3DA%2520novel%2520probe%2520for%2520the%2520cannabinoid%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D2065%26epage%3D2069%26doi%3D10.1021%2Fjm00089a018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Rinaldi-Carmona, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaulme, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neliat, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caput, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soubrié, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brelière, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Fur, G.</span><span> </span><span class="NLM_article-title">SR141716A, a potent and selective antagonist of the brain cannabinoid receptor</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span><span class="refDoi"> DOI: 10.1016/0014-5793(94)00773-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2F0014-5793%2894%2900773-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=8070571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADyaK2cXmsVKjsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=1994&pages=240-244&author=M.+Rinaldi-Carmonaauthor=F.+Barthauthor=M.+Heaulmeauthor=D.+Shireauthor=B.+Calandraauthor=C.+Congyauthor=S.+Martinezauthor=J.+Maruaniauthor=G.+Neliatauthor=D.+Caputauthor=P.+Ferraraauthor=P.+Soubri%C3%A9author=J.+C.+Breli%C3%A8reauthor=G.+Le+Fur&title=SR141716A%2C+a+potent+and+selective+antagonist+of+the+brain+cannabinoid+receptor&doi=10.1016%2F0014-5793%2894%2900773-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">SR141716A, a potent and selective antagonist of the brain cannabinoid receptor</span></div><div class="casAuthors">Rinaldi-Carmona, Murielle; Barth, Francis; Heaulme, Michel; Shire, David; Calandra, Bernard; Congy, Christian; Martinez, Serge; Maruani, Jeanne; Neliat, Gervais; et al.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">240-4</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">SR141716A is the first selective and orally active antagonist of the brain cannabinoid receptor.  This compd. displays nanomolar affinity for the central cannabinoid receptor but is not active on the peripheral cannabinoid receptor.  In vitro, SR141716A antagonizes the inhibitory effects of cannabinoid receptor agonists on both mouse vas deferens contractions and adenylyl cyclase activity in rat brain membranes.  After i.p. or oral administration, SR141716A antagonizes classical pharmacol. and behavioral effects of cannabinoid receptor agonists.  This compd. should prove to be a powerful tool for investigating the in vivo functions of the anandamide/cannabinoid system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLJ59LaZb2cbVg90H21EOLACvtfcHk0lhfe2FqeMNJNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmsVKjsrw%253D&md5=1eebdfec28d2dde64729cddb859aa6c8</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2894%2900773-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252894%252900773-X%26sid%3Dliteratum%253Aachs%26aulast%3DRinaldi-Carmona%26aufirst%3DM.%26aulast%3DBarth%26aufirst%3DF.%26aulast%3DHeaulme%26aufirst%3DM.%26aulast%3DShire%26aufirst%3DD.%26aulast%3DCalandra%26aufirst%3DB.%26aulast%3DCongy%26aufirst%3DC.%26aulast%3DMartinez%26aufirst%3DS.%26aulast%3DMaruani%26aufirst%3DJ.%26aulast%3DNeliat%26aufirst%3DG.%26aulast%3DCaput%26aufirst%3DD.%26aulast%3DFerrara%26aufirst%3DP.%26aulast%3DSoubri%25C3%25A9%26aufirst%3DP.%26aulast%3DBreli%25C3%25A8re%26aufirst%3DJ.%2BC.%26aulast%3DLe%2BFur%26aufirst%3DG.%26atitle%3DSR141716A%252C%2520a%2520potent%2520and%2520selective%2520antagonist%2520of%2520the%2520brain%2520cannabinoid%2520receptor%26jtitle%3DFEBS%2520Lett.%26date%3D1994%26volume%3D350%26spage%3D240%26epage%3D244%26doi%3D10.1016%2F0014-5793%2894%2900773-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Fulp, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortoff, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seltzman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fennell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maitra, R.</span><span> </span><span class="NLM_article-title">Design and synthesis of cannabinoid receptor 1 antagonists for peripheral selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2820</span><span class="NLM_x">–</span> <span class="NLM_lpage">2834</span><span class="refDoi"> DOI: 10.1021/jm201731z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201731z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVGju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2820-2834&author=A.+Fulpauthor=K.+Bortoffauthor=H.+Seltzmanauthor=Y.+Zhangauthor=J.+Mathewsauthor=R.+Snyderauthor=T.+Fennellauthor=R.+Maitra&title=Design+and+synthesis+of+cannabinoid+receptor+1+antagonists+for+peripheral+selectivity&doi=10.1021%2Fjm201731z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Cannabinoid Receptor 1 Antagonists for Peripheral Selectivity</span></div><div class="casAuthors">Fulp, Alan; Bortoff, Katherine; Seltzman, Herbert; Zhang, Yanan; Mathews, James; Snyder, Rodney; Fennell, Tim; Maitra, Rangan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2820-2834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Antagonists of cannabinoid receptor 1 (CB1) have potential for the treatment of several diseases such as obesity, liver disease, and diabetes.  Recently, development of several CB1 antagonists was halted because of adverse central nervous system (CNS) related side effects obsd. with rimonabant, the first clin. approved CB1 inverse agonist.  However, recent studies indicate that regulation of peripherally expressed CB1 with CNS-sparing compds. is a viable strategy to treat several important disorders.  The reported efforts aimed at rationally designing peripherally restricted CB1 antagonists have resulted in compds. that have limited blood-brain barrier (BBB) permeability and CNS exposure in preclin. in vitro and in vivo models.  Typically, compds. with high topol. polar surface areas (TPSAs) do not cross the BBB passively.  Compds. with TPSAs higher than that for rimonabant (rimonabant TPSA = 50) and excellent functional activity with limited CNS penetration were identified.  These compds. will serve as templates for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxIk0YtV78UbVg90H21EOLACvtfcHk0lhfe2FqeMNJNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVGju74%253D&md5=95a56654ab10a8b238ee16949fc10e18</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm201731z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201731z%26sid%3Dliteratum%253Aachs%26aulast%3DFulp%26aufirst%3DA.%26aulast%3DBortoff%26aufirst%3DK.%26aulast%3DSeltzman%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMathews%26aufirst%3DJ.%26aulast%3DSnyder%26aufirst%3DR.%26aulast%3DFennell%26aufirst%3DT.%26aulast%3DMaitra%26aufirst%3DR.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520cannabinoid%2520receptor%25201%2520antagonists%2520for%2520peripheral%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2820%26epage%3D2834%26doi%3D10.1021%2Fjm201731z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">D’Ambra, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estep, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eissenstat, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josef, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haycock, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baizman, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casiano, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beglin, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chippari, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grego, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kullnig, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daley, G. T.</span><span> </span><span class="NLM_article-title">Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span><span class="refDoi"> DOI: 10.1021/jm00079a016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00079a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=124-135&author=T.+E.+D%E2%80%99Ambraauthor=K.+G.+Estepauthor=M.+R.+Bellauthor=M.+A.+Eissenstatauthor=K.+A.+Josefauthor=S.+J.+Wardauthor=D.+A.+Haycockauthor=E.+R.+Baizmanauthor=F.+M.+Casianoauthor=N.+C.+Beglinauthor=S.+M.+Chippariauthor=J.+D.+Gregoauthor=R.+K.+Kullnigauthor=G.+T.+Daley&title=Conformationally+restrained+analogues+of+pravadoline%3A+nanomolar+potent%2C+enantioselective%2C+%28aminoalkyl%29indole+agonists+of+the+cannabinoid+receptor&doi=10.1021%2Fjm00079a016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm00079a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00079a016%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Ambra%26aufirst%3DT.%2BE.%26aulast%3DEstep%26aufirst%3DK.%2BG.%26aulast%3DBell%26aufirst%3DM.%2BR.%26aulast%3DEissenstat%26aufirst%3DM.%2BA.%26aulast%3DJosef%26aufirst%3DK.%2BA.%26aulast%3DWard%26aufirst%3DS.%2BJ.%26aulast%3DHaycock%26aufirst%3DD.%2BA.%26aulast%3DBaizman%26aufirst%3DE.%2BR.%26aulast%3DCasiano%26aufirst%3DF.%2BM.%26aulast%3DBeglin%26aufirst%3DN.%2BC.%26aulast%3DChippari%26aufirst%3DS.%2BM.%26aulast%3DGrego%26aufirst%3DJ.%2BD.%26aulast%3DKullnig%26aufirst%3DR.%2BK.%26aulast%3DDaley%26aufirst%3DG.%2BT.%26atitle%3DConformationally%2520restrained%2520analogues%2520of%2520pravadoline%253A%2520nanomolar%2520potent%252C%2520enantioselective%252C%2520%2528aminoalkyl%2529indole%2520agonists%2520of%2520the%2520cannabinoid%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D124%26epage%3D135%26doi%3D10.1021%2Fjm00079a016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rager, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kardos, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobson, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidalgo, I. J.</span><span> </span><span class="NLM_article-title">Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier</span> <span class="citation_source-journal">Int. J. Pharm. (Amsterdam, Neth.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span><span class="refDoi"> DOI: 10.1016/j.ijpharm.2004.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.ijpharm.2004.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=15620875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFGhurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2005&pages=349-359&author=Q.+Wangauthor=J.+D.+Ragerauthor=K.+Weinsteinauthor=P.+S.+Kardosauthor=G.+L.+Dobsonauthor=J.+Liauthor=I.+J.+Hidalgo&title=Evaluation+of+the+MDR-MDCK+cell+line+as+a+permeability+screen+for+the+blood-brain+barrier&doi=10.1016%2Fj.ijpharm.2004.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier</span></div><div class="casAuthors">Wang, Qing; Rager, Joseph D.; Weinstein, Kathryn; Kardos, Paula S.; Dobson, Glenn L.; Li, Jibin; Hidalgo, Ismael J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">349-359</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The objectives of this study were to (1) characterize MDR-MDCK monolayers as an in vitro model to predict brain uptake potential; (2) examine the ability of MDR-MDCK monolayers to identify the brain uptake potential of compds. that interact with P-glycoprotein (P-gp).  The study measured the bi-directional transport of 28 compds. across MDR-MDCK monolayers.  The brain uptake of a subset of the compds. was detd. in the rat brain perfusion model.  Drug concns. were analyzed by LC-MS-MS.  CNS-pos. drugs exhibited absorptive permeability coeffs. (Papp, A-B) values ranging from 3.4 × 10-6 to 20.2 × 10-6 cm/s; whereas CNS-neg. drugs showed Papp (A-B) ranging from 0.03 × 10-6 to 0.83 × 10-6 cm/s.  Inhibition of P-gp by cyclosporin A (CsA) significantly reduced secretory flux of compds. known to be P-pg substrates, but only enhanced the absorptive flux of compds. with high efflux ratio (>100).  In vitro results were confirmed by brain perfusion studies on selected compds.  MDR-MDCK monolayers can be used to classify compds. into CNS-pos. or CNS-neg. based on the permeability coeffs. (Papp, A-B).  Under the authors' exptl. conditions, compds. with Papp (A-B) >3 × 10-6 cm/s have high brain uptake potential; compds. with Papp (A-B) < 1 × 10-6 cm/s are unable to penetrate the blood-brain barrier (BBB); the brain uptake of compds. with Papp (A-B) < 1 × 10-6 cm/s and a P-gp-mediated efflux ratio of >100 may be enhanced by inhibiting P-gp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvF-zoLte8trVg90H21EOLACvtfcHk0lhCN5-2aY1tIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFGhurvE&md5=7d2cb9e13b2767b337bf808e73141ae1</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2004.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2004.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DRager%26aufirst%3DJ.%2BD.%26aulast%3DWeinstein%26aufirst%3DK.%26aulast%3DKardos%26aufirst%3DP.%2BS.%26aulast%3DDobson%26aufirst%3DG.%2BL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHidalgo%26aufirst%3DI.%2BJ.%26atitle%3DEvaluation%2520of%2520the%2520MDR-MDCK%2520cell%2520line%2520as%2520a%2520permeability%2520screen%2520for%2520the%2520blood-brain%2520barrier%26jtitle%3DInt.%2520J.%2520Pharm.%2520%2528Amsterdam%252C%2520Neth.%2529%26date%3D2005%26volume%3D288%26spage%3D349%26epage%3D359%26doi%3D10.1016%2Fj.ijpharm.2004.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McAllister, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizvi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anavi-Goffer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett-Norris, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggio, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abood, M. E.</span><span> </span><span class="NLM_article-title">An aromatic microdomain at the cannabinoid CB<sub>1</sub> receptor constitutes an agonist/inverse agonist binding region</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">5139</span><span class="NLM_x">–</span> <span class="NLM_lpage">5152</span><span class="refDoi"> DOI: 10.1021/jm0302647</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0302647" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=5139-5152&author=S.+D.+McAllisterauthor=G.+Rizviauthor=S.+Anavi-Gofferauthor=D.+P.+Hurstauthor=J.+Barnett-Norrisauthor=D.+L.+Lynchauthor=P.+H.+Reggioauthor=M.+E.+Abood&title=An+aromatic+microdomain+at+the+cannabinoid+CB1+receptor+constitutes+an+agonist%2Finverse+agonist+binding+region&doi=10.1021%2Fjm0302647"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1021%2Fjm0302647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0302647%26sid%3Dliteratum%253Aachs%26aulast%3DMcAllister%26aufirst%3DS.%2BD.%26aulast%3DRizvi%26aufirst%3DG.%26aulast%3DAnavi-Goffer%26aufirst%3DS.%26aulast%3DHurst%26aufirst%3DD.%2BP.%26aulast%3DBarnett-Norris%26aufirst%3DJ.%26aulast%3DLynch%26aufirst%3DD.%2BL.%26aulast%3DReggio%26aufirst%3DP.%2BH.%26aulast%3DAbood%26aufirst%3DM.%2BE.%26atitle%3DAn%2520aromatic%2520microdomain%2520at%2520the%2520cannabinoid%2520CB1%2520receptor%2520constitutes%2520an%2520agonist%252Finverse%2520agonist%2520binding%2520region%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D5139%26epage%3D5152%26doi%3D10.1021%2Fjm0302647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Reggio, P. H.</span><span> </span><span class="NLM_article-title">Pharmacophores for ligand recognition and activation/inactivation of the cannabinoid receptors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1607</span><span class="NLM_x">–</span> <span class="NLM_lpage">1633</span><span class="refDoi"> DOI: 10.2174/1381612033454577</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.2174%2F1381612033454577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=12871061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmt1GnsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=1607-1633&author=P.+H.+Reggio&title=Pharmacophores+for+ligand+recognition+and+activation%2Finactivation+of+the+cannabinoid+receptors&doi=10.2174%2F1381612033454577"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30bR"><div class="casContent"><span class="casTitleNuber">30b</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophores for ligand recognition and activation/inactivation of the cannabinoid receptors</span></div><div class="casAuthors">Reggio, Patricia H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1607-1633</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The cannabinoid CB1 and CB2 receptors belong to the Class A, rhodopsin-like family of G protein-coupled receptors.  Antagonists for each receptor sub-type, as well as four structural classes of agonists that bind to both receptors, have been identified.  An extensive amt. of SAR has been developed for agonists and antagonists that bind at CB1, while the SAR of CB2 ligands is only now emerging in the literature.  Cannabinoid agonists have been suggested to have potential therapeutic uses as appetite stimulants, analgesics, anti-emetics, anti-diarrheals, anti-spasmodics, tumor anti-proliferative agents, anti-glaucoma agents and as agents for the treatment of diseases assocd. with inappropriate retention of aversive memories such as post-traumatic stress disorders and phobias.  Cannabinoid CB1 antagonists have been suggested to have potential therapeutic uses as appetite suppressants and as agents that improve memory.  This review focuses first on recent CB1 and CB2 SAR and on the pharmacophores that have been developed for ligand recognition at the CB1 receptor.  Emerging ideas about how the cannabinoid receptors are activated by agonists or inactivated by inverse agonists are then presented.  Challenges for future SAR and pharmacophore development are also identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9wsB2MKnOrVg90H21EOLACvtfcHk0lh_OJtx7gshqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmt1GnsL4%253D&md5=f10ef4389fbcbb56fe26d7a56084f8c0</span></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.2174%2F1381612033454577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612033454577%26sid%3Dliteratum%253Aachs%26aulast%3DReggio%26aufirst%3DP.%2BH.%26atitle%3DPharmacophores%2520for%2520ligand%2520recognition%2520and%2520activation%252Finactivation%2520of%2520the%2520cannabinoid%2520receptors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2003%26volume%3D9%26spage%3D1607%26epage%3D1633%26doi%3D10.2174%2F1381612033454577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Eissenstat, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Ambra, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daum, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackerman, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estep, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olefirowicz, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetzel, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, J. D.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haycock, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttinger, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casiano, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chippari, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuster, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. J.</span><span> </span><span class="NLM_article-title">Aminoalkylindoles: structure-activity relationships of novel cannabinoid mimetics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">3094</span><span class="NLM_x">–</span> <span class="NLM_lpage">3105</span><span class="refDoi"> DOI: 10.1021/jm00016a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00016a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=3094-3105&author=M.+A.+Eissenstatauthor=M.+R.+Bellauthor=T.+E.+D%E2%80%99Ambraauthor=E.+J.+Alexanderauthor=S.+J.+Daumauthor=J.+H.+Ackermanauthor=M.+D.+Gruettauthor=V.+Kumarauthor=K.+G.+Estepauthor=E.+M.+Olefirowiczauthor=J.+R.+Wetzelauthor=M.+D.+Alexanderauthor=J.+D.+Weaverauthor=D.+A.+Haycockauthor=D.+A.+Luttingerauthor=F.+M.+Casianoauthor=S.+M.+Chippariauthor=J.+E.+Kusterauthor=J.+I.+Stevensonauthor=S.+J.+Ward&title=Aminoalkylindoles%3A+structure-activity+relationships+of+novel+cannabinoid+mimetics&doi=10.1021%2Fjm00016a013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm00016a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00016a013%26sid%3Dliteratum%253Aachs%26aulast%3DEissenstat%26aufirst%3DM.%2BA.%26aulast%3DBell%26aufirst%3DM.%2BR.%26aulast%3DD%25E2%2580%2599Ambra%26aufirst%3DT.%2BE.%26aulast%3DAlexander%26aufirst%3DE.%2BJ.%26aulast%3DDaum%26aufirst%3DS.%2BJ.%26aulast%3DAckerman%26aufirst%3DJ.%2BH.%26aulast%3DGruett%26aufirst%3DM.%2BD.%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DEstep%26aufirst%3DK.%2BG.%26aulast%3DOlefirowicz%26aufirst%3DE.%2BM.%26aulast%3DWetzel%26aufirst%3DJ.%2BR.%26aulast%3DAlexander%26aufirst%3DM.%2BD.%26aulast%3DWeaver%26aufirst%3DJ.%2BD.%26aulast%3DHaycock%26aufirst%3DD.%2BA.%26aulast%3DLuttinger%26aufirst%3DD.%2BA.%26aulast%3DCasiano%26aufirst%3DF.%2BM.%26aulast%3DChippari%26aufirst%3DS.%2BM.%26aulast%3DKuster%26aufirst%3DJ.%2BE.%26aulast%3DStevenson%26aufirst%3DJ.%2BI.%26aulast%3DWard%26aufirst%3DS.%2BJ.%26atitle%3DAminoalkylindoles%253A%2520structure-activity%2520relationships%2520of%2520novel%2520cannabinoid%2520mimetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D3094%26epage%3D3105%26doi%3D10.1021%2Fjm00016a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Huffman, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szklennik, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almond, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bushell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassidy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4110</span><span class="NLM_x">–</span> <span class="NLM_lpage">4113</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2005.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.bmcl.2005.06.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4110-4113&author=J.+W.+Huffmanauthor=P.+V.+Szklennikauthor=A.+Almondauthor=K.+Bushellauthor=D.+E.+Selleyauthor=H.+Heauthor=M.+P.+Cassidyauthor=J.+L.+Wileyauthor=B.+R.+Martin&title=1-Pentyl-3-phenylacetylindoles%2C+a+new+class+of+cannabimimetic+indoles&doi=10.1016%2Fj.bmcl.2005.06.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DHuffman%26aufirst%3DJ.%2BW.%26aulast%3DSzklennik%26aufirst%3DP.%2BV.%26aulast%3DAlmond%26aufirst%3DA.%26aulast%3DBushell%26aufirst%3DK.%26aulast%3DSelley%26aufirst%3DD.%2BE.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DCassidy%26aufirst%3DM.%2BP.%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3D1-Pentyl-3-phenylacetylindoles%252C%2520a%2520new%2520class%2520of%2520cannabimimetic%2520indoles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4110%26epage%3D4113%26doi%3D10.1016%2Fj.bmcl.2005.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Brents, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallus-Zawada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radominska-Pandya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasiljevik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prisinzano, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantegrossi, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prather, P. L.</span><span> </span><span class="NLM_article-title">Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity</span> <span class="citation_source-journal">Biochem. Pharmacol. (Amsterdam, Neth.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">952</span><span class="NLM_x">–</span> <span class="NLM_lpage">961</span><span class="refDoi"> DOI: 10.1016/j.bcp.2012.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.bcp.2012.01.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=952-961&author=L.+K.+Brentsauthor=A.+Gallus-Zawadaauthor=A.+Radominska-Pandyaauthor=T.+Vasiljevikauthor=T.+E.+Prisinzanoauthor=W.+E.+Fantegrossiauthor=J.+H.+Moranauthor=P.+L.+Prather&title=Monohydroxylated+metabolites+of+the+K2+synthetic+cannabinoid+JWH-073+retain+intermediate+to+high+cannabinoid+1+receptor+%28CB1R%29+affinity+and+exhibit+neutral+antagonist+to+partial+agonist+activity&doi=10.1016%2Fj.bcp.2012.01.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DBrents%26aufirst%3DL.%2BK.%26aulast%3DGallus-Zawada%26aufirst%3DA.%26aulast%3DRadominska-Pandya%26aufirst%3DA.%26aulast%3DVasiljevik%26aufirst%3DT.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DFantegrossi%26aufirst%3DW.%2BE.%26aulast%3DMoran%26aufirst%3DJ.%2BH.%26aulast%3DPrather%26aufirst%3DP.%2BL.%26atitle%3DMonohydroxylated%2520metabolites%2520of%2520the%2520K2%2520synthetic%2520cannabinoid%2520JWH-073%2520retain%2520intermediate%2520to%2520high%2520cannabinoid%25201%2520receptor%2520%2528CB1R%2529%2520affinity%2520and%2520exhibit%2520neutral%2520antagonist%2520to%2520partial%2520agonist%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%2520%2528Amsterdam%252C%2520Neth.%2529%26date%3D2012%26volume%3D83%26spage%3D952%26epage%3D961%26doi%3D10.1016%2Fj.bcp.2012.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Brents, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichard, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantegrossi, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prather, P. L.</span><span> </span><span class="NLM_article-title">Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e21917</span><span class="refDoi"> DOI: 10.1371/journal.pone.0021917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1371%2Fjournal.pone.0021917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=21755008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFChsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e21917&author=L.+K.+Brentsauthor=E.+E.+Reichardauthor=S.+M.+Zimmermanauthor=J.+H.+Moranauthor=W.+E.+Fantegrossiauthor=P.+L.+Prather&title=Phase+I+hydroxylated+metabolites+of+the+K2+synthetic+cannabinoid+JWH-018+retain+in+vitro+and+in+vivo+cannabinoid+1+receptor+affinity+and+activity&doi=10.1371%2Fjournal.pone.0021917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity</span></div><div class="casAuthors">Brents, Lisa K.; Reichard, Emily E.; Zimmerman, Sarah M.; Moran, Jeffery H.; Fantegrossi, William E.; Prather, Paul L.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e21917</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">K2 products are synthetic cannabinoid-laced, marijuana-like drugs of abuse, use of which is often assocd. with clin. symptoms atypical of marijuana use, including hypertension, agitation, hallucinations, psychosis, seizures and panic attacks.  JWH-018, a prevalent K2 synthetic cannabinoid, is structurally distinct from Δ9-THC, the main psychoactive ingredient in marijuana.  Since even subtle structural differences can lead to differential metab., formation of novel, biol. active metabolites may be responsible for the distinct effects assocd. with K2 use.  The present study proposes that K2's high adverse effect occurrence is due, at least in part, to distinct JWH-018 metabolite activity at the cannabinoid 1 receptor (CB1R).  JWH-018, five potential monohydroxylated metabolites (M1-M5), and one carboxy metabolite (M6) were examd. in mouse brain homogenates contg. CB1Rs, first for CB1R affinity using a competition binding assay employing the cannabinoid receptor radioligand [3H]CP-55,940, and then for CB1R intrinsic efficacy using an [35S]GTPγS binding assay.  JWH-018 and M1-M5 bound CB1Rs with high affinity, exhibiting Ki values that were lower than or equiv. to Δ9-THC.  These mols. also stimulated G-proteins with equal or greater efficacy relative to Δ9-THC, a CB1R partial agonist.  Most importantly, JWH-018, M2, M3, and M5 produced full CB1R agonist levels of activation.  CB1R-mediated activation was demonstrated by blockade with O-2050, a CB1R-selective neutral antagonist.  Similar to Δ9-THC, JWH-018 and M1 produced a marked depression of locomotor activity and core body temp. in mice that were both blocked by the CB1R-preferring antagonist/inverse agonist AM251.  Unlike metabolites of most drugs, the studied JWH-018 monohydroxylated compds., but not the carboxy metabolite, retain in vitro and in vivo activity at CB1Rs.  These observations, combined with higher CB1R affinity and activity relative to Δ9-THC, may contribute to the greater prevalence of adverse effects obsd. with JWH-018-contg. products relative to cannabis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHN28ACeRV0LVg90H21EOLACvtfcHk0lh_OJtx7gshqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFChsL0%253D&md5=a40b0f6749f9552fd544fa0f6f2dc2ba</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0021917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0021917%26sid%3Dliteratum%253Aachs%26aulast%3DBrents%26aufirst%3DL.%2BK.%26aulast%3DReichard%26aufirst%3DE.%2BE.%26aulast%3DZimmerman%26aufirst%3DS.%2BM.%26aulast%3DMoran%26aufirst%3DJ.%2BH.%26aulast%3DFantegrossi%26aufirst%3DW.%2BE.%26aulast%3DPrather%26aufirst%3DP.%2BL.%26atitle%3DPhase%2520I%2520hydroxylated%2520metabolites%2520of%2520the%2520K2%2520synthetic%2520cannabinoid%2520JWH-018%2520retain%2520in%2520vitro%2520and%2520in%2520vivo%2520cannabinoid%25201%2520receptor%2520affinity%2520and%2520activity%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De21917%26doi%3D10.1371%2Fjournal.pone.0021917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Löscher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potschka, H.</span><span> </span><span class="NLM_article-title">Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span><span class="refDoi"> DOI: 10.1016/j.pneurobio.2005.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.pneurobio.2005.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=16011870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADC%252BD2MzpvFSgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2005&pages=22-76&author=W.+L%C3%B6scherauthor=H.+Potschka&title=Role+of+drug+efflux+transporters+in+the+brain+for+drug+disposition+and+treatment+of+brain+diseases&doi=10.1016%2Fj.pneurobio.2005.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases</span></div><div class="casAuthors">Loscher Wolfgang; Potschka Heidrun</div><div class="citationInfo"><span class="NLM_cas:title">Progress in neurobiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-76</span>
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    </div><div class="casAbstract">The blood-brain barrier (BBB) serves as a protective mechanism for the brain by preventing entry of potentially harmful substances from free access to the central nervous system (CNS).  Tight junctions present between the brain microvessel endothelial cells form a diffusion barrier, which selectively excludes most blood-borne substances from entering the brain.  Astrocytic end-feet tightly ensheath the vessel wall and appear to be critical for the induction and maintenance of the barrier properties of the brain capillary endothelial cells.  Because of these properties, the BBB only allows entry of lipophilic compounds with low molecular weights by passive diffusion.  However, many lipophilic drugs show negligible brain uptake.  They are substrates for drug efflux transporters such as P-glycoprotein (Pgp), multidrug resistance proteins (MRPs) or organic anion transporting polypeptides (OATPs) that are expressed at brain capillary endothelial cells and/or astrocytic end-feet and are key elements of the molecular machinery that confers the special permeability properties to the BBB.  The combined action of these carrier systems results in rapid efflux of xenobiotics from the CNS.  The objective of this review is to summarize transporter characteristics (cellular localization, specificity, regulation, and potential inhibition) for drug efflux transport systems identified in the BBB and blood-cerebrospinal fluid (CSF) barrier.  A variety of experimental approaches available to ascertain or predict the impact of efflux transport on brain access of therapeutic drugs also are described and critically discussed.  The potential impact of efflux transport on the pharmacodynamics of agents acting in the CNS is illustrated.  Furthermore, the current knowledge about drug efflux transporters as a major determinant of multidrug resistance of brain diseases such as epilepsy is reviewed.  Finally, we summarize strategies for modulating or by-passing drug efflux transporters at the BBB as novel therapeutic approaches to drug-resistant brain diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRe07yo5jk4UPSAs_PE1QvifW6udTcc2eYX_l-5img3qbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzpvFSgtw%253D%253D&md5=146aa11977c71b08a1182aba1354db84</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2005.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2005.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6scher%26aufirst%3DW.%26aulast%3DPotschka%26aufirst%3DH.%26atitle%3DRole%2520of%2520drug%2520efflux%2520transporters%2520in%2520the%2520brain%2520for%2520drug%2520disposition%2520and%2520treatment%2520of%2520brain%2520diseases%26jtitle%3DProg.%2520Neurobiol.%26date%3D2005%26volume%3D76%26spage%3D22%26epage%3D76%26doi%3D10.1016%2Fj.pneurobio.2005.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Montesinos, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gromand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beduneau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamprecht, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellequer, Y.</span><span> </span><span class="NLM_article-title">Coadministration of P-glycoprotein modulators on loperamide pharmacokinetics and brain distribution</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">700</span><span class="NLM_x">–</span> <span class="NLM_lpage">706</span><span class="refDoi"> DOI: 10.1124/dmd.113.055566</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1124%2Fdmd.113.055566" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=24398461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvVKqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=700-706&author=R.+N.+Montesinosauthor=B.+Moulariauthor=J.+Gromandauthor=A.+Beduneauauthor=A.+Lamprechtauthor=Y.+Pellequer&title=Coadministration+of+P-glycoprotein+modulators+on+loperamide+pharmacokinetics+and+brain+distribution&doi=10.1124%2Fdmd.113.055566"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Coadministration of P-glycoprotein modulators on loperamide pharmacokinetics and brain distribution</span></div><div class="casAuthors">Montesinos, Rita Nieto; Moulari, Brice; Gromand, Jessica; Beduneau, Arnaud; Lamprecht, Alf; Pellequer, Yann</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">700-706, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The efflux transporter P-glycoprotein, expressed at high levels at the blood-brain barrier, exerts a profound effect on the disposition of various therapeutic compds. in the brain.  A rapid and efficient modulation of this efflux transporter could enhance the distribution of its substrates and thereby improve central nervous system pharmaco-therapies.  This study explored the impact of the i.v. co-administration of two P-glycoprotein modulators, tariquidar and elacridar, on the pharmacokinetics and brain distribution of loperamide, a P-glycoprotein substrate probe, in rats.  After 1 h postdosing, tariquidar and elacridar, both at a dose of 1.0 mg/kg, increased loperamide levels in the brain by 2.3- and 3.5-fold, resp.  However, the concurrent administration of both P-glycoprotein modulators, each at a dose of 0.5 mg/kg, increased loperamide levels in the brain by 5.8-fold and resulted in the most pronounced opioid-induced clin. signs.  This phenomenon may be the result of a combined noncompetitive modulation by tariquidar and elacridar.  Besides, the simultaneous administration of elacridar and tariquidar did not significantly modify the pharmacokinetic parameters of loperamide.  This observation potentially allows the concurrent use of low but therapeutic doses of P-gp modulators to achieve full inhibitory effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1SQBbE-KSrrVg90H21EOLACvtfcHk0lhvG80C6GhUYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvVKqt7w%253D&md5=8c0f4ceb7d6e08bbd22cf360e0d331da</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.055566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.055566%26sid%3Dliteratum%253Aachs%26aulast%3DMontesinos%26aufirst%3DR.%2BN.%26aulast%3DMoulari%26aufirst%3DB.%26aulast%3DGromand%26aufirst%3DJ.%26aulast%3DBeduneau%26aufirst%3DA.%26aulast%3DLamprecht%26aufirst%3DA.%26aulast%3DPellequer%26aufirst%3DY.%26atitle%3DCoadministration%2520of%2520P-glycoprotein%2520modulators%2520on%2520loperamide%2520pharmacokinetics%2520and%2520brain%2520distribution%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26spage%3D700%26epage%3D706%26doi%3D10.1124%2Fdmd.113.055566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Fuchs, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gansser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanswell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiguro, N.</span><span> </span><span class="NLM_article-title">Brain penetration of WEB 2086 (Apafant) and dantrolene in Mdr1a (P-glycoprotein) and Bcrp knockout rats</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1761</span><span class="NLM_x">–</span> <span class="NLM_lpage">1765</span><span class="refDoi"> DOI: 10.1124/dmd.114.058545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1124%2Fdmd.114.058545" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=1761-1765&author=H.+Fuchsauthor=W.+Kishimotoauthor=D.+Gansserauthor=P.+Tanswellauthor=N.+Ishiguro&title=Brain+penetration+of+WEB+2086+%28Apafant%29+and+dantrolene+in+Mdr1a+%28P-glycoprotein%29+and+Bcrp+knockout+rats&doi=10.1124%2Fdmd.114.058545"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.058545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.058545%26sid%3Dliteratum%253Aachs%26aulast%3DFuchs%26aufirst%3DH.%26aulast%3DKishimoto%26aufirst%3DW.%26aulast%3DGansser%26aufirst%3DD.%26aulast%3DTanswell%26aufirst%3DP.%26aulast%3DIshiguro%26aufirst%3DN.%26atitle%3DBrain%2520penetration%2520of%2520WEB%25202086%2520%2528Apafant%2529%2520and%2520dantrolene%2520in%2520Mdr1a%2520%2528P-glycoprotein%2529%2520and%2520Bcrp%2520knockout%2520rats%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26spage%3D1761%26epage%3D1765%26doi%3D10.1124%2Fdmd.114.058545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mitrirattanakul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramakul, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrero, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faull, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spigelman, I.</span><span> </span><span class="NLM_article-title">Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">114</span><span class="refDoi"> DOI: 10.1016/j.pain.2006.06.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.pain.2006.06.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=16844297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1agtrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2006&pages=102-114&author=S.+Mitrirattanakulauthor=N.+Ramakulauthor=A.+V.+Guerreroauthor=Y.+Matsukaauthor=T.+Onoauthor=H.+Iwaseauthor=K.+Mackieauthor=K.+Faullauthor=I.+Spigelman&title=Site-specific+increases+in+peripheral+cannabinoid+receptors+and+their+endogenous+ligands+in+a+model+of+neuropathic+pain&doi=10.1016%2Fj.pain.2006.06.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37aR"><div class="casContent"><span class="casTitleNuber">37a</span><div class="casTitle"><span class="NLM_cas:atitle">Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain</span></div><div class="casAuthors">Mitrirattanakul, Somsak; Ramakul, Navapoln; Guerrero, Andre V.; Matsuka, Yoshizo; Ono, Takeshi; Iwase, Hirotate; Mackie, Ken; Faull, Kym F.; Spigelman, Igor</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">102-114</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Selective activation of the peripheral cannabinoid receptor 1 (CB1R) has been shown to suppress neuropathic pain symptoms in rodents.  However, relatively little is known about changes in CB1R and its endogenous ligands during development or maintenance of neuropathic pain.  Using immunohistochem., Western blot, real-time reverse transcription polymerase chain reaction, as well as liq. chromatog./mass spectrometry, we studied the changes in CB1Rs and endocannabinoids N-arachidonoylethanolamine/anandamide (AEA) and 2-arachidonoylglycerol (2-AG) in rat lumbar (L4 and L5) dorsal root ganglia (DRG) after neuropathic pain induction (L5 spinal nerve ligation: SNL).  Immunohistochem. revealed that in control rats, CB1R is expressed in the majority (76-83%) of nociceptive neurons as indicated by co-labeling with isolectin B4 (IB4) or antibodies recognizing transient receptor potential vanilloid (TRPV1), calcitonin gene related peptide (CGRP), and the NR2C/2D subunits of the N-methyl- -aspartate receptor.  After L5 SNL, CB1R mRNA and protein increases in the ipsilateral uninjured L4 DRG whereas the percentages of CB1R immunoreactive (CB1R-ir) neurons remain unchanged in L4 and L5 DRG.  However, for these CB1R-ir neurons, we observe significant increases in percentage of TRPV1-ir cells in ipsilateral L4 DRG, and decreases in percentage of IB4- and CGRP-co-labeled cells in ipsilateral L5 DRG.  Levels of both AEA and 2-AG increase significantly only in the ipsilateral L5 DRG.  These results are consistent with the preserved analgesic effects of cannabinoids in neuropathic pain and provide a rational framework for the development of peripherally acting endocannabinoid-based therapeutic interventions for neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd_X-EqUbWL7Vg90H21EOLACvtfcHk0ljGIa5W42ztXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1agtrbE&md5=1826c96080736624b3729fb246350731</span></div><a href="/servlet/linkout?suffix=cit37a&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2006.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2006.06.016%26sid%3Dliteratum%253Aachs%26aulast%3DMitrirattanakul%26aufirst%3DS.%26aulast%3DRamakul%26aufirst%3DN.%26aulast%3DGuerrero%26aufirst%3DA.%2BV.%26aulast%3DMatsuka%26aufirst%3DY.%26aulast%3DOno%26aufirst%3DT.%26aulast%3DIwase%26aufirst%3DH.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DFaull%26aufirst%3DK.%26aulast%3DSpigelman%26aufirst%3DI.%26atitle%3DSite-specific%2520increases%2520in%2520peripheral%2520cannabinoid%2520receptors%2520and%2520their%2520endogenous%2520ligands%2520in%2520a%2520model%2520of%2520neuropathic%2520pain%26jtitle%3DPain%26date%3D2006%26volume%3D126%26spage%3D102%26epage%3D114%26doi%3D10.1016%2Fj.pain.2006.06.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit37b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wotherspoon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, J.</span><span> </span><span class="NLM_article-title">Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2005.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.neuroscience.2005.06.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2005&pages=235-245&author=G.+Wotherspoonauthor=A.+Foxauthor=P.+McIntyreauthor=S.+Colleyauthor=S.+Bevanauthor=J.+Winter&title=Peripheral+nerve+injury+induces+cannabinoid+receptor+2+protein+expression+in+rat+sensory+neurons&doi=10.1016%2Fj.neuroscience.2005.06.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37b&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2005.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2005.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DWotherspoon%26aufirst%3DG.%26aulast%3DFox%26aufirst%3DA.%26aulast%3DMcIntyre%26aufirst%3DP.%26aulast%3DColley%26aufirst%3DS.%26aulast%3DBevan%26aufirst%3DS.%26aulast%3DWinter%26aufirst%3DJ.%26atitle%3DPeripheral%2520nerve%2520injury%2520induces%2520cannabinoid%2520receptor%25202%2520protein%2520expression%2520in%2520rat%2520sensory%2520neurons%26jtitle%3DNeuroscience%26date%3D2005%26volume%3D135%26spage%3D235%26epage%3D245%26doi%3D10.1016%2Fj.neuroscience.2005.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Ubogu, E. E.</span><span> </span><span class="NLM_article-title">The molecular and biophysical characterization of the human blood-nerve barrier: current concepts</span> <span class="citation_source-journal">J. Vasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span><span class="refDoi"> DOI: 10.1159/000353293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1159%2F000353293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=23839247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADC%252BC3sjptlCksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2013&pages=289-303&author=E.+E.+Ubogu&title=The+molecular+and+biophysical+characterization+of+the+human+blood-nerve+barrier%3A+current+concepts&doi=10.1159%2F000353293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular and biophysical characterization of the human blood-nerve barrier: current concepts</span></div><div class="casAuthors">Ubogu Eroboghene E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of vascular research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">289-303</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The internal microenvironment in peripheral nerves is highly regulated in order to maintain normal axonal impulse transmission to or from the central nervous system.  In humans, this regulation is facilitated by specialized tight junction (TJ)-forming endoneurial microvascular endothelial cells and perineurial myofibroblasts that form multiple concentric layers around nerve fascicles.  The endoneurial endothelial cells come in direct contact with circulating blood and, thus, can be considered the blood-nerve barrier (BNB).  Studies on the molecular and biophysical properties of the human BNB in vivo or in situ are limited.  Owing to the recent isolation of primary human endoneurial endothelial cells and the development of simian virus 40 large T-antigen immortalized cell lines, data are emerging on the structural and functional characteristics of these cells.  These data aim to increase our understanding of how solutes, macromolecules, nutrients and hematogenous leukocytes gain access into or are restricted from the endoneurium of peripheral nerves.  These concepts have clinical relevance in understanding normal peripheral nerve homeostasis, the response of peripheral nerves to external insult and stresses such as drugs and toxins and the pathogenesis of peripheral neuropathies.  This review discusses current knowledge in this nascent and exciting field of microvascular biology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTQ7Kub-o5M2BBrI9DTGjC0fW6udTcc2eZB2-358Pp9xLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjptlCksA%253D%253D&md5=df91b7d7e2a2d701b34d758d828ccd6d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1159%2F000353293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000353293%26sid%3Dliteratum%253Aachs%26aulast%3DUbogu%26aufirst%3DE.%2BE.%26atitle%3DThe%2520molecular%2520and%2520biophysical%2520characterization%2520of%2520the%2520human%2520blood-nerve%2520barrier%253A%2520current%2520concepts%26jtitle%3DJ.%2520Vasc.%2520Res.%26date%3D2013%26volume%3D50%26spage%3D289%26epage%3D303%26doi%3D10.1159%2F000353293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ragavendran, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laferriere, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padi, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coderre, T. J.</span><span> </span><span class="NLM_article-title">Topical combinations aimed at treating microvascular dysfunction reduce allodynia in rat models of CRPS-I and neuropathic pain</span> <span class="citation_source-journal">J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span><span class="refDoi"> DOI: 10.1016/j.jpain.2012.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.jpain.2012.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=23273834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsV2rtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=66-78&author=J.+V.+Ragavendranauthor=A.+Laferriereauthor=W.+H.+Xiaoauthor=G.+J.+Bennettauthor=S.+S.+Padiauthor=J.+Zhangauthor=T.+J.+Coderre&title=Topical+combinations+aimed+at+treating+microvascular+dysfunction+reduce+allodynia+in+rat+models+of+CRPS-I+and+neuropathic+pain&doi=10.1016%2Fj.jpain.2012.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39aR"><div class="casContent"><span class="casTitleNuber">39a</span><div class="casTitle"><span class="NLM_cas:atitle">Topical Combinations Aimed at Treating Microvascular Dysfunction Reduce Allodynia in Rat Models of CRPS-I and Neuropathic Pain</span></div><div class="casAuthors">Ragavendran, J. Vaigunda; Laferriere, Andre; Xiao, Wen Hua; Bennett, Gary J.; Padi, Satyanarayana S. V.; Zhang, Ji; Coderre, Terence J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-78</span>CODEN:
                <span class="NLM_cas:coden">JPOAB5</span>;
        ISSN:<span class="NLM_cas:issn">1526-5900</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Growing evidence indicates that various chronic pain syndromes exhibit tissue abnormalities caused by microvasculature dysfunction in the blood vessels of skin, muscle, or nerve.  We tested whether topical combinations aimed at improving microvascular function would relieve allodynia in animal models of complex regional pain syndrome type I (CRPS-I) and neuropathic pain.  We hypothesized that topical administration of either α2-adrenergic (α2A) receptor agonists or nitric oxide (NO) donors combined with either phosphodiesterase (PDE) or phosphatidic acid (PA) inhibitors would effectively reduce allodynia in these animal models of chronic pain.  Single topical agents produced significant dose-dependent antiallodynic effects in rats with chronic postischemia pain, and the antiallodynic dose-response curves of PDE and PA inhibitors were shifted 2.5- to 10-fold leftward when combined with nonanalgesic doses of α2A receptor agonists or NO donors.  Topical combinations also produced significant antiallodynic effects in rats with sciatic nerve injury, painful diabetic neuropathy, and chemotherapy-induced painful neuropathy.  These effects were shown to be produced by a local action, lasted up to 6 h after acute treatment, and did not produce tolerance over 15 days of chronic daily dosing.  The present results support the hypothesis that allodynia in animal models of CRPS-I and neuropathic pain is effectively relieved by topical combinations of α2A or NO donors with PDE or PA inhibitors.  This suggests that topical treatments aimed at improving microvascular function may reduce allodynia in patients with CRPS-I and neuropathic pain.  Perspective: This article presents the synergistic antiallodynic effects of combinations of α2A or NO donors with PDE or PA inhibitors in animal models of CRPS-I and neuropathic pain.  The data suggest that effective clin. treatment of chronic neuropathic pain may be achieved by therapies that alleviate microvascular dysfunction in affected areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomjnXhMksRx7Vg90H21EOLACvtfcHk0ljGIa5W42ztXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsV2rtQ%253D%253D&md5=5ad26dfce9f14f9907d2a88bae57ec57</span></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2012.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2012.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DRagavendran%26aufirst%3DJ.%2BV.%26aulast%3DLaferriere%26aufirst%3DA.%26aulast%3DXiao%26aufirst%3DW.%2BH.%26aulast%3DBennett%26aufirst%3DG.%2BJ.%26aulast%3DPadi%26aufirst%3DS.%2BS.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DCoderre%26aufirst%3DT.%2BJ.%26atitle%3DTopical%2520combinations%2520aimed%2520at%2520treating%2520microvascular%2520dysfunction%2520reduce%2520allodynia%2520in%2520rat%2520models%2520of%2520CRPS-I%2520and%2520neuropathic%2520pain%26jtitle%3DJ.%2520Pain%26date%3D2013%26volume%3D14%26spage%3D66%26epage%3D78%26doi%3D10.1016%2Fj.jpain.2012.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit39b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Greathouse, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palladino, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helton, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubogu, E. E.</span><span> </span><span class="NLM_article-title">Modeling leukocyte trafficking at the human blood-nerve barrier in vitro and in vivo geared towards targeted molecular therapies for peripheral neuroinflammation</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="refDoi"> DOI: 10.1186/s12974-015-0469-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1186%2Fs12974-015-0469-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=26732309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADC%252BC28rnsVymtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=3&author=K.+M.+Greathouseauthor=S.+P.+Palladinoauthor=C.+Dongauthor=E.+S.+Heltonauthor=E.+E.+Ubogu&title=Modeling+leukocyte+trafficking+at+the+human+blood-nerve+barrier+in+vitro+and+in+vivo+geared+towards+targeted+molecular+therapies+for+peripheral+neuroinflammation&doi=10.1186%2Fs12974-015-0469-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39bR"><div class="casContent"><span class="casTitleNuber">39b</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling leukocyte trafficking at the human blood-nerve barrier in vitro and in vivo geared towards targeted molecular therapies for peripheral neuroinflammation</span></div><div class="casAuthors">Greathouse Kelsey M; Palladino Steven P; Dong Chaoling; Helton Eric S; Ubogu Eroboghene E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroinflammation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Peripheral neuroinflammation is characterized by hematogenous mononuclear leukocyte infiltration into peripheral nerves.  Despite significant clinical knowledge, advancements in molecular biology and progress in developing specific drugs for inflammatory disorders such as rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis, there are currently no specific therapies that modulate pathogenic peripheral nerve inflammation.  Modeling leukocyte trafficking at the blood-nerve barrier using a reliable human in vitro model and potential intravital microscopy techniques in representative animal models guided by human observational data should facilitate the targeted modulation of the complex inflammatory cascade needed to develop safe and efficacious therapeutics for immune-mediated neuropathies and chronic neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS24DWjL7i85mhHGZei4OW9fW6udTcc2ebGRSYJUMAserntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rnsVymtg%253D%253D&md5=67043be4c1760d51124024d7a9400c3c</span></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.1186%2Fs12974-015-0469-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12974-015-0469-3%26sid%3Dliteratum%253Aachs%26aulast%3DGreathouse%26aufirst%3DK.%2BM.%26aulast%3DPalladino%26aufirst%3DS.%2BP.%26aulast%3DDong%26aufirst%3DC.%26aulast%3DHelton%26aufirst%3DE.%2BS.%26aulast%3DUbogu%26aufirst%3DE.%2BE.%26atitle%3DModeling%2520leukocyte%2520trafficking%2520at%2520the%2520human%2520blood-nerve%2520barrier%2520in%2520vitro%2520and%2520in%2520vivo%2520geared%2520towards%2520targeted%2520molecular%2520therapies%2520for%2520peripheral%2520neuroinflammation%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2016%26volume%3D13%26spage%3D3%26doi%3D10.1186%2Fs12974-015-0469-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit39c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kanda, T.</span><span> </span><span class="NLM_article-title">Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies</span> <span class="citation_source-journal">J. Neurol., Neurosurg. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span><span class="refDoi"> DOI: 10.1136/jnnp-2012-302312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1136%2Fjnnp-2012-302312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=23243216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADC%252BC3s3it12ltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=208-212&author=T.+Kanda&title=Biology+of+the+blood-nerve+barrier+and+its+alteration+in+immune+mediated+neuropathies&doi=10.1136%2Fjnnp-2012-302312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39cR"><div class="casContent"><span class="casTitleNuber">39c</span><div class="casTitle"><span class="NLM_cas:atitle">Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies</span></div><div class="casAuthors">Kanda Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">208-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The blood-nerve barrier (BNB) is a dynamic and competent interface between the endoneurial microenvironment and the surrounding extracellular space or blood.  It is localised at the innermost layer of the multilayered ensheathing perineurium and endoneurial microvessels, and is the key structure that controls the internal milieu of the peripheral nerve parenchyma.  Since the endoneurial BNB is the point of entry for pathogenic T cells and various soluble factors, including cytokines, chemokines and immunoglobulins, understanding this structure is important to prevent and treat human immune mediated neuropathies such as Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy, POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes) syndrome and a subset of diabetic neuropathy.  However, compared with the blood-brain barrier, only limited knowledge has been accumulated regarding the function, cell biology and clinical significance of the BNB.  This review describes the basic structure and functions of the endoneurial BNB, provides an update of the biology of the cells comprising the BNB, and highlights the pathology and pathomechanisms of BNB breakdown in immune mediated neuropathies.  The human immortalised cell lines of BNB origin established in our laboratory will facilitate the future development of BNB research.  Potential therapeutic strategies for immune mediated neuropathies manipulating the BNB are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIECvdOWcgRBWfpMXQLRstfW6udTcc2ebGRSYJUMAserntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3it12ltg%253D%253D&md5=9581941bfe64e83d26181eb0aa347c86</span></div><a href="/servlet/linkout?suffix=cit39c&amp;dbid=16384&amp;doi=10.1136%2Fjnnp-2012-302312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp-2012-302312%26sid%3Dliteratum%253Aachs%26aulast%3DKanda%26aufirst%3DT.%26atitle%3DBiology%2520of%2520the%2520blood-nerve%2520barrier%2520and%2520its%2520alteration%2520in%2520immune%2520mediated%2520neuropathies%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D2013%26volume%3D84%26spage%3D208%26epage%3D212%26doi%3D10.1136%2Fjnnp-2012-302312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit39d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lim, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luheshi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivest, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span> </span><span class="NLM_article-title">Blood-nerve barrier dysfunction contributes to the generation of neuropathic pain and allows targeting of injured nerves for pain relief</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">954</span><span class="NLM_x">–</span> <span class="NLM_lpage">967</span><span class="refDoi"> DOI: 10.1016/j.pain.2014.01.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.pain.2014.01.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2014&pages=954-967&author=T.+K.+Limauthor=X.+Q.+Shiauthor=H.+C.+Martinauthor=H.+Huangauthor=G.+Luheshiauthor=S.+Rivestauthor=J.+Zhang&title=Blood-nerve+barrier+dysfunction+contributes+to+the+generation+of+neuropathic+pain+and+allows+targeting+of+injured+nerves+for+pain+relief&doi=10.1016%2Fj.pain.2014.01.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39d&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2014.01.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2014.01.026%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DT.%2BK.%26aulast%3DShi%26aufirst%3DX.%2BQ.%26aulast%3DMartin%26aufirst%3DH.%2BC.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLuheshi%26aufirst%3DG.%26aulast%3DRivest%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DBlood-nerve%2520barrier%2520dysfunction%2520contributes%2520to%2520the%2520generation%2520of%2520neuropathic%2520pain%2520and%2520allows%2520targeting%2520of%2520injured%2520nerves%2520for%2520pain%2520relief%26jtitle%3DPain%26date%3D2014%26volume%3D155%26spage%3D954%26epage%3D967%26doi%3D10.1016%2Fj.pain.2014.01.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit39e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Ubogu, E. E.</span><span> </span><span class="NLM_article-title">Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span><span class="refDoi"> DOI: 10.1007/s00401-015-1466-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1007%2Fs00401-015-1466-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=26264608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlOhtLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2015&pages=445-468&author=E.+E.+Ubogu&title=Inflammatory+neuropathies%3A+pathology%2C+molecular+markers+and+targets+for+specific+therapeutic+intervention&doi=10.1007%2Fs00401-015-1466-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39eR"><div class="casContent"><span class="casTitleNuber">39e</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention</span></div><div class="casAuthors">Ubogu, Eroboghene E.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">445-468</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Inflammatory neuropathies encompass groups of heterogeneous disorders characterized by pathogenic immune-mediated hematogenous leukocyte infiltration of peripheral nerves, nerve roots or both, with resultant demyelination or axonal degeneration or both.  Inflammatory neuropathies may be divided into three major disease categories: Guillain-Barre´ syndrome (particularly the acute inflammatory demyelinating polyradiculoneuropathy variant), chronic inflammatory demyelinating polyradiculoneuropathy and nonsystemic vasculitic neuropathy (or peripheral nerve vasculitis).  Despite major advances in mol. biol., pathol. and genetics, the pathogenesis of these disorders remains elusive.  There is insufficient knowledge on the mechanisms of hematogenous leukocyte trafficking into the peripheral nervous system to guide the development of specific mol. therapies for immune-mediated inflammatory neuropathies compared to disorders such as psoriasis, inflammatory bowel disease, rheumatoid arthritis or multiple sclerosis.  The recent isolation and characterization of human endoneurial endothelial cells that form the blood-nerve barrier provides an opportunity to elucidate leukocyte-endothelial cell interactions crit. to the pathogenesis of inflammatory neuropathies at the interface between the systemic circulation and peripheral nerve endoneurium.  This review discusses our current knowledge of the classic pathol. features of inflammatory neuropathies, attempts at mol. classification and genetic determinants, the utilization of in vitro and in vivo animal models to det. pathogenic mechanisms at the interface between the systemic circulation and the peripheral nervous system relevant to these disorders and prospects for future potential mol. pathol. biomarkers and targets for specific therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYWh9hfa_K3rVg90H21EOLACvtfcHk0lirLiCt0Zrksg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlOhtLnI&md5=a134eb4f38e1bc8b72c1a8b5f76c77d3</span></div><a href="/servlet/linkout?suffix=cit39e&amp;dbid=16384&amp;doi=10.1007%2Fs00401-015-1466-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-015-1466-4%26sid%3Dliteratum%253Aachs%26aulast%3DUbogu%26aufirst%3DE.%2BE.%26atitle%3DInflammatory%2520neuropathies%253A%2520pathology%252C%2520molecular%2520markers%2520and%2520targets%2520for%2520specific%2520therapeutic%2520intervention%26jtitle%3DActa%2520Neuropathol.%26date%3D2015%26volume%3D130%26spage%3D445%26epage%3D468%26doi%3D10.1007%2Fs00401-015-1466-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Martin, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basbaum, A. I.</span><span> </span><span class="NLM_article-title">Spinal cannabinoids are anti-allodynic in rats with persistent inflammation</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span><span class="refDoi"> DOI: 10.1016/S0304-3959(99)00045-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2FS0304-3959%2899%2900045-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1999&pages=199-205&author=W.+J.+Martinauthor=C.+M.+Looauthor=A.+I.+Basbaum&title=Spinal+cannabinoids+are+anti-allodynic+in+rats+with+persistent+inflammation&doi=10.1016%2FS0304-3959%2899%2900045-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2FS0304-3959%2899%2900045-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3959%252899%252900045-7%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DW.%2BJ.%26aulast%3DLoo%26aufirst%3DC.%2BM.%26aulast%3DBasbaum%26aufirst%3DA.%2BI.%26atitle%3DSpinal%2520cannabinoids%2520are%2520anti-allodynic%2520in%2520rats%2520with%2520persistent%2520inflammation%26jtitle%3DPain%26date%3D1999%26volume%3D82%26spage%3D199%26epage%3D205%26doi%3D10.1016%2FS0304-3959%2899%2900045-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Potenzieri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harding-Rose, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simone, D. A.</span><span> </span><span class="NLM_article-title">The cannabinoid receptor agonist, WIN 55, 212–2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1215</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span><span class="refDoi"> DOI: 10.1016/j.brainres.2008.03.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.brainres.2008.03.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=18486111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvVOjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1215&publication_year=2008&pages=69-75&author=C.+Potenzieriauthor=C.+Harding-Roseauthor=D.+A.+Simone&title=The+cannabinoid+receptor+agonist%2C+WIN+55%2C+212%E2%80%932%2C+attenuates+tumor-evoked+hyperalgesia+through+peripheral+mechanisms&doi=10.1016%2Fj.brainres.2008.03.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The cannabinoid receptor agonist, WIN 55,212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms</span></div><div class="casAuthors">Potenzieri, Carl; Harding-Rose, Catherine; Simone, Donald A.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1215</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">69-75</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Several lines of evidence suggest that cannabinoids can attenuate various types of pain and hyperalgesia through peripheral mechanisms.  The development of rodent cancer pain models has provided the opportunity to investigate novel approaches to treat this common form of pain.  In the present study, we examd. the ability of peripherally administered cannabinoids to attenuate tumor-evoked mech. hyperalgesia in a murine model of cancer pain.  Unilateral injection of osteolytic fibrosarcoma cells into and around the calcaneus bone resulted in tumor formation and mech. hyperalgesia in the injected hindpaw.  Mech. hyperalgesia was defined as an increase in the frequency of paw withdrawals to a suprathreshold von Frey filament (3.4 mN) applied to the plantar surface of the hindpaw.  WIN 55,212-2 (1.5 to 10 μg) injected s.c. into the tumor-bearing hindpaw produced a dose-dependent decrease in paw withdrawal frequencies to suprathreshold von Frey filament stimulation.  Injection of WIN 55,212-2 (10 μg) into the contralateral hindpaw did not decrease paw withdrawal frequencies in the tumor-bearing hindpaw.  Injection of the highest antihyperalgesic dose of WIN 55,212-2 (10 μg) did not produce catalepsy as detd. by the bar test.  Co-administration of WIN 55,212-2 with either cannabinoid 1 (AM251) or cannabinoid 2 (AM630) receptor antagonists attenuated the antihyperalgesic effects of WIN 55, 212-2.  In conclusion, peripherally administered WIN 55,212-2 attenuated tumor-evoked mech. hyperalgesia by activation of both peripheral cannabinoid 1 and cannabinoid 2 receptors.  These results suggest that peripherally-administered cannabinoids may be effective in attenuating cancer pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp87ppQUQVu1bVg90H21EOLACvtfcHk0lgN-EQGGyuebw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvVOjsLY%253D&md5=d145fd4fdab6e2cf996904e8bbdbec1f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2008.03.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2008.03.063%26sid%3Dliteratum%253Aachs%26aulast%3DPotenzieri%26aufirst%3DC.%26aulast%3DHarding-Rose%26aufirst%3DC.%26aulast%3DSimone%26aufirst%3DD.%2BA.%26atitle%3DThe%2520cannabinoid%2520receptor%2520agonist%252C%2520WIN%252055%252C%2520212%25E2%2580%25932%252C%2520attenuates%2520tumor-evoked%2520hyperalgesia%2520through%2520peripheral%2520mechanisms%26jtitle%3DBrain%2520Res.%26date%3D2008%26volume%3D1215%26spage%3D69%26epage%3D75%26doi%3D10.1016%2Fj.brainres.2008.03.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Melvin, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbert, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milne, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, A.</span><span> </span><span class="NLM_article-title">A cannabinoid derived prototypical analgesic</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span><span class="refDoi"> DOI: 10.1021/jm00367a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00367a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADyaL2cXit1eksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1984&pages=67-71&author=L.+S.+Melvinauthor=M.+R.+Johnsonauthor=C.+A.+Harbertauthor=G.+M.+Milneauthor=A.+Weissman&title=A+cannabinoid+derived+prototypical+analgesic&doi=10.1021%2Fjm00367a013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">A cannabinoid derived prototypical analgesic</span></div><div class="casAuthors">Melvin, Lawrence S.; Johnson, M. Ross; Harbert, Charles A.; Milne, George M.; Weissman, Albert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-71</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The synthesis and analgesic testing of 3-[4-(1,1-dimethylheptyl)-2-hydroxyphenyl]cyclohexanol (I) are described.  I was prepd. in 9 steps from [3-(benzyloxy)phenyl]acetonitrile.  Biol. testing in five models of pain shows that I and morphine are equally potent as analgesics and demonstrates that the pyran ring of 9-nor-9β-hydroxyhexahydrocannabinol is not necessary for biol. activity.  Further simplification of I was pursued by the synthesis of 4-[4-(1,1-dimethylheptyl)-2-hydroxyphenyl]-2-pentanol, but this deriv. exhibits significantly reduced analgesic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlhm9E7nbBmbVg90H21EOLACvtfcHk0lgN-EQGGyuebw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXit1eksw%253D%253D&md5=354ca5cc32ee5f395b0ab415aacd2907</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm00367a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00367a013%26sid%3Dliteratum%253Aachs%26aulast%3DMelvin%26aufirst%3DL.%2BS.%26aulast%3DJohnson%26aufirst%3DM.%2BR.%26aulast%3DHarbert%26aufirst%3DC.%2BA.%26aulast%3DMilne%26aufirst%3DG.%2BM.%26aulast%3DWeissman%26aufirst%3DA.%26atitle%3DA%2520cannabinoid%2520derived%2520prototypical%2520analgesic%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1984%26volume%3D27%26spage%3D67%26epage%3D71%26doi%3D10.1021%2Fjm00367a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Fulp, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortoff, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seltzman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maitra, R.</span><span> </span><span class="NLM_article-title">Towards rational design of cannabinoid receptor 1 (CB1) antagonists for peripheral selectivity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5711</span><span class="NLM_x">–</span> <span class="NLM_lpage">5714</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.08.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.bmcl.2011.08.032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5711-5714&author=A.+Fulpauthor=K.+Bortoffauthor=Y.+Zhangauthor=H.+Seltzmanauthor=R.+Snyderauthor=R.+Maitra&title=Towards+rational+design+of+cannabinoid+receptor+1+%28CB1%29+antagonists+for+peripheral+selectivity&doi=10.1016%2Fj.bmcl.2011.08.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.08.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.08.032%26sid%3Dliteratum%253Aachs%26aulast%3DFulp%26aufirst%3DA.%26aulast%3DBortoff%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSeltzman%26aufirst%3DH.%26aulast%3DSnyder%26aufirst%3DR.%26aulast%3DMaitra%26aufirst%3DR.%26atitle%3DTowards%2520rational%2520design%2520of%2520cannabinoid%2520receptor%25201%2520%2528CB1%2529%2520antagonists%2520for%2520peripheral%2520selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D5711%26epage%3D5714%26doi%3D10.1016%2Fj.bmcl.2011.08.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Matsuka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitrirattanakul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omoto, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, N. Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spigelman, I.</span><span> </span><span class="NLM_article-title">Altered ATP release and metabolism in dorsal root ganglia of neuropathic rats</span> <span class="citation_source-journal">Mol. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="refDoi"> DOI: 10.1186/1744-8069-4-66</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1186%2F1744-8069-4-66" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=19108746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FpslGqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=66&author=Y.+Matsukaauthor=T.+Onoauthor=H.+Iwaseauthor=S.+Mitrirattanakulauthor=K.+S.+Omotoauthor=T.+Choauthor=N.+Y.+Y.+Lamauthor=B.+Snyderauthor=I.+Spigelman&title=Altered+ATP+release+and+metabolism+in+dorsal+root+ganglia+of+neuropathic+rats&doi=10.1186%2F1744-8069-4-66"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Altered ATP release and metabolism in dorsal root ganglia of neuropathic rats</span></div><div class="casAuthors">Matsuka Yoshizo; Ono Takeshi; Iwase Hirotate; Mitrirattanakul Somsak; Omoto Kevin S; Cho Ting; Lam Yan Yan N; Snyder Bradley; Spigelman Igor</div><div class="citationInfo"><span class="NLM_cas:title">Molecular pain</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Adenosine 5'-triphosphate (ATP) has a ubiquitous role in metabolism and a major role in pain responses after tissue injury.  We investigated the changes in basal and KCl-evoked ATP release from rat dorsal root ganglia (DRG) after peripheral neuropathy induction by unilateral sciatic nerve entrapment (SNE).  RESULTS:  After SNE, rats develop long-lasting decreases in ipsilateral hindpaw withdrawal thresholds to mechanical and thermal stimulation.  At 15-21 days after neuropathy induction, excised ipsilateral L4-L5 DRG display significantly elevated basal extracellular ATP levels compared to contralateral or control (naive) DRG.  However, KCl-evoked ATP release is no longer observed in ipsilateral DRG.  We hypothesized that the differential SNE effects on basal and evoked ATP release could result from the conversion of extracellular ATP to adenosine with subsequent activation of adenosine A1 receptors (A1Rs) on DRG neurons.  Adding the selective A1R agonist, 2-chloro-N(6)-cyclopentyladenosine (100 nM) significantly decreased basal and evoked ATP release in DRG from naive rats, indicating functional A1R activation.  In DRG ipsilateral to SNE, adding a selective A1R antagonist, 8-cyclopentyl-1,3-dipropylxanthine (30 nM), further increased basal ATP levels and relieved the blockade of KCl-evoked ATP release suggesting that increased A1R activation attenuates evoked ATP release in neurons ipsilateral to SNE.  To determine if altered ATP release was a consequence of altered DRG metabolism we compared O(2) consumption between control and neuropathic DRG.  DRG ipsilateral to SNE consumed O(2) at a higher rate than control or contralateral DRG.  CONCLUSION:  These data suggest that peripheral nerve entrapment increases DRG metabolism and ATP release, which in turn is modulated by increased A1R activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSOFh2J7Fa4m7JzI8owOhpDfW6udTcc2eatMQNbPj5lZ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FpslGqsQ%253D%253D&md5=a55454ca8db9d0c82b1b388c5f21816c</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1186%2F1744-8069-4-66&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-8069-4-66%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuka%26aufirst%3DY.%26aulast%3DOno%26aufirst%3DT.%26aulast%3DIwase%26aufirst%3DH.%26aulast%3DMitrirattanakul%26aufirst%3DS.%26aulast%3DOmoto%26aufirst%3DK.%2BS.%26aulast%3DCho%26aufirst%3DT.%26aulast%3DLam%26aufirst%3DN.%2BY.%2BY.%26aulast%3DSnyder%26aufirst%3DB.%26aulast%3DSpigelman%26aufirst%3DI.%26atitle%3DAltered%2520ATP%2520release%2520and%2520metabolism%2520in%2520dorsal%2520root%2520ganglia%2520of%2520neuropathic%2520rats%26jtitle%3DMol.%2520Pain%26date%3D2008%26volume%3D4%26spage%3D66%26doi%3D10.1186%2F1744-8069-4-66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dunham, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miya, T. S.</span><span> </span><span class="NLM_article-title">A note on a simple apparatus for detecting neurological deficit in rats and mice</span> <span class="citation_source-journal">J. Am. Pharm. Assoc., Sci. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span><span class="refDoi"> DOI: 10.1002/jps.3030460322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1002%2Fjps.3030460322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADyaG1c%252FksV2htw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1957&pages=208-209&author=N.+W.+Dunhamauthor=T.+S.+Miya&title=A+note+on+a+simple+apparatus+for+detecting+neurological+deficit+in+rats+and+mice&doi=10.1002%2Fjps.3030460322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45aR"><div class="casContent"><span class="casTitleNuber">45a</span><div class="casTitle"><span class="NLM_cas:atitle">A note on a simple apparatus for detecting neurological deficit in rats and mice</span></div><div class="casAuthors">DUNHAM N W; MIYA T S</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Pharmaceutical Association. American Pharmaceutical Association</span>
        (<span class="NLM_cas:date">1957</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">208-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-u0xB6bg24z0SWnHPWbmmfW6udTcc2eatMQNbPj5lZ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG1c%252FksV2htw%253D%253D&md5=06ea7b35b8b0ac2361f7696ab43adb75</span></div><a href="/servlet/linkout?suffix=cit45a&amp;dbid=16384&amp;doi=10.1002%2Fjps.3030460322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.3030460322%26sid%3Dliteratum%253Aachs%26aulast%3DDunham%26aufirst%3DN.%2BW.%26aulast%3DMiya%26aufirst%3DT.%2BS.%26atitle%3DA%2520note%2520on%2520a%2520simple%2520apparatus%2520for%2520detecting%2520neurological%2520deficit%2520in%2520rats%2520and%2520mice%26jtitle%3DJ.%2520Am.%2520Pharm.%2520Assoc.%252C%2520Sci.%2520Ed.%26date%3D1957%26volume%3D46%26spage%3D208%26epage%3D209%26doi%3D10.1002%2Fjps.3030460322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit45b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pryor, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenzie, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braude, M. C.</span><span> </span><span class="NLM_article-title">Interactions between Δ9-tetrahydrocannabinol and phencyclidine hydrochloride in rats</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span><span class="refDoi"> DOI: 10.1016/0091-3057(77)90168-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2F0091-3057%2877%2990168-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1977&pages=123-136&author=G.+T.+Pryorauthor=S.+Husainauthor=F.+Larsenauthor=C.+E.+McKenzieauthor=J.+D.+Carrauthor=M.+C.+Braude&title=Interactions+between+%CE%949-tetrahydrocannabinol+and+phencyclidine+hydrochloride+in+rats&doi=10.1016%2F0091-3057%2877%2990168-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45b&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2877%2990168-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252877%252990168-X%26sid%3Dliteratum%253Aachs%26aulast%3DPryor%26aufirst%3DG.%2BT.%26aulast%3DHusain%26aufirst%3DS.%26aulast%3DLarsen%26aufirst%3DF.%26aulast%3DMcKenzie%26aufirst%3DC.%2BE.%26aulast%3DCarr%26aufirst%3DJ.%2BD.%26aulast%3DBraude%26aufirst%3DM.%2BC.%26atitle%3DInteractions%2520between%2520%25CE%25949-tetrahydrocannabinol%2520and%2520phencyclidine%2520hydrochloride%2520in%2520rats%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1977%26volume%3D6%26spage%3D123%26epage%3D136%26doi%3D10.1016%2F0091-3057%2877%2990168-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Pertwee, R. G.</span><span> </span><span class="NLM_article-title">The ring test: a quantitative method for assessing the ’cataleptic’ effect of cannabis in mice</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.1972.tb06900.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1111%2Fj.1476-5381.1972.tb06900.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=4655271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADyaE3sXms1Oltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1972&pages=753-763&author=R.+G.+Pertwee&title=The+ring+test%3A+a+quantitative+method+for+assessing+the+%E2%80%99cataleptic%E2%80%99+effect+of+cannabis+in+mice&doi=10.1111%2Fj.1476-5381.1972.tb06900.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Ring test.  Quantitative method for assessing the cataleptic effect of cannabis in mice</span></div><div class="casAuthors">Pertwee, R. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">753-63</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">The length of time a mouse remained completely immobile when placed in a prone position across a horizontally suspended wire ring 5.5 cm in diam. could be used to assess the cataleptic effect of cannabis.  The effect of cannabis on motility was a dose-related, graded response.  Threshold doses of cannabis ext. were 12.5 mg per kg when injected i.v. and 100 mg per kg when injected i.p. or s.c.  Characteristic changes in behavior on the ring induced by cannabis ext. were also produced by chlorpromazine-HCl, but not by Na barbitone.  Δ1-Tetrahydrocannabinol (THC) [1972-08-3] was largely responsible for the effect of cannabis ext. on motility; the potency ratio of THC to cannabis ext. was between 10 and 20.  Δ1-Tetrahydrocannabidivarol [31262-37-0] also affected mobility but was less active than THC.  Cannabidiol [13956-29-1] had no effect, even at doses up to 100 mg per kg, i.p.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2Lm_ZL8Wp5rVg90H21EOLACvtfcHk0li7YzsuRZ7WAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXms1Oltg%253D%253D&md5=e3ed3a63360b54de7f394e1afb399328</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1972.tb06900.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1972.tb06900.x%26sid%3Dliteratum%253Aachs%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26atitle%3DThe%2520ring%2520test%253A%2520a%2520quantitative%2520method%2520for%2520assessing%2520the%2520%25E2%2580%2599cataleptic%25E2%2580%2599%2520effect%2520of%2520cannabis%2520in%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1972%26volume%3D46%26spage%3D753%26epage%3D763%26doi%3D10.1111%2Fj.1476-5381.1972.tb06900.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Pegg, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroink, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kattner, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. X.</span><span> </span><span class="NLM_article-title">Technique for collection of cerebrospinal fluid from the cisterna magna in rat</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">187</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1016/j.jneumeth.2009.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.jneumeth.2009.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=20005255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADC%252BC3c7jtVekuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2010&pages=8-12&author=C.+C.+Peggauthor=C.+Heauthor=A.+R.+Stroinkauthor=K.+A.+Kattnerauthor=C.+X.+Wang&title=Technique+for+collection+of+cerebrospinal+fluid+from+the+cisterna+magna+in+rat&doi=10.1016%2Fj.jneumeth.2009.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Technique for collection of cerebrospinal fluid from the cisterna magna in rat</span></div><div class="casAuthors">Pegg Christina C; He Chunyan; Stroink Ann R; Kattner Keith A; Wang Chen Xu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroscience methods</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cerebrospinal fluid (CSF) is in direct contact with the extracellular space in the central nervous system (CNS), and biological changes in the brain can be reflected in CSF.  In the present article, a procedure for collection of CSF in rats is described.  The technique quickly and reliably yields large quantities of CSF (50-150 microl) in rats.  More importantly, blood contamination of the CSF is avoided.  Furthermore, detections of ATP and interleukin (IL)-1 beta in the CSF have been carried out.  ATP concentration in the CSF samples was between 8.3 and 15.8 nM, with an average of 10.5+/-0.83 nM (mean+/-SEM).  The concentrations of IL-1beta were below the detection limit in the CSF in the laminectomy control rats, but it increased to 0.26+/-0.07 ng/ml at 1h after spinal cord injury.  This technique offers an alternative method to surgical cannulation for the collection of CSF in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSoyBovJP6UDWLFM_lbR1VmfW6udTcc2ebvPAZNg1JHrrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7jtVekuw%253D%253D&md5=359298768c5e282ae8ec2acb7d6eb1d2</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.jneumeth.2009.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneumeth.2009.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DPegg%26aufirst%3DC.%2BC.%26aulast%3DHe%26aufirst%3DC.%26aulast%3DStroink%26aufirst%3DA.%2BR.%26aulast%3DKattner%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DC.%2BX.%26atitle%3DTechnique%2520for%2520collection%2520of%2520cerebrospinal%2520fluid%2520from%2520the%2520cisterna%2520magna%2520in%2520rat%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D2010%26volume%3D187%26spage%3D8%26epage%3D12%26doi%3D10.1016%2Fj.jneumeth.2009.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Hassler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmour, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fennell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinscheid, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Runyon, S. P.</span><span> </span><span class="NLM_article-title">Identification of neuropeptide S antagonists: structure-activity relationship studies, X-ray crystallography, and in vivo evaluation</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">731</span><span class="NLM_x">–</span> <span class="NLM_lpage">744</span><span class="refDoi"> DOI: 10.1021/cn500113c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn500113c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVentbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=731-744&author=C.+Hasslerauthor=Y.+Zhangauthor=B.+Gilmourauthor=T.+Grafauthor=T.+Fennellauthor=R.+Snyderauthor=J.+R.+Deschampsauthor=R.+K.+Reinscheidauthor=C.+Garauauthor=S.+P.+Runyon&title=Identification+of+neuropeptide+S+antagonists%3A+structure-activity+relationship+studies%2C+X-ray+crystallography%2C+and+in+vivo+evaluation&doi=10.1021%2Fcn500113c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Neuropeptide S Antagonists: Structure-Activity Relationship Studies, X-ray Crystallography, and in Vivo Evaluation</span></div><div class="casAuthors">Hassler, Carla; Zhang, Yanan; Gilmour, Brian; Graf, Tyler; Fennell, Timothy; Snyder, Rodney; Deschamps, Jeffrey R.; Reinscheid, Rainer K.; Garau, Celia; Runyon, Scott P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">731-744</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Modulation of the neuropeptide S (NPS) system has been linked to a variety of CNS disorders such as panic disorder, anxiety, sleeping disorders, asthma, obesity, PTSD, and substance abuse.  In this study, a series of diphenyltetrahydro-1H-oxazolo[3,4-α]pyrazin-3(5H)-ones were synthesized and evaluated for antagonist activity at the neuropeptide S receptor.  The abs. configuration was detd. by chiral resoln. of the key synthetic intermediate, followed by anal. of one of the individual enantiomers by X-ray crystallog.  The R isomer was then converted to a biol. active compd. (34) that had a Ke of 36 nM.  The most potent compd. displayed enhanced aq. soly. compared with the prototypical antagonist SHA-68 and demonstrated favorable pharmacokinetic properties for behavioral assessment.  In vivo anal. in mice indicated a significant blockade of NPS induced locomotor activity at an i.p. dose of 50 mg/kg.  This suggests that analogs having improved drug-like properties will facilitate more detailed studies of the neuropeptide S receptor system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxKsSXZnr3irVg90H21EOLACvtfcHk0ljdLVed4SbJVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVentbvM&md5=87610e340854924b7896019173d441fe</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fcn500113c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn500113c%26sid%3Dliteratum%253Aachs%26aulast%3DHassler%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGilmour%26aufirst%3DB.%26aulast%3DGraf%26aufirst%3DT.%26aulast%3DFennell%26aufirst%3DT.%26aulast%3DSnyder%26aufirst%3DR.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DReinscheid%26aufirst%3DR.%2BK.%26aulast%3DGarau%26aufirst%3DC.%26aulast%3DRunyon%26aufirst%3DS.%2BP.%26atitle%3DIdentification%2520of%2520neuropeptide%2520S%2520antagonists%253A%2520structure-activity%2520relationship%2520studies%252C%2520X-ray%2520crystallography%252C%2520and%2520in%2520vivo%2520evaluation%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D731%26epage%3D744%26doi%3D10.1021%2Fcn500113c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2a','cit2b','cit2c'],'ref3':['cit3a','cit3b','cit3c'],'ref4':['cit4a','cit4b'],'ref5':['cit5'],'ref6':['cit6a','cit6b','cit6c','cit6d'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10a','cit10b'],'ref11':['cit11a','cit11b','cit11c','cit11d','cit11e','cit11f','cit11g'],'ref12':['cit12a','cit12b','cit12c','cit12d','cit12e','cit12f'],'ref13':['cit13a','cit13b','cit13c','cit13d'],'ref14':['cit14'],'ref15':['cit15a','cit15b','cit15c'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21a','cit21b'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24a','cit24b','cit24c'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30a','cit30b'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33a','cit33b'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37a','cit37b'],'ref38':['cit38'],'ref39':['cit39a','cit39b','cit39c','cit39d','cit39e'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45a','cit45b'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 35 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Mingxu Cui, Xueying Guo, Herman H. Y. Sung, Ian D. Williams, Zhenyang Lin, <span class="NLM_string-name hlFld-ContribAuthor">Guochen Jia</span>. </span><span class="cited-content_cbyCitation_article-title">Halide Effects on the Stability of Osmium Indenylidene Complexes: Isolation, Characterization, and Reactivities. </span><span class="cited-content_cbyCitation_journal-name">Organometallics</span><span> <strong>2020,</strong> <em>39 </em>
                                    (11)
                                     , 2142-2151. <a href="https://doi.org/10.1021/acs.organomet.0c00214" title="DOI URL">https://doi.org/10.1021/acs.organomet.0c00214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.organomet.0c00214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.organomet.0c00214%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganometallics%26atitle%3DHalide%252BEffects%252Bon%252Bthe%252BStability%252Bof%252BOsmium%252BIndenylidene%252BComplexes%25253A%252BIsolation%25252C%252BCharacterization%25252C%252Band%252BReactivities%26aulast%3DCui%26aufirst%3DMingxu%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29032020%26date%3D15052020%26volume%3D39%26issue%3D11%26spage%3D2142%26epage%3D2151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xia Song, Bao Nguyen Do Doan, Xinying Zhang, Richmond Lee, <span class="NLM_string-name hlFld-ContribAuthor">Xuesen Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Complementary C–H Functionalization Mode of Benzoylacetonitriles: Computer-Augmented Study of a Regio- and Stereoselective Synthesis of Functionalized Benzofulvenes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (1)
                                     , 46-51. <a href="https://doi.org/10.1021/acs.orglett.9b03858" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b03858</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b03858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b03858%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DComplementary%252BC%2525E2%252580%252593H%252BFunctionalization%252BMode%252Bof%252BBenzoylacetonitriles%25253A%252BComputer-Augmented%252BStudy%252Bof%252Ba%252BRegio-%252Band%252BStereoselective%252BSynthesis%252Bof%252BFunctionalized%252BBenzofulvenes%26aulast%3DSong%26aufirst%3DXia%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D29102019%26date%3D23122019%26volume%3D22%26issue%3D1%26spage%3D46%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matthias Scheiner, Dominik Dolles, Sandra Gunesch, Matthias Hoffmann, Massimo Nabissi, Oliviero Marinelli, Marina Naldi, Manuela Bartolini, Sabrina Petralla, Eleonora Poeta, Barbara Monti, Christina Falkeis, Michael Vieth, Harald Hübner, Peter Gmeiner, Rangan Maitra, Tangui Maurice, <span class="NLM_string-name hlFld-ContribAuthor">Michael Decker</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-Acting Cholinesterase–Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (20)
                                     , 9078-9102. <a href="https://doi.org/10.1021/acs.jmedchem.9b00623" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00623</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00623%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual-Acting%252BCholinesterase%2525E2%252580%252593Human%252BCannabinoid%252BReceptor%252B2%252BLigands%252BShow%252BPronounced%252BNeuroprotection%252Bin%252BVitro%252Band%252BOveradditive%252Band%252BDisease-Modifying%252BNeuroprotective%252BEffects%252Bin%252BVivo%26aulast%3DScheiner%26aufirst%3DMatthias%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D30042019%26date%3D14102019%26volume%3D62%26issue%3D20%26spage%3D9078%26epage%3D9102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jeyun Jo, Myeonggyo Jeong, Ji-Su Ahn, Jinia Akter, Hyung-Sik Kim, Young-Ger Suh, <span class="NLM_string-name hlFld-ContribAuthor">Hwayoung Yun</span>. </span><span class="cited-content_cbyCitation_article-title">Total Synthesis of Anmindenol A and Its Application to the Design, Synthesis, and Biological Evaluation of Derivatives Thereof. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (17)
                                     , 10953-10961. <a href="https://doi.org/10.1021/acs.joc.9b01564" title="DOI URL">https://doi.org/10.1021/acs.joc.9b01564</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b01564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b01564%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTotal%252BSynthesis%252Bof%252BAnmindenol%252BA%252Band%252BIts%252BApplication%252Bto%252Bthe%252BDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BDerivatives%252BThereof%26aulast%3DJo%26aufirst%3DJeyun%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D12062019%26date%3D12082019%26date%3D30072019%26volume%3D84%26issue%3D17%26spage%3D10953%26epage%3D10961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Óscar Díaz, James A. R. Dalton, <span class="NLM_string-name hlFld-ContribAuthor">Jesús Giraldo</span>. </span><span class="cited-content_cbyCitation_article-title">Revealing the Mechanism of Agonist-Mediated Cannabinoid Receptor 1 (CB1) Activation and Phospholipid-Mediated Allosteric Modulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (11)
                                     , 5638-5654. <a href="https://doi.org/10.1021/acs.jmedchem.9b00612" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00612</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00612%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRevealing%252Bthe%252BMechanism%252Bof%252BAgonist-Mediated%252BCannabinoid%252BReceptor%252B1%252B%252528CB1%252529%252BActivation%252Band%252BPhospholipid-Mediated%252BAllosteric%252BModulation%26aulast%3DD%25C3%25ADaz%26aufirst%3D%25C3%2593scar%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D09042019%26date%3D29052019%26date%3D16052019%26volume%3D62%26issue%3D11%26spage%3D5638%26epage%3D5654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xinfei Ji, Jialu Li, Mingsheng Wu, <span class="NLM_string-name hlFld-ContribAuthor">Song Cao</span>. </span><span class="cited-content_cbyCitation_article-title">Facile Synthesis of 3-Arylindenes by HMPA-Promoted Direct Arylation of Indenes with Aryl Fluorides. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (8)
                                     , 10099-10106. <a href="https://doi.org/10.1021/acsomega.8b01542" title="DOI URL">https://doi.org/10.1021/acsomega.8b01542</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b01542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b01542%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DFacile%252BSynthesis%252Bof%252B3-Arylindenes%252Bby%252BHMPA-Promoted%252BDirect%252BArylation%252Bof%252BIndenes%252Bwith%252BAryl%252BFluorides%26aulast%3DJi%26aufirst%3DXinfei%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D05072018%26date%3D02082018%26volume%3D3%26issue%3D8%26spage%3D10099%26epage%3D10106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raquel  Barroso</span>, <span class="hlFld-ContribAuthor ">Miguel  Paraja</span>, <span class="hlFld-ContribAuthor ">María-Paz  Cabal</span>, and <span class="hlFld-ContribAuthor ">Carlos  Valdés</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of 1,1-Disubstituted Indenes and Dihydronaphthalenes through C–C/C–C Bond-Forming Pd-Catalyzed Autotandem Reactions. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (15)
                                     , 4086-4089. <a href="https://doi.org/10.1021/acs.orglett.7b01870" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b01870</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b01870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b01870%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252B1%25252C1-Disubstituted%252BIndenes%252Band%252BDihydronaphthalenes%252Bthrough%252BC%2525E2%252580%252593C%25252FC%2525E2%252580%252593C%252BBond-Forming%252BPd-Catalyzed%252BAutotandem%252BReactions%26aulast%3DBarroso%26aufirst%3DRaquel%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D20062017%26date%3D19072017%26date%3D04082017%26volume%3D19%26issue%3D15%26spage%3D4086%26epage%3D4089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patricia  García-García</span>, <span class="hlFld-ContribAuthor ">Ana M.  Sanjuán</span>, <span class="hlFld-ContribAuthor ">Muhammad A.  Rashid</span>, <span class="hlFld-ContribAuthor ">Alberto  Martínez-Cuezva</span>, <span class="hlFld-ContribAuthor ">Manuel A.  Fernández-Rodríguez</span>, <span class="hlFld-ContribAuthor ">Félix  Rodríguez</span>, and <span class="hlFld-ContribAuthor ">Roberto  Sanz</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of Functionalized 1H-Indenes and Benzofulvenes through Iodocyclization of o-(Alkynyl)styrenes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (2)
                                     , 1155-1165. <a href="https://doi.org/10.1021/acs.joc.6b02788" title="DOI URL">https://doi.org/10.1021/acs.joc.6b02788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b02788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b02788%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BFunctionalized%252B1H-Indenes%252Band%252BBenzofulvenes%252Bthrough%252BIodocyclization%252Bof%252Bo-%252528Alkynyl%252529styrenes%26aulast%3DGarc%25C3%25ADa-Garc%25C3%25ADa%26aufirst%3DPatricia%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D21112016%26date%3D30122016%26date%3D20012017%26date%3D19122016%26volume%3D82%26issue%3D2%26spage%3D1155%26epage%3D1165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toru  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Yatendra  Mulpuri</span>, <span class="hlFld-ContribAuthor ">Mikhail  Izraylev</span>, <span class="hlFld-ContribAuthor ">Qianyi  Li</span>, <span class="hlFld-ContribAuthor ">Menooa  Simonian</span>, <span class="hlFld-ContribAuthor ">Christian  Kramme</span>, <span class="hlFld-ContribAuthor ">Brian L.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Herbert H.  Seltzman</span>, <span class="hlFld-ContribAuthor ">Igor  Spigelman</span>. </span><span class="cited-content_cbyCitation_article-title">Selective targeting of peripheral cannabinoid receptors prevents behavioral symptoms and sensitization of trigeminal neurons in mouse models of migraine and medication overuse headache. </span><span class="cited-content_cbyCitation_journal-name">Pain</span><span> <strong>2021,</strong> <em>162 </em>
                                    (8)
                                     , 2246-2262. <a href="https://doi.org/10.1097/j.pain.0000000000002214" title="DOI URL">https://doi.org/10.1097/j.pain.0000000000002214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/j.pain.0000000000002214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2Fj.pain.0000000000002214%26sid%3Dliteratum%253Aachs%26jtitle%3DPain%26atitle%3DSelective%252Btargeting%252Bof%252Bperipheral%252Bcannabinoid%252Breceptors%252Bprevents%252Bbehavioral%252Bsymptoms%252Band%252Bsensitization%252Bof%252Btrigeminal%252Bneurons%252Bin%252Bmouse%252Bmodels%252Bof%252Bmigraine%252Band%252Bmedication%252Boveruse%252Bheadache%26aulast%3DYamamoto%26aufirst%3DToru%26date%3D2021%26date%3D2021%26volume%3D162%26issue%3D8%26spage%3D2246%26epage%3D2262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Savanah L.  Saldaña-Shumaker</span>, <span class="hlFld-ContribAuthor ">Alexander J.  Grenning</span>, <span class="hlFld-ContribAuthor ">Christopher W.  Cunningham</span>. </span><span class="cited-content_cbyCitation_article-title">Modern approaches to the development of synthetic cannabinoid receptor probes. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology Biochemistry and Behavior</span><span> <strong>2021,</strong> <em>203 </em>, 173119. <a href="https://doi.org/10.1016/j.pbb.2021.173119" title="DOI URL">https://doi.org/10.1016/j.pbb.2021.173119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pbb.2021.173119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pbb.2021.173119%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520Biochemistry%2520and%2520Behavior%26atitle%3DModern%252Bapproaches%252Bto%252Bthe%252Bdevelopment%252Bof%252Bsynthetic%252Bcannabinoid%252Breceptor%252Bprobes%26aulast%3DSalda%25C3%25B1a-Shumaker%26aufirst%3DSavanah%2BL.%26date%3D2021%26volume%3D203%26spage%3D173119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fumitoshi  Yagishita</span>, <span class="hlFld-ContribAuthor ">Keita  Hoshi</span>, <span class="hlFld-ContribAuthor ">Yasushi  Yoshida</span>, <span class="hlFld-ContribAuthor ">Shoko  Ueta</span>, <span class="hlFld-ContribAuthor ">Keiji  Minagawa</span>, <span class="hlFld-ContribAuthor ">Yasushi  Imada</span>, <span class="hlFld-ContribAuthor ">Yasuhiko  Kawamura</span>. </span><span class="cited-content_cbyCitation_article-title">Facile Construction of Benzofulvene Scaffold from Tetraaryl[3]cumulene Through Electrophilic Iodocyclization. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>2021 </em>
                                    (2)
                                     , 235-238. <a href="https://doi.org/10.1002/ejoc.202001200" title="DOI URL">https://doi.org/10.1002/ejoc.202001200</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202001200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202001200%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DFacile%252BConstruction%252Bof%252BBenzofulvene%252BScaffold%252Bfrom%252BTetraaryl%25255B3%25255Dcumulene%252BThrough%252BElectrophilic%252BIodocyclization%26aulast%3DYagishita%26aufirst%3DFumitoshi%26date%3D2021%26date%3D2020%26volume%3D2021%26issue%3D2%26spage%3D235%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srinivasa N.  Raja</span>, <span class="hlFld-ContribAuthor ">Matthias  Ringkamp</span>, <span class="hlFld-ContribAuthor ">Yun  Guan</span>, <span class="hlFld-ContribAuthor ">James N.  Campbell</span>. </span><span class="cited-content_cbyCitation_article-title">John J. Bonica Award Lecture: Peripheral neuronal hyperexcitability: the “low-hanging” target for safe therapeutic strategies in neuropathic pain. </span><span class="cited-content_cbyCitation_journal-name">Pain</span><span> <strong>2020,</strong> <em>161 </em>
                                    (Supplement 1)
                                     , S14-S26. <a href="https://doi.org/10.1097/j.pain.0000000000001838" title="DOI URL">https://doi.org/10.1097/j.pain.0000000000001838</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/j.pain.0000000000001838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2Fj.pain.0000000000001838%26sid%3Dliteratum%253Aachs%26jtitle%3DPain%26atitle%3DJohn%252BJ.%252BBonica%252BAward%252BLecture%25253A%252BPeripheral%252Bneuronal%252Bhyperexcitability%25253A%252Bthe%252B%2525E2%252580%25259Clow-hanging%2525E2%252580%25259D%252Btarget%252Bfor%252Bsafe%252Btherapeutic%252Bstrategies%252Bin%252Bneuropathic%252Bpain%26aulast%3DRaja%26aufirst%3DSrinivasa%2BN.%26date%3D2020%26volume%3D161%26issue%3DSupplement%25201%26spage%3DS14%26epage%3DS26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Teddy E  Kim</span>, <span class="hlFld-ContribAuthor ">Robert K  Townsend</span>, <span class="hlFld-ContribAuthor ">Charles L  Branch</span>, <span class="hlFld-ContribAuthor ">Edgar A  Romero-Sandoval</span>, <span class="hlFld-ContribAuthor ">Wesley  Hsu</span>. </span><span class="cited-content_cbyCitation_article-title">Cannabinoids in the Treatment of Back Pain. </span><span class="cited-content_cbyCitation_journal-name">Neurosurgery</span><span> <strong>2020,</strong> <em>87 </em>
                                    (2)
                                     , 166-175. <a href="https://doi.org/10.1093/neuros/nyz573" title="DOI URL">https://doi.org/10.1093/neuros/nyz573</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/neuros/nyz573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fneuros%2Fnyz573%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurosurgery%26atitle%3DCannabinoids%252Bin%252Bthe%252BTreatment%252Bof%252BBack%252BPain%26aulast%3DKim%26aufirst%3DTeddy%2BE%26date%3D2020%26date%3D2020%26volume%3D87%26issue%3D2%26spage%3D166%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cosmin I.  Ciotu</span>, <span class="hlFld-ContribAuthor ">Michael J. M.  Fischer</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Analgesics with Peripheral Targets. </span><span class="cited-content_cbyCitation_journal-name">Neurotherapeutics</span><span> <strong>2020,</strong> <em>17 </em>
                                    (3)
                                     , 784-825. <a href="https://doi.org/10.1007/s13311-020-00937-z" title="DOI URL">https://doi.org/10.1007/s13311-020-00937-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13311-020-00937-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13311-020-00937-z%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurotherapeutics%26atitle%3DNovel%252BAnalgesics%252Bwith%252BPeripheral%252BTargets%26aulast%3DCiotu%26aufirst%3DCosmin%2BI.%26date%3D2020%26date%3D2020%26volume%3D17%26issue%3D3%26spage%3D784%26epage%3D825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ercan  Ozdemir</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of the Cannabinoid System in Opioid Analgesia and Tolerance. </span><span class="cited-content_cbyCitation_journal-name">Mini-Reviews in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (10)
                                     , 875-885. <a href="https://doi.org/10.2174/1389557520666200313120835" title="DOI URL">https://doi.org/10.2174/1389557520666200313120835</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389557520666200313120835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389557520666200313120835%26sid%3Dliteratum%253Aachs%26jtitle%3DMini-Reviews%2520in%2520Medicinal%2520Chemistry%26atitle%3DThe%252BRole%252Bof%252Bthe%252BCannabinoid%252BSystem%252Bin%252BOpioid%252BAnalgesia%252Band%252BTolerance%26aulast%3DOzdemir%26aufirst%3DErcan%26date%3D2020%26volume%3D20%26issue%3D10%26spage%3D875%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathalia Nahas  Donatello</span>, <span class="hlFld-ContribAuthor ">Aline Armiliato  Emer</span>, <span class="hlFld-ContribAuthor ">Daiana Cristina  Salm</span>, <span class="hlFld-ContribAuthor ">Daniela Dero  Ludtke</span>, <span class="hlFld-ContribAuthor ">Silvana Aparecida Strapazzon Ribeiro  Bordignon</span>, <span class="hlFld-ContribAuthor ">Júlia Koerich  Ferreira</span>, <span class="hlFld-ContribAuthor ">Afonso Shiguemi Inoue  Salgado</span>, <span class="hlFld-ContribAuthor ">Dalila  Venzke</span>, <span class="hlFld-ContribAuthor ">Lizandra C.  Bretanha</span>, <span class="hlFld-ContribAuthor ">Gustavo A.  Micke</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Martins</span>. </span><span class="cited-content_cbyCitation_article-title">Lavandula angustifolia essential oil inhalation reduces mechanical hyperalgesia in a model of inflammatory and neuropathic pain: The involvement of opioid and cannabinoid receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuroimmunology</span><span> <strong>2020,</strong> <em>340 </em>, 577145. <a href="https://doi.org/10.1016/j.jneuroim.2020.577145" title="DOI URL">https://doi.org/10.1016/j.jneuroim.2020.577145</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jneuroim.2020.577145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jneuroim.2020.577145%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuroimmunology%26atitle%3DLavandula%252Bangustifolia%252Bessential%252Boil%252Binhalation%252Breduces%252Bmechanical%252Bhyperalgesia%252Bin%252Ba%252Bmodel%252Bof%252Binflammatory%252Band%252Bneuropathic%252Bpain%25253A%252BThe%252Binvolvement%252Bof%252Bopioid%252Band%252Bcannabinoid%252Breceptors%26aulast%3DDonatello%26aufirst%3DNathalia%2BNahas%26date%3D2020%26volume%3D340%26spage%3D577145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad Zakir  Hossain</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Ando</span>, <span class="hlFld-ContribAuthor ">Shumpei  Unno</span>, <span class="hlFld-ContribAuthor ">Junichi  Kitagawa</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (4)
                                     , 1423. <a href="https://doi.org/10.3390/ijms21041423" title="DOI URL">https://doi.org/10.3390/ijms21041423</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21041423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21041423%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DTargeting%252BPeripherally%252BRestricted%252BCannabinoid%252BReceptor%252B1%25252C%252BCannabinoid%252BReceptor%252B2%25252C%252Band%252BEndocannabinoid-Degrading%252BEnzymes%252Bfor%252Bthe%252BTreatment%252Bof%252BNeuropathic%252BPain%252BIncluding%252BNeuropathic%252BOrofacial%252BPain%26aulast%3DHossain%26aufirst%3DMohammad%2BZakir%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D4%26spage%3D1423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amber L.  Milligan</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Szabo-Pardi</span>, <span class="hlFld-ContribAuthor ">Michael D.  Burton</span>. </span><span class="cited-content_cbyCitation_article-title">Cannabinoid Receptor Type 1 and Its Role as an Analgesic: An Opioid Alternative?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Dual Diagnosis</span><span> <strong>2020,</strong> <em>16 </em>
                                    (1)
                                     , 106-119. <a href="https://doi.org/10.1080/15504263.2019.1668100" title="DOI URL">https://doi.org/10.1080/15504263.2019.1668100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/15504263.2019.1668100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F15504263.2019.1668100%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Dual%2520Diagnosis%26atitle%3DCannabinoid%252BReceptor%252BType%252B1%252Band%252BIts%252BRole%252Bas%252Ban%252BAnalgesic%25253A%252BAn%252BOpioid%252BAlternative%25253F%26aulast%3DMilligan%26aufirst%3DAmber%2BL.%26date%3D2020%26date%3D2019%26volume%3D16%26issue%3D1%26spage%3D106%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonia  Rinaldi</span>, <span class="hlFld-ContribAuthor ">Dina  Scarpi</span>, <span class="hlFld-ContribAuthor ">Ernesto G.  Occhiato</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Synthesis of Indenes. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (45)
                                     , 7401-7419. <a href="https://doi.org/10.1002/ejoc.201901425" title="DOI URL">https://doi.org/10.1002/ejoc.201901425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201901425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201901425%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BSynthesis%252Bof%252BIndenes%26aulast%3DRinaldi%26aufirst%3DAntonia%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D45%26spage%3D7401%26epage%3D7419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elaine D.  Gonçalves</span>, <span class="hlFld-ContribAuthor ">Rafael C.  Dutra</span>. </span><span class="cited-content_cbyCitation_article-title">Cannabinoid receptors as therapeutic targets for autoimmune diseases: where do we stand?. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2019,</strong> <em>24 </em>
                                    (9)
                                     , 1845-1853. <a href="https://doi.org/10.1016/j.drudis.2019.05.023" title="DOI URL">https://doi.org/10.1016/j.drudis.2019.05.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2019.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2019.05.023%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DCannabinoid%252Breceptors%252Bas%252Btherapeutic%252Btargets%252Bfor%252Bautoimmune%252Bdiseases%25253A%252Bwhere%252Bdo%252Bwe%252Bstand%25253F%26aulast%3DGon%25C3%25A7alves%26aufirst%3DElaine%2BD.%26date%3D2019%26volume%3D24%26issue%3D9%26spage%3D1845%26epage%3D1853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ritesh J.  Dhanorkar</span>, <span class="hlFld-ContribAuthor ">Virendra Kumar  Gupta</span>, <span class="hlFld-ContribAuthor ">Chandra  Prakash Gocher</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 1
              H
              ‐Inden‐1‐ylidenes via Carboannulation of Internal Alkynes with (
              E
              )‐3‐(2‐Bromophenyl) Acrylaldehyde: Potential Precursors for Drug Development. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>8 </em>
                                    (6)
                                     , 909-915. <a href="https://doi.org/10.1002/ajoc.201900183" title="DOI URL">https://doi.org/10.1002/ajoc.201900183</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.201900183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.201900183%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B1%252BH%252B%2525E2%252580%252590Inden%2525E2%252580%2525901%2525E2%252580%252590ylidenes%252Bvia%252BCarboannulation%252Bof%252BInternal%252BAlkynes%252Bwith%252B%252528%252BE%252B%252529%2525E2%252580%2525903%2525E2%252580%252590%2525282%2525E2%252580%252590Bromophenyl%252529%252BAcrylaldehyde%25253A%252BPotential%252BPrecursors%252Bfor%252BDrug%252BDevelopment%26aulast%3DDhanorkar%26aufirst%3DRitesh%2BJ.%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D6%26spage%3D909%26epage%3D915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin‐Bao  Peng</span>, <span class="hlFld-ContribAuthor ">Fu‐Peng  Wu</span>, <span class="hlFld-ContribAuthor ">Anke  Spannenberg</span>, <span class="hlFld-ContribAuthor ">Xiao‐Feng  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium‐Catalyzed Tunable Carbonylative Synthesis of Enones and Benzofulvenes. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2019,</strong> <em>96 </em><a href="https://doi.org/10.1002/chem.201901530" title="DOI URL">https://doi.org/10.1002/chem.201901530</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201901530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201901530%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DPalladium%2525E2%252580%252590Catalyzed%252BTunable%252BCarbonylative%252BSynthesis%252Bof%252BEnones%252Band%252BBenzofulvenes%26aulast%3DPeng%26aufirst%3DJin%25E2%2580%2590Bao%26date%3D2019%26date%3D2019%26volume%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samuel D.  Banister</span>, <span class="hlFld-ContribAuthor ">Kaavya  Krishna Kumar</span>, <span class="hlFld-ContribAuthor ">Vineet  Kumar</span>, <span class="hlFld-ContribAuthor ">Brian K.  Kobilka</span>, <span class="hlFld-ContribAuthor ">Sanjay V.  Malhotra</span>. </span><span class="cited-content_cbyCitation_article-title">Selective modulation of the cannabinoid type 1 (CB
              1
              ) receptor as an emerging platform for the treatment of neuropathic pain. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2019,</strong> <em>10 </em>
                                    (5)
                                     , 647-659. <a href="https://doi.org/10.1039/C8MD00595H" title="DOI URL">https://doi.org/10.1039/C8MD00595H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00595H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00595H%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSelective%252Bmodulation%252Bof%252Bthe%252Bcannabinoid%252Btype%252B1%252B%252528CB%252B1%252B%252529%252Breceptor%252Bas%252Ban%252Bemerging%252Bplatform%252Bfor%252Bthe%252Btreatment%252Bof%252Bneuropathic%252Bpain%26aulast%3DBanister%26aufirst%3DSamuel%2BD.%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D5%26spage%3D647%26epage%3D659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard A.  Slivicki</span>, <span class="hlFld-ContribAuthor ">Zhili  Xu</span>, <span class="hlFld-ContribAuthor ">Sonali S.  Mali</span>, <span class="hlFld-ContribAuthor ">Andrea G.  Hohmann</span>. </span><span class="cited-content_cbyCitation_article-title">Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2019,</strong> <em>142 </em>, 267-282. <a href="https://doi.org/10.1016/j.phrs.2019.02.002" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.02.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.02.002%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DBrain%252Bpermeant%252Band%252Bimpermeant%252Binhibitors%252Bof%252Bfatty-acid%252Bamide%252Bhydrolase%252Bsuppress%252Bthe%252Bdevelopment%252Band%252Bmaintenance%252Bof%252Bpaclitaxel-induced%252Bneuropathic%252Bpain%252Bwithout%252Bproducing%252Btolerance%252Bor%252Bphysical%252Bdependence%252Bin%252Bvivo%252Band%252Bsynergize%252Bwith%252Bpaclitaxel%252Bto%252Breduce%252Btumor%252Bcell%252Bline%252Bviability%252Bin%252Bvitro%26aulast%3DSlivicki%26aufirst%3DRichard%2BA.%26date%3D2019%26volume%3D142%26spage%3D267%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinhua  Li</span>, <span class="hlFld-ContribAuthor ">Huijun  Kang</span>, <span class="hlFld-ContribAuthor ">Kaiyue  Zhuo</span>, <span class="hlFld-ContribAuthor ">Qingde  Zhuo</span>, <span class="hlFld-ContribAuthor ">Hong  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu-Mei  Lin</span>, <span class="hlFld-ContribAuthor ">Haiping  Xia</span>. </span><span class="cited-content_cbyCitation_article-title">Alternation of Metal-Bridged Metallacycle Skeletons: From Ruthenapentalyne to Ruthenapentalene and Ruthenaindene Derivative. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2018,</strong> <em>36 </em>
                                    (12)
                                     , 1156-1160. <a href="https://doi.org/10.1002/cjoc.201800362" title="DOI URL">https://doi.org/10.1002/cjoc.201800362</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.201800362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.201800362%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DAlternation%252Bof%252BMetal-Bridged%252BMetallacycle%252BSkeletons%25253A%252BFrom%252BRuthenapentalyne%252Bto%252BRuthenapentalene%252Band%252BRuthenaindene%252BDerivative%26aulast%3DLi%26aufirst%3DJinhua%26date%3D2018%26date%3D2018%26volume%3D36%26issue%3D12%26spage%3D1156%26epage%3D1160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Weiwei  Lin</span>, <span class="hlFld-ContribAuthor ">Nan  Wu</span>, <span class="hlFld-ContribAuthor ">Xibing  He</span>, <span class="hlFld-ContribAuthor ">Junmei  Wang</span>, <span class="hlFld-ContribAuthor ">Zhiwei  Feng</span>, <span class="hlFld-ContribAuthor ">Xiang-Qun  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">An insight into paracetamol and its metabolites using molecular docking and molecular dynamics simulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2018,</strong> <em>24 </em>
                                    (9)
                                     <a href="https://doi.org/10.1007/s00894-018-3790-9" title="DOI URL">https://doi.org/10.1007/s00894-018-3790-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-018-3790-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-018-3790-9%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DAn%252Binsight%252Binto%252Bparacetamol%252Band%252Bits%252Bmetabolites%252Busing%252Bmolecular%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bsimulation%26aulast%3DWang%26aufirst%3DYuanqiang%26date%3D2018%26date%3D2018%26volume%3D24%26issue%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yatendra  Mulpuri</span>, <span class="hlFld-ContribAuthor ">Vincent N.  Marty</span>, <span class="hlFld-ContribAuthor ">Joseph J.  Munier</span>, <span class="hlFld-ContribAuthor ">Ken  Mackie</span>, <span class="hlFld-ContribAuthor ">Brian L.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Herbert H.  Seltzman</span>, <span class="hlFld-ContribAuthor ">Igor  Spigelman</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2018,</strong> <em>139 </em>, 85-97. <a href="https://doi.org/10.1016/j.neuropharm.2018.07.002" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2018.07.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2018.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2018.07.002%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DSynthetic%252Bperipherally-restricted%252Bcannabinoid%252Bsuppresses%252Bchemotherapy-induced%252Bperipheral%252Bneuropathy%252Bpain%252Bsymptoms%252Bby%252BCB1%252Breceptor%252Bactivation%26aulast%3DMulpuri%26aufirst%3DYatendra%26date%3D2018%26volume%3D139%26spage%3D85%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Zhang</span>, <span class="hlFld-ContribAuthor ">Dominique M.  Lund</span>, <span class="hlFld-ContribAuthor ">Haley A.  Ciccone</span>, <span class="hlFld-ContribAuthor ">William D.  Staatz</span>, <span class="hlFld-ContribAuthor ">Mohab M.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Tally M.  Largent-Milnes</span>, <span class="hlFld-ContribAuthor ">Herbert H.  Seltzman</span>, <span class="hlFld-ContribAuthor ">Igor  Spigelman</span>, <span class="hlFld-ContribAuthor ">Todd W.  Vanderah</span>. </span><span class="cited-content_cbyCitation_article-title">Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain. </span><span class="cited-content_cbyCitation_journal-name">Pain</span><span> <strong>2018,</strong> <em>159 </em>
                                    (9)
                                     , 1814-1823. <a href="https://doi.org/10.1097/j.pain.0000000000001278" title="DOI URL">https://doi.org/10.1097/j.pain.0000000000001278</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/j.pain.0000000000001278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2Fj.pain.0000000000001278%26sid%3Dliteratum%253Aachs%26jtitle%3DPain%26atitle%3DPeripherally%252Brestricted%252Bcannabinoid%252B1%252Breceptor%252Bagonist%252Bas%252Ba%252Bnovel%252Banalgesic%252Bin%252Bcancer-induced%252Bbone%252Bpain%26aulast%3DZhang%26aufirst%3DHong%26date%3D2018%26date%3D2018%26volume%3D159%26issue%3D9%26spage%3D1814%26epage%3D1823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amie L.  Severino</span>, <span class="hlFld-ContribAuthor ">Arash  Shadfar</span>, <span class="hlFld-ContribAuthor ">Joshua K.  Hakimian</span>, <span class="hlFld-ContribAuthor ">Oliver  Crane</span>, <span class="hlFld-ContribAuthor ">Ganeev  Singh</span>, <span class="hlFld-ContribAuthor ">Keith  Heinzerling</span>, <span class="hlFld-ContribAuthor ">Wendy M.  Walwyn</span>. </span><span class="cited-content_cbyCitation_article-title">Pain Therapy Guided by Purpose and Perspective in Light of the Opioid Epidemic. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Psychiatry</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fpsyt.2018.00119" title="DOI URL">https://doi.org/10.3389/fpsyt.2018.00119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fpsyt.2018.00119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffpsyt.2018.00119%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Psychiatry%26atitle%3DPain%252BTherapy%252BGuided%252Bby%252BPurpose%252Band%252BPerspective%252Bin%252BLight%252Bof%252Bthe%252BOpioid%252BEpidemic%26aulast%3DSeverino%26aufirst%3DAmie%2BL.%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rongnan  Yi</span>, <span class="hlFld-ContribAuthor ">Jinyang  Chen</span>, <span class="hlFld-ContribAuthor ">Xueyan  Wang</span>, <span class="hlFld-ContribAuthor ">Zhiwu  Liang</span>, <span class="hlFld-ContribAuthor ">Xinhua  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">A Rapid and Highly Efficient Method for the Synthesis of Benzofulvenes via CsOH-Catalyzed Condensation of Indene and Aldehydes. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (11)
                                     , 1347-1351. <a href="https://doi.org/10.1002/ejoc.201701710" title="DOI URL">https://doi.org/10.1002/ejoc.201701710</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201701710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201701710%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DA%252BRapid%252Band%252BHighly%252BEfficient%252BMethod%252Bfor%252Bthe%252BSynthesis%252Bof%252BBenzofulvenes%252Bvia%252BCsOH-Catalyzed%252BCondensation%252Bof%252BIndene%252Band%252BAldehydes%26aulast%3DYi%26aufirst%3DRongnan%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D11%26spage%3D1347%26epage%3D1351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Salvador  Sierra</span>, <span class="hlFld-ContribAuthor ">Natasha  Luquin</span>, <span class="hlFld-ContribAuthor ">Judith  Navarro-Otano</span>. </span><span class="cited-content_cbyCitation_article-title">The endocannabinoid system in cardiovascular function: novel insights and clinical implications. </span><span class="cited-content_cbyCitation_journal-name">Clinical Autonomic Research</span><span> <strong>2018,</strong> <em>28 </em>
                                    (1)
                                     , 35-52. <a href="https://doi.org/10.1007/s10286-017-0488-5" title="DOI URL">https://doi.org/10.1007/s10286-017-0488-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10286-017-0488-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10286-017-0488-5%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Autonomic%2520Research%26atitle%3DThe%252Bendocannabinoid%252Bsystem%252Bin%252Bcardiovascular%252Bfunction%25253A%252Bnovel%252Binsights%252Band%252Bclinical%252Bimplications%26aulast%3DSierra%26aufirst%3DSalvador%26date%3D2018%26date%3D2017%26volume%3D28%26issue%3D1%26spage%3D35%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiang  Yin</span>, <span class="hlFld-ContribAuthor ">Mauro  Mato</span>, <span class="hlFld-ContribAuthor ">Antonio M.  Echavarren</span>. </span><span class="cited-content_cbyCitation_article-title">Gold(I)-Catalyzed Synthesis of Indenes and Cyclopentadienes: Access to (±)-Laurokamurene B and the Skeletons of the Cycloaurenones and Dysiherbols. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2017,</strong> <em>129 </em>
                                    (46)
                                     , 14783-14787. <a href="https://doi.org/10.1002/ange.201708947" title="DOI URL">https://doi.org/10.1002/ange.201708947</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201708947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201708947%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DGold%252528I%252529-Catalyzed%252BSynthesis%252Bof%252BIndenes%252Band%252BCyclopentadienes%25253A%252BAccess%252Bto%252B%252528%2525C2%2525B1%252529-Laurokamurene%2525E2%252580%252585B%252Band%252Bthe%252BSkeletons%252Bof%252Bthe%252BCycloaurenones%252Band%252BDysiherbols%26aulast%3DYin%26aufirst%3DXiang%26date%3D2017%26date%3D2017%26volume%3D129%26issue%3D46%26spage%3D14783%26epage%3D14787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiang  Yin</span>, <span class="hlFld-ContribAuthor ">Mauro  Mato</span>, <span class="hlFld-ContribAuthor ">Antonio M.  Echavarren</span>. </span><span class="cited-content_cbyCitation_article-title">Gold(I)-Catalyzed Synthesis of Indenes and Cyclopentadienes: Access to (±)-Laurokamurene B and the Skeletons of the Cycloaurenones and Dysiherbols. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2017,</strong> <em>56 </em>
                                    (46)
                                     , 14591-14595. <a href="https://doi.org/10.1002/anie.201708947" title="DOI URL">https://doi.org/10.1002/anie.201708947</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201708947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201708947%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DGold%252528I%252529-Catalyzed%252BSynthesis%252Bof%252BIndenes%252Band%252BCyclopentadienes%25253A%252BAccess%252Bto%252B%252528%2525C2%2525B1%252529-Laurokamurene%2525E2%252580%252585B%252Band%252Bthe%252BSkeletons%252Bof%252Bthe%252BCycloaurenones%252Band%252BDysiherbols%26aulast%3DYin%26aufirst%3DXiang%26date%3D2017%26date%3D2017%26volume%3D56%26issue%3D46%26spage%3D14591%26epage%3D14595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaness A.  Grenald</span>, <span class="hlFld-ContribAuthor ">Madison A.  Young</span>, <span class="hlFld-ContribAuthor ">Yue  Wang</span>, <span class="hlFld-ContribAuthor ">Michael H.  Ossipov</span>, <span class="hlFld-ContribAuthor ">Mohab M.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Tally M.  Largent-Milnes</span>, <span class="hlFld-ContribAuthor ">Todd W.  Vanderah</span>. </span><span class="cited-content_cbyCitation_article-title">Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2017,</strong> <em>116 </em>, 59-70. <a href="https://doi.org/10.1016/j.neuropharm.2016.12.008" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2016.12.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2016.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2016.12.008%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DSynergistic%252Battenuation%252Bof%252Bchronic%252Bpain%252Busing%252Bmu%252Bopioid%252Band%252Bcannabinoid%252Breceptor%252B2%252Bagonists%26aulast%3DGrenald%26aufirst%3DShaness%2BA.%26date%3D2017%26volume%3D116%26spage%3D59%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei  Gao</span>, <span class="hlFld-ContribAuthor ">Jiu-Tao  Wang</span>, <span class="hlFld-ContribAuthor ">Lin-Lin  Liu</span>, <span class="hlFld-ContribAuthor ">Na  Ma</span>, <span class="hlFld-ContribAuthor ">Chao  Yang</span>, <span class="hlFld-ContribAuthor ">Yuan  Gao</span>, <span class="hlFld-ContribAuthor ">Wujiong  Xia</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of carbonylated heteroaromatic compounds via visible-light-driven intramolecular decarboxylative cyclization of o-alkynylated carboxylic acids. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2017,</strong> <em>53 </em>
                                    (61)
                                     , 8533-8536. <a href="https://doi.org/10.1039/C7CC04813K" title="DOI URL">https://doi.org/10.1039/C7CC04813K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7CC04813K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7CC04813K%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DSynthesis%252Bof%252Bcarbonylated%252Bheteroaromatic%252Bcompounds%252Bvia%252Bvisible-light-driven%252Bintramolecular%252Bdecarboxylative%252Bcyclization%252Bof%252Bo-alkynylated%252Bcarboxylic%252Bacids%26aulast%3DGao%26aufirst%3DFei%26date%3D2017%26date%3D2017%26volume%3D53%26issue%3D61%26spage%3D8533%26epage%3D8536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/medium/jm-2016-00516h_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00516&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/medium/jm-2016-00516h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00516&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/medium/jm-2016-00516h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00516&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/medium/jm-2016-00516h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reversible suppression of SNE-induced mechanical allodynia by representative indenes. (A) Schematic of sciatic nerve entrapment and relevant peripheral nerve and spinal ganglia. (B) Graph of withdrawal thresholds to mechanical stimulation of hindpaws ipsilateral and contralateral to SNE at 1 h before and 3, 6, 24, and 48 h after <b>2</b>-<b>5u</b> (0.3 mg/kg, ip) injection. At 3 h postinjection, ipsilateral thresholds are increased to levels of predrug contralateral thresholds and are indistinguishable from thresholds measured prior to neuropathy development (pre-SNE). Also note the drug-induced small, but significant increases in contralateral thresholds (mean ± SEM, <i>n</i> = 8 rats). (C) In the same rats, administration of <b>2</b>-<b>5j</b> (0.3 mg/kg), but not vehicle alone, results in similar increases in ipsilateral thresholds to pre-SNE values. (D) <b>2</b>-<b>5a</b> (0.3 mg/kg) produces considerably smaller increases in thresholds than <b>2</b>-<b>5u</b> or <b>2</b>-<b>5j</b>. (E) Changes in plasma [<b>2</b>-<b>5u</b>] and calculated pharmacokinetic parameters after injection (0.3 mg/kg, ip) in naı̈ve rats (<i>n</i> = 3) are consistent with the time course of its effects on SNE neuropathy symptoms. Brain and CSF/plasma ratios of PrNMI obtained from samples collected from 3 other rats at ∼75 min after <b>2</b>-<b>5u</b> (0.3 mg/kg, ip) suggest minimal CNS penetration. (F) Oral administration of <b>2</b>-<b>5u</b> (3 mg/kg) reversibly suppresses SNE neuropathy symptoms (<i>n</i> = 8 rats). *, <i>p</i> < 0.05 vs predrug (−1 h) values (one-way RM ANOVA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00516&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/medium/jm-2016-00516h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00516&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/medium/jm-2016-00516h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Activity of <b>1</b>, <b>2</b>-<b>5u</b>, <b>2</b>-<b>5t</b>, and <b>2</b>-<b>5j</b> in the “tetrad” assays. (A–D) Rats were tested in each assay 1 h prior and up to 48 h following intraperitoneal injection of vehicle, <b>1</b> (0.01 mg/kg) or <b>2</b>-<b>5u</b> (0.3 mg/kg). Note the profound CNS side effects of <b>1</b> vs <b>2</b>-<b>5u</b> in the ring, core temperature, and rotarod tests. The small analgesic effect of <b>2</b>-<b>5u</b> in the tail-flick assay is consistent with peripheral activation of CBRs. *, <i>p</i> < 0.05 vs predrug (−1 h) values (one-way RM ANOVA). (E–H) Dose-dependence of brain-permeant <b>1</b> and compounds <b>2</b>-<b>5t</b>, <b>2</b>-<b>5u</b>, or <b>2</b>-<b>5j</b> in the tetrad assays after intraperitoneal administration. Each point represents mean peak effect ± SEM of <b>1</b> (<i>n</i> = 6 rats), <b>2</b>-<b>5t</b> (<i>n</i> = 8 rats), <b>2</b>-<b>5u</b> (<i>n</i> = 8 rats), and <b>2</b>-<b>5j</b> (<i>n</i> = 8 rats), each subtracted from its vehicle control. (I–L) Dose-dependence of <b>2</b>-<b>5t</b>, <b>2</b>-<b>5u</b>, and <b>2</b>-<b>5j</b> in the tetrad assays after oral administration. Each point represents mean peak effect ± SEM of <b>2</b>-<b>5t</b> (<i>n</i> = 8 rats), <b>2</b>-<b>5u</b> (<i>n</i> = 8 rats), and <b>2</b>-<b>5j</b> (<i>n</i> = 8 rats), each subtracted from its vehicle control. Note the relative lack of side effects in the catalepsy, motor incoordination, and hypothermia assays. The small effects in the tail-flick assay are consistent with antinociceptive effects due to activation of peripheral CBRs in naı̈ve rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00516&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/medium/jm-2016-00516h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. CB1Rs mediate antiallodynic effects of <b>2</b>-<b>5u</b> in the SNE neuropathy. (A) Suppression of SNE-induced mechanical allodynia by <b>2</b>-<b>5u</b> (0.6 mg/kg). (B) In the same rats (<i>n</i> = 8), pretreatment with the CB1R inhibitor <b>2</b> (rimonabant, 3 mg/kg, ip) completely blocks the response to <b>2</b>-<b>5u</b>. (C) A peripherally restricted rimonabant analogue, <b>18A</b>, also blocked the response to <b>2</b>-<b>5u</b>. (D) By contrast, the selective CB2R inhibitor <b>3</b> (3 mg/kg, ip) produced only a small decrease in the response to <b>2</b>-<b>5u</b>. (E) Summary of effects of selective CB1R and CB2R inhibition on antiallodynic effects of <b>2</b>-<b>5u</b>. *, <i>p</i> < 0.05 vs treatment with <b>2</b>-<b>5u</b> alone (one-way ANOVA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00516/20160819/images/large/jm-2016-00516h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00516&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i92">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21273" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21273" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 48 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Johannes, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dworkin, R. H.</span><span> </span><span class="NLM_article-title">The prevalence of chronic pain in United States adults: results of an Internet-based survey</span> <span class="citation_source-journal">J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1230</span><span class="NLM_x">–</span> <span class="NLM_lpage">1239</span><span class="refDoi"> DOI: 10.1016/j.jpain.2010.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.jpain.2010.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=20797916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADC%252BC3cblt1Siuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=1230-1239&author=C.+B.+Johannesauthor=T.+K.+Leauthor=X.+Zhouauthor=J.+A.+Johnstonauthor=R.+H.+Dworkin&title=The+prevalence+of+chronic+pain+in+United+States+adults%3A+results+of+an+Internet-based+survey&doi=10.1016%2Fj.jpain.2010.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The prevalence of chronic pain in United States adults: results of an Internet-based survey</span></div><div class="casAuthors">Johannes Catherine B; Le T Kim; Zhou Xiaolei; Johnston Joseph A; Dworkin Robert H</div><div class="citationInfo"><span class="NLM_cas:title">The journal of pain : official journal of the American Pain Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1230-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">UNLABELLED:  A cross-sectional, Internet-based survey was conducted in a nationally representative sample of United States (US) adults to estimate the point prevalence of chronic pain and to describe sociodemographic correlates and characteristics of chronic pain.  The survey was distributed to 35,718 members (aged 18 years and older) of a Web-enabled panel that is representative of the US population, and 27,035 individuals responded.  Crude and weighted prevalence estimates were calculated and stratified by age, sex, and type of chronic pain.  The weighted point-prevalence of chronic pain (defined as chronic, recurrent, or long-lasting pain lasting for at least 6 months) was 30.7% (95% CI, 29.8-31.7).  Prevalence was higher for females (34.3%) than males (26.7%) and increased with age.  The weighted prevalence of primary chronic lower back pain was 8.1% and primary osteoarthritis pain was 3.9%.  Half of respondents with chronic pain experienced daily pain, and average (past 3 months) pain intensity was severe (≥ 7 on a scale ranging from 0 to 10) for 32%.  Multiple logistic regression analysis identified low household income and unemployment as significant socioeconomic correlates of chronic pain.  Chronic pain is prevalent among US adults and is related to indicators of poorer socioeconomic status.  PERSPECTIVE:  The results of this cross-sectional Internet-based survey suggest a considerable burden of chronic pain in US adults.  Chronic pain, experienced by about a third of the population, was correlated with indicators of poorer socioeconomic status.  Primary chronic pain was most commonly attributed to lower back pain, followed by osteoarthritis pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSDQ-bsE_l1rTDnmmyUf5qOfW6udTcc2eaghfrXqozOebntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cblt1Siuw%253D%253D&md5=d328413cc4c38bf33309705a7b39cbef</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2010.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2010.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DJohannes%26aufirst%3DC.%2BB.%26aulast%3DLe%26aufirst%3DT.%2BK.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DJohnston%26aufirst%3DJ.%2BA.%26aulast%3DDworkin%26aufirst%3DR.%2BH.%26atitle%3DThe%2520prevalence%2520of%2520chronic%2520pain%2520in%2520United%2520States%2520adults%253A%2520results%2520of%2520an%2520Internet-based%2520survey%26jtitle%3DJ.%2520Pain%26date%3D2010%26volume%3D11%26spage%3D1230%26epage%3D1239%26doi%3D10.1016%2Fj.jpain.2010.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sessle, B.</span><span> </span><span class="NLM_article-title">Unrelieved pain: a crisis</span> <span class="citation_source-journal">Pain Res. Manag.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">416</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span><span class="refDoi"> DOI: 10.1155/2011/513423</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1155%2F2011%2F513423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=22184550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADC%252BC38%252Fos1ynuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=416-420&author=B.+Sessle&title=Unrelieved+pain%3A+a+crisis&doi=10.1155%2F2011%2F513423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Unrelieved pain: a crisis</span></div><div class="casAuthors">Sessle Barry</div><div class="citationInfo"><span class="NLM_cas:title">Pain research & management</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">416-20</span>
        ISSN:<span class="NLM_cas:issn">1203-6765</span>.
    </div><div class="casAbstract">Despite many recent advances in the past 40 years in the understanding of pain mechanisms, and in pain diagnosis and management, considerable gaps in knowledge remain, with chronic pain present in epidemic proportions in most countries.  It is often unrelieved and is associated with significant socioeconomic burdens.  Several opportunities and approaches to address this crisis are identified in the present article.  Most crucial is the need to increase pain awareness, enhance pain education, improve access to pain care and increase pain research resources.  Given the variability among countries in health care policies and programs, resources and educational programs, many of the approaches and strategies outlined will need to be tailored to each country's socioeconomic and educational situation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTR4JB_Qz01vbmQt-ICR3qNfW6udTcc2eYvfRgG0cVVarntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252Fos1ynuw%253D%253D&md5=e26edc0c8d5421ffc0e65727b9a6eb40</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1155%2F2011%2F513423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2011%252F513423%26sid%3Dliteratum%253Aachs%26aulast%3DSessle%26aufirst%3DB.%26atitle%3DUnrelieved%2520pain%253A%2520a%2520crisis%26jtitle%3DPain%2520Res.%2520Manag.%26date%3D2011%26volume%3D16%26spage%3D416%26epage%3D420%26doi%3D10.1155%2F2011%2F513423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ossipov, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span> </span><span class="NLM_article-title">Challenges in the development of novel treatment strategies for neuropathic pain</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">650</span><span class="NLM_x">–</span> <span class="NLM_lpage">661</span><span class="refDoi"> DOI: 10.1602/neurorx.2.4.650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1602%2Fneurorx.2.4.650" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=650-661&author=M.+H.+Ossipovauthor=F.+Porreca&title=Challenges+in+the+development+of+novel+treatment+strategies+for+neuropathic+pain&doi=10.1602%2Fneurorx.2.4.650"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.650%26sid%3Dliteratum%253Aachs%26aulast%3DOssipov%26aufirst%3DM.%2BH.%26aulast%3DPorreca%26aufirst%3DF.%26atitle%3DChallenges%2520in%2520the%2520development%2520of%2520novel%2520treatment%2520strategies%2520for%2520neuropathic%2520pain%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D650%26epage%3D661%26doi%3D10.1602%2Fneurorx.2.4.650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kinloch, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, P. J.</span><span> </span><span class="NLM_article-title">New targets for neuropathic pain therapeutics</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span><span class="refDoi"> DOI: 10.1517/14728222.9.4.685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1517%2F14728222.9.4.685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=16083337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFelsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2005&pages=685-698&author=R.+A.+Kinlochauthor=P.+J.+Cox&title=New+targets+for+neuropathic+pain+therapeutics&doi=10.1517%2F14728222.9.4.685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">New targets for neuropathic pain therapeutics</span></div><div class="casAuthors">Kinloch, Ross A.; Cox, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">685-698</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Neuropathic pain (NeP) is initiated by a lesion or dysfunction in the nervous system.  Unlike physiol. pain it serves no useful purpose and is usually sustained and chronic.  NeP encompasses a wide range of pain syndromes of diverse etiologies which together account for > 12 million sufferers in the US.  Currently, there are a no. of therapies available for NeP, including gabapentin, pregabalin, anticonvulsants (tiagabine HCl), tricyclic antidepressants (amitriptyline, nortriptyline) and acetaminophen/opioid combination products (Vicodin, Tylenol #3).  However, these products do not provide sufficient pain relief and a significant proportion of sufferers are refractory (60%).  Therefore, there is a need for new therapies that provide more predictable efficacy in all patients with improved tolerability.  Over the last decade, understanding of the basic mechanisms contributing to the generation of NeP in preclin. animal models has greatly improved.  Together with the completion of the various genome sequencing projects and significant advances in microarray and target validation strategies, new therapeutic approaches are being rigorously pursued.  This article reviews the rationale behind a no. of these mechanism-based approaches, briefly discusses specific challenges that they face, and finally, speculates on the potential of emerging technologies as alternative therapeutic strategies to the traditional "small-mol." approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqREHZgouV37LVg90H21EOLACvtfcHk0lh36hNy1D6AhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFelsrY%253D&md5=38f5aaae4eddffda1f9721e9f2c1581a</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1517%2F14728222.9.4.685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.9.4.685%26sid%3Dliteratum%253Aachs%26aulast%3DKinloch%26aufirst%3DR.%2BA.%26aulast%3DCox%26aufirst%3DP.%2BJ.%26atitle%3DNew%2520targets%2520for%2520neuropathic%2520pain%2520therapeutics%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2005%26volume%3D9%26spage%3D685%26epage%3D698%26doi%3D10.1517%2F14728222.9.4.685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sullivan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, C. Q.</span><span> </span><span class="NLM_article-title">Opioid therapy for chronic pain in the United States: promises and perils</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S94</span><span class="NLM_x">–</span> <span class="NLM_lpage">S100</span><span class="refDoi"> DOI: 10.1016/j.pain.2013.09.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.pain.2013.09.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=S94-S100&issue=Suppl+1&author=M.+D.+Sullivanauthor=C.+Q.+Howe&title=Opioid+therapy+for+chronic+pain+in+the+United+States%3A+promises+and+perils&doi=10.1016%2Fj.pain.2013.09.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2013.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2013.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DM.%2BD.%26aulast%3DHowe%26aufirst%3DC.%2BQ.%26atitle%3DOpioid%2520therapy%2520for%2520chronic%2520pain%2520in%2520the%2520United%2520States%253A%2520promises%2520and%2520perils%26jtitle%3DPain%26date%3D2013%26volume%3D154%26issue%3DSuppl%25201%26spage%3DS94%26epage%3DS100%26doi%3D10.1016%2Fj.pain.2013.09.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Karst, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conrad, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, U.</span><span> </span><span class="NLM_article-title">Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial</span> <span class="citation_source-journal">JAMA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">1757</span><span class="NLM_x">–</span> <span class="NLM_lpage">1762</span><span class="refDoi"> DOI: 10.1001/jama.290.13.1757</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1001%2Fjama.290.13.1757" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2003&pages=1757-1762&author=M.+Karstauthor=K.+Salimauthor=S.+Bursteinauthor=I.+Conradauthor=L.+Hoyauthor=U.+Schneider&title=Analgesic+effect+of+the+synthetic+cannabinoid+CT-3+on+chronic+neuropathic+pain%3A+a+randomized+controlled+trial&doi=10.1001%2Fjama.290.13.1757"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1001%2Fjama.290.13.1757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.290.13.1757%26sid%3Dliteratum%253Aachs%26aulast%3DKarst%26aufirst%3DM.%26aulast%3DSalim%26aufirst%3DK.%26aulast%3DBurstein%26aufirst%3DS.%26aulast%3DConrad%26aufirst%3DI.%26aulast%3DHoy%26aufirst%3DL.%26aulast%3DSchneider%26aufirst%3DU.%26atitle%3DAnalgesic%2520effect%2520of%2520the%2520synthetic%2520cannabinoid%2520CT-3%2520on%2520chronic%2520neuropathic%2520pain%253A%2520a%2520randomized%2520controlled%2520trial%26jtitle%3DJAMA%26date%3D2003%26volume%3D290%26spage%3D1757%26epage%3D1762%26doi%3D10.1001%2Fjama.290.13.1757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Berman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symonds, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birch, R.</span><span> </span><span class="NLM_article-title">Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">306</span><span class="refDoi"> DOI: 10.1016/j.pain.2004.09.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.pain.2004.09.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2004&pages=299-306&author=J.+S.+Bermanauthor=C.+Symondsauthor=R.+Birch&title=Efficacy+of+two+cannabis+based+medicinal+extracts+for+relief+of+central+neuropathic+pain+from+brachial+plexus+avulsion%3A+results+of+a+randomised+controlled+trial&doi=10.1016%2Fj.pain.2004.09.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2004.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2004.09.013%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DJ.%2BS.%26aulast%3DSymonds%26aufirst%3DC.%26aulast%3DBirch%26aufirst%3DR.%26atitle%3DEfficacy%2520of%2520two%2520cannabis%2520based%2520medicinal%2520extracts%2520for%2520relief%2520of%2520central%2520neuropathic%2520pain%2520from%2520brachial%2520plexus%2520avulsion%253A%2520results%2520of%2520a%2520randomised%2520controlled%2520trial%26jtitle%3DPain%26date%3D2004%26volume%3D112%26spage%3D299%26epage%3D306%26doi%3D10.1016%2Fj.pain.2004.09.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Notcutt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newport, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sansom, C.</span><span> </span><span class="NLM_article-title">Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 ’N of 1’ studies</span> <span class="citation_source-journal">Anaesthesia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span><span class="refDoi"> DOI: 10.1111/j.1365-2044.2004.03674.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1111%2Fj.1365-2044.2004.03674.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2004&pages=440-452&author=W.+Notcuttauthor=M.+Priceauthor=R.+Millerauthor=S.+Newportauthor=C.+Phillipsauthor=S.+Simmonsauthor=C.+Sansom&title=Initial+experiences+with+medicinal+extracts+of+cannabis+for+chronic+pain%3A+results+from+34+%E2%80%99N+of+1%E2%80%99+studies&doi=10.1111%2Fj.1365-2044.2004.03674.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2044.2004.03674.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2044.2004.03674.x%26sid%3Dliteratum%253Aachs%26aulast%3DNotcutt%26aufirst%3DW.%26aulast%3DPrice%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DNewport%26aufirst%3DS.%26aulast%3DPhillips%26aufirst%3DC.%26aulast%3DSimmons%26aufirst%3DS.%26aulast%3DSansom%26aufirst%3DC.%26atitle%3DInitial%2520experiences%2520with%2520medicinal%2520extracts%2520of%2520cannabis%2520for%2520chronic%2520pain%253A%2520results%2520from%252034%2520%25E2%2580%2599N%2520of%25201%25E2%2580%2599%2520studies%26jtitle%3DAnaesthesia%26date%3D2004%26volume%3D59%26spage%3D440%26epage%3D452%26doi%3D10.1111%2Fj.1365-2044.2004.03674.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Herzberg, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eliav, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopin, I. J.</span><span> </span><span class="NLM_article-title">The analgesic effects of R(+)-WIN 55,212–2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">221</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span><span class="refDoi"> DOI: 10.1016/S0304-3940(96)13308-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2FS0304-3940%2896%2913308-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=1997&pages=157-160&author=U.+Herzbergauthor=E.+Eliavauthor=G.+J.+Bennettauthor=I.+J.+Kopin&title=The+analgesic+effects+of+R%28%2B%29-WIN+55%2C212%E2%80%932+mesylate%2C+a+high+affinity+cannabinoid+agonist%2C+in+a+rat+model+of+neuropathic+pain&doi=10.1016%2FS0304-3940%2896%2913308-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2896%2913308-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252896%252913308-5%26sid%3Dliteratum%253Aachs%26aulast%3DHerzberg%26aufirst%3DU.%26aulast%3DEliav%26aufirst%3DE.%26aulast%3DBennett%26aufirst%3DG.%2BJ.%26aulast%3DKopin%26aufirst%3DI.%2BJ.%26atitle%3DThe%2520analgesic%2520effects%2520of%2520R%2528%252B%2529-WIN%252055%252C212%25E2%2580%25932%2520mesylate%252C%2520a%2520high%2520affinity%2520cannabinoid%2520agonist%252C%2520in%2520a%2520rat%2520model%2520of%2520neuropathic%2520pain%26jtitle%3DNeurosci.%2520Lett.%26date%3D1997%26volume%3D221%26spage%3D157%26epage%3D160%26doi%3D10.1016%2FS0304-3940%2896%2913308-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fox, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesingland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNair, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I.</span><span> </span><span class="NLM_article-title">The role of central and peripheral Cannabinoid<sub>1</sub> receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span><span class="refDoi"> DOI: 10.1016/S0304-3959(00)00474-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2FS0304-3959%2800%2900474-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2001&pages=91-100&author=A.+Foxauthor=A.+Kesinglandauthor=C.+Gentryauthor=K.+McNairauthor=S.+Patelauthor=L.+Urbanauthor=I.+James&title=The+role+of+central+and+peripheral+Cannabinoid1+receptors+in+the+antihyperalgesic+activity+of+cannabinoids+in+a+model+of+neuropathic+pain&doi=10.1016%2FS0304-3959%2800%2900474-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1016%2FS0304-3959%2800%2900474-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3959%252800%252900474-7%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DA.%26aulast%3DKesingland%26aufirst%3DA.%26aulast%3DGentry%26aufirst%3DC.%26aulast%3DMcNair%26aufirst%3DK.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DUrban%26aufirst%3DL.%26aulast%3DJames%26aufirst%3DI.%26atitle%3DThe%2520role%2520of%2520central%2520and%2520peripheral%2520Cannabinoid1%2520receptors%2520in%2520the%2520antihyperalgesic%2520activity%2520of%2520cannabinoids%2520in%2520a%2520model%2520of%2520neuropathic%2520pain%26jtitle%3DPain%26date%3D2001%26volume%3D92%26spage%3D91%26epage%3D100%26doi%3D10.1016%2FS0304-3959%2800%2900474-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Mackie, K.</span><span> </span><span class="NLM_article-title">Distribution of cannabinoid receptors in the central and peripheral nervous system</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span><span class="refDoi"> DOI: 10.1007/3-540-26573-2_10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1007%2F3-540-26573-2_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=16596779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFeqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2005&pages=299-325&author=K.+Mackie&title=Distribution+of+cannabinoid+receptors+in+the+central+and+peripheral+nervous+system&doi=10.1007%2F3-540-26573-2_10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of cannabinoid receptors in the central and peripheral nervous system</span></div><div class="casAuthors">Mackie, K.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">Cannabinoids</span>),
    <span class="NLM_cas:pages">299-325</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  CB1 cannabinoid receptors appear to mediate most, if not all of the psychoactive effects of delta-9-tetrahydrocannabinol and related compds.  This G protein-coupled receptor has a characteristic distribution in the nervous system: it is particularly enriched in cortex, hippocampus, amygdala, basal ganglia outflow tracts, and cerebellum-a distribution that corresponds to the most prominent behavioral effects of cannabis.  In addn., this distribution helps to predict neurol. and psychol. maladies for which manipulation of the endocannabinoid system might be beneficial.  CB1 receptors are primarily expressed on neurons, where most of the receptors are found on axons and synaptic terminals, emphasizing the important role of this receptor in modulating neurotransmission at specific synapses.  While our knowledge of CB1 localization in the nervous system has advanced tremendously over the past 15 yr, there is still more to learn.  Particularly pressing is the need for (1) detailed anatomical studies of brain regions important in the therapeutic actions of drugs that modify the endocannabinoid system and (2) the detn. of the localization of the enzymes that synthesize, degrade, and transport the endocannabinoids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyn5OlPTVo9LVg90H21EOLACvtfcHk0lgD_6-M_lEQxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFeqsL0%253D&md5=9c050ab9a3d1ff72b874235e2d683594</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2F3-540-26573-2_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F3-540-26573-2_10%26sid%3Dliteratum%253Aachs%26aulast%3DMackie%26aufirst%3DK.%26atitle%3DDistribution%2520of%2520cannabinoid%2520receptors%2520in%2520the%2520central%2520and%2520peripheral%2520nervous%2520system%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2005%26volume%3D168%26spage%3D299%26epage%3D325%26doi%3D10.1007%2F3-540-26573-2_10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Amaya, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimosato, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span> </span><span class="NLM_article-title">Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span><span class="refDoi"> DOI: 10.1016/j.pain.2006.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.pain.2006.04.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2006&pages=175-183&author=F.+Amayaauthor=G.+Shimosatoauthor=Y.+Kawasakiauthor=S.+Hashimotoauthor=Y.+Tanakaauthor=R.+R.+Jiauthor=M.+Tanaka&title=Induction+of+CB1+cannabinoid+receptor+by+inflammation+in+primary+afferent+neurons+facilitates+antihyperalgesic+effect+of+peripheral+CB1+agonist&doi=10.1016%2Fj.pain.2006.04.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2006.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2006.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DAmaya%26aufirst%3DF.%26aulast%3DShimosato%26aufirst%3DG.%26aulast%3DKawasaki%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DR.%2BR.%26aulast%3DTanaka%26aufirst%3DM.%26atitle%3DInduction%2520of%2520CB1%2520cannabinoid%2520receptor%2520by%2520inflammation%2520in%2520primary%2520afferent%2520neurons%2520facilitates%2520antihyperalgesic%2520effect%2520of%2520peripheral%2520CB1%2520agonist%26jtitle%3DPain%26date%3D2006%26volume%3D124%26spage%3D175%26epage%3D183%26doi%3D10.1016%2Fj.pain.2006.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gutierrez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farthing, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvonok, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohmann, A. G.</span><span> </span><span class="NLM_article-title">Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0706984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1038%2Fsj.bjp.0706984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=17160008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFeqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2007&pages=153-163&author=T.+Gutierrezauthor=J.+N.+Farthingauthor=A.+M.+Zvonokauthor=A.+Makriyannisauthor=A.+G.+Hohmann&title=Activation+of+peripheral+cannabinoid+CB1+and+CB2+receptors+suppresses+the+maintenance+of+inflammatory+nociception%3A+a+comparative+analysis&doi=10.1038%2Fsj.bjp.0706984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis</span></div><div class="casAuthors">Gutierrez, T.; Farthing, J. N.; Zvonok, A. M.; Makriyannis, A.; Hohmann, A. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-163</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Effects of locally administered agonists and antagonists for cannabinoid CB1 and CB2 receptors on mech. and thermal hypersensitivity were compared after the establishment of chronic inflammation.  Carrageenan was administered unilaterally to the rat hindpaw on day 1.  Prophylactic efficacy of locally administered CB1- and CB2-selective agonists, ACEA and AM1241, resp.- on mech. and thermal hypersensitivity were compared on day 2.  Pharmacol. specificity was evaluated using locally administered CB1 and CB2-selective antagonists, SR141716A and SR144528, resp.  Administration of either ACEA or AM1241 to the inflamed but not noninflamed paw suppressed the maintenance of carrageenan-evoked mech. hyperalgesia and tactile allodynia and attenuated thermal hyperalgesia.  The ACEA-induced suppression of mech. and thermal hypersensitivity was blocked by local injection of SR141716A but not SR144528.  AM1241 suppressed mech. hypersensitivity with the reverse pharmacol. specificity.  The AM1241-induced suppression of thermal hyperalgesia was blocked by SR144528 and to a lesser extent by SR14176A.  Coadministration of ACEA with AM1241 in the inflamed paw increased the magnitude but not the duration of thermal antihyperalgesia compared to intraplantar administration of either agonist alone.  Cannabinoids act locally through distinct CB1 and CB2 mechanisms to suppress mech. hypersensitivity after the establishment of chronic inflammation, at doses that produced modest changes in thermal hyperalgesia.  Additive antihyperalgesic effects were obsd. following prophylactic coadministration of the CB1- and CB2-selective agonists.  Our results suggest that peripheral cannabinoid antihyperalgesic actions may be exploited for treatment of inflammatory pain states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkP6JkKBYGErVg90H21EOLACvtfcHk0lhSNHkg4lVrrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFeqtQ%253D%253D&md5=61eda426c6f792b1483b3184cbf328b0</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706984%26sid%3Dliteratum%253Aachs%26aulast%3DGutierrez%26aufirst%3DT.%26aulast%3DFarthing%26aufirst%3DJ.%2BN.%26aulast%3DZvonok%26aufirst%3DA.%2BM.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DHohmann%26aufirst%3DA.%2BG.%26atitle%3DActivation%2520of%2520peripheral%2520cannabinoid%2520CB1%2520and%2520CB2%2520receptors%2520suppresses%2520the%2520maintenance%2520of%2520inflammatory%2520nociception%253A%2520a%2520comparative%2520analysis%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D150%26spage%3D153%26epage%3D163%26doi%3D10.1038%2Fsj.bjp.0706984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Johanek, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simone, D. A.</span><span> </span><span class="NLM_article-title">Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">432</span><span class="NLM_x">–</span> <span class="NLM_lpage">442</span><span class="refDoi"> DOI: 10.1016/j.pain.2004.02.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.pain.2004.02.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2004&pages=432-442&author=L.+M.+Johanekauthor=D.+A.+Simone&title=Activation+of+peripheral+cannabinoid+receptors+attenuates+cutaneous+hyperalgesia+produced+by+a+heat+injury&doi=10.1016%2Fj.pain.2004.02.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2004.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2004.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DJohanek%26aufirst%3DL.%2BM.%26aulast%3DSimone%26aufirst%3DD.%2BA.%26atitle%3DActivation%2520of%2520peripheral%2520cannabinoid%2520receptors%2520attenuates%2520cutaneous%2520hyperalgesia%2520produced%2520by%2520a%2520heat%2520injury%26jtitle%3DPain%26date%3D2004%26volume%3D109%26spage%3D432%26epage%3D442%26doi%3D10.1016%2Fj.pain.2004.02.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Richardson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, K. M.</span><span> </span><span class="NLM_article-title">Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">119</span><span class="refDoi"> DOI: 10.1016/S0304-3959(97)00213-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2FS0304-3959%2897%2900213-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1998&pages=111-119&author=J.+D.+Richardsonauthor=S.+Kiloauthor=K.+M.+Hargreaves&title=Cannabinoids+reduce+hyperalgesia+and+inflammation+via+interaction+with+peripheral+CB1+receptors&doi=10.1016%2FS0304-3959%2897%2900213-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1016%2FS0304-3959%2897%2900213-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3959%252897%252900213-3%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DJ.%2BD.%26aulast%3DKilo%26aufirst%3DS.%26aulast%3DHargreaves%26aufirst%3DK.%2BM.%26atitle%3DCannabinoids%2520reduce%2520hyperalgesia%2520and%2520inflammation%2520via%2520interaction%2520with%2520peripheral%2520CB1%2520receptors%26jtitle%3DPain%26date%3D1998%26volume%3D75%26spage%3D111%26epage%3D119%26doi%3D10.1016%2FS0304-3959%2897%2900213-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Agarwal, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacher, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tegeder, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaya, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constantin, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalski, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsicano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monory, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marian, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batkai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parolaro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kress, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolf, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuner, R.</span><span> </span><span class="NLM_article-title">Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">870</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span><span class="refDoi"> DOI: 10.1038/nn1916</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1038%2Fnn1916" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=17558404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmvFKmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=870-879&author=N.+Agarwalauthor=P.+Pacherauthor=I.+Tegederauthor=F.+Amayaauthor=C.+E.+Constantinauthor=G.+J.+Brennerauthor=T.+Rubinoauthor=C.+W.+Michalskiauthor=G.+Marsicanoauthor=K.+Monoryauthor=K.+Mackieauthor=C.+Marianauthor=S.+Batkaiauthor=D.+Parolaroauthor=M.+J.+Fischerauthor=P.+Reehauthor=G.+Kunosauthor=M.+Kressauthor=B.+Lutzauthor=C.+J.+Woolfauthor=R.+Kuner&title=Cannabinoids+mediate+analgesia+largely+via+peripheral+type+1+cannabinoid+receptors+in+nociceptors&doi=10.1038%2Fnn1916"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors</span></div><div class="casAuthors">Agarwal, Nitin; Pacher, Pal; Tegeder, Irmgard; Amaya, Fumimasa; Constantin, Cristina E.; Brenner, Gary J.; Rubino, Tiziana; Michalski, Christoph W.; Marsicano, Giovanni; Monory, Krisztina; Mackie, Ken; Marian, Claudiu; Batkai, Sandor; Parolaro, Daniela; Fischer, Michael J.; Reeh, Peter; Kunos, George; Kress, Michaela; Lutz, Beat; Woolf, Clifford J.; Kuner, Rohini</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">870-879</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although endocannabinoids constitute one of the first lines of defense against pain, the anatomical locus and the precise receptor mechanisms underlying cannabinergic modulation of pain are uncertain.  Clin. exploitation of the system is severely hindered by the cognitive deficits, memory impairment, motor disturbances and psychotropic effects resulting from the central actions of cannabinoids.  We deleted the type 1 cannabinoid receptor (CB1) specifically in nociceptive neurons localized in the peripheral nervous system of mice, preserving its expression in the CNS, and analyzed these genetically modified mice in preclin. models of inflammatory and neuropathic pain.  The nociceptor-specific loss of CB1 substantially reduced the analgesia produced by local and systemic, but not intrathecal, delivery of cannabinoids.  We conclude that the contribution of CB1-type receptors expressed on the peripheral terminals of nociceptors to cannabinoid-induced analgesia is paramount, which should enable the development of peripherally acting CB1 analgesic agonists without any central side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAZzekYhyFgbVg90H21EOLACvtfcHk0lhzlMt1rPjPzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmvFKmsL8%253D&md5=d10b61aba8255952cbbd5fc1ab7f796e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnn1916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn1916%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DN.%26aulast%3DPacher%26aufirst%3DP.%26aulast%3DTegeder%26aufirst%3DI.%26aulast%3DAmaya%26aufirst%3DF.%26aulast%3DConstantin%26aufirst%3DC.%2BE.%26aulast%3DBrenner%26aufirst%3DG.%2BJ.%26aulast%3DRubino%26aufirst%3DT.%26aulast%3DMichalski%26aufirst%3DC.%2BW.%26aulast%3DMarsicano%26aufirst%3DG.%26aulast%3DMonory%26aufirst%3DK.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DMarian%26aufirst%3DC.%26aulast%3DBatkai%26aufirst%3DS.%26aulast%3DParolaro%26aufirst%3DD.%26aulast%3DFischer%26aufirst%3DM.%2BJ.%26aulast%3DReeh%26aufirst%3DP.%26aulast%3DKunos%26aufirst%3DG.%26aulast%3DKress%26aufirst%3DM.%26aulast%3DLutz%26aufirst%3DB.%26aulast%3DWoolf%26aufirst%3DC.%2BJ.%26aulast%3DKuner%26aufirst%3DR.%26atitle%3DCannabinoids%2520mediate%2520analgesia%2520largely%2520via%2520peripheral%2520type%25201%2520cannabinoid%2520receptors%2520in%2520nociceptors%26jtitle%3DNat.%2520Neurosci.%26date%3D2007%26volume%3D10%26spage%3D870%26epage%3D879%26doi%3D10.1038%2Fnn1916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Spigelman, I.</span><span> </span><span class="NLM_article-title">Frontiers in neuroscience: therapeutic targeting of peripheral cannabinoid receptors in inflammatory and neuropathic pain states</span>. In  <span class="citation_source-book">Translational Pain Research: from Mouse to Man</span>; <span class="NLM_contrib-group">Kruger, L.; Light, A. R.</span>, Eds.; <span class="NLM_publisher-name">Taylor & Francis Group, LLC</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=99-137&author=I.+Spigelmanauthor=L.+Kruger&author=A.+R.+Light&title=Translational+Pain+Research%3A+from+Mouse+to+Man"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSpigelman%26aufirst%3DI.%26atitle%3DFrontiers%2520in%2520neuroscience%253A%2520therapeutic%2520targeting%2520of%2520peripheral%2520cannabinoid%2520receptors%2520in%2520inflammatory%2520and%2520neuropathic%2520pain%2520states%26btitle%3DTranslational%2520Pain%2520Research%253A%2520from%2520Mouse%2520to%2520Man%26aulast%3DKruger%26aufirst%3DL.%26pub%3DTaylor%2520%2526%2520Francis%2520Group%252C%2520LLC%26date%3D2010%26spage%3D99%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Pertwee, R. G.</span><span> </span><span class="NLM_article-title">The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0707442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1038%2Fsj.bjp.0707442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=17828291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFCkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=199-215&author=R.+G.+Pertwee&title=The+diverse+CB1+and+CB2+receptor+pharmacology+of+three+plant+cannabinoids%3A+%CE%949-tetrahydrocannabinol%2C+cannabidiol+and+%CE%949-tetrahydrocannabivarin&doi=10.1038%2Fsj.bjp.0707442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin</span></div><div class="casAuthors">Pertwee, R. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-215</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cannabis sativa is the source of a unique set of compds. known collectively as plant cannabinoids or phytocannabinoids.  This review focuses on the manner with which three of these compds., (-)-trans-Δ9-tetrahydrocannabinol (Δ9-THC), (-)-cannabidiol (CBD) and (-)-trans-Δ9-tetrahydrocannabivarin (Δ9-THCV), interact with cannabinoid CB1 and CB2 receptors. Δ9-THC, the main psychotropic constituent of cannabis, is a CB1 and CB2 receptor partial agonist and in line with classical pharmacol., the responses it elicits appear to be strongly influenced both by the expression level and signalling efficiency of cannabinoid receptors and by ongoing endogenous cannabinoid release.  CBD displays unexpectedly high potency as an antagonist of CB1/CB2 receptor agonists in CB1- and CB2-expressing cells or tissues, the manner with which it interacts with CB2 receptors providing a possible explanation for its ability to inhibit evoked immune cell migration. Δ9-THCV behaves as a potent CB2 receptor partial agonist in vitro.  In contrast, it antagonizes cannabinoid receptor agonists in CB1-expressing tissues.  This it does with relatively high potency and in a manner that is both tissue and ligand dependent. Δ9-THCV also interacts with CB1 receptors when administered in vivo, behaving either as a CB1 antagonist or, at higher doses, as a CB1 receptor agonist.  Brief mention is also made in this review, first of the prodn. by Δ9-THC of pharmacodynamic tolerance, second of current knowledge about the extent to which Δ9-THC, CBD and Δ9-THCV interact with pharmacol. targets other than CB1 or CB2 receptors, and third of actual and potential therapeutic applications for each of these cannabinoids.  British Journal of Pharmacol. (2008) 153, 199-215; doi:10.1038/sj.bjp.0707442; published online 10 Sept. 2007.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdNia0Z97Wz7Vg90H21EOLACvtfcHk0lgnOeOW1qrFrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFCkuw%253D%253D&md5=53187d5a54c048cbbd0d0b0143feb206</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707442%26sid%3Dliteratum%253Aachs%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26atitle%3DThe%2520diverse%2520CB1%2520and%2520CB2%2520receptor%2520pharmacology%2520of%2520three%2520plant%2520cannabinoids%253A%2520%25CE%25949-tetrahydrocannabinol%252C%2520cannabidiol%2520and%2520%25CE%25949-tetrahydrocannabivarin%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D199%26epage%3D215%26doi%3D10.1038%2Fsj.bjp.0707442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bridges, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, A. S.</span><span> </span><span class="NLM_article-title">The synthetic cannabinoid WIN55,212–2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">586</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0704110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1038%2Fsj.bjp.0704110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=11399676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkvFSlur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2001&pages=586-594&author=D.+Bridgesauthor=K.+Ahmadauthor=A.+S.+Rice&title=The+synthetic+cannabinoid+WIN55%2C212%E2%80%932+attenuates+hyperalgesia+and+allodynia+in+a+rat+model+of+neuropathic+pain&doi=10.1038%2Fsj.bjp.0704110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain</span></div><div class="casAuthors">Bridges, Daniel; Ahmad, Kamran; Rice, Andrew S. C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">586-594</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The analgesic properties of the synthetic cannabinoid WIN55,212-2 were investigated in a model of neuropathic pain.  In male Wistar rats, bilateral hind limb withdrawal thresholds to cold, mech. and noxious thermal stimuli were measured.  Following this, unilateral L5 spinal nerve ligation was performed.  Seven days later, sensory thresholds were reassessed and the development of allodynia to cold and mech. stimuli and hyperalgesia to a noxious thermal stimulus confirmed.  The effect of WIN55,212-2 (0.1-5.0 mg kg-1, i.p.) on the signs of neuropathy was then detd.; there was a dose related reversal of all three signs of painful neuropathy at doses which did not generally alter sensory thresholds in the contralateral unligated limb.  This effect was prevented by co-administration of the CB1 receptor antagonist SR141716a, but not by co-administration of the CB2 receptor antagonist SR144528, suggesting this action of WIN55,212-2 is mediated via the CB1 receptor.  Administration of SR141716a alone had no affect on the obsd. allodynia and hyperalgesia, which does not support the concept of an endogenous analgesic tone.  These data indicate that cannabinoids may have therapeutic potential in neuropathic pain, and that this effect is mediated through the CB1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofAvZq7kfVY7Vg90H21EOLACvtfcHk0lgnOeOW1qrFrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkvFSlur0%253D&md5=65055bbe7877dd7e55fec92950a3cb54</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704110%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DD.%26aulast%3DAhmad%26aufirst%3DK.%26aulast%3DRice%26aufirst%3DA.%2BS.%26atitle%3DThe%2520synthetic%2520cannabinoid%2520WIN55%252C212%25E2%2580%25932%2520attenuates%2520hyperalgesia%2520and%2520allodynia%2520in%2520a%2520rat%2520model%2520of%2520neuropathic%2520pain%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D133%26spage%3D586%26epage%3D594%26doi%3D10.1038%2Fsj.bjp.0704110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Costa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colleoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trovato, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotgiu, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giagnoni, G.</span><span> </span><span class="NLM_article-title">Repeated treatment with the synthetic cannabinoid WIN 55,212–2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0705587</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1038%2Fsj.bjp.0705587" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=14662732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFaltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2004&pages=4-8&author=B.+Costaauthor=M.+Colleoniauthor=S.+Contiauthor=A.+E.+Trovatoauthor=M.+Bianchiauthor=M.+L.+Sotgiuauthor=G.+Giagnoni&title=Repeated+treatment+with+the+synthetic+cannabinoid+WIN+55%2C212%E2%80%932+reduces+both+hyperalgesia+and+production+of+pronociceptive+mediators+in+a+rat+model+of+neuropathic+pain&doi=10.1038%2Fsj.bjp.0705587"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain</span></div><div class="casAuthors">Costa, B.; Colleoni, M.; Conti, S.; Trovato, A. E.; Bianchi, M.; Sotgiu, M. L.; Giagnoni, G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-8</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The antinociceptive properties of cannabinoids in persistent pain are not fully elucidated.  We investigated the effect of repeated treatment with the synthetic cannabinoid receptor agonist WIN 55,212-2 on the neuropathic pain induced in rats by chronic constriction of the sciatic nerve.  WIN 55,212-2 administered daily throughout the development of neuropathy reversed the hyperalgesia, at a dose (0.1 mg kg-1, s.c.) that had no effect on the nociceptive responses of either paw contralateral to the sciatic ligation or of animals subjected to sham surgery.  At 14 days after injury, the levels of mediators known to be involved in neuropathic pain, such as prostaglandin E2, NO and the neuronal NOS, were increased.  Repeated treatment with WIN 55,212-2 abolished these increases.  In the light of the current clin. need for neuropathic pain treatments, these findings indicate that cannabinoid agonists, at doses devoid of psychoactive effects, could constitute important compds. for the development of new analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfUpCdA8eperVg90H21EOLACvtfcHk0lgnOeOW1qrFrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFaltbY%253D&md5=8cd5073c34b0f25453b269e390d99767</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705587%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DB.%26aulast%3DColleoni%26aufirst%3DM.%26aulast%3DConti%26aufirst%3DS.%26aulast%3DTrovato%26aufirst%3DA.%2BE.%26aulast%3DBianchi%26aufirst%3DM.%26aulast%3DSotgiu%26aufirst%3DM.%2BL.%26aulast%3DGiagnoni%26aufirst%3DG.%26atitle%3DRepeated%2520treatment%2520with%2520the%2520synthetic%2520cannabinoid%2520WIN%252055%252C212%25E2%2580%25932%2520reduces%2520both%2520hyperalgesia%2520and%2520production%2520of%2520pronociceptive%2520mediators%2520in%2520a%2520rat%2520model%2520of%2520neuropathic%2520pain%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D141%26spage%3D4%26epage%3D8%26doi%3D10.1038%2Fsj.bjp.0705587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, D. J.</span><span> </span><span class="NLM_article-title">Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1016/0304-3959(95)00022-K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2F0304-3959%2895%2900022-K" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1995&pages=353-364&author=J.+Maoauthor=D.+D.+Priceauthor=D.+J.+Mayer&title=Experimental+mononeuropathy+reduces+the+antinociceptive+effects+of+morphine%3A+implications+for+common+intracellular+mechanisms+involved+in+morphine+tolerance+and+neuropathic+pain&doi=10.1016%2F0304-3959%2895%2900022-K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2895%2900022-K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252895%252900022-K%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BD.%26aulast%3DMayer%26aufirst%3DD.%2BJ.%26atitle%3DExperimental%2520mononeuropathy%2520reduces%2520the%2520antinociceptive%2520effects%2520of%2520morphine%253A%2520implications%2520for%2520common%2520intracellular%2520mechanisms%2520involved%2520in%2520morphine%2520tolerance%2520and%2520neuropathic%2520pain%26jtitle%3DPain%26date%3D1995%26volume%3D61%26spage%3D353%26epage%3D364%26doi%3D10.1016%2F0304-3959%2895%2900022-K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ossipov, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span> </span><span class="NLM_article-title">The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">199</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span><span class="refDoi"> DOI: 10.1016/0304-3940(95)12022-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2F0304-3940%2895%2912022-V" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=199&publication_year=1995&pages=87-90&author=M.+H.+Ossipovauthor=Y.+Lopezauthor=M.+L.+Nicholsauthor=D.+Bianauthor=F.+Porreca&title=The+loss+of+antinociceptive+efficacy+of+spinal+morphine+in+rats+with+nerve+ligation+injury+is+prevented+by+reducing+spinal+afferent+drive&doi=10.1016%2F0304-3940%2895%2912022-V"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2F0304-3940%2895%2912022-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3940%252895%252912022-V%26sid%3Dliteratum%253Aachs%26aulast%3DOssipov%26aufirst%3DM.%2BH.%26aulast%3DLopez%26aufirst%3DY.%26aulast%3DNichols%26aufirst%3DM.%2BL.%26aulast%3DBian%26aufirst%3DD.%26aulast%3DPorreca%26aufirst%3DF.%26atitle%3DThe%2520loss%2520of%2520antinociceptive%2520efficacy%2520of%2520spinal%2520morphine%2520in%2520rats%2520with%2520nerve%2520ligation%2520injury%2520is%2520prevented%2520by%2520reducing%2520spinal%2520afferent%2520drive%26jtitle%3DNeurosci.%2520Lett.%26date%3D1995%26volume%3D199%26spage%3D87%26epage%3D90%26doi%3D10.1016%2F0304-3940%2895%2912022-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rashid, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, H.</span><span> </span><span class="NLM_article-title">Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span><span class="refDoi"> DOI: 10.1124/jpet.103.060582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1124%2Fjpet.103.060582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=14718584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivFamur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=380-387&author=M.+H.+Rashidauthor=M.+Inoueauthor=K.+Todaauthor=H.+Ueda&title=Loss+of+peripheral+morphine+analgesia+contributes+to+the+reduced+effectiveness+of+systemic+morphine+in+neuropathic+pain&doi=10.1124%2Fjpet.103.060582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain</span></div><div class="casAuthors">Rashid, Md Harunor; Inoue, Makoto; Toda, Kazuo; Ueda, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">380-387</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">It is well known that the analgesic potency of morphine is reduced in neuropathic pain.  In this study, we demonstrate that the decreased effectiveness of systemic morphine in neuropathic pain might be caused by the loss of morphine analgesia at the periphery.  When given s.c. or i.t., the dose-response curves for morphine analgesia in Hargreaves thermal test were shifted rightward in partial sciatic nerve-injured mice compared with control sham-operated mice.  The dose-response curves for i.c.v. morphine analgesia, however, were unchanged in nerve-injured mice, indicating no decrease in morphine potency at the supraspinal level.  On the other hand, the dose-dependent analgesia produced by intraplantar (i.pl.) morphine in sham-operated mice almost completely disappeared in nerve-injured mice.  With the more sensitive algogenic-induced nociceptive flexion test, significant redn. in the analgesic potency of systemic morphine was obsd. for bradykinin (BK) nociception in nerve-injured mice, and the analgesic effect of i.pl. morphine against BK nociception in sham-operated mice disappeared in nerve-injured mice.  In immunohistochem. expts., we found that, under normal state, μ-opioid receptors (MOPs) were mainly expressed in small-diam. unmyelinated dorsal root ganglion (DRG) neurons and colocalized with bradykinin B2 receptors.  When we examd. MOP expression in the DRG of nerve-injured mice, we obsd. a drastic decrease in MOP expression.  Altogether, these data suggest that the lower potency of systemic morphine in neuropathic pain could be at least partly caused by the decreased MOP expression in DRG and subsequent loss of peripheral morphine analgesia in such a condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy5q3DvHJjcLVg90H21EOLACvtfcHk0lirCCpeTpYNBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivFamur0%253D&md5=ec8382a4d5ade2f5f956f9cc339d519e</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.060582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.060582%26sid%3Dliteratum%253Aachs%26aulast%3DRashid%26aufirst%3DM.%2BH.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DToda%26aufirst%3DK.%26aulast%3DUeda%26aufirst%3DH.%26atitle%3DLoss%2520of%2520peripheral%2520morphine%2520analgesia%2520contributes%2520to%2520the%2520reduced%2520effectiveness%2520of%2520systemic%2520morphine%2520in%2520neuropathic%2520pain%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D380%26epage%3D387%26doi%3D10.1124%2Fjpet.103.060582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ballantyne, J. C.</span><span> </span><span class="NLM_article-title">Opioid analgesia: perspectives on right use and utility</span> <span class="citation_source-journal">Pain Physician</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">491</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=479-491&author=J.+C.+Ballantyne&title=Opioid+analgesia%3A+perspectives+on+right+use+and+utility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBallantyne%26aufirst%3DJ.%2BC.%26atitle%3DOpioid%2520analgesia%253A%2520perspectives%2520on%2520right%2520use%2520and%2520utility%26jtitle%3DPain%2520Physician%26date%3D2007%26volume%3D10%26spage%3D479%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Ballantyne, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaForge, K. S.</span><span> </span><span class="NLM_article-title">Opioid dependence and addiction during opioid treatment of chronic pain</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1016/j.pain.2007.03.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.pain.2007.03.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=235-255&author=J.+C.+Ballantyneauthor=K.+S.+LaForge&title=Opioid+dependence+and+addiction+during+opioid+treatment+of+chronic+pain&doi=10.1016%2Fj.pain.2007.03.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11e&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2007.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2007.03.028%26sid%3Dliteratum%253Aachs%26aulast%3DBallantyne%26aufirst%3DJ.%2BC.%26aulast%3DLaForge%26aufirst%3DK.%2BS.%26atitle%3DOpioid%2520dependence%2520and%2520addiction%2520during%2520opioid%2520treatment%2520of%2520chronic%2520pain%26jtitle%3DPain%26date%3D2007%26volume%3D129%26spage%3D235%26epage%3D255%26doi%3D10.1016%2Fj.pain.2007.03.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Holtman, J. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jellish, W. S.</span><span> </span><span class="NLM_article-title">Opioid-induced hyperalgesia and burn pain</span> <span class="citation_source-journal">J. Burn Care Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">692</span><span class="NLM_x">–</span> <span class="NLM_lpage">701</span><span class="refDoi"> DOI: 10.1097/BCR.0b013e31825adcb0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1097%2FBCR.0b013e31825adcb0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=23143613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADC%252BC3s7isFelsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=692-701&author=J.+R.+Holtmanauthor=W.+S.+Jellish&title=Opioid-induced+hyperalgesia+and+burn+pain&doi=10.1097%2FBCR.0b013e31825adcb0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11fR"><div class="casContent"><span class="casTitleNuber">11f</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid-induced hyperalgesia and burn pain</span></div><div class="casAuthors">Holtman Joseph R Jr; Jellish W Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of burn care & research : official publication of the American Burn Association</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">692-701</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The treatment of pain produced during the management of burn injury has been an ongoing problem for physicians caring for these patients.  The main therapeutic option for analgesia has been the repeated and prolonged use of opioids.  The adverse effects of opioids are well known but the long term use of opioids which produces tolerance with accompanying dose escalation and dependence is most problematic.  Another potentially important consequence of opioid exposure that sometimes masks as tolerance is that of opioid induced hyperalgesia.  This syndrome is manifest as enhanced pain, sensitivity and loss of analgesic efficacy in patients treated with opioids who actually become sensitized to painful stimuli.  This article focuses on the treatment of burn pain and how current analgesic therapies with opioids may cause hyperalgesia and affect the adequacy of treatment for burn pain.  This article also provides possible modalities to help therapeutically manage these patients and considers future analgesic strategies which may help to improve pain management in this complicated patient population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVktREYYSs3bxanA7vODO6fW6udTcc2eY3mGEuJJ9uTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7isFelsg%253D%253D&md5=a5c6121786efc6314cf14d5e800b697c</span></div><a href="/servlet/linkout?suffix=cit11f&amp;dbid=16384&amp;doi=10.1097%2FBCR.0b013e31825adcb0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FBCR.0b013e31825adcb0%26sid%3Dliteratum%253Aachs%26aulast%3DHoltman%26aufirst%3DJ.%2BR.%26aulast%3DJellish%26aufirst%3DW.%2BS.%26atitle%3DOpioid-induced%2520hyperalgesia%2520and%2520burn%2520pain%26jtitle%3DJ.%2520Burn%2520Care%2520Res.%26date%3D2012%26volume%3D33%26spage%3D692%26epage%3D701%26doi%3D10.1097%2FBCR.0b013e31825adcb0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Pohl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L.</span><span> </span><span class="NLM_article-title">Chronic pain and addiction: challenging co-occurring disorders</span> <span class="citation_source-journal">J. Psychoact. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1080/02791072.2012.684621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1080%2F02791072.2012.684621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=22880539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADC%252BC38fmvFyisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2012&pages=119-124&author=M.+Pohlauthor=L.+Smith&title=Chronic+pain+and+addiction%3A+challenging+co-occurring+disorders&doi=10.1080%2F02791072.2012.684621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11gR"><div class="casContent"><span class="casTitleNuber">11g</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic pain and addiction: challenging co-occurring disorders</span></div><div class="casAuthors">Pohl Mel; Smith Logan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychoactive drugs</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-24</span>
        ISSN:<span class="NLM_cas:issn">0279-1072</span>.
    </div><div class="casAbstract">Chronic pain is commonly treated by prescribing an opioid medication.  For those suffering from both chronic pain and substance dependence, barriers to adequate pain management increase.  This often causes both disorders to exacerbate one another.  Effective treatment may also be hampered by opioid-induced hyperalgesia, tolerance, physical dependence, "chemical coping," and diminished physical and emotional functioning.  This article reviews current research trends, potential problems stemming from prescription opioid use, and suggestions for clinical practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSeg6RX_ioKkzAEfvC7EH1LfW6udTcc2eY3mGEuJJ9uTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38fmvFyisg%253D%253D&md5=54113e585c97d355487d3df4fc00ff9e</span></div><a href="/servlet/linkout?suffix=cit11g&amp;dbid=16384&amp;doi=10.1080%2F02791072.2012.684621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F02791072.2012.684621%26sid%3Dliteratum%253Aachs%26aulast%3DPohl%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DL.%26atitle%3DChronic%2520pain%2520and%2520addiction%253A%2520challenging%2520co-occurring%2520disorders%26jtitle%3DJ.%2520Psychoact.%2520Drugs%26date%3D2012%26volume%3D44%26spage%3D119%26epage%3D124%26doi%3D10.1080%2F02791072.2012.684621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Calignano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Rana, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuffrida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Control of pain initiation by endogenous cannabinoids</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">394</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span><span class="refDoi"> DOI: 10.1038/28393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1038%2F28393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=9685157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADyaK1cXkvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=1998&pages=277-281&author=A.+Calignanoauthor=G.+La+Ranaauthor=A.+Giuffridaauthor=D.+Piomelli&title=Control+of+pain+initiation+by+endogenous+cannabinoids&doi=10.1038%2F28393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Control of pain initiation by endogenous cannabinoids</span></div><div class="casAuthors">Calignano, Antonio; La Rana, Giovanna; Giuffrida, Andrea; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">394</span>
        (<span class="NLM_cas:issue">6690</span>),
    <span class="NLM_cas:pages">277-281</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The potent analgesic effects of cannabis-like drugs and the presence of CB1-type cannabinoid receptors in pain-processing areas of the brain and spinal cord indicate that endogenous cannabinoids such as anandamide may contribute to the control of pain transmission within the central nervous system (CNS).  Here the authors show that anandamide attenuates the pain behavior produced by chem. damage to cutaneous tissue by interacting with CB1-like cannabinoid receptors located outside the CNS.  Palmitylethanolamide (PEA), which is released together with anandamide from a common phospholipid precursor, exerts a similar effect by activating peripheral CB2-like receptors.  When administered together, the two compds. at synergistically reducing pain responses 100-fold more potently than does each compd. alone.  Gas-chromatog./mass-spectrometry measurements indicate that the levels of anandamide and PEA in the skin are enough to cause a tonic activation of local cannabinoid receptors.  In agreement with this possibility, the CB1 antagonist SR141716A and the CB2 antagonist SR144528 prolong and enhance the pain behavior produced by tissue damage.  These results indicate that peripheral CB1-like and CB2-like receptors participate in the intrinsic control of pain initiation and that locally generated anandamide and PEA may mediate this effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpKwHMI3BI9LVg90H21EOLACvtfcHk0lja6Gxsm3d4oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvVKjt7w%253D&md5=811026d275d0cba5c01567bdebe16ec8</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1038%2F28393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F28393%26sid%3Dliteratum%253Aachs%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DGiuffrida%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DControl%2520of%2520pain%2520initiation%2520by%2520endogenous%2520cannabinoids%26jtitle%3DNature%26date%3D1998%26volume%3D394%26spage%3D277%26epage%3D281%26doi%3D10.1038%2F28393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Elmes, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winyard, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhurst, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendall, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, V.</span><span> </span><span class="NLM_article-title">Activation of CB<sub>1</sub> and CB<sub>2</sub> receptors attenuates the induction and maintenance of inflammatory pain in the rat</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span><span class="refDoi"> DOI: 10.1016/j.pain.2005.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.pain.2005.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=16289798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSjsb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2005&pages=327-335&author=S.+J.+Elmesauthor=L.+A.+Winyardauthor=S.+J.+Medhurstauthor=N.+M.+Claytonauthor=A.+W.+Wilsonauthor=D.+A.+Kendallauthor=V.+Chapman&title=Activation+of+CB1+and+CB2+receptors+attenuates+the+induction+and+maintenance+of+inflammatory+pain+in+the+rat&doi=10.1016%2Fj.pain.2005.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat</span></div><div class="casAuthors">Elmes, Steven J. R.; Winyard, Lisa A.; Medhurst, Stephen J.; Clayton, Nick M.; Wilson, Alex W.; Kendall, David A.; Chapman, Victoria</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">327-335</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The aim of the present study was to investigate the effects of cannabinoid agonists on established inflammatory hyperalgesia.  We have compared the effects of pre-administration vs. post-administration of a potent non-selective cannabinoid agonist HU210 and a selective CB2 receptor agonist JWH-133 on hindpaw wt. bearing and paw edema in the carrageenan model of inflammatory hyperalgesia.  For comparative purposes we also detd. the effects of the μ-opioid receptor agonist morphine and the COX2 inhibitor rofecoxib in this model.  At 3 h following intraplantar injection of carrageenan (2%, 100 μl) there was a significant (P<0.001) redn. in wt. bearing on the ipsilateral hindpaw, compared to vehicle treated rats and a concomitant increase in ipsilateral hindpaw vol. (P<0.001), compared to vehicle treated rats.  Systemic administration of HU210 (10 μg/kg) and JWH-133 (10 mg/kg) at 3 h following injection of carrageenan, significantly attenuated decreases in ipsilateral hindpaw wt. bearing (P<0.05 for both) and paw vol. (P<0.001 for both).  Pre-administration of HU210 and JWH-133 had similar effects on wt. bearing in this model.  Pre-administered HU210 also significantly decreased carrageenan-induced changes in paw vol. (P<0.001), this was not the case for JWH-133.  Effects of post-administered HU210 and JWH-133 on ipsilateral hindpaw wt. bearing and paw vol. were comparable to the effect of systemic post-administration of morphine and rofecoxib (3 mg/kg for both).  In summary, both HU210 and JWH-133 attenuated established inflammatory hypersensitivity and swelling, suggesting that cannabinoid-based drugs have clin. potential for the treatment of established inflammatory pain responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZo9E44b0qx7Vg90H21EOLACvtfcHk0lja6Gxsm3d4oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSjsb3E&md5=03b0af0fd44cb8b40660e093dd44892d</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2005.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2005.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DElmes%26aufirst%3DS.%2BJ.%26aulast%3DWinyard%26aufirst%3DL.%2BA.%26aulast%3DMedhurst%26aufirst%3DS.%2BJ.%26aulast%3DClayton%26aufirst%3DN.%2BM.%26aulast%3DWilson%26aufirst%3DA.%2BW.%26aulast%3DKendall%26aufirst%3DD.%2BA.%26aulast%3DChapman%26aufirst%3DV.%26atitle%3DActivation%2520of%2520CB1%2520and%2520CB2%2520receptors%2520attenuates%2520the%2520induction%2520and%2520maintenance%2520of%2520inflammatory%2520pain%2520in%2520the%2520rat%26jtitle%3DPain%26date%3D2005%26volume%3D118%26spage%3D327%26epage%3D335%26doi%3D10.1016%2Fj.pain.2005.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Malan, T. P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mata, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderah, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span> </span><span class="NLM_article-title">CB<sub>2</sub> cannabinoid receptor-mediated peripheral antinociception</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.1016/S0304-3959(01)00321-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2FS0304-3959%2801%2900321-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=11514083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtFWis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2001&pages=239-245&author=T.+P.+Malanauthor=M.+M.+Ibrahimauthor=H.+Dengauthor=Q.+Liuauthor=H.+P.+Mataauthor=T.+Vanderahauthor=F.+Porrecaauthor=A.+Makriyannis&title=CB2+cannabinoid+receptor-mediated+peripheral+antinociception&doi=10.1016%2FS0304-3959%2801%2900321-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12c</span><div class="casTitle"><span class="NLM_cas:atitle">CB2 cannabinoid receptor-mediated peripheral antinociception</span></div><div class="casAuthors">Malan, T. P., Jr.; Ibrahim, M. M.; Deng, H.; Liu, Q.; Mata, H. P.; Vanderah, T.; Porreca, F.; Makriyannis, A.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">239-245</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Cannabinoid receptor agonists diminish responses to painful stimuli.  Extensive evidence implicates the CB1 receptor in the prodn. of antinociception.  However, the capacity of CB2 receptors, which are located outside the central nervous system (CNS), to produce antinociception is not known.  Using AM1241, a CB2 receptor-selective agonist, the authors demonstrate that CB2 receptors produce antinociception to thermal stimuli.  Injection of AM1241 in the hindpaw produced antinociception to a stimulus applied to the same paw.  Injection of an equiv. dose of AM1241 into the paw contralateral to the side of testing did not.  The antinociceptive actions of AM1241 were blocked by the CB2 receptor-selective antagonist AM630, but not by the CB1 receptor-selective antagonist AM251.  AM1241 also produced antinociception when injected systemically (i.p.).  The antinociceptive actions of systemic AM1241 were blocked by injection of AM630 into the paw where the thermal stimulus was applied, but not the contralateral paw.  These findings demonstrate the local, peripheral nature of CB2 cannabinoid antinociception.  AM1241 did not produce the CNS cannabinoid effects of hypothermia, catalepsy, inhibition of activity or impaired ambulation, while this tetrad of effects was produced by the mixed CB1/CB2 receptor agonist WIN55,212-2.  Peripheral antinociception without CNS effects is consistent with the peripheral distribution of CB2 receptors.  CB2 receptor agonists may have promise clin. for the treatment of pain without CNS cannabinoid side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbSM0BBV85Z7Vg90H21EOLACvtfcHk0lja6Gxsm3d4oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtFWis7Y%253D&md5=640486f3ba52db896bdc7fe2f040381c</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1016%2FS0304-3959%2801%2900321-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3959%252801%252900321-9%26sid%3Dliteratum%253Aachs%26aulast%3DMalan%26aufirst%3DT.%2BP.%26aulast%3DIbrahim%26aufirst%3DM.%2BM.%26aulast%3DDeng%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DMata%26aufirst%3DH.%2BP.%26aulast%3DVanderah%26aufirst%3DT.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DCB2%2520cannabinoid%2520receptor-mediated%2520peripheral%2520antinociception%26jtitle%3DPain%26date%3D2001%26volume%3D93%26spage%3D239%26epage%3D245%26doi%3D10.1016%2FS0304-3959%2801%2900321-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Nackley, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suplita, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohmann, A. G.</span><span> </span><span class="NLM_article-title">A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">659</span><span class="NLM_x">–</span> <span class="NLM_lpage">670</span><span class="refDoi"> DOI: 10.1016/S0306-4522(02)00870-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2FS0306-4522%2802%2900870-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2003&pages=659-670&author=A.+G.+Nackleyauthor=R.+L.+Suplitaauthor=A.+G.+Hohmann&title=A+peripheral+cannabinoid+mechanism+suppresses+spinal+fos+protein+expression+and+pain+behavior+in+a+rat+model+of+inflammation&doi=10.1016%2FS0306-4522%2802%2900870-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=10.1016%2FS0306-4522%2802%2900870-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0306-4522%252802%252900870-9%26sid%3Dliteratum%253Aachs%26aulast%3DNackley%26aufirst%3DA.%2BG.%26aulast%3DSuplita%26aufirst%3DR.%2BL.%26aulast%3DHohmann%26aufirst%3DA.%2BG.%26atitle%3DA%2520peripheral%2520cannabinoid%2520mechanism%2520suppresses%2520spinal%2520fos%2520protein%2520expression%2520and%2520pain%2520behavior%2520in%2520a%2520rat%2520model%2520of%2520inflammation%26jtitle%3DNeuroscience%26date%3D2003%26volume%3D117%26spage%3D659%26epage%3D670%26doi%3D10.1016%2FS0306-4522%2802%2900870-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Quartilho, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mata, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderah, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malan, T. P.,  Jr.</span><span> </span><span class="NLM_article-title">Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors</span> <span class="citation_source-journal">Anesthesiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">955</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span><span class="refDoi"> DOI: 10.1097/00000542-200310000-00031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1097%2F00000542-200310000-00031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2003&pages=955-960&author=A.+Quartilhoauthor=H.+P.+Mataauthor=M.+M.+Ibrahimauthor=T.+W.+Vanderahauthor=F.+Porrecaauthor=A.+Makriyannisauthor=T.+P.+Malan&title=Inhibition+of+inflammatory+hyperalgesia+by+activation+of+peripheral+CB2+cannabinoid+receptors&doi=10.1097%2F00000542-200310000-00031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12e&amp;dbid=16384&amp;doi=10.1097%2F00000542-200310000-00031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00000542-200310000-00031%26sid%3Dliteratum%253Aachs%26aulast%3DQuartilho%26aufirst%3DA.%26aulast%3DMata%26aufirst%3DH.%2BP.%26aulast%3DIbrahim%26aufirst%3DM.%2BM.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DMalan%26aufirst%3DT.%2BP.%26atitle%3DInhibition%2520of%2520inflammatory%2520hyperalgesia%2520by%2520activation%2520of%2520peripheral%2520CB2%2520cannabinoid%2520receptors%26jtitle%3DAnesthesiology%26date%3D2003%26volume%3D99%26spage%3D955%26epage%3D960%26doi%3D10.1097%2F00000542-200310000-00031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Guindon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P.</span><span> </span><span class="NLM_article-title">Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">814</span><span class="NLM_x">–</span> <span class="NLM_lpage">823</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2005.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.neuropharm.2005.12.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=814-823&author=J.+Guindonauthor=P.+Beaulieu&title=Antihyperalgesic+effects+of+local+injections+of+anandamide%2C+ibuprofen%2C+rofecoxib+and+their+combinations+in+a+model+of+neuropathic+pain&doi=10.1016%2Fj.neuropharm.2005.12.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12f&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2005.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2005.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DGuindon%26aufirst%3DJ.%26aulast%3DBeaulieu%26aufirst%3DP.%26atitle%3DAntihyperalgesic%2520effects%2520of%2520local%2520injections%2520of%2520anandamide%252C%2520ibuprofen%252C%2520rofecoxib%2520and%2520their%2520combinations%2520in%2520a%2520model%2520of%2520neuropathic%2520pain%26jtitle%3DNeuropharmacology%26date%3D2006%26volume%3D50%26spage%3D814%26epage%3D823%26doi%3D10.1016%2Fj.neuropharm.2005.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cheng, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pourashraf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walpole, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salois, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St-Onge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payza, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lessard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszewski, M. J.</span><span> </span><span class="NLM_article-title">γ-Carbolines: a novel class of cannabinoid agonists with high aqueous solubility and restricted CNS penetration</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1619</span><span class="NLM_x">–</span> <span class="NLM_lpage">1624</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.12.124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.bmcl.2011.12.124" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1619-1624&author=Y.+X.+Chengauthor=M.+Pourashrafauthor=X.+Luoauthor=S.+Srivastavaauthor=C.+Walpoleauthor=D.+Saloisauthor=S.+St-Ongeauthor=K.+Payzaauthor=E.+Lessardauthor=X.+H.+Yuauthor=M.+J.+Tomaszewski&title=%CE%B3-Carbolines%3A+a+novel+class+of+cannabinoid+agonists+with+high+aqueous+solubility+and+restricted+CNS+penetration&doi=10.1016%2Fj.bmcl.2011.12.124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.12.124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.12.124%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%2BX.%26aulast%3DPourashraf%26aufirst%3DM.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DSrivastava%26aufirst%3DS.%26aulast%3DWalpole%26aufirst%3DC.%26aulast%3DSalois%26aufirst%3DD.%26aulast%3DSt-Onge%26aufirst%3DS.%26aulast%3DPayza%26aufirst%3DK.%26aulast%3DLessard%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DX.%2BH.%26aulast%3DTomaszewski%26aufirst%3DM.%2BJ.%26atitle%3D%25CE%25B3-Carbolines%253A%2520a%2520novel%2520class%2520of%2520cannabinoid%2520agonists%2520with%2520high%2520aqueous%2520solubility%2520and%2520restricted%2520CNS%2520penetration%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1619%26epage%3D1624%26doi%3D10.1016%2Fj.bmcl.2011.12.124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dziadulewicz, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevan, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brain, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coote, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culshaw, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groarke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesingland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Vecchia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyothier, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNair, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Farrell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peacock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schopfer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaqoob, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zadrobilek, J.</span><span> </span><span class="NLM_article-title">Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: a potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3851</span><span class="NLM_x">–</span> <span class="NLM_lpage">3856</span><span class="refDoi"> DOI: 10.1021/jm070317a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070317a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3851-3856&author=E.+K.+Dziadulewiczauthor=S.+J.+Bevanauthor=C.+T.+Brainauthor=P.+R.+Cooteauthor=A.+J.+Culshawauthor=A.+J.+Davisauthor=L.+J.+Edwardsauthor=A.+J.+Fisherauthor=A.+J.+Foxauthor=C.+Gentryauthor=A.+Groarkeauthor=T.+W.+Hartauthor=W.+Huberauthor=I.+F.+Jamesauthor=A.+Kesinglandauthor=L.+La+Vecchiaauthor=Y.+Loongauthor=I.+Lyothierauthor=K.+McNairauthor=C.+O%E2%80%99Farrellauthor=M.+Peacockauthor=R.+Portmannauthor=U.+Schopferauthor=M.+Yaqoobauthor=J.+Zadrobilek&title=Naphthalen-1-yl-%284-pentyloxynaphthalen-1-yl%29methanone%3A+a+potent%2C+orally+bioavailable+human+CB1%2FCB2+dual+agonist+with+antihyperalgesic+properties+and+restricted+central+nervous+system+penetration&doi=10.1021%2Fjm070317a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Fjm070317a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070317a%26sid%3Dliteratum%253Aachs%26aulast%3DDziadulewicz%26aufirst%3DE.%2BK.%26aulast%3DBevan%26aufirst%3DS.%2BJ.%26aulast%3DBrain%26aufirst%3DC.%2BT.%26aulast%3DCoote%26aufirst%3DP.%2BR.%26aulast%3DCulshaw%26aufirst%3DA.%2BJ.%26aulast%3DDavis%26aufirst%3DA.%2BJ.%26aulast%3DEdwards%26aufirst%3DL.%2BJ.%26aulast%3DFisher%26aufirst%3DA.%2BJ.%26aulast%3DFox%26aufirst%3DA.%2BJ.%26aulast%3DGentry%26aufirst%3DC.%26aulast%3DGroarke%26aufirst%3DA.%26aulast%3DHart%26aufirst%3DT.%2BW.%26aulast%3DHuber%26aufirst%3DW.%26aulast%3DJames%26aufirst%3DI.%2BF.%26aulast%3DKesingland%26aufirst%3DA.%26aulast%3DLa%2BVecchia%26aufirst%3DL.%26aulast%3DLoong%26aufirst%3DY.%26aulast%3DLyothier%26aufirst%3DI.%26aulast%3DMcNair%26aufirst%3DK.%26aulast%3DO%25E2%2580%2599Farrell%26aufirst%3DC.%26aulast%3DPeacock%26aufirst%3DM.%26aulast%3DPortmann%26aufirst%3DR.%26aulast%3DSchopfer%26aufirst%3DU.%26aulast%3DYaqoob%26aufirst%3DM.%26aulast%3DZadrobilek%26aufirst%3DJ.%26atitle%3DNaphthalen-1-yl-%25284-pentyloxynaphthalen-1-yl%2529methanone%253A%2520a%2520potent%252C%2520orally%2520bioavailable%2520human%2520CB1%252FCB2%2520dual%2520agonist%2520with%2520antihyperalgesic%2520properties%2520and%2520restricted%2520central%2520nervous%2520system%2520penetration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3851%26epage%3D3856%26doi%3D10.1021%2Fjm070317a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yu, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morinville, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St-Onge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lessard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laird, J. M.</span><span> </span><span class="NLM_article-title">A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span><span class="refDoi"> DOI: 10.1016/j.pain.2010.07.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.pain.2010.07.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2010&pages=337-344&author=X.+H.+Yuauthor=C.+Q.+Caoauthor=G.+Martinoauthor=C.+Pumaauthor=A.+Morinvilleauthor=S.+St-Ongeauthor=E.+Lessardauthor=M.+N.+Perkinsauthor=J.+M.+Laird&title=A+peripherally+restricted+cannabinoid+receptor+agonist+produces+robust+anti-nociceptive+effects+in+rodent+models+of+inflammatory+and+neuropathic+pain&doi=10.1016%2Fj.pain.2010.07.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2010.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2010.07.019%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%2BH.%26aulast%3DCao%26aufirst%3DC.%2BQ.%26aulast%3DMartino%26aufirst%3DG.%26aulast%3DPuma%26aufirst%3DC.%26aulast%3DMorinville%26aufirst%3DA.%26aulast%3DSt-Onge%26aufirst%3DS.%26aulast%3DLessard%26aufirst%3DE.%26aulast%3DPerkins%26aufirst%3DM.%2BN.%26aulast%3DLaird%26aufirst%3DJ.%2BM.%26atitle%3DA%2520peripherally%2520restricted%2520cannabinoid%2520receptor%2520agonist%2520produces%2520robust%2520anti-nociceptive%2520effects%2520in%2520rodent%2520models%2520of%2520inflammatory%2520and%2520neuropathic%2520pain%26jtitle%3DPain%26date%3D2010%26volume%3D151%26spage%3D337%26epage%3D344%26doi%3D10.1016%2Fj.pain.2010.07.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Clapper, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno-Sanz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guijarro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacondio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciolino, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spradley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohmann, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calignano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1265</span><span class="NLM_x">–</span> <span class="NLM_lpage">1270</span><span class="refDoi"> DOI: 10.1038/nn.2632</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1038%2Fnn.2632" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=20852626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOht73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=1265-1270&author=J.+R.+Clapperauthor=G.+Moreno-Sanzauthor=R.+Russoauthor=A.+Guijarroauthor=F.+Vacondioauthor=A.+Durantiauthor=A.+Tontiniauthor=S.+Sanchiniauthor=N.+R.+Sciolinoauthor=J.+M.+Spradleyauthor=A.+G.+Hohmannauthor=A.+Calignanoauthor=M.+Morauthor=G.+Tarziaauthor=D.+Piomelli&title=Anandamide+suppresses+pain+initiation+through+a+peripheral+endocannabinoid+mechanism&doi=10.1038%2Fnn.2632"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13dR"><div class="casContent"><span class="casTitleNuber">13d</span><div class="casTitle"><span class="NLM_cas:atitle">Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism</span></div><div class="casAuthors">Clapper, Jason R.; Moreno-Sanz, Guillermo; Russo, Roberto; Guijarro, Ana; Vacondio, Federica; Duranti, Andrea; Tontini, Andrea; Sanchini, Silvano; Sciolino, Natale R.; Spradley, Jessica M.; Hohmann, Andrea G.; Calignano, Antonio; Mor, Marco; Tarzia, Giorgio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1265-1270</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Peripheral cannabinoid receptors exert a powerful inhibitory control over pain initiation, but the endocannabinoid signal that normally engages this intrinsic analgesic mechanism is unknown.  To address this question, we developed a peripherally restricted inhibitor (URB937) of fatty acid amide hydrolase (FAAH), the enzyme responsible for the degrdn. of the endocannabinoid anandamide.  URB937 suppressed FAAH activity and increased anandamide levels outside the rodent CNS.  Despite its inability to access brain and spinal cord, URB937 attenuated behavioral responses indicative of persistent pain in rodent models of peripheral nerve injury and inflammation and prevented noxious stimulus-evoked neuronal activation in spinal cord regions implicated in nociceptive processing.  CB1 cannabinoid receptor blockade prevented these effects.  These results suggest that anandamide-mediated signaling at peripheral CB1 receptors controls the access of pain-related inputs to the CNS.  Brain-impenetrant FAAH inhibitors, which strengthen this gating mechanism, might offer a new approach to pain therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2AxNb5bVlE7Vg90H21EOLACvtfcHk0lix3i7sKNcE0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOht73O&md5=f75c13a37e3524ab4130b2ebd67d6348</span></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=10.1038%2Fnn.2632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2632%26sid%3Dliteratum%253Aachs%26aulast%3DClapper%26aufirst%3DJ.%2BR.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DGuijarro%26aufirst%3DA.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DSanchini%26aufirst%3DS.%26aulast%3DSciolino%26aufirst%3DN.%2BR.%26aulast%3DSpradley%26aufirst%3DJ.%2BM.%26aulast%3DHohmann%26aufirst%3DA.%2BG.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAnandamide%2520suppresses%2520pain%2520initiation%2520through%2520a%2520peripheral%2520endocannabinoid%2520mechanism%26jtitle%3DNat.%2520Neurosci.%26date%3D2010%26volume%3D13%26spage%3D1265%26epage%3D1270%26doi%3D10.1038%2Fnn.2632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Hind, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tufarelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neophytou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Sullivan, S. E.</span><span> </span><span class="NLM_article-title">Endocannabinoids modulate human blood-brain barrier permeability in vitro</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">3015</span><span class="NLM_x">–</span> <span class="NLM_lpage">3027</span><span class="refDoi"> DOI: 10.1111/bph.13106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1111%2Fbph.13106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=25651941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVent73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=3015-3027&author=W.+H.+Hindauthor=C.+Tufarelliauthor=M.+Neophytouauthor=S.+I.+Andersonauthor=T.+J.+Englandauthor=S.+E.+O%E2%80%99Sullivan&title=Endocannabinoids+modulate+human+blood-brain+barrier+permeability+in+vitro&doi=10.1111%2Fbph.13106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoids modulate human blood-brain barrier permeability in vitro</span></div><div class="casAuthors">Hind, William H.; Tufarelli, Cristina; Neophytou, Maria; Anderson, Susan I.; England, Timothy J.; O'Sullivan, Saoirse E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3015-3027</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Endocannabinoids alter permeability at various epithelial barriers, and cannabinoid receptors and endocannabinoid levels are elevated by stroke, with potential neuroprotective effects.  We therefore explored the role of endocannabinoids in modulating blood-brain barrier (BBB) permeability in normal conditions and in an ischemia/reperfusion model.  Exptl. Approach : Human brain microvascular endothelial cell and astrocyte co-cultures modelled the BBB.  Ischemia was modelled by oxygen-glucose deprivation (OGD) and permeability was measured by transepithelial elec. resistance.  Endocannabinoids or endocannabinoid-like compds. were assessed for their ability to modulate baseline permeability or OGD-induced hyperpermeability.  Target sites of action were investigated using receptor antagonists and subsequently identified with real-time PCR.  Key Results : Anandamide (10 μM) and oleoylethanolamide (OEA, 10 μM) decreased BBB permeability (i.e. increased resistance).  This was mediated by cannabinoid CB2 receptors, transient receptor potential vanilloid 1 (TRPV1) channels, calcitonin gene-regulated peptide (CGRP) receptor (anandamide only) and PPARα (OEA only).  Application of OEA, palmitoylethanolamide (both PPARα mediated) or virodhamine (all 10 μM) decreased the OGD-induced increase in permeability during reperfusion. 2-Arachidonoyl glycerol, noladin ether and oleamide did not affect BBB permeability in normal or OGD conditions.  N-arachidonoyl-dopamine increased permeability through a cytotoxic mechanism.  PPARα and γ, CB1 receptors, TRPV1 channels and CGRP receptors were expressed in both cell types, but mRNA for CB2 receptors was only present in astrocytes.  Conclusion and Implication : The endocannabinoids may play an important modulatory role in normal BBB physiol., and also afford protection to the BBB during ischemic stroke, through a no. of target sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4GmdriBZaObVg90H21EOLACvtfcHk0lix3i7sKNcE0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVent73O&md5=a8632c455cd771221a9c879c7bd1fc7f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fbph.13106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13106%26sid%3Dliteratum%253Aachs%26aulast%3DHind%26aufirst%3DW.%2BH.%26aulast%3DTufarelli%26aufirst%3DC.%26aulast%3DNeophytou%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DS.%2BI.%26aulast%3DEngland%26aufirst%3DT.%2BJ.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DS.%2BE.%26atitle%3DEndocannabinoids%2520modulate%2520human%2520blood-brain%2520barrier%2520permeability%2520in%2520vitro%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D3015%26epage%3D3027%26doi%3D10.1111%2Fbph.13106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Huffman, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mabon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggio, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB<sub>1</sub> cannabinoid receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">539</span><span class="NLM_x">–</span> <span class="NLM_lpage">549</span><span class="refDoi"> DOI: 10.1016/S0968-0896(02)00451-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2FS0968-0896%2802%2900451-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=539-549&author=J.+W.+Huffmanauthor=R.+Mabonauthor=M.+J.+Wuauthor=J.+Luauthor=R.+Hartauthor=D.+P.+Hurstauthor=P.+H.+Reggioauthor=J.+L.+Wileyauthor=B.+R.+Martin&title=3-Indolyl-1-naphthylmethanes%3A+new+cannabimimetic+indoles+provide+evidence+for+aromatic+stacking+interactions+with+the+CB1+cannabinoid+receptor&doi=10.1016%2FS0968-0896%2802%2900451-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2802%2900451-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252802%252900451-0%26sid%3Dliteratum%253Aachs%26aulast%3DHuffman%26aufirst%3DJ.%2BW.%26aulast%3DMabon%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DM.%2BJ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DHart%26aufirst%3DR.%26aulast%3DHurst%26aufirst%3DD.%2BP.%26aulast%3DReggio%26aufirst%3DP.%2BH.%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3D3-Indolyl-1-naphthylmethanes%253A%2520new%2520cannabimimetic%2520indoles%2520provide%2520evidence%2520for%2520aromatic%2520stacking%2520interactions%2520with%2520the%2520CB1%2520cannabinoid%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D539%26epage%3D549%26doi%3D10.1016%2FS0968-0896%2802%2900451-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewin, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascarella, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seltzman, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P. A.</span><span> </span><span class="NLM_article-title">Designer drugs: a medicinal chemistry perspective</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1248</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span><span class="refDoi"> DOI: 10.1111/j.1749-6632.2011.06199.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1111%2Fj.1749-6632.2011.06199.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=22092008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks1yit7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1248&publication_year=2012&pages=18-38&author=F.+I.+Carrollauthor=A.+H.+Lewinauthor=S.+W.+Mascarellaauthor=H.+H.+Seltzmanauthor=P.+A.+Reddy&title=Designer+drugs%3A+a+medicinal+chemistry+perspective&doi=10.1111%2Fj.1749-6632.2011.06199.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Designer drugs: a medicinal chemistry perspective</span></div><div class="casAuthors">Carroll, F. Ivy; Lewin, Anita H.; Mascarella, S. Wayne; Seltzman, Herbert H.; Reddy, P. Anantha</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1248</span>
        (<span class="NLM_cas:issue">Addiction Reviews</span>),
    <span class="NLM_cas:pages">18-38</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  There are numerous medicinal chem. reports in the literature describing the pharmacol. properties of thousands of narcotics, stimulants, hallucinogens, sedative-hypnotic drugs, cannabinoids, and other psychoactive substances as well as synthetic methods for their prepns.  This information, while essential for the advancement of science, has been used by clandestine chemists to manuf. and market an endless variety of analogs of so-called designer drugs.  In this review, we describe how clandestine chemists used the principles of medicinal chem. to design mols., referred to as designer drugs, that elicit the effects of opioids, amphetamine and analogs, cannabinoids, and phencyclidine analogs while circumventing the law.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOD7q1w811wLVg90H21EOLACvtfcHk0lix3i7sKNcE0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xks1yit7w%253D&md5=9156e46929ce795b7fde9d2ad3f8532f</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.2011.06199.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.2011.06199.x%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DLewin%26aufirst%3DA.%2BH.%26aulast%3DMascarella%26aufirst%3DS.%2BW.%26aulast%3DSeltzman%26aufirst%3DH.%2BH.%26aulast%3DReddy%26aufirst%3DP.%2BA.%26atitle%3DDesigner%2520drugs%253A%2520a%2520medicinal%2520chemistry%2520perspective%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2012%26volume%3D1248%26spage%3D18%26epage%3D38%26doi%3D10.1111%2Fj.1749-6632.2011.06199.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Huffman, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zengin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hynd, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bushell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bushell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggio, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassidy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.1016/j.bmc.2004.09.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.bmc.2004.09.050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=89-112&author=J.+W.+Huffmanauthor=G.+Zenginauthor=M.+J.+Wuauthor=J.+Luauthor=G.+Hyndauthor=K.+Bushellauthor=A.+L.+Thompsonauthor=S.+Bushellauthor=C.+Tartalauthor=D.+P.+Hurstauthor=P.+H.+Reggioauthor=D.+E.+Selleyauthor=M.+P.+Cassidyauthor=J.+L.+Wileyauthor=B.+R.+Martin&title=Structure-activity+relationships+for+1-alkyl-3-%281-naphthoyl%29indoles+at+the+cannabinoid+CB%281%29+and+CB%282%29+receptors%3A+steric+and+electronic+effects+of+naphthoyl+substituents.+New+highly+selective+CB%282%29+receptor+agonists&doi=10.1016%2Fj.bmc.2004.09.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.09.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.09.050%26sid%3Dliteratum%253Aachs%26aulast%3DHuffman%26aufirst%3DJ.%2BW.%26aulast%3DZengin%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DM.%2BJ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DHynd%26aufirst%3DG.%26aulast%3DBushell%26aufirst%3DK.%26aulast%3DThompson%26aufirst%3DA.%2BL.%26aulast%3DBushell%26aufirst%3DS.%26aulast%3DTartal%26aufirst%3DC.%26aulast%3DHurst%26aufirst%3DD.%2BP.%26aulast%3DReggio%26aufirst%3DP.%2BH.%26aulast%3DSelley%26aufirst%3DD.%2BE.%26aulast%3DCassidy%26aufirst%3DM.%2BP.%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DStructure-activity%2520relationships%2520for%25201-alkyl-3-%25281-naphthoyl%2529indoles%2520at%2520the%2520cannabinoid%2520CB%25281%2529%2520and%2520CB%25282%2529%2520receptors%253A%2520steric%2520and%2520electronic%2520effects%2520of%2520naphthoyl%2520substituents.%2520New%2520highly%2520selective%2520CB%25282%2529%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D89%26epage%3D112%26doi%3D10.1016%2Fj.bmc.2004.09.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Innocenzi, P.; Benchikh, E.; Fitzgerald, P.; Lowry, P.; McConnell, I.</span><span> </span><span class="NLM_article-title">Detection of synthetic cannabinoids</span>. EP2487155A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=P.+Innocenzi&author=E.+Benchikh&author=P.+Fitzgerald&author=P.+Lowry&author=I.+McConnell&title=Detection+of+synthetic+cannabinoids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DInnocenzi%26aufirst%3DP.%26atitle%3DDetection%2520of%2520synthetic%2520cannabinoids%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Reggio, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu-Dutt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett-Norris, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seltzman, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliam, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertwee, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abood, M. E.</span><span> </span><span class="NLM_article-title">The bioactive conformation of aminoalkylindoles at the cannabinoid CB1 and CB2 receptors: insights gained from (E)- and (Z)-naphthylidene indenes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">5177</span><span class="NLM_x">–</span> <span class="NLM_lpage">5187</span><span class="refDoi"> DOI: 10.1021/jm9801197</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9801197" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=5177-5187&author=P.+H.+Reggioauthor=S.+Basu-Duttauthor=J.+Barnett-Norrisauthor=M.+T.+Castroauthor=D.+P.+Hurstauthor=H.+H.+Seltzmanauthor=M.+J.+Rocheauthor=A.+F.+Gilliamauthor=B.+F.+Thomasauthor=L.+A.+Stevensonauthor=R.+G.+Pertweeauthor=M.+E.+Abood&title=The+bioactive+conformation+of+aminoalkylindoles+at+the+cannabinoid+CB1+and+CB2+receptors%3A+insights+gained+from+%28E%29-+and+%28Z%29-naphthylidene+indenes&doi=10.1021%2Fjm9801197"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm9801197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9801197%26sid%3Dliteratum%253Aachs%26aulast%3DReggio%26aufirst%3DP.%2BH.%26aulast%3DBasu-Dutt%26aufirst%3DS.%26aulast%3DBarnett-Norris%26aufirst%3DJ.%26aulast%3DCastro%26aufirst%3DM.%2BT.%26aulast%3DHurst%26aufirst%3DD.%2BP.%26aulast%3DSeltzman%26aufirst%3DH.%2BH.%26aulast%3DRoche%26aufirst%3DM.%2BJ.%26aulast%3DGilliam%26aufirst%3DA.%2BF.%26aulast%3DThomas%26aufirst%3DB.%2BF.%26aulast%3DStevenson%26aufirst%3DL.%2BA.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DAbood%26aufirst%3DM.%2BE.%26atitle%3DThe%2520bioactive%2520conformation%2520of%2520aminoalkylindoles%2520at%2520the%2520cannabinoid%2520CB1%2520and%2520CB2%2520receptors%253A%2520insights%2520gained%2520from%2520%2528E%2529-%2520and%2520%2528Z%2529-naphthylidene%2520indenes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D5177%26epage%3D5187%26doi%3D10.1021%2Fjm9801197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Mosconi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, L.</span><span> </span><span class="NLM_article-title">Fixed-diameter polyethylene cuffs applied to the rat sciatic nerve induce a painful neuropathy: Ultrastructural morphometric analysis of axonal alterations</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span><span class="refDoi"> DOI: 10.1016/0304-3959(95)00077-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2F0304-3959%2895%2900077-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1996&pages=37-57&author=T.+Mosconiauthor=L.+Kruger&title=Fixed-diameter+polyethylene+cuffs+applied+to+the+rat+sciatic+nerve+induce+a+painful+neuropathy%3A+Ultrastructural+morphometric+analysis+of+axonal+alterations&doi=10.1016%2F0304-3959%2895%2900077-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2895%2900077-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252895%252900077-1%26sid%3Dliteratum%253Aachs%26aulast%3DMosconi%26aufirst%3DT.%26aulast%3DKruger%26aufirst%3DL.%26atitle%3DFixed-diameter%2520polyethylene%2520cuffs%2520applied%2520to%2520the%2520rat%2520sciatic%2520nerve%2520induce%2520a%2520painful%2520neuropathy%253A%2520Ultrastructural%2520morphometric%2520analysis%2520of%2520axonal%2520alterations%26jtitle%3DPain%26date%3D1996%26volume%3D64%26spage%3D37%26epage%3D57%26doi%3D10.1016%2F0304-3959%2895%2900077-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Pitcher, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritchie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, J. L.</span><span> </span><span class="NLM_article-title">Nerve constriction in the rat: model of neuropathic, surgical and central pain</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span><span class="refDoi"> DOI: 10.1016/S0304-3959(99)00085-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2FS0304-3959%2899%2900085-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10506670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADyaK1MvjvVaitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1999&pages=37-46&author=G.+M.+Pitcherauthor=J.+Ritchieauthor=J.+L.+Henry&title=Nerve+constriction+in+the+rat%3A+model+of+neuropathic%2C+surgical+and+central+pain&doi=10.1016%2FS0304-3959%2899%2900085-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Nerve constriction in the rat: model of neuropathic, surgical and central pain</span></div><div class="casAuthors">Pitcher G M; Ritchie J; Henry J L</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-46</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">In preparation for a series of electrophysiological experiments in a model of neuropathic pain, the present spinal reflex study was done to determine the optimal time after sciatic nerve constriction in the rat for tactile allodynia and to determine also the appropriate 'control' for the nerve constriction model.  Therefore, this study focused on the magnitude and time course of change in paw withdrawal threshold following unilateral sciatic nerve constriction in the rat.  Male Sprague-Dawley rats (375-425g) were used.  Nerve constriction was done by placing a 2 mm polyethylene cuff (PE-90) around the left sciatic nerve (n=8).  A second group of rats (n=8) received unilateral sham surgery and a third group (n=8) was unoperated.  The ipsi- and contralateral hind paw withdrawal thresholds in each of the 3 groups were measured using von Frey hairs.  In unoperated rats, the withdrawal threshold of each of the hind paws remained unchanged at approximately 50 g throughout the entire time course of the study, which lasted 145 days.  However, in cuff-implanted rats, the withdrawal threshold of the nerve-injured hind paw decreased as soon as 1 day after surgery, reached as low as 1 to 2 g by 5 days and remained low throughout the test period.  Threshold in sham-operated rats showed a bilateral decrease starting on days 1-3, which stabilised at about 30 g until about day 40, after which values returned gradually toward the unoperated withdrawal thresholds.  In nerve-constricted rats the withdrawal threshold of the hind paw contralateral to the cuff followed the same change seen in sham-operated rats until about day 37, after which the withdrawal threshold matched that of the cuff-implanted hind paw.  The data show that the cuff-induced sciatic nerve constriction produces a sustained hypersensitivity to normally innocuous tactile sensory input and that a relatively constant ipsilateral mechanical hyperalgesia can be found from days 5-27.  It is also demonstrated that the contralateral hind paw and either hind paw in sham-operated rats are inappropriate as 'controls'.  The data in this study suggest that three distinct types of allodynia are expressed.  Ipsilateral allodynia may be representative of a model of neuropathic pain.  The contralateral allodynia may be a model of central pain, as it likely arises from changes in central sensory processing.  Allodynia in sham-operated rats was also expressed bilaterally and may be a model of long-term postoperative pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQQNm5x0OdY95agfuraLLzSfW6udTcc2eYmdCaSXaQ_57ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1MvjvVaitQ%253D%253D&md5=1d7eeb9b5fec35a0f5c466ba1a6bb8fe</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0304-3959%2899%2900085-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3959%252899%252900085-8%26sid%3Dliteratum%253Aachs%26aulast%3DPitcher%26aufirst%3DG.%2BM.%26aulast%3DRitchie%26aufirst%3DJ.%26aulast%3DHenry%26aufirst%3DJ.%2BL.%26atitle%3DNerve%2520constriction%2520in%2520the%2520rat%253A%2520model%2520of%2520neuropathic%252C%2520surgical%2520and%2520central%2520pain%26jtitle%3DPain%26date%3D1999%26volume%3D83%26spage%3D37%26epage%3D46%26doi%3D10.1016%2FS0304-3959%2899%2900085-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Bailey, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro-da-Silva, A.</span><span> </span><span class="NLM_article-title">Transient loss of terminals from non-peptidergic nociceptive fibers in the substantia gelatinosa of spinal cord following chronic constriction injury of the sciatic nerve</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">690</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2005.11.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.neuroscience.2005.11.051" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2006&pages=675-690&author=A.+L.+Baileyauthor=A.+Ribeiro-da-Silva&title=Transient+loss+of+terminals+from+non-peptidergic+nociceptive+fibers+in+the+substantia+gelatinosa+of+spinal+cord+following+chronic+constriction+injury+of+the+sciatic+nerve&doi=10.1016%2Fj.neuroscience.2005.11.051"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2005.11.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2005.11.051%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DA.%2BL.%26aulast%3DRibeiro-da-Silva%26aufirst%3DA.%26atitle%3DTransient%2520loss%2520of%2520terminals%2520from%2520non-peptidergic%2520nociceptive%2520fibers%2520in%2520the%2520substantia%2520gelatinosa%2520of%2520spinal%2520cord%2520following%2520chronic%2520constriction%2520injury%2520of%2520the%2520sciatic%2520nerve%26jtitle%3DNeuroscience%26date%3D2006%26volume%3D138%26spage%3D675%26epage%3D690%26doi%3D10.1016%2Fj.neuroscience.2005.11.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Thakor, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruangsri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spigelman, I.</span><span> </span><span class="NLM_article-title">Increased peripheral nerve excitability and local NaV1.8 mRNA up-regulation in painful neuropathy</span> <span class="citation_source-journal">Mol. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="refDoi"> DOI: 10.1186/1744-8069-5-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1186%2F1744-8069-5-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=19320998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADC%252BD1M3mvFKhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=14&author=D.+K.+Thakorauthor=A.+Linauthor=Y.+Matsukaauthor=E.+M.+Meyerauthor=S.+Ruangsriauthor=I.+Nishimuraauthor=I.+Spigelman&title=Increased+peripheral+nerve+excitability+and+local+NaV1.8+mRNA+up-regulation+in+painful+neuropathy&doi=10.1186%2F1744-8069-5-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Increased peripheral nerve excitability and local NaV1.8 mRNA up-regulation in painful neuropathy</span></div><div class="casAuthors">Thakor Devang Kashyap; Lin Audrey; Matsuka Yoshizo; Meyer Edward M; Ruangsri Supanigar; Nishimura Ichiro; Spigelman Igor</div><div class="citationInfo"><span class="NLM_cas:title">Molecular pain</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Neuropathic pain caused by peripheral nerve injury is a chronic disorder that represents a significant clinical challenge because the pathological mechanisms have not been fully elucidated.  Several studies have suggested the involvement of various sodium channels, including tetrodotoxin-resistant NaV1.8, in affected dorsal root ganglion (DRG) neurons.  We have hypothesized that altered local expression of NaV1.8 in the peripheral axons of DRG neurons could facilitate nociceptive signal generation and propagation after neuropathic injury.  RESULTS:  After unilateral sciatic nerve entrapment injury in rats, compound action potential amplitudes were increased in both myelinated and unmyelinated fibers of the ipsilateral sciatic nerve.  Tetrodotoxin resistance of both fiber populations and sciatic nerve NaV1.8 immunoreactivity were also increased.  Further analysis of NaV1.8 distribution revealed that immunoreactivity and mRNA levels were decreased and unaffected, respectively, in the ipsilateral L4 and L5 DRG; however sciatic nerve NaV1.8 mRNA showed nearly an 11-fold ipsilateral increase.  Nav1.8 mRNA observed in the sciatic nerve was likely of axonal origin since it was not detected in non-neuronal cells cultured from nerve tissue.  Absence of changes in NaV1.8 mRNA polyadenylation suggests that increased mRNA stability was not responsible for the selective peripheral mRNA increase.  Furthermore, mRNA levels of NaV1.3, NaV1.5, NaV1.6, NaV1.7, and NaV1.9 were not significantly different between ipsilateral and contralateral nerves.  We therefore propose that selective NaV1.8 mRNA axonal transport and local up-regulation could contribute to the hyperexcitability of peripheral nerves in some neuropathic pain states.  CONCLUSION:  Cuff entrapment injury resulted in significantly elevated axonal excitability and increased NaV1.8 immunoreactivity in rat sciatic nerves.  The concomitant axonal accumulation of NaV1.8 mRNA may play a role in the pathogenesis of this model of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRpaCUg5wG0du2qxNLjzXe8fW6udTcc2eaqOqLoJZHoRrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3mvFKhsw%253D%253D&md5=52d7b734a503554f91da581db489276e</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1186%2F1744-8069-5-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-8069-5-14%26sid%3Dliteratum%253Aachs%26aulast%3DThakor%26aufirst%3DD.%2BK.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DMatsuka%26aufirst%3DY.%26aulast%3DMeyer%26aufirst%3DE.%2BM.%26aulast%3DRuangsri%26aufirst%3DS.%26aulast%3DNishimura%26aufirst%3DI.%26aulast%3DSpigelman%26aufirst%3DI.%26atitle%3DIncreased%2520peripheral%2520nerve%2520excitability%2520and%2520local%2520NaV1.8%2520mRNA%2520up-regulation%2520in%2520painful%2520neuropathy%26jtitle%3DMol.%2520Pain%26date%3D2009%26volume%3D5%26spage%3D14%26doi%3D10.1186%2F1744-8069-5-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ruangsri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulpuri, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spigelman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, I.</span><span> </span><span class="NLM_article-title">Relationship of axonal voltage-gated sodium channel 1.8 (NaV1.8) mRNA accumulation to sciatic nerve injury-induced painful neuropathy in rats</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">39836</span><span class="NLM_x">–</span> <span class="NLM_lpage">39847</span><span class="refDoi"> DOI: 10.1074/jbc.M111.261701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1074%2Fjbc.M111.261701" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=39836-39847&author=S.+Ruangsriauthor=A.+Linauthor=Y.+Mulpuriauthor=K.+Leeauthor=I.+Spigelmanauthor=I.+Nishimura&title=Relationship+of+axonal+voltage-gated+sodium+channel+1.8+%28NaV1.8%29+mRNA+accumulation+to+sciatic+nerve+injury-induced+painful+neuropathy+in+rats&doi=10.1074%2Fjbc.M111.261701"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.261701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.261701%26sid%3Dliteratum%253Aachs%26aulast%3DRuangsri%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DMulpuri%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DSpigelman%26aufirst%3DI.%26aulast%3DNishimura%26aufirst%3DI.%26atitle%3DRelationship%2520of%2520axonal%2520voltage-gated%2520sodium%2520channel%25201.8%2520%2528NaV1.8%2529%2520mRNA%2520accumulation%2520to%2520sciatic%2520nerve%2520injury-induced%2520painful%2520neuropathy%2520in%2520rats%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D39836%26epage%3D39847%26doi%3D10.1074%2Fjbc.M111.261701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Martin, I.</span><span> </span><span class="NLM_article-title">Prediction of blood-brain barrier penetration: are we missing the point?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span><span class="refDoi"> DOI: 10.1016/S1359-6446(03)02961-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2FS1359-6446%2803%2902961-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=161-162&author=I.+Martin&title=Prediction+of+blood-brain+barrier+penetration%3A+are+we+missing+the+point%3F&doi=10.1016%2FS1359-6446%2803%2902961-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2803%2902961-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252803%252902961-1%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DI.%26atitle%3DPrediction%2520of%2520blood-brain%2520barrier%2520penetration%253A%2520are%2520we%2520missing%2520the%2520point%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D161%26epage%3D162%26doi%3D10.1016%2FS1359-6446%2803%2902961-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Adam, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fields, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeremiah, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyoi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maidment, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratcliffe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottney, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deehan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, I.</span><span> </span><span class="NLM_article-title">Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2932</span><span class="NLM_x">–</span> <span class="NLM_lpage">2937</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.bmcl.2012.02.048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2932-2937&author=J.+M.+Adamauthor=J.+K.+Clarkauthor=K.+Daviesauthor=K.+Everettauthor=R.+Fieldsauthor=S.+Francisauthor=F.+Jeremiahauthor=T.+Kiyoiauthor=M.+Maidmentauthor=A.+Morrisonauthor=P.+Ratcliffeauthor=A.+Prosserauthor=J.+Schulzauthor=G.+Wishartauthor=J.+Bakerauthor=S.+Boyceauthor=R.+Campbellauthor=J.+E.+Cottneyauthor=M.+Deehanauthor=I.+Martin&title=Low+brain+penetrant+CB1+receptor+agonists+for+the+treatment+of+neuropathic+pain&doi=10.1016%2Fj.bmcl.2012.02.048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.048%26sid%3Dliteratum%253Aachs%26aulast%3DAdam%26aufirst%3DJ.%2BM.%26aulast%3DClark%26aufirst%3DJ.%2BK.%26aulast%3DDavies%26aufirst%3DK.%26aulast%3DEverett%26aufirst%3DK.%26aulast%3DFields%26aufirst%3DR.%26aulast%3DFrancis%26aufirst%3DS.%26aulast%3DJeremiah%26aufirst%3DF.%26aulast%3DKiyoi%26aufirst%3DT.%26aulast%3DMaidment%26aufirst%3DM.%26aulast%3DMorrison%26aufirst%3DA.%26aulast%3DRatcliffe%26aufirst%3DP.%26aulast%3DProsser%26aufirst%3DA.%26aulast%3DSchulz%26aufirst%3DJ.%26aulast%3DWishart%26aufirst%3DG.%26aulast%3DBaker%26aufirst%3DJ.%26aulast%3DBoyce%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DCottney%26aufirst%3DJ.%2BE.%26aulast%3DDeehan%26aufirst%3DM.%26aulast%3DMartin%26aufirst%3DI.%26atitle%3DLow%2520brain%2520penetrant%2520CB1%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520neuropathic%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2932%26epage%3D2937%26doi%3D10.1016%2Fj.bmcl.2012.02.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Martin, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Little, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razdan, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melvin, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechoulam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. J.</span><span> </span><span class="NLM_article-title">Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span><span class="refDoi"> DOI: 10.1016/0091-3057(91)90349-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2F0091-3057%2891%2990349-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1666911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADyaK38XnsFOjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1991&pages=471-478&author=B.+R.+Martinauthor=D.+R.+Comptonauthor=B.+F.+Thomasauthor=W.+R.+Prescottauthor=P.+J.+Littleauthor=R.+K.+Razdanauthor=M.+R.+Johnsonauthor=L.+S.+Melvinauthor=R.+Mechoulamauthor=S.+J.+Ward&title=Behavioral%2C+biochemical%2C+and+molecular+modeling+evaluations+of+cannabinoid+analogs&doi=10.1016%2F0091-3057%2891%2990349-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs</span></div><div class="casAuthors">Martin, Billy R.; Compton, David R.; Thomas, Brian F.; Prescott, William R.; Little, Patrick J.; Razdan, Raj K.; Johnson, M. Ross; Melvin, Lawrence S.; Mechoulam, Raphael; Ward, Susan J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">471-8</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    </div><div class="casAbstract">Numerous cannabinoids have been synthesized by the authors that are extremely potent in behavioral assays.  An important feature in increasing potency has been the substitution of a dimethylheptyl (DMH) side chain for the pentyl side chain.  The authors previous studies have shown that (-)-11-OH-Δ8-THC-dimethylheptyl was 80-1150 times more potent than Δ9-THC.  Stereospecificity was demonstrated by its (+)-enantiomer which was more than 1400-7500 times less potent.  A related series of DMH cannabinoid analogs has recently been synthesized and preliminary evaluations reported here.  (-)-11-OH-Δ9-THC-DMH was found to be equipotent with (-)-11-OH-Δ8-THC-DMH.  The aldehyde (-)-11-oxo-Δ9-THC-DMH was 15-50 times more potent than Δ9-THC.  Surprisingly, (-)-11-carboxy-Δ9-THC-DMH was also active, being slightly more potent than Δ9-THC.  In the bicyclic cannabinoid series, the length and bulk of the side chain were found to be equally important.  Aminoalkylindoles, which are structurally dissimilar from classical cannabinoids, have been found to exhibit a pharmacol. profile similar to Δ9-THC.  Though not extremely potent in vivo, they appear to represent an entirely new approach to studying the actions of the cannabinoids.  The structural diversity and wide-ranging potencies of the analogs described herein provide the opportunity to develop a pharmacophore for the cannabinoids using mol. modeling techniques.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgUpOWKwFy3LVg90H21EOLACvtfcHk0li7neM2xzHcaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XnsFOjsA%253D%253D&md5=f285af18dbc132632d65d84d168079f3</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2891%2990349-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252891%252990349-7%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DB.%2BR.%26aulast%3DCompton%26aufirst%3DD.%2BR.%26aulast%3DThomas%26aufirst%3DB.%2BF.%26aulast%3DPrescott%26aufirst%3DW.%2BR.%26aulast%3DLittle%26aufirst%3DP.%2BJ.%26aulast%3DRazdan%26aufirst%3DR.%2BK.%26aulast%3DJohnson%26aufirst%3DM.%2BR.%26aulast%3DMelvin%26aufirst%3DL.%2BS.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DWard%26aufirst%3DS.%2BJ.%26atitle%3DBehavioral%252C%2520biochemical%252C%2520and%2520molecular%2520modeling%2520evaluations%2520of%2520cannabinoid%2520analogs%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1991%26volume%3D40%26spage%3D471%26epage%3D478%26doi%3D10.1016%2F0091-3057%2891%2990349-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Smith, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razdan, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechoulam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=8035318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADyaK2cXkvF2lurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1994&pages=219-227&author=P.+B.+Smithauthor=D.+R.+Comptonauthor=S.+P.+Welchauthor=R.+K.+Razdanauthor=R.+Mechoulamauthor=B.+R.+Martin&title=The+pharmacological+activity+of+anandamide%2C+a+putative+endogenous+cannabinoid%2C+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice</span></div><div class="casAuthors">Smith, Peter B.; Compton, David R.; Welch, Sandra P.; Razdan, Raj K.; Mechoulam, Raphael; Martin, Billy R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">219-27</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The arachidonic acid deriv. anandamide (arachidonylethanolamide) has been isolated from porcine brain and has been shown to bind competitively to the cannabinoid receptor.  Although the pharmacol. activity of this compd. has not yet been fully detd., preliminary data suggest that it produces several effects similar to the cannabinoids.  In the present expts. anandamide produced effects similar to those of Δ9-tetrahydrocannabinol, including antinociception (as detd. in a latency to tail-flick evaluation), hypothermia, hypomotility and catalepsy in mice after i.v., i.t. and i.p. administration.  In general, the effects of anandamide occurred with a rapid onset, but with a rather short duration of action.  Prominent antinociceptive effects (>80% maximal possible effect) were measured immediately after i.v. and i.t. administration.  Anandamide produced significant decreases in rectal temp. (2-4°C) after either i.v. or i.t. injection.  Maximal effects on motor activity (approx. 85% inhibition) were obsd. immediately after i.v. and i.p. administration and 10 min after i.t. administration.  Max. immobility obsd. after i.v. administration was over 80%, yet that produced after i.p. and i.t. administration was too small (≤20%) to be considered pharmacol. relevant.  Anandamide was less potent (1.3 to 18 times) than Δ9-tetrahydrocannibinol in all behavioral assays.  Pretreatment with nor-binaltorphimine, a kappa opioid antagonist which blocks i.t. Δ9-tetrahydrocannibinol-induced antinociception, failed to alter antinociception after i.t. anandamide administration.  Binding studies demonstrated that anandamide displaces [3H]CP-55,940 from rat whole brain P2 membrane prepns. with a KD of 101 ± 15 nM.  These findings demonstrate that anandamide produces effects in a tetrad of tests used to predict cannabimimetic activity and supports the contention of its role as an endogenous cannabinoid ligand.  However, there appear to be distinct differences between anandamide and the cannabinoids with regard to their antinociceptive properties, and other properties vary as a function of route of administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUxz_HmpJfMbVg90H21EOLACvtfcHk0li7neM2xzHcaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkvF2lurw%253D&md5=ad31867900269b1cd3909b878f3b059e</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DP.%2BB.%26aulast%3DCompton%26aufirst%3DD.%2BR.%26aulast%3DWelch%26aufirst%3DS.%2BP.%26aulast%3DRazdan%26aufirst%3DR.%2BK.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DThe%2520pharmacological%2520activity%2520of%2520anandamide%252C%2520a%2520putative%2520endogenous%2520cannabinoid%252C%2520in%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1994%26volume%3D270%26spage%3D219%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Compton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Costa, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razdan, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melvin, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Cannabinoid structure–activity relationships: correlation of receptor binding and in vivo activities</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">265</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=8474008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADyaK3sXks1ansLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1993&pages=218-226&author=D.+R.+Comptonauthor=K.+C.+Riceauthor=B.+R.+de+Costaauthor=R.+K.+Razdanauthor=L.+S.+Melvinauthor=M.+R.+Johnsonauthor=B.+R.+Martin&title=Cannabinoid+structure%E2%80%93activity+relationships%3A+correlation+of+receptor+binding+and+in+vivo+activities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24cR"><div class="casContent"><span class="casTitleNuber">24c</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities</span></div><div class="casAuthors">Compton, David R.; Rice, Kenner C.; De Costa, Brian R.; Razdan, Raj K.; Melvin, Lawrence S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">265</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">218-26</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Although a receptor exists for cannabinoid drugs, it is uncertain which pharmacol. actions this receptor mediates.  The structure-activity relationship investigation was initiated to det. which effects might correspond to binding affinity for the cannabinoid receptor, as well as to explore the binding requirements of this site.  The ability of nearly 60 cannabinoids to displace [3H]CP-55,940 {(-)-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-4-[3-hydroxy propyl] cyclohexan-1-ol} was determinated before establishing correlations between receptor affinity and in vivo pharmacol. potency.  Anal. of [3H]CP-55,940 binding indicated a Hill coeff. of 0.97, a Bmax of 499 pM (3.3 pmol/mg of protein) and an apparent Kd of 924 pM.  Closer inspection indicated the binding assay exhibited "zone B" characteristics, and use of correction equations indicated a true Kd for CP-55,940 of 675 pM.  The structure-activity relationship indicated the importance of side chain structure to high-affinity binding, with the most potent analogs (Ki < 10 nM) possessing either a dimethylheptyl side-chain, a similarly complex branched side chain or a halogen substituent at the 5' position.  Comparative anal. of KI values to in vivo potency in a mouse model indicated a high degree of correlation between parameters for the depression of spontaneous locomotor activity (r = 0.91) and for the prodn. of antinociception (r = 0.90), hypothermia (r = 0.89) and catalepsy (r = 0.85).  Similarly high correlations were demonstrated between binding affinity and in vivo potency in both the rat drug discrimination model (r = 0.81) and for psychotomimetic activity in humans (r = 0.88).  Thus, these studies appear to indicate that the requirements for activation of the cannabinoid receptor are similar across different species, and that receptor binding is sufficient to mediate many of the known pharmacol. effects of cannabinoids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDemJQ_tCfxLVg90H21EOLACvtfcHk0li7neM2xzHcaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXks1ansLs%253D&md5=29e4889026f638bf4699d5eda5333a93</span></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCompton%26aufirst%3DD.%2BR.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3Dde%2BCosta%26aufirst%3DB.%2BR.%26aulast%3DRazdan%26aufirst%3DR.%2BK.%26aulast%3DMelvin%26aufirst%3DL.%2BS.%26aulast%3DJohnson%26aufirst%3DM.%2BR.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DCannabinoid%2520structure%25E2%2580%2593activity%2520relationships%253A%2520correlation%2520of%2520receptor%2520binding%2520and%2520in%2520vivo%2520activities%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1993%26volume%3D265%26spage%3D218%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Devane, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breuer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheskin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarbe, T. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisen, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechoulam, R.</span><span> </span><span class="NLM_article-title">A novel probe for the cannabinoid receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2065</span><span class="NLM_x">–</span> <span class="NLM_lpage">2069</span><span class="refDoi"> DOI: 10.1021/jm00089a018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00089a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADyaK38XltVensLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=2065-2069&author=W.+A.+Devaneauthor=A.+Breuerauthor=T.+Sheskinauthor=T.+U.+Jarbeauthor=M.+S.+Eisenauthor=R.+Mechoulam&title=A+novel+probe+for+the+cannabinoid+receptor&doi=10.1021%2Fjm00089a018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A novel probe for the cannabinoid receptor</span></div><div class="casAuthors">Devane, William A.; Breuer, Aviva; Sheskin, Tzviel; Jaerbe, Torbjoern U. C.; Eisen, Moris S.; Mechoulam, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2065-9</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The 1,1-dimethylheptyl (DMH) homolog of 7-hydroxy-Δ6-tetrahydrocannabinol (I) is the most potent cannabimimetic substance reported so far.  Hydrogenation of I leads to a mixt. of the epimers of 10-(1,1-dimethylheptyl)-7-hydroxyhexahydrocannabinol or to either the equatorial (II) or to the axial epimer (III), depending on the catalysts and conditions used.  II discriminates for Δ1-THC in pigeons (ED50 = 0.002 mg/kg, after 4.5 h), at the potency level of I, and binds to the cannabinoid receptor with a KD of 45 pM, considerably lower than the Ki of 180 pM measured for compd. I and the Ki of 2.00 nM measured for CP-55940, a widely employed ligand.  Tritiated II was used as a novel probe for the cannabinoid receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUfsrZby2tgLVg90H21EOLACvtfcHk0li7neM2xzHcaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XltVensLY%253D&md5=4828d5b76236f906546b716fb9d2ff3e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm00089a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00089a018%26sid%3Dliteratum%253Aachs%26aulast%3DDevane%26aufirst%3DW.%2BA.%26aulast%3DBreuer%26aufirst%3DA.%26aulast%3DSheskin%26aufirst%3DT.%26aulast%3DJarbe%26aufirst%3DT.%2BU.%26aulast%3DEisen%26aufirst%3DM.%2BS.%26aulast%3DMechoulam%26aufirst%3DR.%26atitle%3DA%2520novel%2520probe%2520for%2520the%2520cannabinoid%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D2065%26epage%3D2069%26doi%3D10.1021%2Fjm00089a018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Rinaldi-Carmona, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaulme, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neliat, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caput, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soubrié, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brelière, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Fur, G.</span><span> </span><span class="NLM_article-title">SR141716A, a potent and selective antagonist of the brain cannabinoid receptor</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span><span class="refDoi"> DOI: 10.1016/0014-5793(94)00773-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2F0014-5793%2894%2900773-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=8070571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADyaK2cXmsVKjsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=1994&pages=240-244&author=M.+Rinaldi-Carmonaauthor=F.+Barthauthor=M.+Heaulmeauthor=D.+Shireauthor=B.+Calandraauthor=C.+Congyauthor=S.+Martinezauthor=J.+Maruaniauthor=G.+Neliatauthor=D.+Caputauthor=P.+Ferraraauthor=P.+Soubri%C3%A9author=J.+C.+Breli%C3%A8reauthor=G.+Le+Fur&title=SR141716A%2C+a+potent+and+selective+antagonist+of+the+brain+cannabinoid+receptor&doi=10.1016%2F0014-5793%2894%2900773-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">SR141716A, a potent and selective antagonist of the brain cannabinoid receptor</span></div><div class="casAuthors">Rinaldi-Carmona, Murielle; Barth, Francis; Heaulme, Michel; Shire, David; Calandra, Bernard; Congy, Christian; Martinez, Serge; Maruani, Jeanne; Neliat, Gervais; et al.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">240-4</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">SR141716A is the first selective and orally active antagonist of the brain cannabinoid receptor.  This compd. displays nanomolar affinity for the central cannabinoid receptor but is not active on the peripheral cannabinoid receptor.  In vitro, SR141716A antagonizes the inhibitory effects of cannabinoid receptor agonists on both mouse vas deferens contractions and adenylyl cyclase activity in rat brain membranes.  After i.p. or oral administration, SR141716A antagonizes classical pharmacol. and behavioral effects of cannabinoid receptor agonists.  This compd. should prove to be a powerful tool for investigating the in vivo functions of the anandamide/cannabinoid system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLJ59LaZb2cbVg90H21EOLACvtfcHk0lgZ3SyxVUFtlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmsVKjsrw%253D&md5=1eebdfec28d2dde64729cddb859aa6c8</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2894%2900773-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252894%252900773-X%26sid%3Dliteratum%253Aachs%26aulast%3DRinaldi-Carmona%26aufirst%3DM.%26aulast%3DBarth%26aufirst%3DF.%26aulast%3DHeaulme%26aufirst%3DM.%26aulast%3DShire%26aufirst%3DD.%26aulast%3DCalandra%26aufirst%3DB.%26aulast%3DCongy%26aufirst%3DC.%26aulast%3DMartinez%26aufirst%3DS.%26aulast%3DMaruani%26aufirst%3DJ.%26aulast%3DNeliat%26aufirst%3DG.%26aulast%3DCaput%26aufirst%3DD.%26aulast%3DFerrara%26aufirst%3DP.%26aulast%3DSoubri%25C3%25A9%26aufirst%3DP.%26aulast%3DBreli%25C3%25A8re%26aufirst%3DJ.%2BC.%26aulast%3DLe%2BFur%26aufirst%3DG.%26atitle%3DSR141716A%252C%2520a%2520potent%2520and%2520selective%2520antagonist%2520of%2520the%2520brain%2520cannabinoid%2520receptor%26jtitle%3DFEBS%2520Lett.%26date%3D1994%26volume%3D350%26spage%3D240%26epage%3D244%26doi%3D10.1016%2F0014-5793%2894%2900773-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Fulp, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortoff, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seltzman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fennell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maitra, R.</span><span> </span><span class="NLM_article-title">Design and synthesis of cannabinoid receptor 1 antagonists for peripheral selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2820</span><span class="NLM_x">–</span> <span class="NLM_lpage">2834</span><span class="refDoi"> DOI: 10.1021/jm201731z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201731z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVGju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2820-2834&author=A.+Fulpauthor=K.+Bortoffauthor=H.+Seltzmanauthor=Y.+Zhangauthor=J.+Mathewsauthor=R.+Snyderauthor=T.+Fennellauthor=R.+Maitra&title=Design+and+synthesis+of+cannabinoid+receptor+1+antagonists+for+peripheral+selectivity&doi=10.1021%2Fjm201731z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Cannabinoid Receptor 1 Antagonists for Peripheral Selectivity</span></div><div class="casAuthors">Fulp, Alan; Bortoff, Katherine; Seltzman, Herbert; Zhang, Yanan; Mathews, James; Snyder, Rodney; Fennell, Tim; Maitra, Rangan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2820-2834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Antagonists of cannabinoid receptor 1 (CB1) have potential for the treatment of several diseases such as obesity, liver disease, and diabetes.  Recently, development of several CB1 antagonists was halted because of adverse central nervous system (CNS) related side effects obsd. with rimonabant, the first clin. approved CB1 inverse agonist.  However, recent studies indicate that regulation of peripherally expressed CB1 with CNS-sparing compds. is a viable strategy to treat several important disorders.  The reported efforts aimed at rationally designing peripherally restricted CB1 antagonists have resulted in compds. that have limited blood-brain barrier (BBB) permeability and CNS exposure in preclin. in vitro and in vivo models.  Typically, compds. with high topol. polar surface areas (TPSAs) do not cross the BBB passively.  Compds. with TPSAs higher than that for rimonabant (rimonabant TPSA = 50) and excellent functional activity with limited CNS penetration were identified.  These compds. will serve as templates for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxIk0YtV78UbVg90H21EOLACvtfcHk0lgZ3SyxVUFtlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVGju74%253D&md5=95a56654ab10a8b238ee16949fc10e18</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm201731z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201731z%26sid%3Dliteratum%253Aachs%26aulast%3DFulp%26aufirst%3DA.%26aulast%3DBortoff%26aufirst%3DK.%26aulast%3DSeltzman%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMathews%26aufirst%3DJ.%26aulast%3DSnyder%26aufirst%3DR.%26aulast%3DFennell%26aufirst%3DT.%26aulast%3DMaitra%26aufirst%3DR.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520cannabinoid%2520receptor%25201%2520antagonists%2520for%2520peripheral%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2820%26epage%3D2834%26doi%3D10.1021%2Fjm201731z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">D’Ambra, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estep, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eissenstat, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josef, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haycock, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baizman, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casiano, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beglin, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chippari, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grego, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kullnig, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daley, G. T.</span><span> </span><span class="NLM_article-title">Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span><span class="refDoi"> DOI: 10.1021/jm00079a016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00079a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=124-135&author=T.+E.+D%E2%80%99Ambraauthor=K.+G.+Estepauthor=M.+R.+Bellauthor=M.+A.+Eissenstatauthor=K.+A.+Josefauthor=S.+J.+Wardauthor=D.+A.+Haycockauthor=E.+R.+Baizmanauthor=F.+M.+Casianoauthor=N.+C.+Beglinauthor=S.+M.+Chippariauthor=J.+D.+Gregoauthor=R.+K.+Kullnigauthor=G.+T.+Daley&title=Conformationally+restrained+analogues+of+pravadoline%3A+nanomolar+potent%2C+enantioselective%2C+%28aminoalkyl%29indole+agonists+of+the+cannabinoid+receptor&doi=10.1021%2Fjm00079a016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm00079a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00079a016%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Ambra%26aufirst%3DT.%2BE.%26aulast%3DEstep%26aufirst%3DK.%2BG.%26aulast%3DBell%26aufirst%3DM.%2BR.%26aulast%3DEissenstat%26aufirst%3DM.%2BA.%26aulast%3DJosef%26aufirst%3DK.%2BA.%26aulast%3DWard%26aufirst%3DS.%2BJ.%26aulast%3DHaycock%26aufirst%3DD.%2BA.%26aulast%3DBaizman%26aufirst%3DE.%2BR.%26aulast%3DCasiano%26aufirst%3DF.%2BM.%26aulast%3DBeglin%26aufirst%3DN.%2BC.%26aulast%3DChippari%26aufirst%3DS.%2BM.%26aulast%3DGrego%26aufirst%3DJ.%2BD.%26aulast%3DKullnig%26aufirst%3DR.%2BK.%26aulast%3DDaley%26aufirst%3DG.%2BT.%26atitle%3DConformationally%2520restrained%2520analogues%2520of%2520pravadoline%253A%2520nanomolar%2520potent%252C%2520enantioselective%252C%2520%2528aminoalkyl%2529indole%2520agonists%2520of%2520the%2520cannabinoid%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D124%26epage%3D135%26doi%3D10.1021%2Fjm00079a016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rager, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kardos, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobson, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidalgo, I. J.</span><span> </span><span class="NLM_article-title">Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier</span> <span class="citation_source-journal">Int. J. Pharm. (Amsterdam, Neth.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span><span class="refDoi"> DOI: 10.1016/j.ijpharm.2004.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.ijpharm.2004.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=15620875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFGhurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2005&pages=349-359&author=Q.+Wangauthor=J.+D.+Ragerauthor=K.+Weinsteinauthor=P.+S.+Kardosauthor=G.+L.+Dobsonauthor=J.+Liauthor=I.+J.+Hidalgo&title=Evaluation+of+the+MDR-MDCK+cell+line+as+a+permeability+screen+for+the+blood-brain+barrier&doi=10.1016%2Fj.ijpharm.2004.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier</span></div><div class="casAuthors">Wang, Qing; Rager, Joseph D.; Weinstein, Kathryn; Kardos, Paula S.; Dobson, Glenn L.; Li, Jibin; Hidalgo, Ismael J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">349-359</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The objectives of this study were to (1) characterize MDR-MDCK monolayers as an in vitro model to predict brain uptake potential; (2) examine the ability of MDR-MDCK monolayers to identify the brain uptake potential of compds. that interact with P-glycoprotein (P-gp).  The study measured the bi-directional transport of 28 compds. across MDR-MDCK monolayers.  The brain uptake of a subset of the compds. was detd. in the rat brain perfusion model.  Drug concns. were analyzed by LC-MS-MS.  CNS-pos. drugs exhibited absorptive permeability coeffs. (Papp, A-B) values ranging from 3.4 × 10-6 to 20.2 × 10-6 cm/s; whereas CNS-neg. drugs showed Papp (A-B) ranging from 0.03 × 10-6 to 0.83 × 10-6 cm/s.  Inhibition of P-gp by cyclosporin A (CsA) significantly reduced secretory flux of compds. known to be P-pg substrates, but only enhanced the absorptive flux of compds. with high efflux ratio (>100).  In vitro results were confirmed by brain perfusion studies on selected compds.  MDR-MDCK monolayers can be used to classify compds. into CNS-pos. or CNS-neg. based on the permeability coeffs. (Papp, A-B).  Under the authors' exptl. conditions, compds. with Papp (A-B) >3 × 10-6 cm/s have high brain uptake potential; compds. with Papp (A-B) < 1 × 10-6 cm/s are unable to penetrate the blood-brain barrier (BBB); the brain uptake of compds. with Papp (A-B) < 1 × 10-6 cm/s and a P-gp-mediated efflux ratio of >100 may be enhanced by inhibiting P-gp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvF-zoLte8trVg90H21EOLACvtfcHk0lg2dZrHcho5pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFGhurvE&md5=7d2cb9e13b2767b337bf808e73141ae1</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2004.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2004.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DRager%26aufirst%3DJ.%2BD.%26aulast%3DWeinstein%26aufirst%3DK.%26aulast%3DKardos%26aufirst%3DP.%2BS.%26aulast%3DDobson%26aufirst%3DG.%2BL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHidalgo%26aufirst%3DI.%2BJ.%26atitle%3DEvaluation%2520of%2520the%2520MDR-MDCK%2520cell%2520line%2520as%2520a%2520permeability%2520screen%2520for%2520the%2520blood-brain%2520barrier%26jtitle%3DInt.%2520J.%2520Pharm.%2520%2528Amsterdam%252C%2520Neth.%2529%26date%3D2005%26volume%3D288%26spage%3D349%26epage%3D359%26doi%3D10.1016%2Fj.ijpharm.2004.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McAllister, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizvi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anavi-Goffer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett-Norris, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggio, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abood, M. E.</span><span> </span><span class="NLM_article-title">An aromatic microdomain at the cannabinoid CB<sub>1</sub> receptor constitutes an agonist/inverse agonist binding region</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">5139</span><span class="NLM_x">–</span> <span class="NLM_lpage">5152</span><span class="refDoi"> DOI: 10.1021/jm0302647</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0302647" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=5139-5152&author=S.+D.+McAllisterauthor=G.+Rizviauthor=S.+Anavi-Gofferauthor=D.+P.+Hurstauthor=J.+Barnett-Norrisauthor=D.+L.+Lynchauthor=P.+H.+Reggioauthor=M.+E.+Abood&title=An+aromatic+microdomain+at+the+cannabinoid+CB1+receptor+constitutes+an+agonist%2Finverse+agonist+binding+region&doi=10.1021%2Fjm0302647"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1021%2Fjm0302647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0302647%26sid%3Dliteratum%253Aachs%26aulast%3DMcAllister%26aufirst%3DS.%2BD.%26aulast%3DRizvi%26aufirst%3DG.%26aulast%3DAnavi-Goffer%26aufirst%3DS.%26aulast%3DHurst%26aufirst%3DD.%2BP.%26aulast%3DBarnett-Norris%26aufirst%3DJ.%26aulast%3DLynch%26aufirst%3DD.%2BL.%26aulast%3DReggio%26aufirst%3DP.%2BH.%26aulast%3DAbood%26aufirst%3DM.%2BE.%26atitle%3DAn%2520aromatic%2520microdomain%2520at%2520the%2520cannabinoid%2520CB1%2520receptor%2520constitutes%2520an%2520agonist%252Finverse%2520agonist%2520binding%2520region%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D5139%26epage%3D5152%26doi%3D10.1021%2Fjm0302647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Reggio, P. H.</span><span> </span><span class="NLM_article-title">Pharmacophores for ligand recognition and activation/inactivation of the cannabinoid receptors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1607</span><span class="NLM_x">–</span> <span class="NLM_lpage">1633</span><span class="refDoi"> DOI: 10.2174/1381612033454577</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.2174%2F1381612033454577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=12871061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmt1GnsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=1607-1633&author=P.+H.+Reggio&title=Pharmacophores+for+ligand+recognition+and+activation%2Finactivation+of+the+cannabinoid+receptors&doi=10.2174%2F1381612033454577"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30bR"><div class="casContent"><span class="casTitleNuber">30b</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophores for ligand recognition and activation/inactivation of the cannabinoid receptors</span></div><div class="casAuthors">Reggio, Patricia H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1607-1633</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The cannabinoid CB1 and CB2 receptors belong to the Class A, rhodopsin-like family of G protein-coupled receptors.  Antagonists for each receptor sub-type, as well as four structural classes of agonists that bind to both receptors, have been identified.  An extensive amt. of SAR has been developed for agonists and antagonists that bind at CB1, while the SAR of CB2 ligands is only now emerging in the literature.  Cannabinoid agonists have been suggested to have potential therapeutic uses as appetite stimulants, analgesics, anti-emetics, anti-diarrheals, anti-spasmodics, tumor anti-proliferative agents, anti-glaucoma agents and as agents for the treatment of diseases assocd. with inappropriate retention of aversive memories such as post-traumatic stress disorders and phobias.  Cannabinoid CB1 antagonists have been suggested to have potential therapeutic uses as appetite suppressants and as agents that improve memory.  This review focuses first on recent CB1 and CB2 SAR and on the pharmacophores that have been developed for ligand recognition at the CB1 receptor.  Emerging ideas about how the cannabinoid receptors are activated by agonists or inactivated by inverse agonists are then presented.  Challenges for future SAR and pharmacophore development are also identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9wsB2MKnOrVg90H21EOLACvtfcHk0lg2dZrHcho5pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmt1GnsL4%253D&md5=f10ef4389fbcbb56fe26d7a56084f8c0</span></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.2174%2F1381612033454577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612033454577%26sid%3Dliteratum%253Aachs%26aulast%3DReggio%26aufirst%3DP.%2BH.%26atitle%3DPharmacophores%2520for%2520ligand%2520recognition%2520and%2520activation%252Finactivation%2520of%2520the%2520cannabinoid%2520receptors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2003%26volume%3D9%26spage%3D1607%26epage%3D1633%26doi%3D10.2174%2F1381612033454577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Eissenstat, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Ambra, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daum, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackerman, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estep, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olefirowicz, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetzel, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, J. D.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haycock, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttinger, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casiano, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chippari, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuster, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. J.</span><span> </span><span class="NLM_article-title">Aminoalkylindoles: structure-activity relationships of novel cannabinoid mimetics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">3094</span><span class="NLM_x">–</span> <span class="NLM_lpage">3105</span><span class="refDoi"> DOI: 10.1021/jm00016a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00016a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=3094-3105&author=M.+A.+Eissenstatauthor=M.+R.+Bellauthor=T.+E.+D%E2%80%99Ambraauthor=E.+J.+Alexanderauthor=S.+J.+Daumauthor=J.+H.+Ackermanauthor=M.+D.+Gruettauthor=V.+Kumarauthor=K.+G.+Estepauthor=E.+M.+Olefirowiczauthor=J.+R.+Wetzelauthor=M.+D.+Alexanderauthor=J.+D.+Weaverauthor=D.+A.+Haycockauthor=D.+A.+Luttingerauthor=F.+M.+Casianoauthor=S.+M.+Chippariauthor=J.+E.+Kusterauthor=J.+I.+Stevensonauthor=S.+J.+Ward&title=Aminoalkylindoles%3A+structure-activity+relationships+of+novel+cannabinoid+mimetics&doi=10.1021%2Fjm00016a013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm00016a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00016a013%26sid%3Dliteratum%253Aachs%26aulast%3DEissenstat%26aufirst%3DM.%2BA.%26aulast%3DBell%26aufirst%3DM.%2BR.%26aulast%3DD%25E2%2580%2599Ambra%26aufirst%3DT.%2BE.%26aulast%3DAlexander%26aufirst%3DE.%2BJ.%26aulast%3DDaum%26aufirst%3DS.%2BJ.%26aulast%3DAckerman%26aufirst%3DJ.%2BH.%26aulast%3DGruett%26aufirst%3DM.%2BD.%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DEstep%26aufirst%3DK.%2BG.%26aulast%3DOlefirowicz%26aufirst%3DE.%2BM.%26aulast%3DWetzel%26aufirst%3DJ.%2BR.%26aulast%3DAlexander%26aufirst%3DM.%2BD.%26aulast%3DWeaver%26aufirst%3DJ.%2BD.%26aulast%3DHaycock%26aufirst%3DD.%2BA.%26aulast%3DLuttinger%26aufirst%3DD.%2BA.%26aulast%3DCasiano%26aufirst%3DF.%2BM.%26aulast%3DChippari%26aufirst%3DS.%2BM.%26aulast%3DKuster%26aufirst%3DJ.%2BE.%26aulast%3DStevenson%26aufirst%3DJ.%2BI.%26aulast%3DWard%26aufirst%3DS.%2BJ.%26atitle%3DAminoalkylindoles%253A%2520structure-activity%2520relationships%2520of%2520novel%2520cannabinoid%2520mimetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D3094%26epage%3D3105%26doi%3D10.1021%2Fjm00016a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Huffman, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szklennik, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almond, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bushell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassidy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4110</span><span class="NLM_x">–</span> <span class="NLM_lpage">4113</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2005.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.bmcl.2005.06.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4110-4113&author=J.+W.+Huffmanauthor=P.+V.+Szklennikauthor=A.+Almondauthor=K.+Bushellauthor=D.+E.+Selleyauthor=H.+Heauthor=M.+P.+Cassidyauthor=J.+L.+Wileyauthor=B.+R.+Martin&title=1-Pentyl-3-phenylacetylindoles%2C+a+new+class+of+cannabimimetic+indoles&doi=10.1016%2Fj.bmcl.2005.06.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DHuffman%26aufirst%3DJ.%2BW.%26aulast%3DSzklennik%26aufirst%3DP.%2BV.%26aulast%3DAlmond%26aufirst%3DA.%26aulast%3DBushell%26aufirst%3DK.%26aulast%3DSelley%26aufirst%3DD.%2BE.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DCassidy%26aufirst%3DM.%2BP.%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3D1-Pentyl-3-phenylacetylindoles%252C%2520a%2520new%2520class%2520of%2520cannabimimetic%2520indoles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4110%26epage%3D4113%26doi%3D10.1016%2Fj.bmcl.2005.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Brents, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallus-Zawada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radominska-Pandya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasiljevik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prisinzano, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantegrossi, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prather, P. L.</span><span> </span><span class="NLM_article-title">Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity</span> <span class="citation_source-journal">Biochem. Pharmacol. (Amsterdam, Neth.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">952</span><span class="NLM_x">–</span> <span class="NLM_lpage">961</span><span class="refDoi"> DOI: 10.1016/j.bcp.2012.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.bcp.2012.01.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=952-961&author=L.+K.+Brentsauthor=A.+Gallus-Zawadaauthor=A.+Radominska-Pandyaauthor=T.+Vasiljevikauthor=T.+E.+Prisinzanoauthor=W.+E.+Fantegrossiauthor=J.+H.+Moranauthor=P.+L.+Prather&title=Monohydroxylated+metabolites+of+the+K2+synthetic+cannabinoid+JWH-073+retain+intermediate+to+high+cannabinoid+1+receptor+%28CB1R%29+affinity+and+exhibit+neutral+antagonist+to+partial+agonist+activity&doi=10.1016%2Fj.bcp.2012.01.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DBrents%26aufirst%3DL.%2BK.%26aulast%3DGallus-Zawada%26aufirst%3DA.%26aulast%3DRadominska-Pandya%26aufirst%3DA.%26aulast%3DVasiljevik%26aufirst%3DT.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DFantegrossi%26aufirst%3DW.%2BE.%26aulast%3DMoran%26aufirst%3DJ.%2BH.%26aulast%3DPrather%26aufirst%3DP.%2BL.%26atitle%3DMonohydroxylated%2520metabolites%2520of%2520the%2520K2%2520synthetic%2520cannabinoid%2520JWH-073%2520retain%2520intermediate%2520to%2520high%2520cannabinoid%25201%2520receptor%2520%2528CB1R%2529%2520affinity%2520and%2520exhibit%2520neutral%2520antagonist%2520to%2520partial%2520agonist%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%2520%2528Amsterdam%252C%2520Neth.%2529%26date%3D2012%26volume%3D83%26spage%3D952%26epage%3D961%26doi%3D10.1016%2Fj.bcp.2012.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Brents, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichard, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantegrossi, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prather, P. L.</span><span> </span><span class="NLM_article-title">Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e21917</span><span class="refDoi"> DOI: 10.1371/journal.pone.0021917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1371%2Fjournal.pone.0021917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=21755008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFChsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e21917&author=L.+K.+Brentsauthor=E.+E.+Reichardauthor=S.+M.+Zimmermanauthor=J.+H.+Moranauthor=W.+E.+Fantegrossiauthor=P.+L.+Prather&title=Phase+I+hydroxylated+metabolites+of+the+K2+synthetic+cannabinoid+JWH-018+retain+in+vitro+and+in+vivo+cannabinoid+1+receptor+affinity+and+activity&doi=10.1371%2Fjournal.pone.0021917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity</span></div><div class="casAuthors">Brents, Lisa K.; Reichard, Emily E.; Zimmerman, Sarah M.; Moran, Jeffery H.; Fantegrossi, William E.; Prather, Paul L.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e21917</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">K2 products are synthetic cannabinoid-laced, marijuana-like drugs of abuse, use of which is often assocd. with clin. symptoms atypical of marijuana use, including hypertension, agitation, hallucinations, psychosis, seizures and panic attacks.  JWH-018, a prevalent K2 synthetic cannabinoid, is structurally distinct from Δ9-THC, the main psychoactive ingredient in marijuana.  Since even subtle structural differences can lead to differential metab., formation of novel, biol. active metabolites may be responsible for the distinct effects assocd. with K2 use.  The present study proposes that K2's high adverse effect occurrence is due, at least in part, to distinct JWH-018 metabolite activity at the cannabinoid 1 receptor (CB1R).  JWH-018, five potential monohydroxylated metabolites (M1-M5), and one carboxy metabolite (M6) were examd. in mouse brain homogenates contg. CB1Rs, first for CB1R affinity using a competition binding assay employing the cannabinoid receptor radioligand [3H]CP-55,940, and then for CB1R intrinsic efficacy using an [35S]GTPγS binding assay.  JWH-018 and M1-M5 bound CB1Rs with high affinity, exhibiting Ki values that were lower than or equiv. to Δ9-THC.  These mols. also stimulated G-proteins with equal or greater efficacy relative to Δ9-THC, a CB1R partial agonist.  Most importantly, JWH-018, M2, M3, and M5 produced full CB1R agonist levels of activation.  CB1R-mediated activation was demonstrated by blockade with O-2050, a CB1R-selective neutral antagonist.  Similar to Δ9-THC, JWH-018 and M1 produced a marked depression of locomotor activity and core body temp. in mice that were both blocked by the CB1R-preferring antagonist/inverse agonist AM251.  Unlike metabolites of most drugs, the studied JWH-018 monohydroxylated compds., but not the carboxy metabolite, retain in vitro and in vivo activity at CB1Rs.  These observations, combined with higher CB1R affinity and activity relative to Δ9-THC, may contribute to the greater prevalence of adverse effects obsd. with JWH-018-contg. products relative to cannabis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHN28ACeRV0LVg90H21EOLACvtfcHk0ljKS0xZjDjBuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFChsL0%253D&md5=a40b0f6749f9552fd544fa0f6f2dc2ba</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0021917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0021917%26sid%3Dliteratum%253Aachs%26aulast%3DBrents%26aufirst%3DL.%2BK.%26aulast%3DReichard%26aufirst%3DE.%2BE.%26aulast%3DZimmerman%26aufirst%3DS.%2BM.%26aulast%3DMoran%26aufirst%3DJ.%2BH.%26aulast%3DFantegrossi%26aufirst%3DW.%2BE.%26aulast%3DPrather%26aufirst%3DP.%2BL.%26atitle%3DPhase%2520I%2520hydroxylated%2520metabolites%2520of%2520the%2520K2%2520synthetic%2520cannabinoid%2520JWH-018%2520retain%2520in%2520vitro%2520and%2520in%2520vivo%2520cannabinoid%25201%2520receptor%2520affinity%2520and%2520activity%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De21917%26doi%3D10.1371%2Fjournal.pone.0021917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Löscher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potschka, H.</span><span> </span><span class="NLM_article-title">Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span><span class="refDoi"> DOI: 10.1016/j.pneurobio.2005.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.pneurobio.2005.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=16011870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADC%252BD2MzpvFSgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2005&pages=22-76&author=W.+L%C3%B6scherauthor=H.+Potschka&title=Role+of+drug+efflux+transporters+in+the+brain+for+drug+disposition+and+treatment+of+brain+diseases&doi=10.1016%2Fj.pneurobio.2005.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases</span></div><div class="casAuthors">Loscher Wolfgang; Potschka Heidrun</div><div class="citationInfo"><span class="NLM_cas:title">Progress in neurobiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-76</span>
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    </div><div class="casAbstract">The blood-brain barrier (BBB) serves as a protective mechanism for the brain by preventing entry of potentially harmful substances from free access to the central nervous system (CNS).  Tight junctions present between the brain microvessel endothelial cells form a diffusion barrier, which selectively excludes most blood-borne substances from entering the brain.  Astrocytic end-feet tightly ensheath the vessel wall and appear to be critical for the induction and maintenance of the barrier properties of the brain capillary endothelial cells.  Because of these properties, the BBB only allows entry of lipophilic compounds with low molecular weights by passive diffusion.  However, many lipophilic drugs show negligible brain uptake.  They are substrates for drug efflux transporters such as P-glycoprotein (Pgp), multidrug resistance proteins (MRPs) or organic anion transporting polypeptides (OATPs) that are expressed at brain capillary endothelial cells and/or astrocytic end-feet and are key elements of the molecular machinery that confers the special permeability properties to the BBB.  The combined action of these carrier systems results in rapid efflux of xenobiotics from the CNS.  The objective of this review is to summarize transporter characteristics (cellular localization, specificity, regulation, and potential inhibition) for drug efflux transport systems identified in the BBB and blood-cerebrospinal fluid (CSF) barrier.  A variety of experimental approaches available to ascertain or predict the impact of efflux transport on brain access of therapeutic drugs also are described and critically discussed.  The potential impact of efflux transport on the pharmacodynamics of agents acting in the CNS is illustrated.  Furthermore, the current knowledge about drug efflux transporters as a major determinant of multidrug resistance of brain diseases such as epilepsy is reviewed.  Finally, we summarize strategies for modulating or by-passing drug efflux transporters at the BBB as novel therapeutic approaches to drug-resistant brain diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRe07yo5jk4UPSAs_PE1QvifW6udTcc2eb-T3w4UB4MVLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzpvFSgtw%253D%253D&md5=146aa11977c71b08a1182aba1354db84</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2005.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2005.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6scher%26aufirst%3DW.%26aulast%3DPotschka%26aufirst%3DH.%26atitle%3DRole%2520of%2520drug%2520efflux%2520transporters%2520in%2520the%2520brain%2520for%2520drug%2520disposition%2520and%2520treatment%2520of%2520brain%2520diseases%26jtitle%3DProg.%2520Neurobiol.%26date%3D2005%26volume%3D76%26spage%3D22%26epage%3D76%26doi%3D10.1016%2Fj.pneurobio.2005.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Montesinos, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gromand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beduneau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamprecht, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellequer, Y.</span><span> </span><span class="NLM_article-title">Coadministration of P-glycoprotein modulators on loperamide pharmacokinetics and brain distribution</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">700</span><span class="NLM_x">–</span> <span class="NLM_lpage">706</span><span class="refDoi"> DOI: 10.1124/dmd.113.055566</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1124%2Fdmd.113.055566" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=24398461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvVKqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=700-706&author=R.+N.+Montesinosauthor=B.+Moulariauthor=J.+Gromandauthor=A.+Beduneauauthor=A.+Lamprechtauthor=Y.+Pellequer&title=Coadministration+of+P-glycoprotein+modulators+on+loperamide+pharmacokinetics+and+brain+distribution&doi=10.1124%2Fdmd.113.055566"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Coadministration of P-glycoprotein modulators on loperamide pharmacokinetics and brain distribution</span></div><div class="casAuthors">Montesinos, Rita Nieto; Moulari, Brice; Gromand, Jessica; Beduneau, Arnaud; Lamprecht, Alf; Pellequer, Yann</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">700-706, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The efflux transporter P-glycoprotein, expressed at high levels at the blood-brain barrier, exerts a profound effect on the disposition of various therapeutic compds. in the brain.  A rapid and efficient modulation of this efflux transporter could enhance the distribution of its substrates and thereby improve central nervous system pharmaco-therapies.  This study explored the impact of the i.v. co-administration of two P-glycoprotein modulators, tariquidar and elacridar, on the pharmacokinetics and brain distribution of loperamide, a P-glycoprotein substrate probe, in rats.  After 1 h postdosing, tariquidar and elacridar, both at a dose of 1.0 mg/kg, increased loperamide levels in the brain by 2.3- and 3.5-fold, resp.  However, the concurrent administration of both P-glycoprotein modulators, each at a dose of 0.5 mg/kg, increased loperamide levels in the brain by 5.8-fold and resulted in the most pronounced opioid-induced clin. signs.  This phenomenon may be the result of a combined noncompetitive modulation by tariquidar and elacridar.  Besides, the simultaneous administration of elacridar and tariquidar did not significantly modify the pharmacokinetic parameters of loperamide.  This observation potentially allows the concurrent use of low but therapeutic doses of P-gp modulators to achieve full inhibitory effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1SQBbE-KSrrVg90H21EOLACvtfcHk0lheHywJD4XTPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvVKqt7w%253D&md5=8c0f4ceb7d6e08bbd22cf360e0d331da</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.055566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.055566%26sid%3Dliteratum%253Aachs%26aulast%3DMontesinos%26aufirst%3DR.%2BN.%26aulast%3DMoulari%26aufirst%3DB.%26aulast%3DGromand%26aufirst%3DJ.%26aulast%3DBeduneau%26aufirst%3DA.%26aulast%3DLamprecht%26aufirst%3DA.%26aulast%3DPellequer%26aufirst%3DY.%26atitle%3DCoadministration%2520of%2520P-glycoprotein%2520modulators%2520on%2520loperamide%2520pharmacokinetics%2520and%2520brain%2520distribution%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26spage%3D700%26epage%3D706%26doi%3D10.1124%2Fdmd.113.055566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Fuchs, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gansser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanswell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiguro, N.</span><span> </span><span class="NLM_article-title">Brain penetration of WEB 2086 (Apafant) and dantrolene in Mdr1a (P-glycoprotein) and Bcrp knockout rats</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1761</span><span class="NLM_x">–</span> <span class="NLM_lpage">1765</span><span class="refDoi"> DOI: 10.1124/dmd.114.058545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1124%2Fdmd.114.058545" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=1761-1765&author=H.+Fuchsauthor=W.+Kishimotoauthor=D.+Gansserauthor=P.+Tanswellauthor=N.+Ishiguro&title=Brain+penetration+of+WEB+2086+%28Apafant%29+and+dantrolene+in+Mdr1a+%28P-glycoprotein%29+and+Bcrp+knockout+rats&doi=10.1124%2Fdmd.114.058545"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.058545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.058545%26sid%3Dliteratum%253Aachs%26aulast%3DFuchs%26aufirst%3DH.%26aulast%3DKishimoto%26aufirst%3DW.%26aulast%3DGansser%26aufirst%3DD.%26aulast%3DTanswell%26aufirst%3DP.%26aulast%3DIshiguro%26aufirst%3DN.%26atitle%3DBrain%2520penetration%2520of%2520WEB%25202086%2520%2528Apafant%2529%2520and%2520dantrolene%2520in%2520Mdr1a%2520%2528P-glycoprotein%2529%2520and%2520Bcrp%2520knockout%2520rats%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26spage%3D1761%26epage%3D1765%26doi%3D10.1124%2Fdmd.114.058545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mitrirattanakul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramakul, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrero, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faull, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spigelman, I.</span><span> </span><span class="NLM_article-title">Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">114</span><span class="refDoi"> DOI: 10.1016/j.pain.2006.06.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.pain.2006.06.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=16844297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1agtrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2006&pages=102-114&author=S.+Mitrirattanakulauthor=N.+Ramakulauthor=A.+V.+Guerreroauthor=Y.+Matsukaauthor=T.+Onoauthor=H.+Iwaseauthor=K.+Mackieauthor=K.+Faullauthor=I.+Spigelman&title=Site-specific+increases+in+peripheral+cannabinoid+receptors+and+their+endogenous+ligands+in+a+model+of+neuropathic+pain&doi=10.1016%2Fj.pain.2006.06.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37aR"><div class="casContent"><span class="casTitleNuber">37a</span><div class="casTitle"><span class="NLM_cas:atitle">Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain</span></div><div class="casAuthors">Mitrirattanakul, Somsak; Ramakul, Navapoln; Guerrero, Andre V.; Matsuka, Yoshizo; Ono, Takeshi; Iwase, Hirotate; Mackie, Ken; Faull, Kym F.; Spigelman, Igor</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">102-114</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Selective activation of the peripheral cannabinoid receptor 1 (CB1R) has been shown to suppress neuropathic pain symptoms in rodents.  However, relatively little is known about changes in CB1R and its endogenous ligands during development or maintenance of neuropathic pain.  Using immunohistochem., Western blot, real-time reverse transcription polymerase chain reaction, as well as liq. chromatog./mass spectrometry, we studied the changes in CB1Rs and endocannabinoids N-arachidonoylethanolamine/anandamide (AEA) and 2-arachidonoylglycerol (2-AG) in rat lumbar (L4 and L5) dorsal root ganglia (DRG) after neuropathic pain induction (L5 spinal nerve ligation: SNL).  Immunohistochem. revealed that in control rats, CB1R is expressed in the majority (76-83%) of nociceptive neurons as indicated by co-labeling with isolectin B4 (IB4) or antibodies recognizing transient receptor potential vanilloid (TRPV1), calcitonin gene related peptide (CGRP), and the NR2C/2D subunits of the N-methyl- -aspartate receptor.  After L5 SNL, CB1R mRNA and protein increases in the ipsilateral uninjured L4 DRG whereas the percentages of CB1R immunoreactive (CB1R-ir) neurons remain unchanged in L4 and L5 DRG.  However, for these CB1R-ir neurons, we observe significant increases in percentage of TRPV1-ir cells in ipsilateral L4 DRG, and decreases in percentage of IB4- and CGRP-co-labeled cells in ipsilateral L5 DRG.  Levels of both AEA and 2-AG increase significantly only in the ipsilateral L5 DRG.  These results are consistent with the preserved analgesic effects of cannabinoids in neuropathic pain and provide a rational framework for the development of peripherally acting endocannabinoid-based therapeutic interventions for neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd_X-EqUbWL7Vg90H21EOLACvtfcHk0lheHywJD4XTPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1agtrbE&md5=1826c96080736624b3729fb246350731</span></div><a href="/servlet/linkout?suffix=cit37a&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2006.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2006.06.016%26sid%3Dliteratum%253Aachs%26aulast%3DMitrirattanakul%26aufirst%3DS.%26aulast%3DRamakul%26aufirst%3DN.%26aulast%3DGuerrero%26aufirst%3DA.%2BV.%26aulast%3DMatsuka%26aufirst%3DY.%26aulast%3DOno%26aufirst%3DT.%26aulast%3DIwase%26aufirst%3DH.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DFaull%26aufirst%3DK.%26aulast%3DSpigelman%26aufirst%3DI.%26atitle%3DSite-specific%2520increases%2520in%2520peripheral%2520cannabinoid%2520receptors%2520and%2520their%2520endogenous%2520ligands%2520in%2520a%2520model%2520of%2520neuropathic%2520pain%26jtitle%3DPain%26date%3D2006%26volume%3D126%26spage%3D102%26epage%3D114%26doi%3D10.1016%2Fj.pain.2006.06.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit37b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wotherspoon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, J.</span><span> </span><span class="NLM_article-title">Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2005.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.neuroscience.2005.06.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2005&pages=235-245&author=G.+Wotherspoonauthor=A.+Foxauthor=P.+McIntyreauthor=S.+Colleyauthor=S.+Bevanauthor=J.+Winter&title=Peripheral+nerve+injury+induces+cannabinoid+receptor+2+protein+expression+in+rat+sensory+neurons&doi=10.1016%2Fj.neuroscience.2005.06.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37b&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2005.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2005.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DWotherspoon%26aufirst%3DG.%26aulast%3DFox%26aufirst%3DA.%26aulast%3DMcIntyre%26aufirst%3DP.%26aulast%3DColley%26aufirst%3DS.%26aulast%3DBevan%26aufirst%3DS.%26aulast%3DWinter%26aufirst%3DJ.%26atitle%3DPeripheral%2520nerve%2520injury%2520induces%2520cannabinoid%2520receptor%25202%2520protein%2520expression%2520in%2520rat%2520sensory%2520neurons%26jtitle%3DNeuroscience%26date%3D2005%26volume%3D135%26spage%3D235%26epage%3D245%26doi%3D10.1016%2Fj.neuroscience.2005.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Ubogu, E. E.</span><span> </span><span class="NLM_article-title">The molecular and biophysical characterization of the human blood-nerve barrier: current concepts</span> <span class="citation_source-journal">J. Vasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span><span class="refDoi"> DOI: 10.1159/000353293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1159%2F000353293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=23839247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADC%252BC3sjptlCksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2013&pages=289-303&author=E.+E.+Ubogu&title=The+molecular+and+biophysical+characterization+of+the+human+blood-nerve+barrier%3A+current+concepts&doi=10.1159%2F000353293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular and biophysical characterization of the human blood-nerve barrier: current concepts</span></div><div class="casAuthors">Ubogu Eroboghene E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of vascular research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">289-303</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The internal microenvironment in peripheral nerves is highly regulated in order to maintain normal axonal impulse transmission to or from the central nervous system.  In humans, this regulation is facilitated by specialized tight junction (TJ)-forming endoneurial microvascular endothelial cells and perineurial myofibroblasts that form multiple concentric layers around nerve fascicles.  The endoneurial endothelial cells come in direct contact with circulating blood and, thus, can be considered the blood-nerve barrier (BNB).  Studies on the molecular and biophysical properties of the human BNB in vivo or in situ are limited.  Owing to the recent isolation of primary human endoneurial endothelial cells and the development of simian virus 40 large T-antigen immortalized cell lines, data are emerging on the structural and functional characteristics of these cells.  These data aim to increase our understanding of how solutes, macromolecules, nutrients and hematogenous leukocytes gain access into or are restricted from the endoneurium of peripheral nerves.  These concepts have clinical relevance in understanding normal peripheral nerve homeostasis, the response of peripheral nerves to external insult and stresses such as drugs and toxins and the pathogenesis of peripheral neuropathies.  This review discusses current knowledge in this nascent and exciting field of microvascular biology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTQ7Kub-o5M2BBrI9DTGjC0fW6udTcc2eaDS0kZcVlRSLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjptlCksA%253D%253D&md5=df91b7d7e2a2d701b34d758d828ccd6d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1159%2F000353293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000353293%26sid%3Dliteratum%253Aachs%26aulast%3DUbogu%26aufirst%3DE.%2BE.%26atitle%3DThe%2520molecular%2520and%2520biophysical%2520characterization%2520of%2520the%2520human%2520blood-nerve%2520barrier%253A%2520current%2520concepts%26jtitle%3DJ.%2520Vasc.%2520Res.%26date%3D2013%26volume%3D50%26spage%3D289%26epage%3D303%26doi%3D10.1159%2F000353293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ragavendran, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laferriere, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padi, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coderre, T. J.</span><span> </span><span class="NLM_article-title">Topical combinations aimed at treating microvascular dysfunction reduce allodynia in rat models of CRPS-I and neuropathic pain</span> <span class="citation_source-journal">J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span><span class="refDoi"> DOI: 10.1016/j.jpain.2012.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.jpain.2012.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=23273834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsV2rtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=66-78&author=J.+V.+Ragavendranauthor=A.+Laferriereauthor=W.+H.+Xiaoauthor=G.+J.+Bennettauthor=S.+S.+Padiauthor=J.+Zhangauthor=T.+J.+Coderre&title=Topical+combinations+aimed+at+treating+microvascular+dysfunction+reduce+allodynia+in+rat+models+of+CRPS-I+and+neuropathic+pain&doi=10.1016%2Fj.jpain.2012.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39aR"><div class="casContent"><span class="casTitleNuber">39a</span><div class="casTitle"><span class="NLM_cas:atitle">Topical Combinations Aimed at Treating Microvascular Dysfunction Reduce Allodynia in Rat Models of CRPS-I and Neuropathic Pain</span></div><div class="casAuthors">Ragavendran, J. Vaigunda; Laferriere, Andre; Xiao, Wen Hua; Bennett, Gary J.; Padi, Satyanarayana S. V.; Zhang, Ji; Coderre, Terence J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-78</span>CODEN:
                <span class="NLM_cas:coden">JPOAB5</span>;
        ISSN:<span class="NLM_cas:issn">1526-5900</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Growing evidence indicates that various chronic pain syndromes exhibit tissue abnormalities caused by microvasculature dysfunction in the blood vessels of skin, muscle, or nerve.  We tested whether topical combinations aimed at improving microvascular function would relieve allodynia in animal models of complex regional pain syndrome type I (CRPS-I) and neuropathic pain.  We hypothesized that topical administration of either α2-adrenergic (α2A) receptor agonists or nitric oxide (NO) donors combined with either phosphodiesterase (PDE) or phosphatidic acid (PA) inhibitors would effectively reduce allodynia in these animal models of chronic pain.  Single topical agents produced significant dose-dependent antiallodynic effects in rats with chronic postischemia pain, and the antiallodynic dose-response curves of PDE and PA inhibitors were shifted 2.5- to 10-fold leftward when combined with nonanalgesic doses of α2A receptor agonists or NO donors.  Topical combinations also produced significant antiallodynic effects in rats with sciatic nerve injury, painful diabetic neuropathy, and chemotherapy-induced painful neuropathy.  These effects were shown to be produced by a local action, lasted up to 6 h after acute treatment, and did not produce tolerance over 15 days of chronic daily dosing.  The present results support the hypothesis that allodynia in animal models of CRPS-I and neuropathic pain is effectively relieved by topical combinations of α2A or NO donors with PDE or PA inhibitors.  This suggests that topical treatments aimed at improving microvascular function may reduce allodynia in patients with CRPS-I and neuropathic pain.  Perspective: This article presents the synergistic antiallodynic effects of combinations of α2A or NO donors with PDE or PA inhibitors in animal models of CRPS-I and neuropathic pain.  The data suggest that effective clin. treatment of chronic neuropathic pain may be achieved by therapies that alleviate microvascular dysfunction in affected areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomjnXhMksRx7Vg90H21EOLACvtfcHk0lgTwHbu5tXOUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsV2rtQ%253D%253D&md5=5ad26dfce9f14f9907d2a88bae57ec57</span></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2012.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2012.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DRagavendran%26aufirst%3DJ.%2BV.%26aulast%3DLaferriere%26aufirst%3DA.%26aulast%3DXiao%26aufirst%3DW.%2BH.%26aulast%3DBennett%26aufirst%3DG.%2BJ.%26aulast%3DPadi%26aufirst%3DS.%2BS.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DCoderre%26aufirst%3DT.%2BJ.%26atitle%3DTopical%2520combinations%2520aimed%2520at%2520treating%2520microvascular%2520dysfunction%2520reduce%2520allodynia%2520in%2520rat%2520models%2520of%2520CRPS-I%2520and%2520neuropathic%2520pain%26jtitle%3DJ.%2520Pain%26date%3D2013%26volume%3D14%26spage%3D66%26epage%3D78%26doi%3D10.1016%2Fj.jpain.2012.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit39b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Greathouse, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palladino, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helton, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubogu, E. E.</span><span> </span><span class="NLM_article-title">Modeling leukocyte trafficking at the human blood-nerve barrier in vitro and in vivo geared towards targeted molecular therapies for peripheral neuroinflammation</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="refDoi"> DOI: 10.1186/s12974-015-0469-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1186%2Fs12974-015-0469-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=26732309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADC%252BC28rnsVymtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=3&author=K.+M.+Greathouseauthor=S.+P.+Palladinoauthor=C.+Dongauthor=E.+S.+Heltonauthor=E.+E.+Ubogu&title=Modeling+leukocyte+trafficking+at+the+human+blood-nerve+barrier+in+vitro+and+in+vivo+geared+towards+targeted+molecular+therapies+for+peripheral+neuroinflammation&doi=10.1186%2Fs12974-015-0469-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39bR"><div class="casContent"><span class="casTitleNuber">39b</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling leukocyte trafficking at the human blood-nerve barrier in vitro and in vivo geared towards targeted molecular therapies for peripheral neuroinflammation</span></div><div class="casAuthors">Greathouse Kelsey M; Palladino Steven P; Dong Chaoling; Helton Eric S; Ubogu Eroboghene E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroinflammation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Peripheral neuroinflammation is characterized by hematogenous mononuclear leukocyte infiltration into peripheral nerves.  Despite significant clinical knowledge, advancements in molecular biology and progress in developing specific drugs for inflammatory disorders such as rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis, there are currently no specific therapies that modulate pathogenic peripheral nerve inflammation.  Modeling leukocyte trafficking at the blood-nerve barrier using a reliable human in vitro model and potential intravital microscopy techniques in representative animal models guided by human observational data should facilitate the targeted modulation of the complex inflammatory cascade needed to develop safe and efficacious therapeutics for immune-mediated neuropathies and chronic neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS24DWjL7i85mhHGZei4OW9fW6udTcc2eaDS0kZcVlRSLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rnsVymtg%253D%253D&md5=67043be4c1760d51124024d7a9400c3c</span></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.1186%2Fs12974-015-0469-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12974-015-0469-3%26sid%3Dliteratum%253Aachs%26aulast%3DGreathouse%26aufirst%3DK.%2BM.%26aulast%3DPalladino%26aufirst%3DS.%2BP.%26aulast%3DDong%26aufirst%3DC.%26aulast%3DHelton%26aufirst%3DE.%2BS.%26aulast%3DUbogu%26aufirst%3DE.%2BE.%26atitle%3DModeling%2520leukocyte%2520trafficking%2520at%2520the%2520human%2520blood-nerve%2520barrier%2520in%2520vitro%2520and%2520in%2520vivo%2520geared%2520towards%2520targeted%2520molecular%2520therapies%2520for%2520peripheral%2520neuroinflammation%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2016%26volume%3D13%26spage%3D3%26doi%3D10.1186%2Fs12974-015-0469-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit39c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kanda, T.</span><span> </span><span class="NLM_article-title">Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies</span> <span class="citation_source-journal">J. Neurol., Neurosurg. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span><span class="refDoi"> DOI: 10.1136/jnnp-2012-302312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1136%2Fjnnp-2012-302312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=23243216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADC%252BC3s3it12ltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=208-212&author=T.+Kanda&title=Biology+of+the+blood-nerve+barrier+and+its+alteration+in+immune+mediated+neuropathies&doi=10.1136%2Fjnnp-2012-302312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39cR"><div class="casContent"><span class="casTitleNuber">39c</span><div class="casTitle"><span class="NLM_cas:atitle">Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies</span></div><div class="casAuthors">Kanda Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">208-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The blood-nerve barrier (BNB) is a dynamic and competent interface between the endoneurial microenvironment and the surrounding extracellular space or blood.  It is localised at the innermost layer of the multilayered ensheathing perineurium and endoneurial microvessels, and is the key structure that controls the internal milieu of the peripheral nerve parenchyma.  Since the endoneurial BNB is the point of entry for pathogenic T cells and various soluble factors, including cytokines, chemokines and immunoglobulins, understanding this structure is important to prevent and treat human immune mediated neuropathies such as Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy, POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes) syndrome and a subset of diabetic neuropathy.  However, compared with the blood-brain barrier, only limited knowledge has been accumulated regarding the function, cell biology and clinical significance of the BNB.  This review describes the basic structure and functions of the endoneurial BNB, provides an update of the biology of the cells comprising the BNB, and highlights the pathology and pathomechanisms of BNB breakdown in immune mediated neuropathies.  The human immortalised cell lines of BNB origin established in our laboratory will facilitate the future development of BNB research.  Potential therapeutic strategies for immune mediated neuropathies manipulating the BNB are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIECvdOWcgRBWfpMXQLRstfW6udTcc2eaDS0kZcVlRSLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3it12ltg%253D%253D&md5=9581941bfe64e83d26181eb0aa347c86</span></div><a href="/servlet/linkout?suffix=cit39c&amp;dbid=16384&amp;doi=10.1136%2Fjnnp-2012-302312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp-2012-302312%26sid%3Dliteratum%253Aachs%26aulast%3DKanda%26aufirst%3DT.%26atitle%3DBiology%2520of%2520the%2520blood-nerve%2520barrier%2520and%2520its%2520alteration%2520in%2520immune%2520mediated%2520neuropathies%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D2013%26volume%3D84%26spage%3D208%26epage%3D212%26doi%3D10.1136%2Fjnnp-2012-302312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit39d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lim, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luheshi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivest, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span> </span><span class="NLM_article-title">Blood-nerve barrier dysfunction contributes to the generation of neuropathic pain and allows targeting of injured nerves for pain relief</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">954</span><span class="NLM_x">–</span> <span class="NLM_lpage">967</span><span class="refDoi"> DOI: 10.1016/j.pain.2014.01.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.pain.2014.01.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2014&pages=954-967&author=T.+K.+Limauthor=X.+Q.+Shiauthor=H.+C.+Martinauthor=H.+Huangauthor=G.+Luheshiauthor=S.+Rivestauthor=J.+Zhang&title=Blood-nerve+barrier+dysfunction+contributes+to+the+generation+of+neuropathic+pain+and+allows+targeting+of+injured+nerves+for+pain+relief&doi=10.1016%2Fj.pain.2014.01.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39d&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2014.01.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2014.01.026%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DT.%2BK.%26aulast%3DShi%26aufirst%3DX.%2BQ.%26aulast%3DMartin%26aufirst%3DH.%2BC.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLuheshi%26aufirst%3DG.%26aulast%3DRivest%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DBlood-nerve%2520barrier%2520dysfunction%2520contributes%2520to%2520the%2520generation%2520of%2520neuropathic%2520pain%2520and%2520allows%2520targeting%2520of%2520injured%2520nerves%2520for%2520pain%2520relief%26jtitle%3DPain%26date%3D2014%26volume%3D155%26spage%3D954%26epage%3D967%26doi%3D10.1016%2Fj.pain.2014.01.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit39e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Ubogu, E. E.</span><span> </span><span class="NLM_article-title">Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span><span class="refDoi"> DOI: 10.1007/s00401-015-1466-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1007%2Fs00401-015-1466-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=26264608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlOhtLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2015&pages=445-468&author=E.+E.+Ubogu&title=Inflammatory+neuropathies%3A+pathology%2C+molecular+markers+and+targets+for+specific+therapeutic+intervention&doi=10.1007%2Fs00401-015-1466-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39eR"><div class="casContent"><span class="casTitleNuber">39e</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention</span></div><div class="casAuthors">Ubogu, Eroboghene E.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">445-468</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Inflammatory neuropathies encompass groups of heterogeneous disorders characterized by pathogenic immune-mediated hematogenous leukocyte infiltration of peripheral nerves, nerve roots or both, with resultant demyelination or axonal degeneration or both.  Inflammatory neuropathies may be divided into three major disease categories: Guillain-Barre´ syndrome (particularly the acute inflammatory demyelinating polyradiculoneuropathy variant), chronic inflammatory demyelinating polyradiculoneuropathy and nonsystemic vasculitic neuropathy (or peripheral nerve vasculitis).  Despite major advances in mol. biol., pathol. and genetics, the pathogenesis of these disorders remains elusive.  There is insufficient knowledge on the mechanisms of hematogenous leukocyte trafficking into the peripheral nervous system to guide the development of specific mol. therapies for immune-mediated inflammatory neuropathies compared to disorders such as psoriasis, inflammatory bowel disease, rheumatoid arthritis or multiple sclerosis.  The recent isolation and characterization of human endoneurial endothelial cells that form the blood-nerve barrier provides an opportunity to elucidate leukocyte-endothelial cell interactions crit. to the pathogenesis of inflammatory neuropathies at the interface between the systemic circulation and peripheral nerve endoneurium.  This review discusses our current knowledge of the classic pathol. features of inflammatory neuropathies, attempts at mol. classification and genetic determinants, the utilization of in vitro and in vivo animal models to det. pathogenic mechanisms at the interface between the systemic circulation and the peripheral nervous system relevant to these disorders and prospects for future potential mol. pathol. biomarkers and targets for specific therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYWh9hfa_K3rVg90H21EOLACvtfcHk0lj21DMbThsiNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlOhtLnI&md5=a134eb4f38e1bc8b72c1a8b5f76c77d3</span></div><a href="/servlet/linkout?suffix=cit39e&amp;dbid=16384&amp;doi=10.1007%2Fs00401-015-1466-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-015-1466-4%26sid%3Dliteratum%253Aachs%26aulast%3DUbogu%26aufirst%3DE.%2BE.%26atitle%3DInflammatory%2520neuropathies%253A%2520pathology%252C%2520molecular%2520markers%2520and%2520targets%2520for%2520specific%2520therapeutic%2520intervention%26jtitle%3DActa%2520Neuropathol.%26date%3D2015%26volume%3D130%26spage%3D445%26epage%3D468%26doi%3D10.1007%2Fs00401-015-1466-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Martin, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basbaum, A. I.</span><span> </span><span class="NLM_article-title">Spinal cannabinoids are anti-allodynic in rats with persistent inflammation</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span><span class="refDoi"> DOI: 10.1016/S0304-3959(99)00045-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2FS0304-3959%2899%2900045-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1999&pages=199-205&author=W.+J.+Martinauthor=C.+M.+Looauthor=A.+I.+Basbaum&title=Spinal+cannabinoids+are+anti-allodynic+in+rats+with+persistent+inflammation&doi=10.1016%2FS0304-3959%2899%2900045-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2FS0304-3959%2899%2900045-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3959%252899%252900045-7%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DW.%2BJ.%26aulast%3DLoo%26aufirst%3DC.%2BM.%26aulast%3DBasbaum%26aufirst%3DA.%2BI.%26atitle%3DSpinal%2520cannabinoids%2520are%2520anti-allodynic%2520in%2520rats%2520with%2520persistent%2520inflammation%26jtitle%3DPain%26date%3D1999%26volume%3D82%26spage%3D199%26epage%3D205%26doi%3D10.1016%2FS0304-3959%2899%2900045-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Potenzieri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harding-Rose, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simone, D. A.</span><span> </span><span class="NLM_article-title">The cannabinoid receptor agonist, WIN 55, 212–2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1215</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span><span class="refDoi"> DOI: 10.1016/j.brainres.2008.03.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.brainres.2008.03.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=18486111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvVOjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1215&publication_year=2008&pages=69-75&author=C.+Potenzieriauthor=C.+Harding-Roseauthor=D.+A.+Simone&title=The+cannabinoid+receptor+agonist%2C+WIN+55%2C+212%E2%80%932%2C+attenuates+tumor-evoked+hyperalgesia+through+peripheral+mechanisms&doi=10.1016%2Fj.brainres.2008.03.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The cannabinoid receptor agonist, WIN 55,212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms</span></div><div class="casAuthors">Potenzieri, Carl; Harding-Rose, Catherine; Simone, Donald A.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1215</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">69-75</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Several lines of evidence suggest that cannabinoids can attenuate various types of pain and hyperalgesia through peripheral mechanisms.  The development of rodent cancer pain models has provided the opportunity to investigate novel approaches to treat this common form of pain.  In the present study, we examd. the ability of peripherally administered cannabinoids to attenuate tumor-evoked mech. hyperalgesia in a murine model of cancer pain.  Unilateral injection of osteolytic fibrosarcoma cells into and around the calcaneus bone resulted in tumor formation and mech. hyperalgesia in the injected hindpaw.  Mech. hyperalgesia was defined as an increase in the frequency of paw withdrawals to a suprathreshold von Frey filament (3.4 mN) applied to the plantar surface of the hindpaw.  WIN 55,212-2 (1.5 to 10 μg) injected s.c. into the tumor-bearing hindpaw produced a dose-dependent decrease in paw withdrawal frequencies to suprathreshold von Frey filament stimulation.  Injection of WIN 55,212-2 (10 μg) into the contralateral hindpaw did not decrease paw withdrawal frequencies in the tumor-bearing hindpaw.  Injection of the highest antihyperalgesic dose of WIN 55,212-2 (10 μg) did not produce catalepsy as detd. by the bar test.  Co-administration of WIN 55,212-2 with either cannabinoid 1 (AM251) or cannabinoid 2 (AM630) receptor antagonists attenuated the antihyperalgesic effects of WIN 55, 212-2.  In conclusion, peripherally administered WIN 55,212-2 attenuated tumor-evoked mech. hyperalgesia by activation of both peripheral cannabinoid 1 and cannabinoid 2 receptors.  These results suggest that peripherally-administered cannabinoids may be effective in attenuating cancer pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp87ppQUQVu1bVg90H21EOLACvtfcHk0lj21DMbThsiNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvVOjsLY%253D&md5=d145fd4fdab6e2cf996904e8bbdbec1f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2008.03.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2008.03.063%26sid%3Dliteratum%253Aachs%26aulast%3DPotenzieri%26aufirst%3DC.%26aulast%3DHarding-Rose%26aufirst%3DC.%26aulast%3DSimone%26aufirst%3DD.%2BA.%26atitle%3DThe%2520cannabinoid%2520receptor%2520agonist%252C%2520WIN%252055%252C%2520212%25E2%2580%25932%252C%2520attenuates%2520tumor-evoked%2520hyperalgesia%2520through%2520peripheral%2520mechanisms%26jtitle%3DBrain%2520Res.%26date%3D2008%26volume%3D1215%26spage%3D69%26epage%3D75%26doi%3D10.1016%2Fj.brainres.2008.03.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Melvin, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbert, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milne, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, A.</span><span> </span><span class="NLM_article-title">A cannabinoid derived prototypical analgesic</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span><span class="refDoi"> DOI: 10.1021/jm00367a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00367a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADyaL2cXit1eksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1984&pages=67-71&author=L.+S.+Melvinauthor=M.+R.+Johnsonauthor=C.+A.+Harbertauthor=G.+M.+Milneauthor=A.+Weissman&title=A+cannabinoid+derived+prototypical+analgesic&doi=10.1021%2Fjm00367a013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">A cannabinoid derived prototypical analgesic</span></div><div class="casAuthors">Melvin, Lawrence S.; Johnson, M. Ross; Harbert, Charles A.; Milne, George M.; Weissman, Albert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-71</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The synthesis and analgesic testing of 3-[4-(1,1-dimethylheptyl)-2-hydroxyphenyl]cyclohexanol (I) are described.  I was prepd. in 9 steps from [3-(benzyloxy)phenyl]acetonitrile.  Biol. testing in five models of pain shows that I and morphine are equally potent as analgesics and demonstrates that the pyran ring of 9-nor-9β-hydroxyhexahydrocannabinol is not necessary for biol. activity.  Further simplification of I was pursued by the synthesis of 4-[4-(1,1-dimethylheptyl)-2-hydroxyphenyl]-2-pentanol, but this deriv. exhibits significantly reduced analgesic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlhm9E7nbBmbVg90H21EOLACvtfcHk0lguVIqpFih0Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXit1eksw%253D%253D&md5=354ca5cc32ee5f395b0ab415aacd2907</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm00367a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00367a013%26sid%3Dliteratum%253Aachs%26aulast%3DMelvin%26aufirst%3DL.%2BS.%26aulast%3DJohnson%26aufirst%3DM.%2BR.%26aulast%3DHarbert%26aufirst%3DC.%2BA.%26aulast%3DMilne%26aufirst%3DG.%2BM.%26aulast%3DWeissman%26aufirst%3DA.%26atitle%3DA%2520cannabinoid%2520derived%2520prototypical%2520analgesic%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1984%26volume%3D27%26spage%3D67%26epage%3D71%26doi%3D10.1021%2Fjm00367a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Fulp, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortoff, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seltzman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maitra, R.</span><span> </span><span class="NLM_article-title">Towards rational design of cannabinoid receptor 1 (CB1) antagonists for peripheral selectivity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5711</span><span class="NLM_x">–</span> <span class="NLM_lpage">5714</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.08.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.bmcl.2011.08.032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5711-5714&author=A.+Fulpauthor=K.+Bortoffauthor=Y.+Zhangauthor=H.+Seltzmanauthor=R.+Snyderauthor=R.+Maitra&title=Towards+rational+design+of+cannabinoid+receptor+1+%28CB1%29+antagonists+for+peripheral+selectivity&doi=10.1016%2Fj.bmcl.2011.08.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.08.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.08.032%26sid%3Dliteratum%253Aachs%26aulast%3DFulp%26aufirst%3DA.%26aulast%3DBortoff%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSeltzman%26aufirst%3DH.%26aulast%3DSnyder%26aufirst%3DR.%26aulast%3DMaitra%26aufirst%3DR.%26atitle%3DTowards%2520rational%2520design%2520of%2520cannabinoid%2520receptor%25201%2520%2528CB1%2529%2520antagonists%2520for%2520peripheral%2520selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D5711%26epage%3D5714%26doi%3D10.1016%2Fj.bmcl.2011.08.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Matsuka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitrirattanakul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omoto, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, N. Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spigelman, I.</span><span> </span><span class="NLM_article-title">Altered ATP release and metabolism in dorsal root ganglia of neuropathic rats</span> <span class="citation_source-journal">Mol. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="refDoi"> DOI: 10.1186/1744-8069-4-66</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1186%2F1744-8069-4-66" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=19108746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FpslGqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=66&author=Y.+Matsukaauthor=T.+Onoauthor=H.+Iwaseauthor=S.+Mitrirattanakulauthor=K.+S.+Omotoauthor=T.+Choauthor=N.+Y.+Y.+Lamauthor=B.+Snyderauthor=I.+Spigelman&title=Altered+ATP+release+and+metabolism+in+dorsal+root+ganglia+of+neuropathic+rats&doi=10.1186%2F1744-8069-4-66"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Altered ATP release and metabolism in dorsal root ganglia of neuropathic rats</span></div><div class="casAuthors">Matsuka Yoshizo; Ono Takeshi; Iwase Hirotate; Mitrirattanakul Somsak; Omoto Kevin S; Cho Ting; Lam Yan Yan N; Snyder Bradley; Spigelman Igor</div><div class="citationInfo"><span class="NLM_cas:title">Molecular pain</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Adenosine 5'-triphosphate (ATP) has a ubiquitous role in metabolism and a major role in pain responses after tissue injury.  We investigated the changes in basal and KCl-evoked ATP release from rat dorsal root ganglia (DRG) after peripheral neuropathy induction by unilateral sciatic nerve entrapment (SNE).  RESULTS:  After SNE, rats develop long-lasting decreases in ipsilateral hindpaw withdrawal thresholds to mechanical and thermal stimulation.  At 15-21 days after neuropathy induction, excised ipsilateral L4-L5 DRG display significantly elevated basal extracellular ATP levels compared to contralateral or control (naive) DRG.  However, KCl-evoked ATP release is no longer observed in ipsilateral DRG.  We hypothesized that the differential SNE effects on basal and evoked ATP release could result from the conversion of extracellular ATP to adenosine with subsequent activation of adenosine A1 receptors (A1Rs) on DRG neurons.  Adding the selective A1R agonist, 2-chloro-N(6)-cyclopentyladenosine (100 nM) significantly decreased basal and evoked ATP release in DRG from naive rats, indicating functional A1R activation.  In DRG ipsilateral to SNE, adding a selective A1R antagonist, 8-cyclopentyl-1,3-dipropylxanthine (30 nM), further increased basal ATP levels and relieved the blockade of KCl-evoked ATP release suggesting that increased A1R activation attenuates evoked ATP release in neurons ipsilateral to SNE.  To determine if altered ATP release was a consequence of altered DRG metabolism we compared O(2) consumption between control and neuropathic DRG.  DRG ipsilateral to SNE consumed O(2) at a higher rate than control or contralateral DRG.  CONCLUSION:  These data suggest that peripheral nerve entrapment increases DRG metabolism and ATP release, which in turn is modulated by increased A1R activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSOFh2J7Fa4m7JzI8owOhpDfW6udTcc2ea5oExboVHmbbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FpslGqsQ%253D%253D&md5=a55454ca8db9d0c82b1b388c5f21816c</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1186%2F1744-8069-4-66&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-8069-4-66%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuka%26aufirst%3DY.%26aulast%3DOno%26aufirst%3DT.%26aulast%3DIwase%26aufirst%3DH.%26aulast%3DMitrirattanakul%26aufirst%3DS.%26aulast%3DOmoto%26aufirst%3DK.%2BS.%26aulast%3DCho%26aufirst%3DT.%26aulast%3DLam%26aufirst%3DN.%2BY.%2BY.%26aulast%3DSnyder%26aufirst%3DB.%26aulast%3DSpigelman%26aufirst%3DI.%26atitle%3DAltered%2520ATP%2520release%2520and%2520metabolism%2520in%2520dorsal%2520root%2520ganglia%2520of%2520neuropathic%2520rats%26jtitle%3DMol.%2520Pain%26date%3D2008%26volume%3D4%26spage%3D66%26doi%3D10.1186%2F1744-8069-4-66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dunham, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miya, T. S.</span><span> </span><span class="NLM_article-title">A note on a simple apparatus for detecting neurological deficit in rats and mice</span> <span class="citation_source-journal">J. Am. Pharm. Assoc., Sci. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span><span class="refDoi"> DOI: 10.1002/jps.3030460322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1002%2Fjps.3030460322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADyaG1c%252FksV2htw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1957&pages=208-209&author=N.+W.+Dunhamauthor=T.+S.+Miya&title=A+note+on+a+simple+apparatus+for+detecting+neurological+deficit+in+rats+and+mice&doi=10.1002%2Fjps.3030460322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45aR"><div class="casContent"><span class="casTitleNuber">45a</span><div class="casTitle"><span class="NLM_cas:atitle">A note on a simple apparatus for detecting neurological deficit in rats and mice</span></div><div class="casAuthors">DUNHAM N W; MIYA T S</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Pharmaceutical Association. American Pharmaceutical Association</span>
        (<span class="NLM_cas:date">1957</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">208-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-u0xB6bg24z0SWnHPWbmmfW6udTcc2ea5oExboVHmbbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG1c%252FksV2htw%253D%253D&md5=06ea7b35b8b0ac2361f7696ab43adb75</span></div><a href="/servlet/linkout?suffix=cit45a&amp;dbid=16384&amp;doi=10.1002%2Fjps.3030460322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.3030460322%26sid%3Dliteratum%253Aachs%26aulast%3DDunham%26aufirst%3DN.%2BW.%26aulast%3DMiya%26aufirst%3DT.%2BS.%26atitle%3DA%2520note%2520on%2520a%2520simple%2520apparatus%2520for%2520detecting%2520neurological%2520deficit%2520in%2520rats%2520and%2520mice%26jtitle%3DJ.%2520Am.%2520Pharm.%2520Assoc.%252C%2520Sci.%2520Ed.%26date%3D1957%26volume%3D46%26spage%3D208%26epage%3D209%26doi%3D10.1002%2Fjps.3030460322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit45b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pryor, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenzie, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braude, M. C.</span><span> </span><span class="NLM_article-title">Interactions between Δ9-tetrahydrocannabinol and phencyclidine hydrochloride in rats</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span><span class="refDoi"> DOI: 10.1016/0091-3057(77)90168-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2F0091-3057%2877%2990168-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1977&pages=123-136&author=G.+T.+Pryorauthor=S.+Husainauthor=F.+Larsenauthor=C.+E.+McKenzieauthor=J.+D.+Carrauthor=M.+C.+Braude&title=Interactions+between+%CE%949-tetrahydrocannabinol+and+phencyclidine+hydrochloride+in+rats&doi=10.1016%2F0091-3057%2877%2990168-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45b&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2877%2990168-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252877%252990168-X%26sid%3Dliteratum%253Aachs%26aulast%3DPryor%26aufirst%3DG.%2BT.%26aulast%3DHusain%26aufirst%3DS.%26aulast%3DLarsen%26aufirst%3DF.%26aulast%3DMcKenzie%26aufirst%3DC.%2BE.%26aulast%3DCarr%26aufirst%3DJ.%2BD.%26aulast%3DBraude%26aufirst%3DM.%2BC.%26atitle%3DInteractions%2520between%2520%25CE%25949-tetrahydrocannabinol%2520and%2520phencyclidine%2520hydrochloride%2520in%2520rats%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1977%26volume%3D6%26spage%3D123%26epage%3D136%26doi%3D10.1016%2F0091-3057%2877%2990168-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Pertwee, R. G.</span><span> </span><span class="NLM_article-title">The ring test: a quantitative method for assessing the ’cataleptic’ effect of cannabis in mice</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.1972.tb06900.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1111%2Fj.1476-5381.1972.tb06900.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=4655271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADyaE3sXms1Oltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1972&pages=753-763&author=R.+G.+Pertwee&title=The+ring+test%3A+a+quantitative+method+for+assessing+the+%E2%80%99cataleptic%E2%80%99+effect+of+cannabis+in+mice&doi=10.1111%2Fj.1476-5381.1972.tb06900.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Ring test.  Quantitative method for assessing the cataleptic effect of cannabis in mice</span></div><div class="casAuthors">Pertwee, R. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">753-63</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">The length of time a mouse remained completely immobile when placed in a prone position across a horizontally suspended wire ring 5.5 cm in diam. could be used to assess the cataleptic effect of cannabis.  The effect of cannabis on motility was a dose-related, graded response.  Threshold doses of cannabis ext. were 12.5 mg per kg when injected i.v. and 100 mg per kg when injected i.p. or s.c.  Characteristic changes in behavior on the ring induced by cannabis ext. were also produced by chlorpromazine-HCl, but not by Na barbitone.  Δ1-Tetrahydrocannabinol (THC) [1972-08-3] was largely responsible for the effect of cannabis ext. on motility; the potency ratio of THC to cannabis ext. was between 10 and 20.  Δ1-Tetrahydrocannabidivarol [31262-37-0] also affected mobility but was less active than THC.  Cannabidiol [13956-29-1] had no effect, even at doses up to 100 mg per kg, i.p.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2Lm_ZL8Wp5rVg90H21EOLACvtfcHk0lgM7Gp1quC6Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXms1Oltg%253D%253D&md5=e3ed3a63360b54de7f394e1afb399328</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1972.tb06900.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1972.tb06900.x%26sid%3Dliteratum%253Aachs%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26atitle%3DThe%2520ring%2520test%253A%2520a%2520quantitative%2520method%2520for%2520assessing%2520the%2520%25E2%2580%2599cataleptic%25E2%2580%2599%2520effect%2520of%2520cannabis%2520in%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1972%26volume%3D46%26spage%3D753%26epage%3D763%26doi%3D10.1111%2Fj.1476-5381.1972.tb06900.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Pegg, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroink, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kattner, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. X.</span><span> </span><span class="NLM_article-title">Technique for collection of cerebrospinal fluid from the cisterna magna in rat</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">187</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1016/j.jneumeth.2009.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=10.1016%2Fj.jneumeth.2009.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=20005255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A280%3ADC%252BC3c7jtVekuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2010&pages=8-12&author=C.+C.+Peggauthor=C.+Heauthor=A.+R.+Stroinkauthor=K.+A.+Kattnerauthor=C.+X.+Wang&title=Technique+for+collection+of+cerebrospinal+fluid+from+the+cisterna+magna+in+rat&doi=10.1016%2Fj.jneumeth.2009.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Technique for collection of cerebrospinal fluid from the cisterna magna in rat</span></div><div class="casAuthors">Pegg Christina C; He Chunyan; Stroink Ann R; Kattner Keith A; Wang Chen Xu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroscience methods</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cerebrospinal fluid (CSF) is in direct contact with the extracellular space in the central nervous system (CNS), and biological changes in the brain can be reflected in CSF.  In the present article, a procedure for collection of CSF in rats is described.  The technique quickly and reliably yields large quantities of CSF (50-150 microl) in rats.  More importantly, blood contamination of the CSF is avoided.  Furthermore, detections of ATP and interleukin (IL)-1 beta in the CSF have been carried out.  ATP concentration in the CSF samples was between 8.3 and 15.8 nM, with an average of 10.5+/-0.83 nM (mean+/-SEM).  The concentrations of IL-1beta were below the detection limit in the CSF in the laminectomy control rats, but it increased to 0.26+/-0.07 ng/ml at 1h after spinal cord injury.  This technique offers an alternative method to surgical cannulation for the collection of CSF in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSoyBovJP6UDWLFM_lbR1VmfW6udTcc2eZ4Z881tk4cwrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7jtVekuw%253D%253D&md5=359298768c5e282ae8ec2acb7d6eb1d2</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.jneumeth.2009.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneumeth.2009.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DPegg%26aufirst%3DC.%2BC.%26aulast%3DHe%26aufirst%3DC.%26aulast%3DStroink%26aufirst%3DA.%2BR.%26aulast%3DKattner%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DC.%2BX.%26atitle%3DTechnique%2520for%2520collection%2520of%2520cerebrospinal%2520fluid%2520from%2520the%2520cisterna%2520magna%2520in%2520rat%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D2010%26volume%3D187%26spage%3D8%26epage%3D12%26doi%3D10.1016%2Fj.jneumeth.2009.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Hassler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmour, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fennell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinscheid, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Runyon, S. P.</span><span> </span><span class="NLM_article-title">Identification of neuropeptide S antagonists: structure-activity relationship studies, X-ray crystallography, and in vivo evaluation</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">731</span><span class="NLM_x">–</span> <span class="NLM_lpage">744</span><span class="refDoi"> DOI: 10.1021/cn500113c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn500113c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVentbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=731-744&author=C.+Hasslerauthor=Y.+Zhangauthor=B.+Gilmourauthor=T.+Grafauthor=T.+Fennellauthor=R.+Snyderauthor=J.+R.+Deschampsauthor=R.+K.+Reinscheidauthor=C.+Garauauthor=S.+P.+Runyon&title=Identification+of+neuropeptide+S+antagonists%3A+structure-activity+relationship+studies%2C+X-ray+crystallography%2C+and+in+vivo+evaluation&doi=10.1021%2Fcn500113c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Neuropeptide S Antagonists: Structure-Activity Relationship Studies, X-ray Crystallography, and in Vivo Evaluation</span></div><div class="casAuthors">Hassler, Carla; Zhang, Yanan; Gilmour, Brian; Graf, Tyler; Fennell, Timothy; Snyder, Rodney; Deschamps, Jeffrey R.; Reinscheid, Rainer K.; Garau, Celia; Runyon, Scott P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">731-744</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Modulation of the neuropeptide S (NPS) system has been linked to a variety of CNS disorders such as panic disorder, anxiety, sleeping disorders, asthma, obesity, PTSD, and substance abuse.  In this study, a series of diphenyltetrahydro-1H-oxazolo[3,4-α]pyrazin-3(5H)-ones were synthesized and evaluated for antagonist activity at the neuropeptide S receptor.  The abs. configuration was detd. by chiral resoln. of the key synthetic intermediate, followed by anal. of one of the individual enantiomers by X-ray crystallog.  The R isomer was then converted to a biol. active compd. (34) that had a Ke of 36 nM.  The most potent compd. displayed enhanced aq. soly. compared with the prototypical antagonist SHA-68 and demonstrated favorable pharmacokinetic properties for behavioral assessment.  In vivo anal. in mice indicated a significant blockade of NPS induced locomotor activity at an i.p. dose of 50 mg/kg.  This suggests that analogs having improved drug-like properties will facilitate more detailed studies of the neuropeptide S receptor system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxKsSXZnr3irVg90H21EOLACvtfcHk0lgM7Gp1quC6Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVentbvM&md5=87610e340854924b7896019173d441fe</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fcn500113c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn500113c%26sid%3Dliteratum%253Aachs%26aulast%3DHassler%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGilmour%26aufirst%3DB.%26aulast%3DGraf%26aufirst%3DT.%26aulast%3DFennell%26aufirst%3DT.%26aulast%3DSnyder%26aufirst%3DR.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DReinscheid%26aufirst%3DR.%2BK.%26aulast%3DGarau%26aufirst%3DC.%26aulast%3DRunyon%26aufirst%3DS.%2BP.%26atitle%3DIdentification%2520of%2520neuropeptide%2520S%2520antagonists%253A%2520structure-activity%2520relationship%2520studies%252C%2520X-ray%2520crystallography%252C%2520and%2520in%2520vivo%2520evaluation%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D731%26epage%3D744%26doi%3D10.1021%2Fcn500113c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-NOTES-d7e6794-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i88"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00516">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_61431"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00516">10.1021/acs.jmedchem.6b00516</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00516/suppl_file/jm6b00516_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00516/suppl_file/jm6b00516_si_001.csv">jm6b00516_si_001.csv (4.46 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00516&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00516%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-16%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00516" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a4dbbedc63c46","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
